2003, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, 2003

Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann. N. Y. Acad. Sci. 998: 424-431 (2003). *
Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454 (2003). *
Abdel-Ghaffar YT, Amin E, Abdel-Rasheed M, Fouad HH. Essential fatty acid status in infants and children with chronic liver disease. East. Mediterr. Health J. 9: 61-69 (2003).
Abdo A, Klassen J, Urbanski S, Raber E, Swain MG. Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient. J. Hepatol. 38: 688-691 (2003). *
Abdo AA, Beck P. Diagnosis and management of microscopic colitis. Can. Fam. Physician 49: 1473-1478 (2003).
Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern. Med. 42: 48-52 (2003). *
Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am. J. Pathol. 162: 1515-1520 (2003). *
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J. Infect. 46: 215-220 (2003).
Abei M, Tanaka N. Prevention of black pigment gallstone formation after cardiac surgery by ursodeoxycholic acid. J. Gastroenterol. 38: 1113-1115 (2003). *
Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 125: 320-327 (2003). *
Abid S. Helicobacter pylori: what test for diagnosis and what treatment for eradication? J. Pak. Med. Assoc. 53: 88-89 (2003).
Aboutwerat A, Pemberton PW, Smith A, Burrows PC, McMahon RF, Jain SK, Warnes TW. Oxidant stress is a significant feature of primary biliary cirrhosis. Biochim. Biophys. Acta 1637: 142-150 (2003). *
Abraham E. Computational design of variant TNF molecules: a novel methodology for inhibition of proinflammatory cascades. Sci. STKE 208: PE51 (2003). *
Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK. Diffuse lymphoplasmacytic chronic cholecystitis is highly specific for extrahepatic biliary tract disease but does not distinguish between primary and secondary sclerosing cholangiopathy. Am. J. Surg. Pathol. 27: 1313-1320 (2003).
Abraham SC, Cruz-Correa M, Argani P, Furth EE, Hruban RH, Boitnott JK. Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am. J. Surg. Pathol. 27: 441-451 (2003).
Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am. J. Surg. Pathol. 27: 110-120 (2003).
Abrantes EF, Pires EG, Carvalho AF, Costa FF, Savino W, Reis LF. Identification, structural characterization, and tissue distribution of Tsg-5: a new TNF-stimulated gene. Genes Immun. 4: 298-311 (2003). *
Abreu MT. Immunologic regulation of Toll-like receptors in gut epithelium. Curr. Opin. Gastroenterol. 19: 559-564 (2003).
Abu-Abed S, Dolle P, Metzger D, Wood C, MacLean G, Chambon P, Petkovich M. Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1. Development 130: 1449-1459 (2003). *
Abu-Mouch S, Selmi C, Benson GD, Kenny TP, Invernizzi P, Zuin M, Podda M, Rossaro L, Gershwin ME. Geographic clusters of primary biliary cirrhosis. Clin. Dev. Immunol. 10: 127-131 (2003). *
Ackerman HC, Ribas G, Jallow M, Mott R, Neville M, Sisay-Joof F, Pinder M, Campbell RD, Kwiatkowski DP. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun. 4: 476-486 (2003). *
Ackerman Z, Karmeli F, Cohen P, Rachmilewitz D. Experimental colitis in rats with portal hypertension and liver disease. Inflamm. Bowel Dis. 9: 18-24 (2003). *
Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3: 939-951 (2003).
Adam O. Dietary fatty acids and immune reactions in synovial tissue. Eur. J. Med. Res. 8: 381-387 (2003).
Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int. 23: 27-36 (2003). *
Adams DD, Knight JG. Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy. J. Clin. Lab. Immunol. 52: 1-22 (2003).
Adams DH, Afford SC, Lalor PF. Cellular immunoreactions in the development of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 27. October 15-16 (2003). *
Adani GL, Baccarani U, Risaliti A, Donini A, Aoki T, Avital I. Appendicectomy and Crohn's disease: clinical and genetic associations. Gastroenterology 125: 1562-1563 (2003). *
Adcock K, Hedberg C, Loggins J, Kruger TE, Baier RJ. The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun. 4: 420-426 (2003). *
Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788 (2003). *
Adler G, Reinshagen M; German Society for Digestive and Metabolic Diseases. Extraintestinal manifestations. Z. Gastroenterol. 41: 54-61 (2003).
Afolabi AO. Recurrent leg ulcers in a 16-year old Nigerian girl. Afr. J. Med. Med. Sci. 32: 93-94 (2003).
Aganna E, Hammond L, Hawkins PN, Aldea A, McKee SA, van Amstel HK, Mischung C, Kusuhara K, Saulsbury FT, Lachmann HJ, Bybee A, McDermott EM, La Regina M, Arostegui JI, Campistol JM, Worthington S, High KP, Molloy MG, Baker N, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum. 48: 2632-2644 (2003). *
Agarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR. Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis 8: 649-654 (2003). *
Aggarwal A, Ong JP, Goormastic M, Nelson DR, Arroliga AC, Farquhar L, Mayes J, Younossi ZM. Survival and resource utilization in liver transplant recipients: the impact of admission to the intensive care unit. Transplant. Proc. 35: 2998-3002 (2003). *
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3: 745-756 (2003). *
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914 (2003). *
Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Rezaei N, Nikzad M, Movahedi M, Gharagozlou M, Atarod L, Ahmadi Afshar A, Bazargan N, Abolmaali K, Mahmoudi M. Adverse effects of intravenous immunoglobulin therapy in patients with antibody deficiency. Iran. J. Allergy Asthma Immunol. 2: 121-126 (2003).
Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am. J. Gastroenterol. 98: 348-353 (2003). *
Agnholt J, Dahlerup JF, Buntzen S, Tottrup A, Nielsen SL, Lundorf E. Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Aliment. Pharmacol. Ther. 17: 703-710 (2003). *
Agnholt J, Dahlerup JF, Kaltoft K. The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures. Cytokine 23: 76-85 (2003). *
Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ. Osteopontin identified as colon cancer tumor progression marker. C.R. Biol. 326: 1041-1043 (2003).
Aguilar F, Nunez-Roldan A, Torres B, Wichmann I, Sanchez-Roman J, Gonzalez-Escribano MF. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus. J. Rheumatol. 30: 1770-1774 (2003).
Aguilar F, Torres B, Sanchez-Roman J, Nunez-Roldan A, Gonzalez-Escribano MF. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 64: 936-940 (2003).
Aguillon JC, Contreras J, Dotte A, Cruzat A, Catalan D, Salazar L, Molina MC, Guerrero J, Lopez M, Soto L, Salazar-Onfray F, Cuchacovich M. New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies. Rev. Med. Chil. 131: 1445-1453 (2003).
Ahmad A, Govil Y, Frank BB. Gastric mucosa-associated lymphoid tissue lymphoma. Am. J. Gastroenterol. 98: 975-986 (2003). *
Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 62: 527-535 (2003). *
Ahmad T, Marshall S, Jewell D. Genotype-based phenotyping heralds a new taxonomy for inflammatory bowel disease. Curr. Opin. Gastroenterol. 19: 327-335 (2003).
Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling KL, Barnardo M, Goldthorpe S, Walton R, Bunce M, Jewell DP, Welsh KI. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum. Mol. Genet. 12: 647-656 (2003). *
Ahmad T, Wallace GR, James T, Neville M, Bunce M, Mulcahy-Hawes K, Armuzzi A, Crawshaw J, Fortune F, Walton R, Stanford MR, Welsh KI, Marshall SE, Jewell DP. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 48: 807-813 (2003). *
Ahmadi KR, Lanchbury JS, Reed P, Chiano M, Thompson D, Galley M, Line A, Lank E, Wong HJ, Strachan D, Spector TD. Novel association suggests multiple independent QTLs within chromosome 5q21-33 region control variation in total humans IgE levels. Genes Immun. 4: 289-297 (2003). *
Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52: 1159-1164 (2003). *
Ahmed SS, Tan FK. Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations. Curr. Opin. Rheumatol. 15: 766-771 (2003).
Aho AD, McNulty AM, Coussens PM. Enhanced expression of interleukin-1alpha and tumor necrosis factor receptor-associated protein 1 in ileal tissues of cattle infected with Mycobacterium avium subsp. paratuberculosis. Infect. Immun. 71: 6479-6486 (2003). *
Ahuja AT, Richards PS, Wong KT, King AD, Yuen HY, Ching AS, To EW, To KF. Kuttner tumour (chronic sclerosing sialadenitis) of the submandibular gland: sonographic appearances. Ultrasound Med. Biol. 29: 913-919 (2003).
Ahuja HS, Szanto A, Nagy L, Davies PJ. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J. Biol. Regul. Homeost. Agents 17: 29-45 (2003).
Ahuja SS, Zhao S, Bellido T, Plotkin LI, Jimenez F, Bonewald LF. CD40 ligand blocks apoptosis induced by tumor necrosis factor alpha, glucocorticoids, and etoposide in osteoblasts and the osteocyte-like cell line murine long bone osteocyte-Y4. Endocrinology 144: 1761-1769 (2003). *
Ai T, Azemoto R, Saisho H. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. J. Gastroenterol. 38: 1071-1076 (2003). *
Aires V, Hichami A, Moutairou K, Khan NA. Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br. J. Pharmacol. 140: 1217-1226 (2003). *
Ajit C, Suvannasankha A, Zaeri N, Munoz SJ. Terbinafine-associated hepatotoxicity. Am. J. Med. Sci. 325: 292-295 (2003).
Akamizu T, Hiratani H, Ikegami S, Rich SS, Bowden DW. Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients. J. Hum. Genet. 48: 236-242 (2003). *
Akin K, Beyler AR, Kaya M, Erden E. The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis. Turk. J. Gastroenterol. 14: 228-233 (2003). *
Akira S. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15: 5-11 (2003).
Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85: 85-95 (2003).
Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in Toll-like receptor signaling. J. Infect. Dis. 187 Suppl. 2: S356-S363 (2003). *
Akkari V, Donadieu J, Piguet C, Bordigoni P, Michel G, Blanche S, Casanova JL, Thomas C, Vilmer E, Fischer A, Bertrand Y; French Langerhans Cell Study Group. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant. 31: 1097-1103 (2003). *
Akoume MY, Perwaiz S, Yousef IM, Plaa GL. Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats. Toxicol. Sci. 73: 378-385 (2003). *
Al-Jabri AA, Al Belushi MS, Nsanze H. Frequency and levels of autoantibodies in healthy adult Omanis. Ann. Saudi Med. 23: 372-375 (2003).
Alarcon-Riquelme ME. A RUNX trio with a taste for autoimmunity. Nat. Genet. 35: 299-300 (2003). *
Alba LM, Lindor K. Review article: non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 17: 977-986 (2003). *
Albanis E, Safadi R, Friedman SL. Treatment of hepatic fibrosis: almost there. Curr. Gastroenterol. Rep. 5: 48-56 (2003).
Albers R, Bol M, Bleumink R, Willems AA, Pieters RH. Effects of supplementation with vitamins A, C, and E, selenium, and zinc on immune function in a murine sensitization model. Nutrition 19: 940-946 (2003). *
Albrecht J. Glucose-derived osmolytes and energy impairment in brain edema accompanying liver failure: the role of glutamine reevaluated. Gastroenterology 125: 976-978 (2003). *
Albrecht M, Domingues FS, Schreiber S, Lengauer T. Structural localization of disease-associated sequence variations in the NACHT and LRR domains of PYPAF1 and NOD2. FEBS Lett. 554: 520-528 (2003). *
Albrecht M, Domingues FS, Schreiber S, Lengauer T. Identification of mammalian orthologs associates PYPAF5 with distinct functional roles. FEBS Lett. 538: 173-177 (2003). *
Albrecht M, Lengauer T, Schreiber S. Disease-associated variants in PYPAF1 and NOD2 result in similar alterations of conserved sequence. Bioinformatics 19: 2171-2175 (2003). *
Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3: 36-50 (2003). *
Aldemir M, Faruk Gey I K M, Faruk Kokoglu O, Buyukbayram HI, Hosoglu SI, Yagmur Y. Effects of ursodeoxycholic acid, glutamine and polyclonal immunoglobulins on bacterial translocation in common bile duct ligated rats. ANZ J. Surg. 73: 722-726 (2003). *
Aldhous MC, Nimmo ER, Satsangi J. NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease. Gut 52: 1533-1535 (2003). *
Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst. Rev. 1: CD003459 (2003). *
Alfke H, Alfke B, Froelich JJ, Klose KJ, Wagner HJ. Treatment of malignant biliary occlusion by means of transhepatic percutaneous biliary drainage with insertion of metal stents - results of an 8-year follow-up and analysis of the prognostic parameters. Rofo. 175: 1125-1129 (2003).
Alison MR. Characterization of the differentiation capacity of rat-derived hepatic stem cells. Semin. Liver Dis. 23: 325-336 (2003).
Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, Genin E, Vasilescu A, Bougerie H, Trojano M, Martins Silva B, Maciel P, Clerget-Darpoux F, Clanet M, Edan G, et al. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann. Neurol. 54: 119-122 (2003). *
Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16: 208-214 (2003). *
Allen A, Obaro S, Bojang K, Awomoyi AA, Greenwood BM, Whittle H, Sirugo G, Newport MJ. Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children. Pediatr. Infect. Dis. J. 22: 1018-1019 (2003).
Allen JD, Van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res. 63: 1339-1344 (2003). *
Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting CP, Bhattacharyya S, Tinsley J, Zhang Y, Holt R, Jones EY, Lench N, Carey A, Jones H, Dickens NJ, Dimon C, Nicholls R, Baker C, Xue L, Townsend E, Kabesch M, Weiland SK, Carr D et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35: 258-263 (2003). *
Allgayer H. Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18 Suppl. 2: 10-14 (2003). *
Allgayer H, Kruis W. PPAR-ligands: a clinically important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer? Z. Gastroenterol. 41: 1035-1038 (2003).
Alonso D, Elgart GW, Schachner LA. Blau syndrome: a new kindred. J. Am. Acad. Dermatol. 49: 299-302 (2003).
Alper CA, Xu J, Cosmopoulos K, Dolinski B, Stein R, Uko G, Larsen CE, Dubey DP, Densen P, Truedsson L, Sturfelt G, Sjoholm AG. Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency. J. Clin. Immunol. 23: 297-305 (2003).
Alpini G, Ueno Y, Tadlock L, Glaser SS, LeSage G, Francis H, Taffetani S, Marzioni M, Alvaro D, Patel T. Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation. Am. J. Physiol. Cell. Physiol. 285: C183-C194 (2003). *
Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst. Rev. 2: CD001939 (2003). *
Alsaeid K, Haider MZ, Ayoub EM. Angiotensin converting enzyme gene insertion-deletion polymorphism is associated with juvenile rheumatoid arthritis. J. Rheumatol. 30: 2705-2709 (2003).
Alsaeid KM, Haider MZ, al-Awadhi AM, Srivastva BS, Ayoub EM. Role of human leukocyte antigen DRB1*0307 and DRB1*0308 in susceptibility to juvenile rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 399-402 (2003).
Alstead EM, Nelson-Piercy C. Inflammatory bowel disease in pregnancy. Gut 52: 159-161 (2003). *
Alzoghaibi MA, Walsh SW, Willey A, Fowler Iii AA, Graham MF. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin. Nutr. 22: 529-535 (2003). *
Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J. Biol. Chem. 278: 7469-7475 (2003). *
Amante MF, Trigo P, Lendoire J, Imventarza O, Parisi C. Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers. Ann. Hepatol. 2: 171-174 (2003). *
Amarapurkar DN, Patel ND, Amarapurkar AD. Hepatic sarcoidosis. Indian J. Gastroenterol. 22: 98-100 (2003).
Amarapurkar DN, Patel ND, Amarapurkar AD, Kankonkar SR. HLA genotyping in type-I autoimmune hepatitis in Western India. J. Assoc. Physicians India 51: 967-969 (2003).
Amat di San Filippo C, Wang Y, Longo N. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency. J. Biol. Chem. 278: 47776-47784 (2003). *
Amati L, Caradonna L, Leandro G, Magrone T, Minenna M, Faleo G, Pellegrino NM, Jirillo E, Caccavo D. Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effects. Curr. Pharm. Design 9: 1937-1945 (2003).
Ambrosino G, Naso A, Feltracco P, Carraro P, Basso SM, Varotto S, Cillo U, Zanus. Cytokines and liver failure: modification of TNF- and IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System (MARS). Acta Biomed. Ateneo Parmense 74 Suppl. 2: 7-9 (2003). *
Amedei A, Bergman MP, Appelmelk BJ, Azzurri A, Benagiano M, Tamburini C, van der Zee R, Telford JL, Vandenbroucke-Grauls CM, D'Elios MM, Del Prete G. Molecular mimicry between Helicobacter pylori antigens and H+, K+ -adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 198: 1147-1156 (2003). *
American Gastroenterological Association. American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders. Gastroenterology 125: 937-940 (2003). *
American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 125: 1503-1507 (2003). *
Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pita O, Puddu P. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr. Drug Targets Inflamm. Allergy 2: 81-94 (2003).
Amre DK, Seidman EG. DNA variants in cytokine and NOD2 genes, exposures to infections and risk for Crohn's disease. Paediatr. Perinat. Epidemiol. 17: 302-312 (2003).
Amsaguine-Safir S, Bianchi A, Collet P, Huin-Schohn C, Jeanvoine A, Becuwe P, Kremarik-Bouillaud P, Domenjoud L, Keller JM, Schohn H, Dauca M. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues. Microsc. Res. Tech. 61: 185-190 (2003). *
Anagnostopoulos GK, Margantinis G, Tsiakos S, Kostopoulos P, Pantes A, Arvanitidis D. Myopericarditis associated with ulcerative colitis. N. Z. Med. J. 116: U667 (2003).
Anakk S, Kalsotra A, Shen Q, Vu MT, Staudinger JL, Davies PJ, Strobel HW. Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. FASEB J. 17: 1736-1738 (2003). *
Anand AC. Bioartificial liver support for fulminant hepatic failure. Indian J. Gastroenterol. 22 Suppl. 2: S69-S74 (2003).
Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig. Dis. Sci. 48: 830-833 (2003). *
Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr. HIV Res. 1: 185-203 (2003).
Anaya JM, Rivera D, Palacio LG, Arcos-Burgos M, Correa PA. D6S439 microsatellite identifies a new susceptibility region for primary Sjogren's syndrome. J. Rheumatol. 30: 2152-2156 (2003).
Anderson P, May B, Morris H. Vitamin D metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 24: 13-26 (2003). *
Anderson P, Sundstedt A, Li L, O'Neill EJ, Li S, Wraith DC, Wang P. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int. Immunol. 15: 1309-1317 (2003). *
Anderson WF, Umar A, Hawk ET. Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin. Pharmacother. 4: 2193-2204 (2003).
Andersson P, Olaison G, Hallbook O, Boeryd B, Sjodahl R. Increased anal resting pressure and rectal sensitivity in Crohn's disease. Dis. Colon Rectum 46: 1685-1689 (2003).
Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 124: 40-46 (2003). *
Andersson U, Tracey KJ. HMGB1 in sepsis. Scand. J. Infect. Dis. 35: 577-584 (2003).
Andoh A, Tsujikawa T, Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des. 9: 347-358 (2003).
Andoh A, Tsujikawa T, Ishizuka I, Araki Y, Sasaki M, Koyama S, Fujiyama Y. n-3 Fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int. J. Mol. Med. 12: 721-725 (2003). *
Andrault JB, Gaillard I, Giorgi D, Rouquier S. Expansion of the BPI family by duplication on human chromosome 20: characterization of the RY gene cluster in 20q11.21 encoding olfactory transporters/antimicrobial-like peptides. Genomics 82: 172-184 (2003). *
Andreeva-Gateva P. Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism. Ann. Biol. Clin. (Paris) 61: 295-303 (2003).
Andrews T, Sullivan KE. Infections in patients with inherited defects in phagocytic function. Clin. Microbiol. Rev. 16: 597-621 (2003). *
Andrieu T, Thibault V, Malet I, Laporte J, Bauvois B, Agut H, Cahour A. Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J. Clin. Virol. 27: 59-68 (2003).
Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A, Ewe K, Scholmerich J; German/Austrian Budesonide Study Group. Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial. Dig. Dis. Sci. 48: 373-378 (2003). *
Andus T, Klebl F, Rogler G, Bregenzer N, Scholmerich J, Straub RH. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment. Pharmacol. Ther. 17: 409-414 (2003). *
Andus T, Stange EF, Hoffler D, Keller-Stanislawski B. Suspected cases of severe side effects after infliximab (Remicade) in Germany. Med. Klin. (Munich) 98: 429-436 (2003).
Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663 (2003). *
Ang HT, Helfgott S. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis? J. Rheumatol. 30: 2315-2318 (2003).
Ang TL, Fock KM, Ng TM, Teo EK, Tan YL. Clinical utility, safety and tolerability of capsule endoscopy in urban Southeast Asian population. World J. Gastroenterol. 9: 2313-2316 (2003). *
Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52: 879-885 (2003). *
Angio LG, Pirrone G, Rivoli G, Fracassi MG, Rosato A, Piazzese E, Pacile V, Sfuncia G, Fiumara F. Pyoderma gangrenosum of the "sinus mammarum" in ulcerative colitis. G. Chir. 24: 247-254 (2003).
Angulo P. Non-alcoholic steatohepatitis. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 87-88. October 17 - 19 (2003). *
Angulo P. Current best treatment for non-alcoholic fatty liver disease. Expert Opin. Pharmacother. 4: 611-623 (2003).
Annacker O, Asseman C, Read S, Powrie F. Interleukin-10 in the regulation of T cell-induced colitis. J. Autoimmun. 20: 277-279 (2003).
Annese V, Latiano A, Andriulli A. Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning? Dig. Liver Dis. 35: 442-449 (2003).
Annese V, Latiano A, Palmieri O, Li HH, Forabosco P, Ferraris A, Andriulli A, Vecchi M, Ardizzone S, Cottone M, Dallapiccola B, Rappaport E, Fortina P, Devoto M. Linkage of ulcerative colitis to the pericentromeric region of chromosome 16 in Italian inflammatory bowel disease families is independent of the presence of common CARD15 mutations. J. Med. Genet. 40: 837-841 (2003). *
Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229: 409-414 (2003). *
Annibale B, Capurso G, Baccini F, Lahner E, D'Ambra G, Di Giulio E, Delle Fave G. Role of small bowel investigation in iron deficiency anaemia after negative endoscopic/histologic evaluation of the upper and lower gastrointestinal tract. Dig. Liver Dis. 35: 784-787 (2003).
Annilo T, Chen ZQ, Shulenin S, Dean M. Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. Mamm. Genome 14: 7-20 (2003). *
Ansell SM, Ackerman MJ, Black JL, Roberts LR, Tefferi A. Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice. Mayo Clin. Proc. 78: 307-317 (2003). *
Anzai C, Morokawa N, Okada H, Kamidono S, Eto Y, Yoshimura K. CFTR gene mutations in Japanese individuals with congenital bilateral absence of the vas deferens. J. Cyst. Fibros. 2: 14-18 (2003).
Appleby MW, Ramsdell F. A forward-genetic approach for analysis of the immune system. Nat. Rev. Immunol. 3: 463-471 (2003). *
Aqel B, Bishop M, Krishna M, Cangemi J. Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature. Dig. Dis. Sci. 48: 2323-2327 (2003). *
Aqui NA, Stein SH, Konkle BA, Abrams CS, Strobl FJ. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J. Clin. Apher. 18: 51-54 (2003).
Aquilina P, Savage NW, Lynham A. Crohn's disease with oral presenting signs masquerading as chronic osteomyelitis. Aust. Dent. J. 48: 134-137 (2003).
Araki A, Hazama S, Oka M, Hinoda Y. Polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 229-232 (2003).
Araki Y, Andoh A, Bamba H, Yoshikawa K, Doi H, Komai Y, Higuchi A, Fujiyama Y. The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Oncol. Rep. 10: 1931-1936 (2003).
Arch-Ferrer JE, Smith JK, Bynon S, Eckhoff DE, Sellers MT, Bland KI, Heslin MJ. Radio-frequency ablation in cirrhotic patients with hepatocellular carcinoma. Am. Surg. 69: 1067-1071 (2003).
Ardaillou R. Genetic polymorphisms linked to myocardial ischemia in a Japanese population. Med. Sci. (Paris) 19: 413-414 (2003).
Ardavín C. Origin, precursors and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 3: 582-590 (2003). *
Ardizzone S. Ulcerative colitis. Orphanet encyclopedia [http://www.orpha.net/data/patho/GB/uk-UC.pdf] (2003). *
Ardizzone S, Bollani S, Manzionna G, Colombo E, Maconi G, Imbesi V, Bianchi Porro G. Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease. Ann. Ital. Chir. 74: 621-625 (2003).
Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig. Liver Dis. 35: 619-627 (2003).
Arend SM, Breedveld FC, van Dissel JT. TNF-alpha blockade and tuberculosis: better look before you leap. Neth. J. Med. 61: 111-119 (2003). *
Arguelles Arias F, Arguelles Martin F, Caunedo Alvarez A, Rodriguez-Tellez M, Herrerias Gutierrez JM. Utility of capsule endoscopy in pediatric gastroenterology. An. Pediatr. (Barc.) 59: 586-589 (2003).
Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur. J. Cancer 39: 2341-2348 (2003). *
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J. Immunol. 171: 5673-5677 (2003). *
Armuzzi A, Ahmad T, Ling KL, De Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 52: 1133-1139 (2003). *
Arnott ID, McNeill G, Satsangi J. An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment. Pharmacol. Ther. 17: 1451-1457 (2003). *
Arnott ID, Satsangi J. Crohn's disease or Crohn's diseases? Gut 52: 460-461 (2003). *
Arnott ID, Watts D, Satsangi J. Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety. Pharmacol. Res. 47: 1-10 (2003). *
Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108: 144-151 (2003). *
Arrese M, Accatino L. Is intrahepatic cholestasis of pregnancy an MDR3-related disease? Gastroenterology 125: 1922-1923 (2003). *
Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol. Med. 9: 558-564 (2003). *
Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solis N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ. Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J. Hepatol. 38: 148-155 (2003). *
Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J. Hepatol. 38 Suppl. 1: S69-S89 (2003). *
Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict. Dig. Liver Dis. 35: 668-672 (2003).
Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tozun N, Hamzaoglu HO, Duman D, Ulker A, Parlak E, Palabiyikoglu M, Dokmeci A. Clinical outcome of Crohn's disease treated with infliximab. Hepatogastroenterology 50: 952-956 (2003).
Arthur LG, Kuenzler KA, Schwartz MZ. Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. J. Gastrointest. Surg. 7: 1062-1068 (2003).
Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum. 48: 2567-2572 (2003). *
Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 25: 61-78 (2003).
Ashrafian H. Hepcidin: the missing link between hemochromatosis and infections. Infect. Immun. 71: 6693-6700 (2003). *
Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23: 504-517 (2003). *
Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. J. Lab. Clin. Med. 142: 385-390 (2003). *
Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92: 1193-1200 (2003). *
Asnani S, Theuma P, Fonseca VA. PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease. Metab. Syndr. Relat. Disord. 1: 23-32 (2003).
Assaraf YG, Rothem L, Hooijberg JH, Stark M, Ifergan I, Kathmann I, Dijkmans BA, Peters GJ, Jansen G. Loss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cells. J. Biol. Chem. 278: 6680-6686 (2003). *
Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaelsson G, Evans J, Munro M, Veal C, Allen M, Leman J, David Burden A, Kirby B, Connolly M, Griffiths CE, Trembath RC, Kere J, Saarialho-Kere U, Barker JN. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J. Invest. Dermatol. 120: 627-632 (2003). *
Asumalahti K, Laitinen T, Lahermo P, Suomela S, Itkonen-Vatjus R, Jansen C, Karvonen J, Karvonen SL, Reunala T, Snellman E, Uurasmaa T, Saarialho-Kere U, Kere J. Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1. J. Invest. Dermatol. 121: 735-740 (2003). *
Atalay G, Cardoso F, Paesmans M, Goldberg RM, Bleiberg H. Second-line treatment in advanced colon cancer: are multiple phase II trials informative enough to guide clinical practice? Anticancer Drugs 14: 703-713 (2003).
Atarod L, Raissi A, Aghamohammadi A, Farhoudi A, Khodadad A, Moin M, Pourpak Z, Movahedi M, Charagozlou M, Rezaei N. A review of gastrointestinal disorders in patients with primary antibody immunodeficiencies during a 10-year period (1990-2000), in Children's Hospital Medical Center. Iran. J. Allergy Asthma Immunol. 2: 75-79 (2003).
Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 52: 181-185 (2003). *
Aucan C, Walley AJ, Hennig BJ, Fitness J, Frodsham A, Zhang L, Kwiatkowski D, Hill AV. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 4: 275-282 (2003). *
Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski CJ. Alternatively spliced isoforms of the human constitutive androstane receptor. Nucleic Acids Res. 31: 3194-3207 (2003). *
Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y. Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests. Clin. Exp. Med. 3: 119-123 (2003). *
Augoustides-Savvopoulou P, Luka Z, Karyda S, Stabler SP, Allen RH, Patsiaoura K, Wagner C, Mudd SH. Glycine N-methyltransferase deficiency: a new patient with a novel mutation. J. Inherit. Metab. Dis. 26: 745-759 (2003). *
Aune TM, Maas K, Moore JH, Olsen NJ. Gene expression profiles in human autoimmune disease. Curr. Pharm. Des. 9: 1905-1917 (2003).
Austin AS, Haas KM, Naugler SM, Bajer AA, Garcia-Tapia D, Estes DM. Identification and characterization of a novel regulatory factor: IgA-inducing protein. J. Immunol. 171: 1336-1342 (2003). *
Autran B, Debre P, Walker B, Katlama C. Therapeutic vaccines against HIV need international partnerships. Nat. Rev. Immunol. 3: 503-508 (2003).
Auvin S, Dalle JH, Ganga-Zandzou PS, Ythier H. Is agranulocytosis following infectious mononucleosis caused by autoimmunity? Pediatr. Hematol. Oncol. 20: 611-615 (2003).
Auwerx J, Cock TA, Knouff C. PPAR-gamma: a thrifty transcription factor. Nucl. Recept. Signal. 1: e006 (2003). *
Avenaud P, Le Bail B, Mayo K, Marais A, Fawaz R, Bioulac-Sage P, Megraud F. Natural history of Helicobacter hepaticus infection in conventional A/J mice, with special reference to liver involvement. Infect. Immun. 71: 3667-3672 (2003). *
Awada H, Abi-Karam G, Fayad F. Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract. Res. Clin. Rheumatol. 17: 971-987 (2003).
Awadallah S, Hamad M. A study of haptoglobin phenotypes in patients with chronic renal failure. Ann. Clin. Biochem. 40: 680-683 (2003).
Ayala de la Cruz Mdel C, Gonzalez Diaz R, Lopez Lara ND. Wegener's granulomatosis. Report of a pediatric case and review of the literature. Rev. Alerg. Mex. 50: 71-75 (2003).
Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J. Trop. Pediatr. 49: 367-370 (2003). *
Azzali G. Structure, lymphatic vascularization and lymphocyte migration in mucosa-associated lymphoid tissue. Immunol. Rev. 195: 178-189 (2003). *
Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 100: 3031-3034 (2003). *
Babron MC, Nilsson S, Adamovic S, Naluai AT, Wahlstrom J, Ascher H, Ciclitira PJ, Sollid LM, Partanen J, Greco L, Clerget-Darpoux F; European Genetics Cluster on Coeliac Disease. Meta and pooled analysis of European coeliac disease data. Eur. J. Hum. Genet. 11: 828-834 (2003). *
Baburajan B, Parkes M. The genetics of inflammatory bowel disease. Hosp. Med. 64: 599-602 (2003).
Baccarani U, Risaliti A, Sainz-Barriga M, Adani GL, Donini A, Toniutto P, Bresadola F. Ileosplenic fistula and splenic abscesses caused by migration of biliary stents in a liver transplant recipient. Gastrointest. Endosc. 58: 811-813 (2003).
Bach JF. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3: 189-198 (2003). *
Bach N, Bodian C, Bodenheimer H, Croen E, Berk PD, Thung SN, Lindor KD, Therneau T, Schaffner F. Methotrexate therapy for primary biliary cirrhosis. Am. J. Gastroenterol. 98: 187-193 (2003). *
Bach N, Odin JA. Primary biliary cirrhosis: a Mount Sinai perspective. Mt. Sinai J. Med. 70: 242-250 (2003). *
Bachmeyer C, Charoud A, Turc Y, Callot V, Blum L, Aractingi S. Isotretinoin-induced bilateral sacroiliitis. Dermatology 206: 285-286 (2003).
Badenhoop K, Seidl C. Fine-tuning of T lymphocytes in autoimmunity: genetic association of CTLA-4 variants and Graves' disease revisited. Clin. Endocrinol. (Oxf.) 59: 555-557 (2003). *
Bader TR, Beavers KL, Semelka RC. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226: 675-685 (2003). *
Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, Rutgeerts P. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N. Engl. J. Med. 348: 601-608 (2003). *
Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. U.S.A. 100: 1751-1756 (2003). *
Bahillo P, Cantero T, Solis P, Aragon P, Gomez S, Cambronero R. Hyper-IgM syndrome with CHARGE association. Pediatr. Allergy Immunol. 14: 487-489 (2003). *
Bahrami H, Daryani NE, Mirmomen S, Kamangar F, Haghpanah B, Djalili M. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol. 3: 27 (2003). *
Bai J, Odin JA. Apoptosis and the liver: relation to autoimmunity and related conditions. Autoimmun. Rev. 2: 36-42 (2003). *
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133: 3748S-3753S (2003). *
Baiocchi L, Alpini G, Glaser S, Angelico M, Alvaro D, Francis H, Marzioni M, Phinizy JL, Barbaro B, LeSage G. Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats. J. Hepatol. 38: 136-147 (2003).
Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, Leahy DT, Vaughan P, Keegan D, O'Morain C, O'Donoghue D, Shanahan F, Parfrey NA, Quane KA. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur. J. Hum. Genet. 11: 237-244 (2003). *
Baixauli J, Kiran RP, Delaney CP. Investigation and management of ischemic colitis. Cleve. Clin. J. Med. 70: 920-921, 925-926, 928-930 (2003). *
Bak D, Sobczynska-Tomaszewska A, Bal J. Hereditary aspects of pancreatitis. Med. Wieku. Rozwoj. 7: 57-66 (2003).
Bak-Romaniszyn L, Planeta-Malecka I, Czkwianianc E, Rozynek E, Dzierzanowska D, Laszewicz W. Drug sensitivity of Helicobacter pylori strains in children and young people from the region of Lodz. Med. Wieku. Rozwoj. VII: 129-135 (2003).
Baker DE. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy. Rev. Gastroenterol. Disord. 3: 150-157 (2003). *
Baker DE. Bioequivalence of azathioprine products. Rev. Gastroenterol. Disord. 3: 219-223 (2003). *
Bakland G, Nordvag BY, Nossent HC. Efficacy of anti-tumour necrosis factor alpha therapy with etanercept in chronic polyarthritis. Tidsskr. Nor. Laegeforen. 123: 2561-2564 (2003).
Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am. J. Gastroenterol. 98: 833-838 (2003). *
Balding J, Healy CM, Livingstone WJ, White B, Mynett-Johnson L, Cafferkey M, Smith OP. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun. 4: 533-540 (2003). *
Balding J, Kane D, Livingstone W, Mynett-Johnson L, Bresnihan B, Smith O, FitzGerald O. Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum. 48: 1408-1413 (2003). *
Balistreri WF. Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Ballot E, Bruneel A, Labas V, Johanet C. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin. Chem. 49: 634-643 (2003). *
Balotescu C, Israil A, Radu R, Alexandru I, Dobre G. Aspects of constitutive and acquired antibioresistance in Aeromonas hydrophila strains isolated from water sources. Roum. Arch. Microbiol. Immunol. 62: 179-189 (2003).
Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV Jr, Yawn BP, Dickson ER, Melton LJ 3rd. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 125: 1364-1369 (2003). *
Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 171: 4868-4874 (2003). *
Bamias G, Sugawara K, Pagnini C, Cominelli F. The Th1 immune pathway as a therapeutic target in Crohn's disease. Curr. Opin. Investig. Drugs 4: 1279-1286 (2003).
Ban M, Sawcer SJ, Heard RN, Bennetts BH, Adams S, Booth D, Perich V, Setakis E, Compston A, Stewart GJ. A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients. J. Neuroimmunol. 143: 60-64 (2003).
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4: 586-593 (2003). *
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124 (2003). *
Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379 (2003).
Banares Canizares R, Catalina Rodriguez MV. Indications and therapeutic possibilities of albumin dialysis (MARS). Rev. Esp. Enferm. Dig. 95: 876-889 (2003).
Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, Chapkin RS. Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic. Biol. Med. 35: 149-159 (2003).
Banerjee B. The light at the end of the tunnel. Inflamm. Bowel Dis. 9: 395 (2003). *
Bangert C, Friedl J, Stary G, Stingl G, Kopp T. Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease? J. Invest. Dermatol. 121: 1409-1418 (2003). *
Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199: 28-35 (2003). *
Banyer JL, Halliday DC, Thomson SA, Hamilton NH. Combinations of IFN-gamma and IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties. Genes Immun. 4: 427-440 (2003). *
Banz A, Peixoto A, Pontoux C, Cordier C, Rocha B, Papiernik M. A unique subpopulation of CD4+ regulatory T cells controls wasting disease, IL-10 secretion and T cell homeostasis. Eur. J. Immunol. 33: 2419-2428 (2003). *
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR. Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family. Ann. N. Y. Acad. Sci. 1005: 348-351 (2003). *
Bar-Oz B, Bulkowstein M, Benyamini L, Greenberg R, Soriano I, Zimmerman D, Bortnik O, Berkovitch M. Use of antibiotic and analgesic drugs during lactation. Drug Saf. 26: 925-935 (2003).
Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ. Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J. Nutr. 133: 2845-2848 (2003). *
Barbier M, Vidal H, Desreumaux P, Dubuquoy L, Bourreille A, Colombel JF, Cherbut C, Galmiche JP. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 27: 987-991 (2003). *
Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B. Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J. Biol. Chem. 278: 32852-32860 (2003). *
Barbier O, Torra IP, Sirvent A, Claudel T, Blanquart C, Duran-Sandoval D, Kuipers F, Kosykh V, Fruchart JC, Staels B. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124: 1926-1940 (2003). *
Barbier O, Villeneuve L, Bocher V, Fontaine C, Torra IP, Duhem C, Kosykh V, Fruchart JC, Guillemette C, Staels B. The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J. Biol. Chem. 278: 13975-13983 (2003). *
Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19: 837-842 (2003). *
Barbuscia M, Pratico C, Di Pietro N, Rizzo AG, Melita G, De Luca M, Castriciano G, Vita F, Sano M, Gorgone S. Diagnosis and treatment of Crohn's disease. G. Chir. 24: 428-434 (2003).
Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL; Multiple Sclerosis Genetics Group. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72: 710-716 (2003). *
Barcelo-Coblijn G, Kitajka K, Puskas LG, Hogyes E, Zvara A, Hackler L Jr, Farkas T. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim. Biophys. Acta 1632: 72-79 (2003). *
Bardaro T, Falco G, Sparago A, Mercadante V, Gean Molins E, Tarantino E, Ursini MV, D'Urso M. Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion. Hum. Mutat. 21: 8-11 (2003).
Barnes BJ, Field AE, Pitha-Rowe PM. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J. Biol. Chem. 278: 16630-16641 (2003). *
Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res. 63: 6424-6431 (2003). *
Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L et al. A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348: 891-899 (2003). *
Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A, Di Leo A, Ierardi E. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 37: 880-886 (2003). *
Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC 3rd. Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am. J. Gastroenterol. 98: 1410-1416 (2003). *
Barta Z, Csipo I, Szabo GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J. Gastroenterol. 9: 2308-2312 (2003). *
Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin. Immunol. 109: 330-337 (2003). *
Barthet M, Dubucquoy L, Garcia S, Gasmi M, Desreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC. Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol. Clin. Biol. 27: 895-900 (2003). *
Bartnik W. Inflammatory bowel disease - Polish contribution. J. Physiol. Pharmacol. 54 Suppl. 3: 205-210 (2003). *
Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J, Donn R. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun. 4: 487-491 (2003). *
Barton SG, Rampton DS, Winrow VR, Domizio P, Feakins RM. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Cell Stress Chaperones 8: 329-334 (2003). *
Bartram SA, Peaston RT, Rawlings DJ, Francis RM, Thompson NP. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment. Pharmacol. Ther. 18: 1121-1127 (2003). *
Bartunkova J, Tesar V, Sediva A. Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin. Immunol. 106: 73-82 (2003). *
Barutca S, Kadikoylu G, Meydan N, Bolaman Z, Gokcen A, Bal F. Two autoimmune diseases: Hashimoto's thyroiditis and vitiligo accompanying breast cancer; a coincidence? J. BUON 8: 177-179 (2003).
Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, Martinelli N, Puccetti A. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362: 1971-1977 (2003). *
Bassas A, Chehab M, Hebby H, Al Shahed M, Al Husseini H, Al Zahrani A, Wali S. Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. Transplant. Proc. 35: 3003-3005 (2003). *
Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37: 493-503 (2003). *
Bathon JM, Genovese MC. The Early Rheumatoid Arthritis (ERA) trial comparing the efficacy and safety of etanercept and methotrexate. Clin. Exp. Rheumatol. 21 (5 Suppl. 31): S195-S197 (2003).
Batra AK, Levey JM, Trister J, Patwardhan R. Pyoderma gangrenosum in a patient with collagenous colitis. J. Am. Acad. Dermatol. 49: 277-279 (2003).
Batra Y, Acharya SK. Acute liver failure: prognostic markers. Indian J. Gastroenterol. 22 Suppl. 2: S66-S68 (2003).
Battelino T, Ursic-Bratina N, Dolzan V, Stopar-Obreza M, Pozzilli P, Krzisnik C, Vidan-Jeras B. The HLA-DRB, -DQB polymorphism and anti-insulin antibody response in Slovenian patients with type 1 diabetes. Eur. J. Immunogenet. 30: 223-227 (2003). *
Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 17: 425-431 (2003).
Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch. Intern. Med. 163: 615-620 (2003). *
Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 361: 1111-1118 (2003). *
Baumann U, Schmidt RE, Gessner JE. New insights into the pathophysiology and in vivo function of IgG Fc receptors through gene deletion studies. Arch. Immunol. Ther. Exp. (Warsz.) 51: 399-406 (2003).
Baumert TF. Novel vaccine strategies. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 58-59. October 20 - 21 (2003). *
Baumgart DC, Dignass AU. Tacrolimus (FK506) in refractory ulcerative colitis: an alternative to proctocolectomy? Z. Gastroenterol. 41: 478-479 (2003).
Baumgart DC, Wiedenmann B, Dignass AU. Biologic therapy of inflammatory bowel disease. Z. Gastroenterol. 41: 1017-1032 (2003).
Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease. Br. J. Plast. Surg. 56: 328-333 (2003).
Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast. Reconstr. Surg. 111: 2133-2139 (2003).
Bayle FJ, Bouvard MP. Anorexia nervosa and Crohn's disease dual diagnosis: a case study. Eur. Psychiatry 18: 421-422 (2003).
Bayley JP, Baggen JM, van der Pouw-Kraan T, Crusius JB, Huizinga TW, Verweij CL. Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. Tissue Antigens 62: 170-174 (2003). *
Bayley JP, Bakker AM, Kaijzel EL, Huizinga TW, Verweij CL. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis. Rheumatology (Oxford) 42: 969-971 (2003). *
Beamer LJ. Structure of human BPI (bactericidal/permeability-increasing protein) and implications for related proteins. Biochem. Soc. Trans. 31: 791-794 (2003). *
Beath SV. Hepatic function and physiology in the newborn. Semin. Neonatol. 8: 337-346 (2003).
Beckebaum S, Cicinnati V, Broelsch CE. Liver transplantation, rejection and disease recurrence. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 55-56. October 15-16 (2003). *
Becker A, Smulders YM, van Guldener C, Stehouwer CD. Epidemiology of homocysteine as a risk factor in diabetes. Metab. Syndr. Relat. Disord. 1: 105-120 (2003).
Becker C, Wirtz S, Blessing M, Pirhonen J, Strand D, Bechthold O, Frick J, Galle PR, Autenrieth I, Neurath MF. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112: 693-706 (2003). *
Bednarczuk T, Hiromatsu Y, Fukutani T, Jazdzewski K, Miskiewicz P, Osikowska M, Nauman J. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur. J. Endocrinol. 148: 13-18 (2003). *
Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J. Interleukin-13 gene polymorphisms in patients with Graves' disease. Clin. Endocrinol. (Oxf.) 59: 519-525 (2003). *
Beehler BC, Hei YJ, Chen S, Lupisella JA, Ostrowski J, Starrett JE, Tortolani D, Tramposch KM, Reczek PR. Inhibition of disease progression by a novel retinoid antagonist in animal models of arthritis. J. Rheumatol. 30: 355-363 (2003).
Befeler AS. New developments in hepatocellular carcinoma. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW. Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin. Exp. Allergy 33: 1111-1117 (2003). *
Beglinger Ch. Treatment of Crohn's disease. Ther. Umsch. 60: 159-163 (2003).
Beil WJ, McEuen AR, Schulz M, Wefelmeyer U, Kraml G, Walls AF, Jensen-Jarolim E, Pabst R, Pammer J. Selective alterations in mast cell subsets and eosinophil infiltration in two complementary types of intestinal inflammation: ascariasis and Crohn's disease. Pathobiology 70: 303-313 (2003).
Bejaoui M, Mellouli F, Chouanine R, Dellagi K, Barbouche MR. The hyper-IgM syndrome: 13 observations. Presse. Med. 32: 544-549 (2003).
Belaiche J, Louis E. Early obstructive colon after treatment of active refractory Crohn's disease with infliximab. Gastroenterol. Clin. Biol. 27: 1045 (2003).
Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18: 481-486 (2003). *
Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun. 4: 4-11 (2003). *
Bellanti JA, Zeligs BJ, Malka-Rais J, Sabra A. Abnormalities of Th1 function in non-IgE food allergy, celiac disease, and ileal lymphonodular hyperplasia: a new relationship? Ann. Allergy Asthma Immunol. 90: 84-89 (2003).
Beltowski J, Wojcicka G, Jamroz A. Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy. Postepy. Hig. Med. Dosw. 57: 199-217 (2003).
Ben-Ari Z, Schmilovotz-Weiss H, Belinki A, Pappo O, Sulkes J, Neuman MG, Kaganovsky E, Kfir B, Tur-Kaspa R, Klein T. Circulating soluble cytochrome c in liver disease as a marker of apoptosis. J. Intern. Med. 254: 168-175 (2003). *
Benahmed M, Mention JJ, Matysiak-Budnik T, Cerf-Bensussan N. Celiac disease: a future without gluten-free diet?? Gastroenterology 125: 1264-1267 (2003). *
Bencsath M, Blaskovits A, Borvendeg J. Biomolecular cytokine therapy. Pathol. Oncol. Res. 9: 24-29 (2003). *
Bender IB. Paget's disease. J. Endod. 29: 720-723 (2003).
Benharouga M, Sharma M, So J, Haardt M, Drzymala L, Popov M, Schwapach B, Grinstein S, Du K, Lukacs GL. The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia. J. Biol. Chem. 278: 22079-22089 (2003). *
Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, Ahmad UA. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig. Dis. Sci. 48: 2077-2082 (2003). *
Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 52: 1355-1362 (2003). *
Bennett MR, Rizvi TA, Karyala S, McKinnon RD, Ratner N. Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants. J. Neurosci. 23: 7207-7217 (2003). *
Bentinger M, Turunen M, Zhang XX, Wan YJ, Dallner G. Involvement of retinoid X receptor alpha in coenzyme Q metabolism. J. Mol. Biol. 326: 795-803 (2003). *
Bentrem DJ, Joehl RJ. Pancreas: healing response in critical illness. Crit. Care Med. 31: S582-S589 (2003).
Beranek H, Teich N, Witt H, Schulz HU, Mossner J, Keim V. Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur. J. Gastroenterol. Hepatol. 15: 1223-1227 (2003).
Bergasa NV. Pruritus and fatigue in primary biliary cirrhosis. Clin. Liver Dis. 7: 879-900 (2003).
Bergasa NV. Management of complications of cholestasis: pruritus, fatigue and bone disease. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 54. October 15-16 (2003). *
Bergasa NV. Studying pruritus in the 21st century. Clin. Gastroenterol. Hepatol. 1: 249-251 (2003). *
Berger J, Kowdley KV. Is silymarin hepatoprotective in alcoholic liver disease? J. Clin. Gastroenterol. 37: 278-279 (2003).
Bergquist A. Tumor markers and genetic markers in the diagnosis of bile duct carcinoma. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 91. October 15-16 (2003). *
Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin. Liver Dis. 23: 227-237 (2003).
Bernard D, Christophe A, Delanghe J, Langlois M, De Buyzere M, Comhaire F. The effect of supplementation with an antioxidant preparation on LDL-oxidation is determined by haptoglobin polymorphism. Redox Rep. 8: 41-46 (2003).
Bernardino AL, Guarita DR, Mott CB, Pedroso MR, Machado MC, Laudanna AA, Tani CM, Almeida FL, Zatz M. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. JOP 4: 169-177 (2003). *
Bernstein CL, Stiffler HL, Jowell PS, Branch MS, Baillie J. Classifying low-grade dysplasia (LGD) as "negative" for malignancy increases the specificity but not the sensitivity of biliary brush cytology in primary sclerosing cholangitis (PSC). Gastrointest. Endosc. 57: AB198 (2003).
Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am. J. Gastroenterol. 98: 2468-2473 (2003). *
Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am. J. Gastroenterol. 98: 2784-2788 (2003). *
Bernstein CN, Leslie WD. The pathophysiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol. 15: 857-864 (2003).
Bernstein CN, Nayar G, Hamel A, Blanchard JF. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J. Clin. Microbiol. 41: 4986-4990 (2003). *
Bernuau J. Hepatic complications of pregnancy. Rev. Prat. 53: 1889-1893 (2003).
Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP, Zouali H, Emilie D, Peuchmaur M. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52: 840-846 (2003). *
Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin. Sci. (Lond.) 105: 13-20 (2003). *
Berthiaume F, MacDonald AD, Kang YH, Yarmush ML. Control analysis of mitochondrial metabolism in intact hepatocytes: effect of interleukin-1beta and interleukin-6. Metab. Eng. 5: 108-123 (2003). *
Bertolotti M, Zambianchi L, Carulli L, Simonini MS, Del Puppo M, Kienle MG, Loria P, Pinetti A, Carulli N. Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption. Hepatology 38: 939-946 (2003). *
Betis F, Brest P, Hofman V, Guignot J, Kansau I, Rossi B, Servin A, Hofman P. Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decay-accelerating factor (CD55), the receptor for Afa/Dr … Infect. Immun. 71: 1774-1783 (2003). *
Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. Ateneo. Parmense. 74: 9-33 (2003).
Bettinardi N, Felicetta I, Tomasi PA, Colombo C. Carbohydrate 19-9 antigen is not a marker of liver disease in patients with cystic fibrosis. Clin. Chem. Lab. Med. 41: 311-316 (2003).
Bettoun DJ, Burris TP, Houck KA, Buck DW 2nd, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol. Endocrinol. 17: 2320-2328 (2003). *
Beuers U. Mechanisms of action of ursodeoxycholic acid in cholestasis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 49-50. October 15-16 (2003). *
Beuers U, Denk GU, Soroka CJ, Wimmer R, Rust C, Paumgartner G, Boyer JL. Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets. J. Biol. Chem. 278: 17810-17818 (2003). *
Beumer C, Wulferink M, Raaben W, Fiechter D, Brands R, Seinen W. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307: 737-744 (2003). *
Beutler B. Science review: key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors. Crit. Care 7: 39-46 (2003). *
Beutler B. Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors. Annu. Rev. Pharmacol. Toxicol. 43: 609-628 (2003). *
Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176 (2003). *
Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology (Am. Soc. Hematol. Educ. Program) 2003: 40-61 (2003). *
Bevins CL. The role of gut flora and innate immunity in pathogenesis of inflammatory bowel disease. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 58. September 12 - 13 (2003). *
Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD. A role for innate immunity in type 1 diabetes? Diabetes Metab. Res. Rev. 19: 89-100 (2003).
Beytout J, Tournilhac O, Laurichesse H. Asplenia and hyposplenism. Presse. Med. 32: S5-S9 (2003).
Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J. Am. Coll. Cardiol. 41: 2130-2137 (2003). *
Bhatnagar A, Wig JD, Majumdar S. Immunological findings in acute and chronic pancreatitis. ANZ J. Surg. 73: 59-64 (2003). *
Bhattacharya R, Kowdley KV. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime? Gastroenterology 125: 615-616 (2003). *
Bi L, Triadafilopoulos G. Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits. Clin. Gastroenterol. Hepatol. 1: 345-355 (2003). *
Bi LC, Kaunitz JD. Gastroduodenal mucosal defense: an integrated protective response. Curr. Opin. Gastroenterol. 19: 526-532 (2003).
Biancone L, Fiori R, Tosti C, Marinetti A, Catarinacci M, De Nigris F, Simonetti G, Pallone F. Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn's disease. Inflamm. Bowel Dis. 9: 343-350 (2003). *
Biancone L, Palmieri G, Lombardi A, Colantoni A, Tonelli F, Das KM, Pallone F. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis. Am. J. Gastroenterol. 98: 2719-2726 (2003). *
Biancone L, Tosti C, Fina D, Fantini M, De Nigris F, Geremia A, Pallone F. Review article: maintenance treatment of Crohn's disease. Aliment. Pharmacol. Ther. 17 Suppl. 2: 31-37 (2003). *
Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin. Chem. 49: 1981-1988 (2003). *
Bickston SJ. Keeping the M in mind: recombinant human GMCSF and Crohn's disease. Inflamm. Bowel Dis. 9: 132 (2003). *
Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).
Bickston SJ, Cominelli F. Optimal dosing of 5-aminosalicylic acid: 5 decades of choosing between politicians. Clin. Gastroenterol. Hepatol. 1: 3-4 (2003). *
Biecker E, Stieger M, Zimmermann A, Reichen J. Autoimmune hepatitis, cryoglobulinaemia and untreated coeliac disease: a case report. Eur. J. Gastroenterol. Hepatol. 15: 423-427 (2003).
Bienvenu T. Cystic fibrosis: relationship between genotype and phenotype. Arch. Pediatr. 10 Suppl. 2: 318s-324s (2003).
Bihl F, Salez L, Beaubier M, Torres D, Lariviere L, Laroche L, Benedetto A, Martel D, Lapointe JM, Ryffel B, Malo D. Overexpression of Toll-like receptor 4 amplifies the host response to lipopolysaccharide and provides a survival advantage in transgenic mice. J. Immunol. 170: 6141-6150 (2003). *
Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin. Transplant. 17: 401-411 (2003). *
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann. N. Y. Acad. Sci. 1005: 314-318 (2003). *
Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins Other Lipid Mediat. 71: 1-22 (2003).
Bismuth M, Aguilar-Martinez P, Michel H. Hereditary haemochromatosis. Presse. Med. 32: 1716-1723 (2003).
Bistrian BR. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. JPEN J. Parenter. Enteral Nutr. 27: 168-175 (2003). *
Biswas P, Mantelli B, Hasson H, Vecchi A, Saniabadi A, Lazzarin A, Beretta A. In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clin. Immunol. 109: 355-358 (2003). *
Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am. J. Gastroenterol. 98: 1616-1620 (2003). *
Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, Laudanna AA, Kalil J, Goldberg AC. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 18: 1061-1066 (2003). *
Bitton A, Sewitch MJ, Peppercorn MA, deB Edwardes MD, Shah S, Ransil B, Locke SE. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am. J. Gastroenterol. 98: 2203-2208 (2003). *
Bizzaro N, Villalta D, Tonutti E, Doria A, Tampoia M, Bassetti D, Tozzoli R. IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig. Dis. Sci. 48: 2360-2365 (2003). *
Bizzaro N, Villalta D, Tonutti E, Tampoia M, Bassetti D, Tozzoli R. Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract. Autoimmun. Rev. 2: 358-363 (2003).
Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, Einarsdottir AS, Sherwood R, Kristjansson K, Kjartansson O, Thjodleifsson B. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 125: 1598-1605 (2003). *
Bjornsson E, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 19: 270-275 (2003).
Black M. Drug hepatotoxicity. Clin. Liver Dis. 7: xi-xii (2003). *
Blackwell JM, Searle S, Mohamed H, White JK. Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. Immunol. Lett. 85: 197-203 (2003).
Blakelock RT, Beasley SW. Infection and the gut. Semin. Pediatr. Surg. 12: 265-274 (2003).
Blanc P, Phelip JM, Bertolino JG, Atger J, Roblin X. Watermelon stomach: a rare cause of iron deficiency anemia, surgically treatable; a new case with review of the literature. Ann. Chir. 128: 462-464 (2003).
Blanchet E, Beau P. Efficacy of hydrostatic balloon dilatation of anastomotic Crohn's disease strictures. Gastroenterol. Clin. Biol. 27: 1105-1109 (2003).
Blanco M, Mesko T, Cura M, Cabello-Inchausti B. Chronic sclerosing sialadenitis (Kuttner's tumor): unusual presentation with bilateral involvement of major and minor salivary glands. Ann. Diagn. Pathol. 7: 25-30 (2003).
Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85: 267-273 (2003).
Blau H, Livne M, Mussaffi H. Cystic fibrosis in adults: a changing scene. Isr. Med. Assoc. J. 5: 491-495 (2003). *
Bliss SK, Alcaraz A, Appleton JA. IL-10 prevents liver necrosis during murine infection with Trichinella spiralis. J. Immunol. 171: 3142-3147 (2003). *
Bloomfeld RS, Onken JE. Mercaptopurine metabolite results in clinical gastroenterology practice. Aliment. Pharmacol. Ther. 17: 69-73 (2003). *
Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257 (2003). *
Blum S, Schiffrin EJ. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr. Issues Intest. Microbiol. 4: 53-60 (2003).
Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst. Rev. 4: CD004525 (2003). *
Boberg KM, Egeland T, Schrumpf E. Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand. J. Gastroenterol. 38: 991-995 (2003). *
Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. J. Hepatol. 39: 453 (2003). *
Boberg KM, Schrumpf E. Diagnosis and differential diagnosis of primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 59-60. October 15-16 (2003). *
Bochud PY, Hawn TR, Aderem A. Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 170: 3451-3454 (2003). *
Bocker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol S, B Sartor R, Singer MV. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin. Exp. Immunol. 131: 53-60 (2003). *
Bocko D, Bilinska M, Dobosz T, Zoledziewska M, Suwalska K, Tutak A, Gruszka E, Frydecka I. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region. Arch. Immunol. Ther. Exp. (Warsz.) 51: 201-205 (2003).
Boden E, Tang Q, Bour-Jordan H, Bluestone JA. The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found. Symp. 252: 55-63 (2003).
Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J. Biol. Chem. 278: 23529-23537 (2003). *
Boedeker EC. Gastrointestinal infections. Curr. Opin. Gastroenterol. 19: 1-3 (2003).
Boehncke WH. Immunomodulatory drugs for psoriasis. BMJ 327: 634-635 (2003). *
Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig. Liver Dis. 35: 801-805 (2003).
Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin. Liver Dis. 7: 759-777, vi (2003).
Bohan A, Chen WS, Denson LA, Held MA, Boyer JL. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J. Biol. Chem. 278: 36688-36698 (2003). *
Boitier E, Gautier JC, Roberts R. Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease. Comp. Hepatol. 2: 3 (2003). *
Boixeda D, Martin De Argila C, Bermejo F, Lopez Sanroman A, Hernandez Ranz F, Garcia Plaza A. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. Factors that influence Helicobacter pylori eradications success. Rev. Esp. Enferm. Dig. 95: 206-209 (2003).
Bokarewa MI, Jin T, Tarkowski A. Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis. J. Rheumatol. 30: 1719-1724 (2003).
Bokszczanin A, Levinson AI. Coexistent yellow nail syndrome and selective antibody deficiency. Ann. Allergy Asthma Immunol. 91: 496-500 (2003).
Bolognesi E, Karell K, Percopo S, Coto I, Greco L, Mantovani V, Suoraniemi E, Partanen J, Mustalahti K, Maki M, Momigliano-Richiardi P. Additional factor in some HLA DR3/DQ2 haplotypes confers a fourfold increased genetic risk of celiac disease. Tissue Antigens 61: 308-316 (2003). *
Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol. 39: 1076-1084 (2003). *
Bombieri C, Belpinati F, Pignatti PF, Luisetti M. Comment on 'CFTR gene mutations in sarcoidosis'. Eur. J. Hum. Genet. 11: 553-554 (2003). *
Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22: 5551-5560 (2003). *
Bonaz B, Boitard J, Marteau P, Lemann M, Coffin B, Flourie B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF; Getaid. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine. Aliment. Pharmacol. Ther. 18: 401-408 (2003). *
Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536 (2003). *
Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140-146 (2003). *
Bonet ML, Ribot J, Felipe F, Palou A. Vitamin A and the regulation of fat reserves. Cell. Mol. Life Sci. 60: 1311-1321 (2003).
Boniotto M, Braida L, Ventura A, Percopo S, Amoroso A, Crovella S. Promoter polymorphisms of the CD14 gene in Italian patients with coeliac disease. J. Med. Genet. 40: e108 (2003). *
Boniotto M, Radillo O, Braida L, Pirulli D, Citta A, Not T, Amoroso A, Crovella S. Detection of MBL-2 gene expression in intestinal biopsies of celiac patients by in situ reverse transcription polymerase chain reaction. Eur. J. Histochem. 47: 177-180 (2003).
Boniotto M, Tossi A, DelPero M, Sgubin S, Antcheva N, Santon D, Masters J, Crovella S. Evolution of the beta defensin 2 gene in primates. Genes Immun. 4: 251-257 (2003). *
Bookout AL, Mangelsdorf DJ. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1: e012 (2003). *
Boone DL, Ma A. Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease. J. Clin. Invest. 111: 1284-1286 (2003). *
Borchers AT, Keen CL, Gershwin ME. Use and misuse of corticosteroids. Compr. Ther. 29: 157-165 (2003).
Borchers AT, Naguwa SM, Keen CL, Gershwin ME. Immunopathogenesis of Sjogren's syndrome. Clin. Rev. Allergy Immunol. 25: 89-104 (2003).
Borchers AT, So C, Naguwa SM, Keen CL, Gershwin ME. Clinical and immunologic components of sarcoidosis. Clin. Rev. Allergy Immunol. 25: 289-303 (2003).
Borda F, Oquinena S, Borobio E, Vila J, Frauca A, Martinez B. Is pre-operative treatment with ursodeoxycholic acid useful in reducing relapses in acute biliary pancreatitis? An. Sist. Sanit. Navar. 26: 225-229 (2003).
Borges-Walmsley MI, McKeegan KS, Walmsley AR. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376: 313-338 (2003). *
Borini P, Guimaraes RC. Noninvasive classification of liver disease in asymptomatic and oligosymptomatic male alcoholics. Braz. J. Med. Biol. Res. 36: 1367-1373 (2003). *
Bosch J. Invasive imaging. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 40. October 17 - 19 (2003). *
Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J. Hepatol. 38 Suppl. 1: S54-S68 (2003). *
Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am. J. Med. Genet. A. 121A: 219-224 (2003).
Bosma PJ. Inherited disorders of bilirubin metabolism. J. Hepatol. 38: 107-117 (2003). *
Bosse Y, Weisnagel SJ, Bouchard C, Despres JP, Perusse L, Vohl MC. Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Quebec Family Study. J. Hum. Genet. 48: 614-621 (2003). *
Botchkarev VA. Neurotrophins and their role in pathogenesis of alopecia areata. J. Investig. Dermatol. Symp. Proc. 8: 195-198 (2003). *
Botsios C, Ostuni P, Sfriso P, Furlan A, Fiocco U, Sgarabotto D, Todesco S. Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects. Reumatismo 55: 224-235 (2003).
Bott C, Lembcke B, Stein J. Colorectal cancer and folate. Z. Gastroenterol. 41: 263-270 (2003).
Botti F, Carrara A, Antonelli B, Quadri F, Maino M, Cesana B, Contessini-Avesani E. The minimal bowel resection in Crohn's disease: analysis of prognostic factors on the surgical recurrence. Ann. Ital. Chir. 74: 627-633 (2003).
Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur. J. Hum. Genet. 11: 671-678 (2003). *
Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A. Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients. Gastroenterol. Clin. Biol. 27: 901-907 (2003).
Boulanger A, McLemore P, Copeland NG, Gilbert DJ, Jenkins NA, Yu SS, Gentleman S, Redmond TM. Identification of beta-carotene 15, 15'-monooxygenase as a peroxisome proliferator-activated receptor target gene. FASEB J. 17: 1304-1306 (2003). *
Boulanger MJ, Chow DC, Brevnova EE, Garcia KC. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300: 2101-2104 (2003). *
Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533 (2003). *
Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, Comas D. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 4: 132-137 (2003). *
Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat. Immunol. 4: 182-188 (2003). *
Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am. J. Clin. Nutr. 78: 675-683 (2003). *
Bourreille A, Doubremelle M, de la Bletiere DR, Segain JP, Toquet C, Buelow R, Galmiche JP. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease. Scand. J. Gastroenterol. 38: 526-532 (2003). *
Bowcock AM, Barker JN. Genetics of psoriasis: the potential impact on new therapies. J. Am. Acad. Dermatol. 49: S51-S56 (2003).
Bowlus CL. The role of iron in T cell development and autoimmunity. Autoimmun. Rev. 2: 73-78 (2003).
Braat H, Peppelenbosch MP, Hommes DW. Interleukin-10-based therapy for inflammatory bowel disease. Expert Opin. Biol. Ther. 3: 725-731 (2003).
Braddock M. Inflammatory Processes in Drug Discovery - SRI Conference. 22-23 September 2003, Philadelphia, PA, USA. IDrugs 6: 1049-1052 (2003).
Bradesi S, McRoberts JA, Anton PA, Mayer EA. Inflammatory bowel disease and irritable bowel syndrome: separate or unified? Curr. Opin. Gastroenterol. 19: 336-342 (2003).
Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin. Immunopathol. 25: 3-18 (2003). *
Brandsaeter B, Broome U, Isoniemi H, Friman S, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Olsson R, Olausson M, Kirkegaard P, Bjoro K. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: outcome after acceptance to the waiting list. Liver Transpl. 9: 961-969 (2003). *
Brandsaeter B, Friman S, Broome U, Isoniemi H, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Bjoro K. Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand. J. Gastroenterol. 38: 1176-1183 (2003). *
Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 21: 3382-3388 (2003). *
Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int. J. Med. Microbiol. 293: 3-15 (2003).
Brandtzaeg P. Mucosal immunity. Dev. Biol. (Basel) 115: 111-117 (2003).
Brandtzaeg P. Impact of immunodeficiency on immunological hoemostasis in the gut. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 61-62. September 12 - 13 (2003). *
Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet.73: 1282-1292 (2003). *
Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm. Bowel Dis. 9: 281-289 (2003). *
Braun J, Sieper J. Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases. Expert Opin. Biol. Ther. 3: 141-168 (2003).
Braun J, van der Heijde D. Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides. Expert Opin. Investig. Drugs 12: 1097-1109 (2003).
Breban M, Said-Nahal R, Hugot JP, Miceli-Richard C. Familial and genetic aspects of spondyloarthropathy. Rheum. Dis. Clin. North Am. 29: 575-594 (2003).
Brennan MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox PC, Baum BJ, Pillemer SR. Sex steroid hormones in primary Sjogren's syndrome. J. Rheumatol. 30: 1267-1271 (2003).
Brenner S, Srebrnik A, Goldberg I. Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols. J. Cosmet. Dermatol. 2: 161-165 (2003).
Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Vaccines for viral diseases with dermatologic manifestations. Dermatol. Clin. 21: 349-369 (2003).
Brentnall T. UC for UC: ursodiol chemoprevention for ulcerative colitis. Inflamm. Bowel Dis. 9: 338 (2003). *
Brentnall TA. Molecular underpinnings of cancer in ulcerative colitis. Curr. Opin. Gastroenterol. 19: 64-68 (2003).
Brentnall TA. Ursodiol: good drug makes good. Gastroenterology 124: 1139-1140 (2003). *
Bresalier RS. Aspirin and the prevention of colorectal neoplasia. Gastroenterology 125: 1539-1541 (2003). *
Breuning MH, Hamdy NA. From gene to disease; SLC3A1, SLC7A9 and cystinuria. Ned. Tijdschr. Geneeskd. 147: 245-247 (2003).
Brewer HB Jr, Santamarina-Fojo S. New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am. J. Cardiol. 91: 3E-11E (2003). *
Brewerton DA. Discovery: HLA and disease. Curr. Opin. Rheumatol. 15: 369-373 (2003).
Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361: 669-673 (2003). *
Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J. Eur. Acad. Dermatol. Venereol. 17: 663-669 (2003). *
Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 305: 737-740 (2003). *
Brinckerhoff CE, Sporn MB. Retinoids and rexinoids for the 21st century: a brave new world for arthritis. J. Rheumatol. 30: 211-213 (2003).
Brinkmeier T, Angelkort B, Frosch PJ, Herbst RA. Vancomycin-induced linear IgA disease. J. Dtsch. Dermatol. Ges. 1: 212-214 (2003).
Bristow CA, Shore P. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Nucleic Acids Res. 31: 2735-2744 (2003). *
British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br. J. Haematol. 122: 10-23 (2003). *
Brodanova M. Cholestasis. Vnitr. Lek. 49: 689-695 (2003).
Brodmerkel CM, Vaddi K. Transgenic animals in inflammatory disease models. Curr. Opin. Biotechnol. 14: 652-658 (2003). *
Broering DC, Sterneck M, Rogiers X. Living donor liver transplantation. J. Hepatol. 38 Suppl. 1: S119-S135 (2003). *
Brogan BL, Olsen NJ. Drug-induced rheumatic syndromes. Curr. Opin. Rheumatol. 15: 76-80 (2003).
Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 24: 207-212 (2003). *
Bronner F. Calcium nutrition and metabolism. Dent. Clin. North Am. 47: 209-224 (2003).
Brooklyn T, Probert C. A Crohn's repertoire: T cell receptor gammadelta. Inflamm. Bowel Dis. 9: 213-214 (2003). *
Broome U. Autoimmune hepatitis and overlap syndromes. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 38-39. September 12 - 13 (2003). *
Broome U, Bergquist A. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreas carcinoma in patients with primary sclerosing cholangitis. Epidemiology and risk factors. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 89-90. October 15-16 (2003). *
Brophy S, Taylor G, Blake D, Calin A. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis. J. Rheumatol. 30: 2054-2058 (2003).
Brousseau ME. ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption. Curr. Opin. Lipidol. 14: 35-40 (2003).
Brousseau ME. Statins, super-statins and cholesterol absorption inhibitors. IDrugs 6: 458-463 (2003).
Brown GR, Lee EL, Thiele DL. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. J. Immunol. 170: 5082-5088 (2003). *
Brown KA, Moonka D. Liver transplantation. Curr. Opin. Gastroenterol. 19: 259-263 (2003).
Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, Cardon L, Calin A, Wordsworth BP. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum. 48: 2234-2239 (2003). *
Brown RS Jr. Evaluation of the potential living donor. Transplant. Proc. 35: 915-916 (2003).
Brown RS Jr, Brenner DA. MELD and the practicing gastroenterologist. Gastroenterology 125: 1009 (2003). *
Brown RS Jr, Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, Hoofnagle JH. A survey of liver transplantation from living adult donors in the United States. N. Engl. J. Med. 348: 818-825 (2003). *
Browning J, Combes B, Mayo MJ. Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 98: 2736-2741 (2003). *
Browning LM. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 62: 447-453 (2003). *
Broxmeyer HE, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, Clapp DW, Kim CH. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J. Immunol. 170: 421-429 (2003). *
Broxmeyer HE, Kohli L, Kim CH, Lee Y, Mantel C, Cooper S, Hangoc G, Shaheen M, Li X, Clapp DW. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J. Leukoc. Biol. 73: 630-638 (2003). *
Brtko J, Thalhamer J. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention. Curr. Pharm. Des. 9: 2067-2077 (2003).
Bruewer M, Krieglstein CF, Utech M, Bode M, Rijcken E, Anthoni C, Laukoetter MG, Schuermann G, Senninger N. Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma? World J. Surg. 27: 611-615 (2003). *
Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171: 6164-6172 (2003). *
Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, Van de Water J, Luketic V, Roche TE, Ansari AA, Coppel RL, Gershwin ME. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 125: 1705-1713 (2003). *
Bruix J. Hepatocellular carcinoma. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 31-33. October 17 - 19 (2003). *
Brummelkamp T, Nijman S, Dirac A, Bernards R. High throughput loss-of-function phenotypic screens in mammalian cells. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 52. October 20 - 21 (2003). *
Brune S, Kolsch H, Ptok U, Majores M, Schulz A, Schlosser R, Rao ML, Maier W, Heun R. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J. Neural. Transm. 110: 1041-1050 (2003). *
Brunner M, Assandri R, Kletter K, Tschurlovits M, Corrado ME, Villa R, Eichler HG, Muller M. Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment. Pharmacol. Ther. 17: 395-402 (2003). *
Brunner M, Greinwald R, Kletter K, Kvaternik H, Corrado ME, Eichler HG, Muller M. Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers. Aliment. Pharmacol. Ther. 17: 1163-1169 (2003). *
Brunt EM, Ramrakhiani S, Cordes BG, Neuschwander-Tetri BA, Janney CG, Bacon BR, Di Bisceglie AM. Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. Mod. Pathol. 16: 49-56 (2003). *
Bryce NS, Schevzov G, Ferguson V, Percival JM, Lin JJ, Matsumura F, Bamburg JR, Jeffrey PL, Hardeman EC, Gunning P, Weinberger RP. Specification of actin filament function and molecular composition by tropomyosin isoforms. Mol. Biol. Cell 14: 1002-1016 (2003). *
Bubnova LN, Pavlova IE, Berkos MV, Solovyeva OI, Simanenkov VI. HLA II class polymorphism in patients with ulcerative colitis. Hum. Immunol. 64 (10 Suppl.): S149 (2003).
Bucheton B, Abel L, Kheir MM, Mirgani A, El-Safi SH, Chevillard C, Dessein A. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun. 4: 104-109 (2003). *
Buckel E, Uribe M, Brahm J, Silva G, Ferrario M, Godoy J, Segovia R, Ceresa S, Hunter B, Alegria S, Berwart F, Smok G, Herzog C, Santander T, Calabran L. Outcomes of orthotopic liver transplantation in Chile. Transplant. Proc. 35: 2509-2510 (2003). *
Bugawan TL, Mirel DB, Valdes AM, Panelo A, Pozzilli P, Erlich HA. Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos. Am. J. Hum. Genet. 72: 1505-1514 (2003). *
Bull AW. The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch. Pathol. Lab. Med. 127: 1121-1123 (2003). *
Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G,. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J. Clin. Microbiol. 41: 2915-2923 (2003). *
Bullen TF, Hershman MJ. Surgery for inflammatory bowel disease. Hosp. Med. 64: 719-723 (2003).
Bullen TF, Hershman MJ. Laparoscopic surgery for inflammatory bowel disease. Hosp. Med. 64: 724-727 (2003).
Buning C, Genschel J, Weltrich R, Lochs H, Schmidt H. The interleukin-25 gene located in the inflammatory bowel disease (IBD) 4 region: no association with inflammatory bowel disease. Eur. J. Immunogenet. 30: 329-333 (2003). *
Buning C, Ockenga J, Kruger S, Jurga J, Baier P, Dignass A, Vogel A, Strassburg C, Weltrich R, Genschel J, Lochs H, Schmidt H. The C/C(-13910) and G/G(-22018) genotypes for adult-type hypolactasia are not associated with inflammatory bowel disease. Scand. J. Gastroenterol. 38: 538-542 (2003). *
Burak KW, Angulo P, Lindor KD. Is there a role for liver biopsy in primary sclerosing cholangitis? Am. J. Gastroenterol. 98: 1155-1158 (2003). *
Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, Schell RF. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71: 3437-3442 (2003). *
Burgner D, Rockett K, Ackerman H, Hull J, Usen S, Pinder M, Kwiatkowski DP. Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes Immun. 4: 506-514 (2003). *
Burke CA, Bauer WM, Lashner B. Chemoprevention of colorectal cancer: slow, steady progress. Cleve. Clin. J. Med. 70: 346-350 (2003). *
Burkhart CN, Gottwald L. Assessment of etiologic agents in acne pathogenesis. Skinmed. 2: 222-228 (2003).
Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263-268 (2003). *
Burns TM. Neurosarcoidosis. Arch. Neurol. 60: 1166-1168 (2003).
Burns TM, Ryan MM, Darras B, Jones HR Jr. Current therapeutic strategies for patients with polyneuropathies secondary to inherited metabolic disorders. Mayo Clin. Proc. 78: 858-868 (2003). *
Burroughs AK. Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative? Dig. Liver Dis. 35: 664-667 (2003).
Burt RK, Marmont A, Arnold R, Heipe F, Firestein GS, Carrier E, Hahn B, Barr W, Oyama Y, Snowden J, Kalunian K, Traynor A. Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus. Bone Marrow Transplant. 32 Suppl. 1: S49-S51 (2003).
Burt RK, Traynor A, Oyama Y, Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 101: 2064-2066 (2003). *
Burt RK, Traynor AE. SLE - hematopoietic stem cell transplantation for systemic lupus erythematosus. Arthritis Res. Ther. 5: 207-209 (2003). *
Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J. Hepatol. 39: 278-285 (2003). *
Butterworth RF. Molecular neurobiology of acute liver failure. Semin. Liver Dis. 23: 251-258 (2003).
Buzi F, Badolato R, Mazza C, Giliani S, Notarangelo LD, Radetti G, Plebani A, Notarangelo LD. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome: time to review diagnostic criteria? J. Clin. Endocrinol. Metab. 88: 3146-3148 (2003). *
Caballeria J. Current concepts in alcohol metabolism. Ann. Hepatol. 2: 60-68 (2003). *
Cabibi D, Licata A, Barresi E, Craxi A, Aragona F. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract. Pathol. Res. Pract. 199: 65-70 (2003).
Cabral VL, Miszputen SJ, Catapani WR. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology 50: 412-415 (2003).
Cabre E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 6: 569-576 (2003).
Cabrero A, Cubero M, Llaverias G, Jove M, Planavila A, Alegret M, Sanchez R, Laguna JC, Carrera MV. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages. Metabolism 52: 652-657 (2003). *
Cadranel S, Gottrand F. Is upper gastro-intestinal endoscopy required for diagnosis and treatment of Helicobacter pylori infection in childhood? Pro and cons. Arch. Pediatr. 10: 256-259 (2003).
Cai Y, Dai T, Ao Y, Konishi T, Chuang KH, Lue Y, Chang C, Wan YJ. Cytochrome P450 genes are differentially expressed in female and male hepatocyte retinoid X receptor alpha-deficient mice. Endocrinology 144: 2311-2318 (2003). *
Caillat-Zucman S. Why mapping celiac disease susceptibility genes is so challenging: lessons from the CTLA-4 gene. J. Pediatr. Gastroenterol. Nutr. 37: 115-116 (2003). *
Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR; Multiple Sclerosis Genetics Group. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun. 4: 312-315 (2003). *
Cakir M, Samanci N, Balci N, Balci MK. Musculoskeletal manifestations in patients with thyroid disease. Clin. Endocrinol. (Oxf.) 59: 162-167 (2003). *
Calabrese V, Butterfield DA, Stella AM. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem. 52: 177-181 (2003).
Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25: 437-444 (2003). *
Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3: 791-800 (2003). *
Calder PC. Immunonutrition. BMJ 327: 117-118 (2003). *
Calder PC. Polyunsaturated fatty acids and cytokine profiles: a clue to the changing prevalence of atopy? Clin. Exp. Allergy 33: 412-415 (2003). *
Calder PC. n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38: 343-352 (2003).
Calder PC. New evidence in support of the cardiovascular benefit of long-chain n-3 fatty acids. Ital. Heart J. 4: 427-429 (2003).
Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz. J. Med. Biol. Res. 36: 433-446 (2003). *
Calder PC, Deckelbaum RJ. Fat as a physiological regulator: the news gets better. Curr. Opin. Clin. Nutr. Metab. Care 6: 127-131 (2003).
Calvo-Alen J, Reveille JD, Rodriguez-Valverde V, McGwin G Jr, Baethge BA, Friedman AW, Alarcon GS. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 12: 377-385 (2003).
Campbell DJ, Debes GF, Johnston B, Wilson E, Butcher EC. Targeting T cell responses by selective chemokine receptor expression. Semin. Immunol. 15: 277-286 (2003). *
Campbell S, Ghosh S. Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome. Dig. Liver Dis. 35: 546-551 (2003).
Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Kiss DR, Habr-Gama A. Pharmacological nutrition in inflammatory bowel diseases. Nutr. Hosp. 18: 57-64 (2003).
Canataroglu A, Tanriverdi K, Inal T, Seydaoglu G, Arslan D, Ozbek S, Baslamisli F. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behcet's disease. Rheumatol. Int. 23: 236-240 (2003). *
Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, Taniai M, Gores GJ. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 112: 152-159 (2003). *
Candore G, Modica MA, Lio D, Colonna-Romano G, Listì F, Grimaldi MP, Russo M, Triolo G, Accardo-Palumbo A, Cuccia MC, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother. 57: 274-277 (2003).
Cannon CL, Kowalski MP, Stopak KS, Pier GB. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell. Mol. Biol. 29: 188-197 (2003). *
Cao L, Owsianik G, Jaspers M, Janssens A, Cuppens H, Cassiman JJ, Nilius B. Functional analysis of CFTR chloride channel activity in cells with elevated MDR1 expression. Biochem. Biophys. Res. Commun. 304: 248-252 (2003). *
Cappell MS. Gastrointestinal disorders during pregnancy. Preface. Gastroenterol. Clin. North Am. 32: xi-xiii (2003). *
Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol. Clin. North Am. 32: 123-179 (2003). *
Cappell MS. Gastric and duodenal ulcers during pregnancy. Gastroenterol. Clin. North Am. 32: 263-308 (2003). *
Cappell MS. Colon cancer during pregnancy. Gastroenterol. Clin. North Am. 32: 341-383 (2003). *
Cappell MS, Friedel D. Abdominal pain during pregnancy. Gastroenterol. Clin. North Am. 32: 1-58 (2003). *
Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Camma C, Corrao G, Latella G. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment. Pharmacol. Ther. 17: 517-523 (2003). *
Caprilli R, Guagnozzi D. CARD 15 and Toll-like receptors: the link with Crohn's disease. Dig. Liver Dis. 35: 753-757 (2003).
Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125: 89-97 (2003). *
Carcao MD, Blanchette VS, Wakefield CD, Stephens D, Ellis J, Matheson K, Denomme GA. Fcgamma receptor IIa and IIIa polymorphisms in childhood immune thrombocytopenic purpura. Br. J. Haematol. 120: 135-141 (2003).
Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 125: 1583-1590 (2003). *
Cardarelli G, Anatra GM. Hepcidin: a key peptide in iron metabolism. Minerva Med. 94: 135-139 (2003).
Cardenas A, Arroyo V. Hepatorenal syndrome. Ann. Hepatol. 2: 23-29 (2003). *
Cariati A, Puglisi R, Zaffarano R, Accarpio FT, Cetta F. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 98: 656-657 (2003). *
Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125: 1480-1491 (2003). *
Cario E. Toll-like receptors and intestinal defence: molecular basis and therapeutic implications. Expert Rev. Mol. Med. 5: 1-15 (2003).
Carithers RL Jr. Primary biliary cirrhosis: specific treatment. Clin. Liver Dis. 7: 923-939 (2003).
Carlson GL. Surgical management of intestinal failure. Proc. Nutr. Soc. 62: 711-718 (2003). *
Carlsson E, Bosaeus I, Nordgren S. What concerns subjects with inflammatory bowel disease and an ileostomy? Scand. J. Gastroenterol. 38: 978-984 (2003). *
Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin. Exp. Rheumatol. 21: S95-S100 (2003).
Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, Morton DH, Bull LN. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat. Genet. 34: 91-96 (2003). *
Carreras E, Saiz A, Marin P, Martinez C, Rovira M, Villamor N, Aymerich M, Lozano M, Fernandez-Aviles F, Urbano-Izpizua A, Montserrat E, Graus F. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 88: 306-314 (2003). *
Carrier J, Medline A, Sohn KJ, Choi M, Martin R, Hwang SW, Kim YI. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice. Cancer Epidemiol. Biomarkers Prev. 12: 1262-1267 (2003). *
Carrion F, Figueroa F, Martinez ME, Massardo L, Perez T, Foster C, Mancilla C, Neira O, Guzman L, Valenzuela V, Urrutia R, Carmona S, Figueroa M, Lubiano A, Wainstein E. Study of polymorphism of Fc gamma IIa receptors in Chilean patients with systemic lupus erythematosus. Rev. Med. Chil. 131: 11-18 (2003).
Carroccio A, Soresi M, Di Prima L, Montalto G. Screening for celiac disease in patients with chronic liver disease. Gastroenterology 125: 1289 (2003). *
Carson CF, Riley TV. Non-antibiotic therapies for infectious diseases. Commun. Dis. Intell. 27 Suppl.: S143-S146 (2003).
Carter JD, Valeriano J, Vasey FB. Crohn disease worsened by anakinra administration. J. Clin. Rheumatol. 9: 276-277 (2003).
Carter K, Bowen DJ, McCune CA, Worwood M. Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis. Br. J. Haematol. 122: 326-332 (2003).
Carter LL, Carreno BM. Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation. Immunol. Res. 28: 49-59 (2003). *
Carty E, Rampton DS. Evaluation of new therapies for inflammatory bowel disease. Br. J. Clin. Pharmacol. 56: 351-361 (2003). *
Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, de Freitas FC, Lapa e Silva JR. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J. Clin. Gastroenterol. 36: 120-125 (2003).
Casp CB, She JX, McCormack WT. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun. 4: 492-499 (2003). *
Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse. Curr. Protoc. Immunol. Chapter 15: Unit 15.6 (2003).
Castagnola E, Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur. J. Haematol. 71: 319-326 (2003). *
Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clin. Drug Investig. 23: 639-650 (2003).
Castano G, Viudez P, Riccitelli M, Sookoian S. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients. Ann. Hepatol. 2: 36-40 (2003). *
Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R, Mazzacca G. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment. Pharmacol. Ther. 18: 1107-1112 (2003). *
Castillo S, Ramaiah B, Blum S, Remy P. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 125: 999 (2003). *
Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449 (2003). *
Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, Tontonoz P. Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell. 12: 805-816 (2003). *
Cat H, Sophani I, Lemann M, Modiglani R, Solue JC. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease. Turk. J. Gastroenterol. 14: 121-127 (2003). *
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Corazza GR; Working Group of the SIGEP; Working Group of 'Club del Tenue'. Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr. Allergy Immunol. 14: 320-324 (2003). *
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Mule AM, Corazza GR; Groups of the SIGEP and "Club del Tenue". Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am. J. Gastroenterol. 98: 850-856 (2003). *
Caturelli E, Castellano L, Fusilli S, Palmentieri B, Niro GA, del Vecchio-Blanco C, Andriulli A, de Sio I. Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. Radiology 226: 691-697 (2003). *
Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. CYP3A4 and MDR1 alleles in a Portuguese population. Clin. Chem. Lab. Med. 41: 1345-1350 (2003).
Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 73: 1683-1690 (2003). *
Cavanaugh JA. IBD International Genetics Consortium: international cooperation making sense of complex disease. Inflamm. Bowel Dis. 9: 190-193 (2003). *
Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O'Callaghan NJ, Rodgers HJ, Magarry GR, Butler WJ, Eaden JA, Roberts-Thomson IC, Pavli P, Wilson SR, Callen DF. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann. Hum. Genet. 67: 35-41 (2003). *
Cave NJ. Chronic inflammatory disorders of the gastrointestinal tract of companion animals. N. Z. Vet. J. 51: 262-274 (2003).
Cavestro GM, Frulloni L, Neri TM, Seghini P, Nouvenne A, Zanetti A, Bovo P, Di Mario F, Okolicsanyi L, Cavallini G. Association of HLA-DRB1*0401 allele with chronic pancreatitis. Pancreas 26: 388-391 (2003).
Ceelie H, Spaargaren-Van Riel CC, De Jong M, Bertina RM, Vos HL. Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer. J. Thromb. Haemost. 1: 1688-1698 (2003). *
Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products - United States, Germany, and Switzerland, 1999-2002. JAMA 289: 36-37 (2003). *
Cerkauskiene R, Kaminskas A, Kaltenis P, Vitkus D. Influence of omega-3 fatty acids on lipid metabolism in children with steroid sensitive nephrotic syndrome. Medicina (Kaunas) 39 Suppl. 1: 82-87 (2003).
Cerwenka A, Lanier LL. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 61: 335-343 (2003). *
Cezard JP, Nouaili N, Talbotec C, Hugot JP, Gobert JG, Schmitz J, Mougenot JF, Alberti C, Goulet O. A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 36: 632-636 (2003). *
Chakir H, Campos-Neto A, Mojibian M, Webb JR. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response. Microbes Infect. 5: 241-249 (2003). *
Chakraborty A, Bremner AR, Moore I, Beattie RM. Coeliac disease and Crohn's disease: an association not to be forgotten. Hosp. Med. 64: 684-655 (2003).
Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am. J. Gastroenterol. 98: 2771-2776 (2003). *
Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 98: 1849-1855 (2003). *
Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 37: 544-550 (2003). *
Chalon SA, Desager JP, Desante KA, Frye RF, Witcher J, Long AJ, Sauer JM, Golnez JL, Smith BP, Thomasson HR, Horsmans Y. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites. Clin. Pharmacol. Ther. 73: 178-191 (2003). *
Chamaillard M, Girardin SE, Viala J, Philpott DJ. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5: 581-592 (2003). *
Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, Valvano MA, Foster SJ, Mak TW, Nunez G, Inohara N. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4: 702-707 (2003). *
Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U.S.A. 100: 3455-3460 (2003). *
Chambers V, Sutherland L, Palmer K, Dalton A, Rigby AS, Sokol R, Pollitt R, Tanner S, Gleeson D. Haemochromatosis-associated HFE genotypes in English blood donors: age-related frequency and biochemical expression. J. Hepatol. 39: 925-931 (2003). *
Chan AT. Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention. Cancer Causes Control 14: 413-418 (2003). *
Chan C, Berthiaume F, Lee K, Yarmush ML. Metabolic flux analysis of cultured hepatocytes exposed to plasma. Biotechnol. Bioeng. 81: 33-49 (2003). *
Chan C, Berthiaume F, Lee K, Yarmush ML. Metabolic flux analysis of hepatocyte function in hormone- and amino acid-supplemented plasma. Metab. Eng. 5: 1-15 (2003). *
Chan C, Hwang D, Stephanopoulos GN, Yarmush ML, Stephanopoulos G. Application of multivariate analysis to optimize function of cultured hepatocytes. Biotechnol. Prog. 19: 580-598 (2003). *
Chan CW, Papatheodoridis GV, Goulis J, Burroughs AK. Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. J. Hepatol. 39: 1094-1095 (2003). *
Chan E, Fonseca VA. Management of hyperhomocysteinemia. Metab. Syndr. Relat. Disord. 1: 159-170 (2003).
Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon 1: 63-75 (2003).
Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon 1: 125-136 (2003).
Chang G. Multidrug resistance ABC transporters. FEBS Lett. 555: 102-105 (2003). *
Chang TK, Bandiera SM, Chen J. Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. Drug Metab. Dispos. 31: 7-10 (2003). *
Chang YT, Tsai SF, Lee DD, Shiao YM, Huang CY, Liu HN, Wang WJ, Wong CK. A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br. J. Dermatol. 148: 418-423 (2003). *
Chang YT, Tsai SF, Lin MW, Liu HN, Lee DD, Shiao YM, Chin PJ, Wang WJ. SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene. Exp. Dermatol. 12: 307-314 (2003). *
Chapman RW. The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17 (2003).
Chapman RW. To perform or not to perform liver biopsy: an alternative view. Gut 52: 1227 (2003). *
Chapman RW. Viruses, protozoans and drugs as etiological factors in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 73-74. October 15-16 (2003). *
Chapman RW. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid. Dig. Liver Dis. 35: 306-308 (2003).
Charron M. Temporal correlation of the erythrocyte sedimentation rate with Tc-99m WBC uptake on children with inflammatory bowel diseases. Clin. Nucl. Med. 28: 905-907 (2003).
Charron M. Inflammatory bowel disease activity assessment with biologic markers and (99m)Tc-WBC scintigraphy: are there different trends in ileitis versus colitis? J. Nucl. Med. 44: 1586-1591 (2003). *
Chatenoud L. CD3-specific antibody-induced active tolerance: from bench to bedside. Nat. Rev. Immunol. 3: 123-132 (2003).
Chatterjee P, Franklin MR. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab. Dispos. 31: 1391-1397 (2003). *
Chawla Y, Dhiman RK. Portal biliopathy: emerging management problems. Trop. Gastroenterol. 24: 165-166 (2003).
Chazouilleres O, Wendum D. Diseases of the intrahepatic bile duct: diagnosis and treatments. Gastroenterol. Clin. Biol. 27: 307-318 (2003).
Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S. The incidence and management of infusion reactions to infliximab: a large center experience. Am. J. Gastroenterol. 98: 1315-1324 (2003). *
Cheikh I, Maamouri N, Chouaib S, Chaabouni H, Ouerghi H, Ben Ammar A. Association of celiac disease and Crohn's disease. A case report. Tunis. Med. 81: 969-971 (2003).
Cheikh I, Said Y, Chaabouni H, Ouerghi H, Ben Ammar A. Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients. Ann. Med. Interne. (Paris) 154: 7-11 (2003).
Chen C, Gulati P, French SW. Pathologic quiz case: a patient with acquired immunodeficiency syndrome and an unusual biliary infection. Arch. Pathol. Lab. Med. 127: 243-244 (2003). *
Chen C, Staudinger JL, Klaassen CD. Nuclear receptor, pregnane X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispos. 31: 908-915 (2003). *
Chen F, Ma L, Dawson PA, Sinal CJ, Sehayek E, Gonzalez FJ, Breslow J, Ananthanarayanan M, Shneider BL. Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter. J. Biol. Chem. 278: 19909-19916 (2003). *
Chen GG, Xu H, Lee JF, Subramaniam M, Leung KL, Wang SH, Chan UP, Spelsberg TC. 15-Hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int. J. Cancer 107: 837-843 (2003). *
Chen JM, Le Marechal C, Lucas D, Raguenes O, Ferec C. "Loss of function" mutations in the cationic trypsinogen gene (PRSS1) may act as a protective factor against pancreatitis. Mol. Genet. Metab. 79: 67-70 (2003). *
Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis: clinical experience with 15 patients. World J. Gastroenterol. 9: 2813-2816 (2003). *
Chen NX, Moe SM. Arterial calcification in diabetes. Curr. Diab. Rep. 3: 28-32 (2003).
Chen P, Soares AM, Lima AA, Gamble MV, Schorling JB, Conway M, Barrett LJ, Blaner WS, Guerrant RL. Association of vitamin A and zinc status with altered intestinal permeability: analyses of cohort data from northeastern Brazil. J. Health Popul. Nutr. 21: 309-315 (2003).
Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall TA. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am. J. Pathol. 162: 665-672 (2003). *
Chen S, Harisinghani MG, Wittenberg J. Small bowel CT fat density target sign in chronic radiation enteritis. Australas. Radiol. 47: 450-452 (2003).
Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 313: 71-82 (2003). *
Chen W, Gluud C. Bile acids for primary sclerosing cholangitis. Cochrane Database Syst. Rev. 2: CD003626 (2003). *
Chen W, Harp JA, Harmsen AG. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice. J. Parasitol. 89: 391-393 (2003).
Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886 (2003). *
Chen W, Li D, Cannan RJ, Stubbs RS. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig. Liver Dis. 35: 237-243 (2003).
Chen XM, Huang BQ, Splinter PL, Cao H, Zhu G, McNiven MA, LaRusso NF. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. Gastroenterology 125: 216-228 (2003). *
Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 63: 4048-4054 (2003). *
Cheng F, Wang HW, Cuenca A, Huang M, Ghansah T, Brayer J, Kerr WG, Takeda K, Akira S, Schoenberger SP, Yu H, Jove R, Sotomayor EM. A critical role for Stat3 signaling in immune tolerance. Immunity 19: 425-436 (2003). *
Cheng JB, Jacquemin E, Gerhardt M, Nazer H, Cresteil D, Heubi JE, Setchell KD, Russell DW. Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J. Clin. Endocrinol. Metab. 88: 1833-1841 (2003). *
Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J. Biol. Chem. 278: 38084-38093 (2003). *
Cheng S, Clancy CJ, Checkley MA, Handfield M, Hillman JD, Progulske-Fox A, Lewin AS, Fidel PL, Nguyen MH. Identification of Candida albicans genes induced during thrush offers insight into pathogenesis. Mol. Microbiol. 48: 1275-1288 (2003). *
Cheng VC, Lo CM, Lau GK. Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East. Semin. Liver Dis. 23: 239-250 (2003).
Cherayil BJ. How not to get bugged by bugs: mechanisms of cellular tolerance to microorganisms. Curr. Opin. Gastroenterol. 19: 572-577 (2003).
Chernova MN, Jiang L, Shmukler BE, Schweinfest CW, Blanco P, Freedman SD, Stewart AK, Alper SL. Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes. J. Physiol. 549: 3-19 (2003). *
Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W, Wan YJ, Moore DD, Klaassen CD. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab. Dispos. 31: 1315-1319 (2003). *
Chetri K, Choudhuri G. Role of trace elements in hepatic encephalopathy: zinc and manganese. Indian J. Gastroenterol. 22 Suppl. 2: S28-S30 (2003).
Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M, Marshall GM. Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter. Int. J. Cancer 105: 856-867 (2003). *
Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice. Biochem. Pharmacol. 66: 2011-2020 (2003). *
Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol. Clin. North Am. 32: 1269-1288 (2003).
Chew SS, Kerdic RI, Yang JL, Shi EC, Newstead GL, Douglas PR. Functional outcome and quality of life after ileal pouch-anal anastomosis in children and adults. ANZ J. Surg. 73: 983-987 (2003). *
Chew SS, Ngo TQ, Douglas PR, Newstead GL, Selby W, Solomon MJ. Cholecystectomy in patients with Crohn's ileitis. Dis. Colon Rectum 46: 1484-1488 (2003).
Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ. Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment. Pharmacol. Ther. 18: 347-353 (2003). *
Chi ZC, Ma SZ. Rheumatologic manifestations of hepatic diseases. Hepatobiliary Pancreat. Dis. Int. 2: 32-37 (2003). *
Chiang JY. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G349-G356 (2003). *
Chignard N, Mergey M, Veissiere D, Poupon R, Capeau J, Parc R, Paul A, Housset C. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G205-G212 (2003). *
Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J. Endocrinol. 179: 301-310 (2003). *
Chikoteev SP, Tovarshinov AI, Plekhanov AN, Lepekhova SA. Transplantation of isolated hepatocytes in hepatic failure. Klin. Med. (Mosk.) 81: 11-15 (2003).
Chikuma S, Bluestone JA. CTLA-4 and tolerance: the biochemical point of view. Immunol. Res. 28: 241-253 (2003). *
Child NJ, Yang IA, Pulletz MC, de Courcy-Golder K, Andrews AL, Pappachan VJ, Holloway JW. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 31: 652-653 (2003). *
Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, Peterson P, Wang Y, Ware C, Fu YX. Lymphotoxin pathway directs thymic Aire expression. Nat. Immunol. 4: 1121-11237 (2003). *
Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3: S41-S45 (2003).
Ching DW, McClintock A, Beswick F. Successful treatment with low-dose thalidomide in a patient with both Behcet's disease and complex regional pain syndrome type I: case report. J. Clin. Rheumatol. 9: 96-98 (2003).
Chistiakov DA. Thyroid-stimulating hormone receptor and its role in Graves' disease. Mol. Genet. Metab. 80: 377-388 (2003). *
Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J. Mol. Endocrinol. 31: 21-36 (2003). *
Chiu CC, Huang SY, Shen WW, Su KP. Omega-3 fatty acids for depression in pregnancy. Am. J. Psychiatry 160: 385 (2003). *
Cho JH. Significant role of genetics in IBD: the NOD2 gene. Rev. Gastroenterol. Disord. 3 Suppl. 1: S18-S22 (2003). *
Cho MC, Lee HS, Kim JH, Choe YK, Hong JT, Paik SG, Yoon do Y. A simple ELISA for screening ligands of peroxisome proliferator-activated receptor-gamma. J. Biochem. Mol. Biol. 36: 207-213 (2003). *
Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R. Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCA. Kidney Int. 63: 96-106 (2003). *
Choi M, Yamamoto K, Itoh T, Makishima M, Mangelsdorf DJ, Moras D, DeLuca HF, Yamada S. Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis. Chem. Biol. 10: 261-270 (2003). *
Choi SW, Bangaru BS, Wu CD, Finlay JL. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. J. Pediatr. Hematol. Oncol. 25: 503-506 (2003).
Choi YH, Im EO, Suh H, Jin Y, Yoo YH, Kim ND. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett. 199: 157-167 (2003). *
Chopin-Delannoy S, Thenot S, Delaunay F, Buisine E, Begue A, Duterque-Coquillaud M, Laudet V. A specific and unusual nuclear localization signal in the DNA binding domain of the Rev-erb orphan receptors. J. Mol. Endocrinol. 30: 197-211 (2003). *
Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab. Dispos. 31: 1337-1345 (2003). *
Choudhury J, Sanyal AJ. Treatment of ascites. Curr. Treat. Options Gastroenterol. 6: 481-491 (2003).
Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6: 33-66 (2003). *
Chow JY, Carlstrom K, Barrett KE. Growth hormone reduces chloride secretion in human colonic epithelial cells via EGF receptor and extracellular regulated kinase. Gastroenterology 125: 1114-1124 (2003). *
Christakos S, Barletta F, Huening M, Dhawan P, Liu Y, Porta A, Peng X. Vitamin D target proteins: function and regulation. J. Cell. Biochem. 88: 238-244 (2003). *
Christakos S, Dhawan P, Liu Y, Peng X, Porta A. New insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88: 695-705 (2003). *
Christensen E. Prognosis of untreated primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 63. October 15-16 (2003). *
Christensen T, Moller-Larsen A. Human endogenous retroviruses and disease? Ugeskr. Laeger. 165: 556-561 (2003).
Chrobak P. Control of T cell responses, tolerance and autoimmunity by regulatory T cells: current concepts. Acta Medica (Hradec Kralove) 46: 131-137 (2003).
Chu SH, Lee-Kang J, Lee KH, Lee K. Roles of reactive oxygen species, NF-kappaB, and peroxiredoxins in glycochenodeoxycholic acid-induced rat hepatocytes death. Pharmacology 69: 12-19 (2003).
Chung CC, Tsang WW, Kwok SY, Li MK. Laparoscopy and its current role in the management of colorectal disease. Colorectal Dis. 5: 528-543 (2003). *
Chung HT, Kim LH, Park BL, Lee JH, Park HS, Choi BW, Hong SJ, Chae SC, Kim JJ, Park CS, Shin HD. Association analysis of novel TBX21 variants with asthma phenotypes. Hum. Mutat. 22: 257 (2003). *
Chung SW, Kang BY, Kim TS. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor. Mol. Pharmacol. 64: 1169-1179 (2003). *
Chung YC, Chang YF. Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology 50: 1910-1913 (2003).
Church RD, Fleshman JW, McLeod HL. Cyclo-oxygenase 2 inhibition in colorectal cancer therapy. Br. J. Surg. 90: 1055-1067 (2003). *
Ciccocioppo R, Di Sabatino A, Ara C, Biagi F, Perilli M, Amicosante G, Cifone MG, Corazza GR. Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin. Exp. Immunol. 134: 516-524 (2003). *
Ciorba MA, Prakash C. Wireless capsule endoscopy in the diagnosis of small bowel Crohn's disease. Inflamm. Bowel Dis. 9: 276 (2003). *
Clabby ML, Robison TA, Quigley HF, Wilson DB, Kelly DP. Retinoid X receptor alpha represses GATA-4-mediated transcription via a retinoid-dependent interaction with the cardiac-enriched repressor FOG-2. J. Biol. Chem. 278: 5760-5767 (2003). *
Clancy R, Borody T, Ren Z, Pang G. Can the response to eradication therapy in Helicobacter pylori infection be predicted? Can. J. Gastroenterol. 17 Suppl. B: 58B-61B (2003).
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98: 960-967 (2003). *
Clark MP, Benjamin E, Alusi G. A rare case of Crohn's disease in head and neck surgery. J. Laryngol. Otol. 117: 146-147 (2003).
Clark-Curtiss JE, Haydel SE. Molecular genetics of Mycobacterium tuberculosis pathogenesis. Annu. Rev. Microbiol. 57: 517-549 (2003). *
Classen JB, Classen DC. Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals. J. Pediatr. Endocrinol. Metab. 16: 495-508 (2003).
Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, Staels B. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125: 544-555 (2003). *
Clavien PA. Organ preservation. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 111. October 17 - 19 (2003). *
Clemente MG, De Virgiliis S, Kang JS, Macatagney R, Musu MP, Di Pierro MR, Drago S, Congia M, Fasano A. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52: 218-223 (2003). *
Clough JD. The promise of molecular biology: efficacy, safety, wallet depletion. Cleve. Clin. J. Med. 70: 584 (2003).
Clough JD. A matter of privacy. Cleve. Clin. J. Med. 70: 166 (2003).
Coeffier M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin. Nutr. 22: 407-413 (2003).
Coghlan MJ, Jacobson PB, Lane B, Nakane M, Lin CW, Elmore SW, Kym PR, Luly JR, Carter GW, Turner R, Tyree CM, Hu J, Elgort M, Rosen J, Miner JN. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17: 860-869 (2003). *
Cohen RD. The mesalamine wars heat up-enter balsalazide. Gastroenterology 124: 574-575 (2003). *
Cohen RD. Infliximab at 5 years - tweaking the recipe for success? Gastroenterology 125: 1902-1903 (2003). *
Cohen RD. IBD indirect costs: the sleeping giant? Gastroenterology 125: 982-984 (2003). *
Cohn JA. Motion - genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments against the motion. Can. J. Gastroenterol. 17: 53-55 (2003). *
Cohran VC, Heubi JE. Treatment of pediatric cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 403-415 (2003).
Colecchia A, Sandri L, Staniscia T, Vestito A, Capodicasa S, Portincasa P, Mazzella G, Roda E, Festi D. Gallbladder motility and functional gastrointestinal disorders. Dig. Liver Dis. 35 Suppl. 3: S30-S34 (2003).
Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proc. Natl. Acad. Sci. U.S.A. 100: 1949-1954 (2003). *
Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide. Encephale 29: 49-58 (2003).
Colle I, Van Vlierberghe H. Diagnosis and therapeutic problems of primary sclerosing cholangitis. Acta Gastroenterol. Belg. 66: 155-159 (2003).
Colle I, Van Vlierberghe H, Pattyn P, Troisi R, Vogelaers D, de Hemptinne B, De Vos M. Cholestasis as presenting symptom of portal cavernoma. Hepatol. Res. 25: 32-37 (2003). *
Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am. J. Clin. Dermatol. 4: 13-20 (2003).
Collins JE, Heward JM, Carr-Smith J, Daykin J, Franklyn JA, Gough SC. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 88: 5039-5042 (2003). *
Collins M, Whitters MJ, Young DA. IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity. Immunol. Res. 28: 131-140 (2003). *
Colombel JF. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? Clin. Gastroenterol. Hepatol. 1: 5-9 (2003). *
Colombel JF, Ricart E, Loftus EV, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ. Management of Crohn's disease of the ileoanal pouch with infliximab. Am. J. Gastroenterol. 98: 2239-2244 (2003). *
Colombo M, Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res. 60: 145-150 (2003). *
Colonna M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 3: 445-453 (2003). *
Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat. Rev. Immunol. 3: 413-425 (2003). *
Cong Y, Konrad A, Iqbal N, Elson CO. Probiotics and immune regulation of inflammatory bowel diseases. Curr. Drug Targets Inflamm. Allergy 2: 145-154 (2003).
Conti F, Morelon E, Calmus Y. Immunosuppressive therapy in liver transplantation. J. Hepatol. 39: 664-678 (2003). *
Conti P, Kempuraj D, Frydas S, Kandere K, Boucher W, Letourneau R, Madhappan B, Sagimoto K, Christodoulou S, Theoharides TC. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol. Lett. 88: 171-174 (2003).
Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33: 125-134 (2003). *
Cook DN, Hollingsworth JW Jr, Schwartz DA. Toll-like receptors and the genetics of innate immunity. Curr. Opin. Allergy Clin. Immunol. 3: 523-529 (2003).
Coppola N, De Stefano G, Marrocco C, Scarano F, Scolastico C, Tarantino L, Rossi G, Battaglia M, Onofrio M, D'Aniello F, Pisapia R, Sagnelli C, Sagnelli E, Piccinino F, Giorgio A, Filippini P. Helicobacter spp. and liver diseases. Infez. Med. 11: 201-207 (2003).
Cordoba-Rodriguez R, Frucht DM. IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin. Biol. Ther. 3: 715-723 (2003).
Coremans G, Dockx S, Wyndaele J, Hendrickx A. Do anal fistulas in Crohn's disease behave differently and defy Goodsall's rule more frequently than fistulas that are cryptoglandular in origin? Am. J. Gastroenterol. 98: 2732-2735 (2003). *
Corpechot C. Primary biliary cirrhosis. Gastroenterol. Clin. Biol. 27: 320-324 (2003).
Corpechot C, Carrat F, Bahr A, Poupon RE, Poupon R. The impact of ursodeoxycholic acid (UDCA) therapy with or without liver transplantation (OLT) on long-term survival in primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 51. October 15-16 (2003). *
Corpechot C, Chazouilleres O. Primary biliary cirrhosis. Primary sclerosing cholangitis. Gastroenterol. Clin. Biol. 27: 325-332 (2003).
Correa PA, Molina JF, Pinto LF, Arcos-Burgos M, Herrera M, Anaya JM. TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus. Ann. Rheum. Dis. 62: 363-365 (2003). *
Cosma CL, Sherman DR, Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu. Rev. Microbiol. 57: 641-676 (2003). *
Costa AM, Tuchweber B, Lamireau T, Yousef IM, Balabaud C, Rosenbaum J, Desmouliere A. Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress. Virchows Arch. 442: 372-380 (2003). *
Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, Sterpi C, Marchi S, Maltinti G. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig. Liver Dis. 35: 642-647 (2003).
Costantino G, Macchiarulo A, Entrena-Guadix A, Camaioni E, Pellicciari R. Binding mode of 6ECDCA, a potent bile acid agonist of the farnesoid X receptor (FXR). Bioorg. Med. Chem. Lett. 13: 1865-1868 (2003). *
Costello JC, Halverson PB. A new era in rheumatoid arthritis treatment. WMJ 102: 29-33 (2003).
Costet P, Lalanne F, Gerbod-Giannone MC, Molina JR, Fu X, Lund EG, Gudas LJ, Tall AR. Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol. Cell. Biol. 23: 7756-7766 (2003). *
Cottone M, Marrone C, Casa A, Oliva L, Orlando A, Calabrese E, Martorana G, Pagliaro L. Familial occurrence of inflammatory bowel disease in celiac disease. Inflamm. Bowel Dis. 9: 321-323 (2003). *
Cottone M, Orlando A, Viscido A, Calabrese E, Camma C, Casa A. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease. Aliment. Pharmacol. Ther. 17 Suppl. 2: 38-42 (2003). *
Coulter-Mackie MB, Gagnier L. Spectrum of mutations in the arylsulfatase A gene in a Canadian DNA collection including two novel frameshift mutations, a new missense mutation (C488R) and an MLD mutation (R84Q) in cis with a pseudodeficiency allele. Mol. Genet. Metab. 79: 91-98 (2003). *
Cournu-Rebeix I, Genin E, Lesca G, Azoulay-Cayla A, Tubridy N, Noe E, Clanet M, Edan G, Clerget-Darpoux F, Semana G, Fontaine B. Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis. Genes Immun. 4: 518-523 (2003). *
Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. Bioartificial liver support devices: historical perspectives. ANZ J. Surg. 73: 739-748 (2003). *
Coverdale SA, Field J, Farrell GC. How reversible is hepatic functional impairment in autoimmune hepatitis? J. Gastroenterol. Hepatol. 18: 371-375 (2003). *
Craig RM, Traynor A, Oyama Y, Burt RK. Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant. 32 Suppl. 1: S57-S59 (2003). *
Cranendonk RJ, Kodde CJ, Chipeta D, Zijlstra EE, Sluiters JF. Cryptosporidium parvum and Isospora belli infections among patients with and without diarrhoea. East Afr. Med. J. 80: 398-401 (2003).
Crawford CL. The schizophrenic career of a "monster drug". Pediatrics 111: 712 (2003). *
Crawford MA, Golfetto I, Ghebremeskel K, Min Y, Moodley T, Poston L, Phylactos A, Cunnane S, Schmidt W. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 38: 303-315 (2003).
Crawford NP, Colliver DW, Galandiuk S. Tumor markers and colorectal cancer: utility in management. J. Surg. Oncol. 84: 239-248 (2003).
Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford) 42: 1295-1298 (2003). *
Crispe IN. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3: 51-62 (2003). *
Crocenzi FA, Mottino AD, Cao J, Veggi LM, Pozzi EJ, Vore M, Coleman R, Roma MG. Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G449-G459 (2003). *
Crocenzi FA, Mottino AD, Sanchez Pozzi EJ, Pellegrino JM, Rodriguez Garay EA, Milkiewicz P, Vore M, Coleman R, Roma MG. Impaired localisation and transport function of canalicular Bsep in taurolithocholate induced cholestasis in the rat. Gut 52: 1170-1177 (2003). *
Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM, Rodriguez Garay EA, Mottino AD, Roma MG. Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat. Biochem. Pharmacol. 66: 355-364 (2003). *
Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620 (2003). *
Croker BP, Gilkeson G, Morel L. Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus. Genes Immun. 4: 575-585 (2003). *
Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol. Res. 27: 185-202 (2003). *
Croog VJ, Ullman TA, Itzkowitz SH. Chemoprevention of colorectal cancer in ulcerative colitis. Int. J. Colorectal Dis. 18: 392-400 (2003). *
Croquet V, Fort J, Oberti F, Roquelaure Y, Ben Bouali AK, Pilette C, Cales P. 1,1,1-Trichloroethane-induced chronic active hepatitis. Gastroenterol. Clin. Biol. 27: 120-122 (2003).
Crosas B, Hyndman DJ, Gallego O, Martras S, Pares X, Flynn TG, Farres J. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem. J. 373: 973-979 (2003). *
Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 179-189 (2003). *
Croucher PJ, Mascheretti S, Foelsch UR, Hampe J, Schreiber S. Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 125: 1919-1920 (2003). *
Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Lu T, Nikolaus S, Yang SK, Krawczak M, Kim WH, Schreiber S. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 11: 6-16 (2003). *
Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H, Payne CM. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem. Biol. Interact. 145: 53-66 (2003). *
Crowson AN, Mihm MC Jr, Magro CM. Cutaneous vasculitis: a review. J. Cutan. Pathol. 30: 161-173 (2003). *
Crowson AN, Nuovo GJ, Mihm MC Jr, Magro C. Cutaneous manifestations of Crohn's disease, its spectrum, and its pathogenesis: intracellular consensus bacterial 16S rRNA is associated with the gastrointestinal but not the cutaneous manifestations of Crohn's disease. Hum. Pathol. 34: 1185-1192 (2003). *
Csepregi A, Obermayer-Straub P, Kneip S, Kayser A, Loges S, Schmidt E, Nemesanszky E, Szalay F, Manns MP, Strassburg CP. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis. Clin. Dev. Immunol. 10: 173-181 (2003). *
Csernok E. Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun. Rev. 2: 158-164 (2003).
Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748 (2003). *
Cucca F, Contu D, Zavattari P, Murru D. Correlation between major histocompatibility complex (MHC)-class II and type 1 diabetes. Minerva Endocrinol. 28: 111-122 (2003).
Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, Soto L, Cruzat A, Salazar-Onfray F, Aguillon JC. The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 42: 308-313 (2003). *
Cui B, Abe M, Hidata S, Nakanishi S, Matsuura B, Michitaka K, Yamamoto K, Horiike N, Onji M. Autoimmune hepatitis associated with Graves' disease. Intern. Med. 42: 331-335 (2003). *
Cui J, Huang L, Zhao A, Lew JL, Yu J, Sahoo S, Meinke PT, Royo I, Pelaez F, Wright SD. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. J. Biol. Chem. 278: 10214-10220 (2003). *
Cui R, He J, Zhang F, Wang B, Ding H, Shen H, Li Y, Chen X. Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br. J. Cancer 88: 1878-1882 (2003). *
Cui Y, Konig J, Nies AT, Pfannschmidt M, Hergt M, Franke WW, Alt W, Moll R, Keppler D. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab. Invest. 83: 527-538 (2003).
Cukovic-Cavka S. Primary biliary cirrhosis. Acta Med. Croatica 57: 221-225 (2003).
Cullen LM, Prat L, Cox DW. Genetic variation in the promoter and 5' UTR of the copper transporter, ATP7B, in patients with Wilson disease. Clin. Genet. 64: 429-432 (2003). *
Cullen M, Malasky M, Harding A, Carrington M. High-density map of short tandem repeats across the human major histocompatibility complex. Immunogenetics 54: 900-910 (2003). *
Cullen S, Chapman R. Primary sclerosing cholangitis. Autoimmun. Rev. 2: 305-312 (2003).
Cummings JH, Macfarlane GT, Macfarlane S. Intestinal bacteria and ulcerative colitis. Curr. Issues Intest. Microbiol. 4: 9-20 (2003).
Cunliffe RN. alpha-Defensins in the gastrointestinal tract. Mol. Immunol. 40: 463-467 (2003). *
Cunningham S, McColm JR, Mallinson A, Boyd I, Marshall TG. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis. Pediatr. Pulmonol. 36: 43-48 (2003).
Curley SA. CHAPTER 99. Diagnosis and Management of Biliary Tract Cancer. (http://www.cancer.org/downloads/PUB/DOCS/SECTION29/99.pdf) SECTION 29. Neoplasms of the Alimentary Canal. pp. 1423-1430 (2003). *
Cuzzocrea S. Emerging biotherapies for inflammatory bowel disease. Expert Opin. Emerg. Drugs 8: 339-347 (2003).
Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br. J. Pharmacol. 140: 366-376 (2003). *
Czaja AJ. The autoimmune hepatitis/hepatitis C overlap syndrome: does it exist? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 42-43. October 15-16 (2003). *
Czaja AJ. Autoimmune liver disease. Curr. Opin. Gastroenterol. 19: 232-242 (2003). *
Czaja AJ, Carpenter HA. Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis. Liver Int. 23: 116-123 (2003). *
Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J. Clin. Gastroenterol. 37: 315-329 (2003).
Czaja AJ, Shums Z, Binder WL, Lewis SJ, Nelson VJ, Norman GL. Frequency and significance of antibodies to chromatin in autoimmune hepatitis. Dig. Dis. Sci. 48: 1658-1664 (2003). *
Czarneski J, Rassa JC, Ross SR. Mouse mammary tumor virus and the immune system. Immunol. Res. 27: 469-480 (2003). *
Czuczejko J, Zachara BA, Staubach-Topczewska E, Halota W, Kedziora J. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim. Pol. 50: 1147-1154 (2003). *
D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin. Nephrol. 23: 117-134 (2003). *
D'Eredita G, Ferrarese F, Cecere V, Fabiano G. Factors affecting prognosis in patients with short bowel syndrome. G. Chir. 24: 302-304 (2003).
D'Haens G. Anti-TNF therapy for Crohn's disease. Curr. Pharm. Des. 9: 289-294 (2003).
D'Haens GR. Infliximab as disease-modifying therapy. Eur. J. Gastroenterol. Hepatol. 15: 233-237 (2003). *
Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 88: 5438-5443 (2003). *
Dabeva MD, Shafritz DA. Hepatic stem cells and liver repopulation. Semin. Liver Dis. 23: 349-362 (2003).
Dafnis G, Blomqvist P, Granath F, Pahlman L, Ekbom A. Colorectal cancer detection by colonoscopy in a Swedish county, 1979-95. Scand. J. Gastroenterol. 38: 1059-1067 (2003). *
Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG. Pediatric-onset primary biliary cirrhosis. Gastroenterology 125: 1476-1479 (2003). *
Dai T, Wu Y, Leng AS, Ao Y, Robel RC, Lu SC, French SW, Wan YJ. RXRalpha-regulated liver SAMe and GSH levels influence susceptibility to alcohol-induced hepatotoxicity. Exp. Mol. Pathol. 75: 194-200 (2003). *
Daikh BE, Ryan CK, Schwartz RH. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture. Ann. Allergy Asthma Immunol. 90: 23-27 (2003).
Daimon Y, Yamanishi K, Murakami Y, Kirishima T, Ito Y, Minami M, Okanoue T. Novel single nucleotide polymorphisms of the cytokeratin 19 pseudogene are associated with primary biliary cirrhosis. Hepatol. Res. 25: 281-286 (2003).
Dalby-Payne JR, O'Loughlin EV, Gunning P. Polarization of specific tropomyosin isoforms in gastrointestinal epithelial cells and their impact on CFTR at the apical surface. Mol. Biol. Cell 14: 4365-4375 (2003). *
Dalwadi H, Wei B, Schrage M, Spicher K, Su TT, Birnbaumer L, Rawlings DJ, Braun J. B cell developmental requirement for the Galphai2 gene. J. Immunol. 170: 1707-1715 (2003). *
Danalioglu A, Kaymakoglu S, Mungan Z, Karaca C, Demir K, Durakoglu Z, Besisik F, Boztas G, Cakaloglu Y, Okyen A. Cyclosporin for severe ulcerative colitis attacks. Hepatogastroenterology 50 Suppl. 2: ccxcviii-ccc (2003).
Danby FW. Night blindness, vitamin A deficiency, and isotretinoin psychotoxicity. Dermatol. Online J. 9: 30 (2003). *
Danelli P, Bartolucci C, Sampietro GM, Panizzo V, Sartani A, Maconi G, Parente E, Taschieri AM. Surgical options in the treatment of perianal Crohn's disease. Ann. Ital. Chir. 74: 635-640 (2003).
Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52: 1435-1441 (2003). *
Dardon A, Corona R, Mendez-Sanchez N. Hepatocellular carcinoma not associated with virus B and C and alcohol. Ann. Hepatol. 2: 46 (2003). *
Das UN, Ramos EJ, Meguid MM. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 6: 413-419 (2003).
Dascher CC, Brenner MB. CD1 antigen presentation and infectious disease. Contrib. Microbiol. 10: 164-182 (2003).
Dattner AM. From medical herbalism to phytotherapy in dermatology: back to the future. Dermatol. Ther. 16: 106-113 (2003).
Davari HR, Malekhossini SA, Salahi HA, Bahador A, Saberifirozi M, Geramizadeh B, Lahsaee SM, Khosravi MB, Imanieh MH, Bagheri MH. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp. Clin. Transplant. 1: 147-152 (2003).
Davidson BL. Hepatic diseases - hitting the target with inhibitory RNAs. N. Engl. J. Med. 349: 2357-2359 (2003). *
Davies DB. The impact of PELD on OPTN liver allocation: preliminary results. Clin. Transpl. 2003: 13-20 (2003).
Davies TF, Greenberg D, Tomer Y. The genetics of the autoimmune thyroid diseases. Ann. Endocrinol. (Paris) 64: 28-30 (2003).
Davies YK, Cox KM, Abdullah BA, Terry AB, Cox KL. Oral vancomycin: treatment of primary sclerosing cholangitis in children. J. Pediatr. Gastroenterol. Nutr. 37: 345-346 (2003). *
Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W; Enbrel Ankylosing Spondylitis Study Group. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 48: 3230-3236 (2003). *
Davis KG, Wertin TM, Schriver JP. The use of simvastatin for the prevention of gallstones in the lithogenic prairie dog model. Obes. Surg. 13: 865-868 (2003).
Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, Parks JS. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J. Biol. Chem. 278: 33920-33927 (2003). *
Day CP. Alcoholic steatohepatitis (ASH). Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 85-86. October 17 - 19 (2003). *
Day RM, Mitchell TJ, Knight SC, Forbes A. Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine 21: 224-233 (2003). *
De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24: 488-522 (2003). *
De Fabiani E, Mitro N, Gilardi F, Caruso D, Galli G, Crestani M. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J. Biol. Chem. 278: 39124-39132 (2003). *
de Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J. Hepatol. 38: 361-363 (2003). *
de Freitas Junior S, Bustorff-Silva JM, Castro e Silva Junior O, Jorge Gde L, Leonardi LS. Retinyl-palmitate reduces liver fibrosis induced by biliary obstruction in rats. Hepatogastroenterology 50: 146-150 (2003).
de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10: 133-139 (2003). *
de Jong DJ, Derijks LJ, Naber AH, Hooymans PM, Mulder CJ. Safety of thiopurines in the treatment of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 239: 69-72 (2003). *
de Jong DJ, Franke B, Naber AH, Willemen JJ, Heister AJ, Brunner HG, de Kovel CG, Hol FA. No evidence for involvement of IL-4R and CD11B from the IBD1 region and STAT6 in the IBD2 region in Crohn's disease. Eur. J. Hum. Genet. 11: 884-887 (2003). *
de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH. Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase. Gut 52: 547-551 (2003). *
De Lange T, Moum BA, Tholfsen JK, Larsen S, Aabakken L. Standardization and quality of endoscopy text reports in ulcerative colitis. Endoscopy 35: 835-840 (2003).
De las Heras D, Fernandez J, Gines P, Cardenas A, Ortega R, Navasa M, Barbera JA, Calahorra B, Guevara M, Bataller R, Jimenez W, Arroyo V, Rodes J. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 38: 452-459 (2003). *
De Miguel S, Jover JA, Vadillo C, Judez E, Loza E, Fernandez-Gutierrez B. B cell activation in rheumatoid arthritis patients under infliximab treatment. Clin. Exp. Rheumatol. 21: 726-732 (2003).
de Oca J, Sanchez-Santos R, Rague JM, Biondo S, Pares D, Osorio A, del Rio C, Jaurrieta E. Long-term results of ileal pouch-anal anastomosis in Crohn's disease. Inflamm. Bowel Dis. 9: 171-175 (2003). *
de Oca J, Vilar L, Castellote J, Sanchez Santos R, Pares D, Biondo S, Osorio A, del Rio C, Jaurrieta E, Marti Rague J. Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease. Rev. Esp. Enferm. Dig. 95: 465-470, 459-464 (2003).
de Raucourt E, Barbier C, Sinda P, Dib M, Peltier JY, Ternisien C. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors. Am. J. Hematol. 74: 187-190 (2003). *
De Rosa FG, Shaz D, Campagna AC, Dellaripa PE, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: a possible healthcare-associated case? Infect. Control Hosp. Epidemiol. 24: 477-482 (2003). *
de Serres FJ. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ. Health Perspect. 111: 1851-1854 (2003). *
de Silva AD, Mylonaki M, Rampton DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm. Bowel Dis. 9: 316-320 (2003). *
de Silva HA, Saparamadu PA, Thabrew MI, Pathmeswaran A, Fonseka MM, de Silva HJ. Liv.52 in alcoholic liver disease: a prospective, controlled trial. J. Ethnopharmacol. 84: 47-50 (2003).
De Tommaso AM, Santos DS, Novaes P, Arieta CE, Hessel G. Steroid-induced cataracts in patients with autoimmune hepatitis. Acta Gastroenterol. Latinoam. 33: 93-97 (2003).
de Vicente JC, Lopez-Arranz E, Garcia J, Lopez-Arranz JS. Chronic sclerosing sialadenitis of the parotid gland. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 96: 77-80 (2003).
de Villartay JP, Fischer A, Durandy A. The mechanisms of immune diversification and their disorders. Nat. Rev. Immunol. 3: 962-972 (2003). *
de Villiers WJ. Crohn's disease and IL-10 therapy: promise regained. Inflamm. Bowel Dis. 9: 210-211 (2003). *
De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J. Parenter. Enteral Nutr. 27: 52-57 (2003). *
de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170: 3883-3889 (2003). *
De Vries EG, Timmer T, Mulder NH, Van Geelen CM, Van Der Graaf WT, Spierings DC, De Hooge MN, Gietema JA, De Jong S. Modulation of death receptor pathways in oncology. Drugs Today (Barc.) 39 Suppl. C: 95-109 (2003).
De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J. Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J. Cyst. Fibros. 2: 72-75 (2003).
Debler J, Schiemann U, Seybold U, Mussack T, Landauer N, Ladurner R, Gross M. Heat-shock protein HSP70-2 genotypes in patients with Crohn's disease: a more severe clinical course with intestinal complications in presence of the PstI-polymorphism. Eur. J. Med. Res. 8: 120-124 (2003).
Dehmer C, Greinwald R, Loffler J, Grotz W, Wolf L, Hagmann HB, Schneider W, Kreisel W; German Salofalk Study Group. No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases. Int. J. Colorectal Dis. 18: 406-412 (2003). *
Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment. Pharmacol. Ther. 18: 1113-1120 (2003). *
Del Castillo IC, Alvarez JG, Freedman SD, Ollero M, Claros L, Song JC, Yoo J, Matthews JB. Docosahexaenoic acid selectively augments muscarinic stimulation of epithelial Cl- secretion. J. Surg. Res. 110: 338-343 (2003). *
Del Zotto B, Mumolo G, Pronio AM, Montesani C, Tersigni R, Boirivant M. TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis. Clin. Exp. Immunol. 134: 120-126 (2003). *
Delacourt C. Inflammation and cystic fibrosis. Arch. Pediatr. 10 Suppl. 2: 338s-341s (2003).
Delaney BC, Moayyedi P, Forman D. Initial management strategies for dyspepsia. Cochrane Database Syst. Rev. 2: CD001961 (2003). *
DeLeve LD. Vascular liver diseases. Curr. Gastroenterol. Rep. 5: 63-70 (2003).
Delgado J, Delgado B, Sztarkier I, Cagnano E, Sperber AD, Fich A. Presentation of Crohn's disease as metastatic cutaneous non-caseating granulomatous lesions. Isr. Med. Assoc. J. 5: 897-898 (2003). *
Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, Gomariz RP. PACAP in immunity and inflammation. Ann. N. Y. Acad. Sci. 992: 141-157 (2003). *
Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, Schenck K, Bogen B, Dembic Z. Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand. J. Immunol. 57: 534-544 (2003). *
Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C, Almgren P, Sjogren M, Hattersley A, Dina C, Tuomi T, McCarthy MI, Froguel P, Groop LC. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum. Mol. Genet. 12: 1865-1873 (2003). *
Dempsey PW, Vaidya SA, Cheng G. The art of war: innate and adaptive immune responses. Cell. Mol. Life Sci. 60: 2604-2621 (2003). *
Deng L, Ding W, Granstein RD. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. J. Invest. Dermatol. 121: 1060-1065 (2003). *
Denis M, Bissonnette R, Haidar B, Krimbou L, Bouvier M, Genest J. Expression, regulation, and activity of ABCA1 in human cell lines. Mol. Genet. Metab. 78: 265-274 (2003). *
Denk H. Alcoholic hepatitis and Mallory bodies. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 46. October 17 - 19 (2003). *
Deodhar NS. Epidemiological perspective of domestic and personal hygiene in India. Int. J. Environ. Health Res. 13 Suppl. 1: S47-S56 (2003).
Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp. Biol. Med. (Maywood) 228: 424-433 (2003). *
Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Eur. J. Gastroenterol. Hepatol. 15: 63-67 (2003).
Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Ranger-Rogez S, Crickx B. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br. J. Dermatol. 148: 1032-1034 (2003). *
Deshmukh R, Franco K. Talking to patients about St. John's wort. Cleve. Clin. J. Med. 70: 985-989 (2003).
Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, Ferri C. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J. Clin. Endocrinol. Metab. 88: 5341-5437 (2003). *
Desiderio S, Yoo JY. A genome-wide analysis of the acute-phase response and its regulation by Stat3beta. Ann. N. Y. Acad. Sci. 987: 280-284 (2003). *
Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol. 3: 280-291 (2003).
Desmet VJ. Classification of chronic hepatitis. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 44-45. October 17 - 19 (2003). *
Desmet VJ. Histology of autoimmune cholestatic liver diseases. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 25-26. October 15-16 (2003). *
Desreumaux P, Colombel JF. Intestinal flora and Crohn's disease. Ann. Pharm. Fr. 61: 276-281 (2003).
DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT; Vaccine Safety Datalink Research Group, National Immunization Program, Centers for Disease Control and Prevention. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch. Neurol. 60: 504-509 (2003). *
Detkova Z, Kupcova V, Prikazska M, Turecky L, Weissova S, Jahnova E. Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor alpha antibody (infliximab) in Crohn's disease. Physiol. Res. 52: 95-100 (2003). *
Deurloo DT, van Berkel MA, van Esch BC, Hofhuis F, Nijkamp FP, Oosterwegel MA, van Oosterhout AJ. CD28/CTLA4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease. Clin. Exp. Allergy 33: 1297-1304 (2003). *
Devaney J, Maher M, Smith T, Houghton JA, Glennon M. HFE alleles in an Irish cystic fibrosis population. Genet. Test. 7: 155-158 (2003).
Devine DA. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol. Immunol. 40: 431-443 (2003). *
Dhillon NK, Mudryj M. Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells. Genes Immun. 4: 336-342 (2003). *
Di Campli C, Gasbarrini G, Gasbarrini A. Review article: a medicine based on cell transplantation - is there a future for treating liver diseases? Aliment. Pharmacol. Ther. 18: 473-480 (2003). *
Di Campli C, Nestola M, Piscaglia AC, Santoliquido A, Gasbarrini G, Pola P, Gasbarrini A. Cell-based therapy for liver diseases. Eur. Rev. Med. Pharmacol. Sci. 7: 41-44 (2003).
Di Leo V, Venturi C, Baragiotta A, Martines D, Floreani A. Gastroduodenal and intestinal permeability in primary biliary cirrhosis. Eur. J. Gastroenterol. Hepatol. 15: 967-73 (2003).
Di Marco R, Mangano K, Quattrocchi C, Musumeci R, Speciale AM, Papaccio G, Buschard K, Bendtzen K, Nicoletti F. Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats. Clin. Immunol. 109: 266-271 (2003). *
Di Sabatino A, Ciccocioppo R, Luinetti O, Ricevuti L, Morera R, Cifone MG, Solcia E, Corazza GR. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis. Colon Rectum 46: 1498-1507 (2003).
Di Sario A, Bendia E, Taffetani S, Marzioni M, Candelaresi C, Pigini P, Schindler U, Kleemann HW, Trozzi L, Macarri G, Benedetti A. Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. Hepatology 37: 256-266 (2003). *
Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M. Complications of infliximab therapy in children and adolescents affected by Crohn's disease. Am. J. Gastroenterol. 98: 2812-2813 (2003). *
Diculescu M, Ciocirlan M, Ciocirlan M, Pitigoi D, Becheanu G, Croitoru A, Spanache S. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence. Rom. J. Gastroenterol. 12: 283-286 (2003).
Didziapetris R, Japertas P, Avdeef A, Petrauskas A. Classification analysis of P-glycoprotein substrate specificity. J. Drug Target. 11: 391-406 (2003).
Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, Sartor RB. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52: 370-376 (2003). *
Dienes HP. Histopathology of overlap syndromes in the liver. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 44-45. October 15-16 (2003). *
Dierkes J, Westphal S, Luley C. Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management. Drug Saf. 26: 81-91 (2003).
Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int. Arch. Allergy Immunol. 132: 98-108 (2003).
Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52: 1788-1795 (2003). *
Dietrich W, Erbguth F. Neurological complications of inflammatory intestinal diseases. Fortschr. Neurol. Psychiatr. 71: 406-414 (2003).
DiGiovanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis, and management. Am. J. Clin. Dermatol. 4: 81-95 (2003).
Dijkstra G, Hospers GA, Kleibeuker JH. Gene therapy with interleukin 10 in Crohn's disease: too early yet. Ned. Tijdschr. Geneeskd. 147: 2153-2156 (2003).
Dikopoulos N, Weidenbach H, Adler G, Schmid RM. Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II. Eur. J. Clin. Invest. 33: 58-64 (2003). *
Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, Dao A, Barbe F, Araujo C, Clement L, Feugier P, Lecompte T, Stoltz JF, Bordigoni P. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplant. 32: 733-737 (2003). *
Dinarello CA. Anti-cytokine therapeutics and infections. Vaccine 21 Suppl. 2: S24-S34 (2003). *
Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43: 149-173 (2003). *
Ding Y, Chen D, Tarcsafalvi A, Su R, Qin L, Bromberg JS. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170: 1383-1391 (2003). *
Ding YL, Tan LL, Deng W. Clinical analysis of intrahepatic cholestasis during pregnancy in 150 patients. Hunan Yi Ke Da Xue Xue Bao 28: 645-647 (2003).
Dionne S, Laberge S, Deslandres C, Seidman EG. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 133: 108-114 (2003). *
Direskeneli H, Saruhan-Direskeneli G. The role of heat shock proteins in Behcet's disease. Clin. Exp. Rheumatol. 21: S44-S48 (2003).
Distante S, Elmberg M, Foss Haug KB, Ovstebo R, Berg JP, Kierulf P, Hultcrantz R, Bell H. Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis. Scand. J. Gastroenterol. 38: 871-877 (2003). *
Ditschkowski M, Einsele H, Schwerdtfeger R, Bunjes D, Trenschel R, Beelen DW, Elmaagacli AH. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75: 1745-1747 (2003).
Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab. 88: 2983-2992 (2003). *
Dittrich S, de Mattos AA, Becker M, Goncaves DM, Cheinquer H. Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis. Hepatogastroenterology 50: 2052-2056 (2003).
Djouadi F, Bonnefont JP, Thuillier L, Droin V, Khadom N, Munnich A, Bastin J. Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate. Pediatr. Res. 54: 446-451 (2003). *
Dobbin CJ, Moriarty C, Bye PT. Granulomatous diseases in a patient with cystic fibrosis. J. Cyst. Fibros. 2: 35-37 (2003).
Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J. Immunol. 170: 508-519 (2003). *
Dode C, Cuisset L, Delpech M, Grateau G. TNFRSF1A-associated periodic syndrome (TRAPS), Muckle-Wells syndrome (MWS) and renal amyloidosis. J. Nephrol. 16: 435-437 (2003).
Dolan M, Lindberg G. The Inflammatory Bowel Disease Act: Congress considers landmark legislation focused exclusively on inflammatory bowel disease. Inflamm. Bowel Dis. 9: 59-60 (2003). *
Dommels YE, Haring MM, Keestra NG, Alink GM, van Bladeren PJ, van Ommen B. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis 24: 385-392 (2003). *
Donadiue J. Langerhans' cell histiocytosis. Orphanet Encyclopedia, May 2003, p 1-8 (http://www.orpha.net/data/patho/GB/uk-LCH.pdf) (2003). *
Donaldson P. HLA system and other genetic markers in PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 71-72. October 15-16 (2003). *
Donaldson PT. Immunogenetics in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 23-24. September 12 - 13 (2003). *
Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J. Gastroenterol. 9: 2533-2538 (2003). *
Doria C, Doyle HR, Mandala L, Marino IR, Caruana G, Gruttadauria S, Lauro A, Magnone M, Scotti Foglieni C, Lamonaca V, Scott VL. Changes in serum electrolytes during treatment of patients in liver failure with molecular adsorbent recirculating system. Int. J. Artif. Organs 26: 918-923 (2003).
Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem. Biophys. Res. Commun. 302: 575-580 (2003). *
Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, Rosenfeld JM, Alvarez JG, Noel JP, Nicolaou KC, Evans RM. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell 11: 1079-1092 (2003). *
Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358 (2003). *
Dragnev KH, Petty WJ, Dmitrovsky E. Retinoid targets in cancer therapy and chemoprevention. Cancer Biol. Ther. 2: S150-S156 (2003).
Drancourt M, Jacomo V, Lepidi H, Lechevallier E, Grisoni V, Coulange C, Ragni E, Alasia C, Dussol B, Berland Y, Raoult D. Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J. Clin. Microbiol. 41: 368-372 (2003). *
Dray X, Marteau P, Bienvenu T, Dusser D, Hubert D. Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 125: 1286 (2003). *
Dresch C, Xavier R, Brenol JC, Nardi NB, Chies JA. Analysis of two T-cell receptor BV gene segment polymorphisms in caucasoid Brazilian patients with rheumatoid arthritis. Immunol. Lett. 90: 77-80 (2003).
Drescher S, Glaeser H, Murdter T, Hitzl M, Eichelbaum M, Fromm MF. P-glycoprotein-mediated intestinal and biliary digoxin transport in humans. Clin. Pharmacol. Ther. 73: 223-231 (2003). *
Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS)… Rheumatology (Oxford) 42: 235-239 (2003). *
Drewe E, Zaitoun AM, Walker DA. Case 11-2003: ulcerative colitis and primary sclerosing cholangitis in a 14-year-old boy. N. Engl. J. Med. 349: 1482 (2003).
Drisko JA, Giles CK, Bischoff BJ. Probiotics in health maintenance and disease prevention. Altern. Med. Rev. 8: 143-155 (2003). *
Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J. Cutan. Med. Surg. 7: 382-386 (2003). *
du Bois RM, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J. Intern. Med. 253: 4-17 (2003). *
Du Y, Zhang QY, Ruan LR, Liang CC, Li QR, He W. The relationship between abnormal apoptosis and Fas expression of thymocytes from patients with myasthenia gravis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19: 450-453 (2003).
Duan HO, Simpson-Haidaris PJ. Functional analysis of interleukin 6 response elements (IL-6REs) on the human gamma-fibrinogen promoter: binding of hepatic Stat3 correlates negatively with transactivation potential of type II IL-6REs. J. Biol. Chem. 278: 41270-41281 (2003). *
Duarte WR, Shibata T, Takenaga K, Takahashi E, Kubota K, Ohya K, Ishikawa I, Yamauchi M, Kasugai S. S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J. Bone Miner. Res. 18: 493-501 (2003).
Dubaniewicz A, Dubaniewicz A. Cholangiocarcinoma - bile ducts cancer. Wiad. Lek. 56: 57-60 (2003).
Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin. Proc. 78: 436-442 (2003). *
Dubey AP, Banerjee S. Measles, mumps, rubella (MMR) vaccine. Indian J. Pediatr. 70: 579-584 (2003).
Dubinsky MC. Optimizing immunomodulator therapy for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 506-511 (2003).
Dubinsky MC. Monitoring of AZA/6-MP treatment in children with IBD is necessary. Inflamm. Bowel Dis. 9: 386-388 (2003). *
Dubinsky MC, Fleshner PP. Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr. Treat. Options Gastroenterol. 6: 183-200 (2003).
Dubinsky MC, Vasiliauskas EA, Singh H, Abreu MT, Papadakis KA, Tran T, Martin P, Vierling JM, Geller SA, Targan SR, Poordad FF. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 125: 298-303 (2003). *
Dubois RN. Will an aspirin a day keep the endoscope away? Gastroenterology 125: 612-614 (2003). *
Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 124: 1265-1276 (2003). *
Duclos P. Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin. Drug Saf. 2: 225-231 (2003).
Duclos-Vallee JC, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C, Karam V, Hurtova M, Feray C, Reynes M, Bismuth H, Samuel D. A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut 52: 893-897 (2003). *
Duerr RH. Update on the genetics of inflammatory bowel disease. J. Clin. Gastroenterol. 37: 358-367 (2003).
Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 4: 245-250 (2003). *
Duhamel GE, Stryker CJ, Lu G, Wong VJ, Tarara RP. Colonic spirochetosis of colony-raised rhesus macaques associated with Brachyspira and Helicobacter. Anaerobe 9: 45-55 (2003).
Dumoutier L, Lejeune D, Hor S, Fickenscher H, Renauld JC. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem. J. 370: 391-396 (2003). *
Dunkelberg JC, Trotter JF, Wachs M, Bak T, Kugelmas M, Steinberg T, Everson GT, Kam I. Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl. 9: 463-468 (2003). *
Dunn DS, Inoko H, Kulski JK. Dimorphic Alu element located between the TFIIH and CDSN genes within the major histocompatibility complex. Electrophoresis 24: 2740-2748 (2003). *
Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J. Biol. Chem. 278: 41443-41451 (2003). *
Dunnwald M, Zuberi AR, Stephens K, Le R, Sundberg JP, Fleckman P, Dale BA. The ichq mutant mouse, a model for the human skin disorder harlequin ichthyosis: mapping, keratinocyte culture, and consideration of candidate genes involved in epidermal growth regulation. Exp. Dermatol. 12: 245-254 (2003). *
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin. Exp. Allergy 33: 442-448 (2003). *
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J. Allergy Clin. Immunol. 112: 1178-1184 (2003). *
Dupe V, Matt N, Garnier JM, Chambon P, Mark M, Ghyselinck NB. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. U.S.A. 100: 14036-14041 (2003). *
Durazzo M, Premoli A, Fagoonee S, Pellicano R. Overlap syndromes of autoimmune hepatitis: what is known so far. Dig. Dis. Sci. 48: 423-430 (2003). *
Dussault I, Beard R, Lin M, Hollister K, Chen J, Xiao JH, Chandraratna R, Forman BM. Identification of gene-selective modulators of the bile acid receptor FXR. J. Biol. Chem. 278: 7027-7033 (2003). *
Dussault I, Yoo HD, Lin M, Wang E, Fan M, Batta AK, Salen G, Erickson SK, Forman BM. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc. Natl. Acad. Sci. U.S.A. 100: 833-838 (2003). *
Duvic M, Norris D, Christiano A, Hordinsky M, Price V. Alopecia areata registry: an overview. J. Investig. Dermatol. Symp. Proc. 8: 219-221 (2003). *
Duymaz-Tozkir J, Gul A, Uyar FA, Ozbek U, Saruhan-Direskeneli G. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behcet's disease. Clin. Exp. Rheumatol. 21: S15-S18 (2003).
Dvorak Z, Modriansky M, Pichard-Garcia L, Balaguer P, Vilarem MJ, Ulrichova J, Maurel P, Pascussi JM. Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol. Pharmacol. 64: 160-169 (2003). *
Dziarski R. Recognition of bacterial peptidoglycan by the innate immune system. Cell. Mol. Life Sci. 60: 1793-1804 (2003). *
Dziarski R, Platt KA, Gelius E, Steiner H, Gupta D. Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic Gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice. Blood 102: 689-697 (2003). *
Eaden J. Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 18 Suppl. 2: 15-21 (2003). *
Eberl G, Littman DR. The role of the nuclear hormone receptor RORgammat in the development of lymph nodes and Peyer's patches. Immunol. Rev. 195: 81-90 (2003). *
Edmond LM, Hopkins MJ, Magee EA, Cummings JH. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria. Inflamm. Bowel Dis. 9: 10-17 (2003). *
Edwards G. Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J. 2 Suppl. 1: S8 (2003). *
Efferth T. Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases. Ageing Res. Rev. 2: 11-24 (2003).
Efrati O, Barak A, Modan-Moses D, Augarten A, Vilozni D, Katznelson D, Szeinberg A, Yahav J, Bujanover Y. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 15: 1073-1078 (2003).
Ehlin AG, Montgomery SM, Ekbom A, Pounder RE, Wakefield AJ. Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 52: 1117-1121 (2003). *
Einarsdottir E, Soderstrom I, Lofgren-Burstrom A, Haraldsson S, Nilsson-Ardnor S, Penha-Goncalves C, Lind L, Holmgren G, Holmberg M, Asplund K, Holmberg D. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease. Eur. J. Hum. Genet. 11: 81-84 (2003). *
Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis. 37: 1496-1505 (2003). *
Ekbom A. Paratuberculosis and Crohn's disease - possible linkage? Acta Vet. Scand. 44: 267-268 (2003).
Eknoyan G. On testing for proteinuria: time for a methodical approach. Cleve. Clin. J. Med. 70: 493, 496-497, 501 (2003).
El-Sayed LH, Ghoneim HM, El-Sayed MH, Deimian SR, Adam AN, Abou Rawash SN, Abou Rawash NM, Ursos P. Immunological abnormalities in workers exposed to pollutants at an Egyptian copper company. Immunopharmacol. Immunotoxicol. 25: 473-490 (2003).
El-Tawil AM. Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility. Andrologia 35: 337-341 (2003).
El-Youssef M. Wilson disease. Mayo Clin. Proc. 78: 1126-1136 (2003). *
Elamiri A, Perwaiz S, Tuchweber B, Yousef IM. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice. Pharmacol. Res. 48: 467-472 (2003). *
Elices MJ. Natalizumab. Elan/Biogen. Curr. Opin. Investig. Drugs 4: 1354-1362 (2003).
Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, Young LS. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene 22: 7557-7569 (2003). *
Elkin PL. Primer on medical genomics. Part V: Bioinformatics. Mayo Clin. Proc. 78: 57-64 (2003). *
Ellingson JL, Cheville JC, Brees D, Miller JM, Cheville NF. Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. Clin. Med. Res. 1: 217-226 (2003). *
Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF, Weinstock JV. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G385-G391 (2003). *
Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology 38: 930-938 (2003). *
Ellis HJ, Pollock EL, Engel W, Fraser JS, Rosen-Bronson S, Wieser H, Ciclitira PJ. Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut 52: 212-217 (2003). *
Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, Lindgren S, Loof L, Stal P, Wallerstedt S, Almer S, Sandberg-Gertzen H, Askling J. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 125: 1733-1741 (2003). *
Eloranta ML, Hakli T, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy. Scand. J. Gastroenterol. 38: 648-652 (2003). *
Elsner HA, Baengeroth K, Blasczyk R. The nature of introns 4-6 suggests reduced lineage specificity in HLA-B alleles. Genes Immun. 4: 391-401 (2003). *
Elson CO, Sartor RB, Targan SR, Sandborn WJ. Challenges in IBD research: updating the scientific agendas. Inflamm. Bowel Dis. 9: 137-153 (2003). *
Emerson SD, Palermo R, Liu CM, Tilley JW, Chen L, Danho W, Madison VS, Greeley DN, Ju G, Fry DC. NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction. Protein Sci. 12: 811-822 (2003). *
Emery P, Seto Y. Role of biologics in early arthritis. Clin. Exp. Rheumatol. 21 (5 Suppl. 31): S191-S194 (2003).
Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144: 5138-5144 (2003). *
Eng B, Nakamura LN, O'Reilly N, Schokman N, Nowaczyk MM, Krivit W, Waye JS. Identification of nine novel arylsulfatase a (ARSA) gene mutations in patients with metachromatic leukodystrophy (MLD). Hum. Mutat. 22: 418-419 (2003). *
Engel P, Eck MJ, Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 3: 813-821 (2003). *
Enghard P, Riemekasten G. Regulatory T cells - a possible promising target in the treatment of autoimmune diseases. Z. Rheumatol. 62: 355-360 (2003).
Engler S, Elsing C, Flechtenmacher C, Theilmann L, Stremmel W, Stiehl A. Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52: 688-693 (2003). *
Enns R, Eloubeidi MA, Mergener K, Jowell PS, Branch MS, Baillie J. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. Can. J. Gastroenterol. 17: 243-248 (2003). *
Ensenauer RE, Reinke SS, Ackerman MJ, Tester DJ, Whiteman DA, Tefferi A. Primer on medical genomics. Part VIII: Essentials of medical genetics for the practicing physician. Mayo Clin. Proc. 78: 846-857 (2003). *
Eraly SA, Hamilton BA, Nigam SK. Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem. Biophys. Res. Commun. 300: 333-342 (2003). *
Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol. 162: 691-702 (2003). *
Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y, Tomczak M, Rogers AB, Horwitz BH, Fox JG. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 63: 6042-6050 (2003). *
Eren M, Saltik-Temizel IN, Demir H. Esophagogastroduodenoscopy in childhood inflammatory bowel disease. Indian J. Gastroenterol. 22: 236-237 (2003).
Erickson SK, Lear SR, Deane S, Dubrac S, Huling SL, Nguyen L, Bollineni JS, Shefer S, Hyogo H, Cohen DE, Shneider B, Sehayek E, Ananthanarayanan M, Balasubramaniyan N, Suchy FJ, Batta AK, Salen G. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J. Lipid Res. 44: 1001-1009 (2003). *
Eriksson A, Shafazand M, Jennische E, Lange S. Effect of antisecretory factor in ulcerative colitis on histological and laborative outcome: a short period clinical trial. Scand. J. Gastroenterol. 38: 1045-1049 (2003). *
Eriksson A, Shafazand M, Jennische E, Lonnroth I, Lange S. Antisecretory factor-induced regression of Crohn's disease in a weak responder to conventional pharmacological treatment. Inflamm. Bowel Dis. 9: 398-400 (2003). *
Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197: 1787-1791 (2003). *
Ertekin V, Selimoglu MA, Orbak Z. An unusual combination of relapsing and cholestatic hepatitis A in childhood. Yonsei. Med. J. 44: 939-942 (2003). *
Escher JC, Taminiau JA, Nieuwenhuis EE, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm. Bowel Dis. 9: 34-58 (2003). *
Eskandari F, Webster JI, Sternberg EM. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res. Ther. 5: 251-265 (2003). *
Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 138: 852-858 (2003). *
Estiarte R, Juan J, Colome E, Artes M, Jimenez FJ. Drug utilization study in patients with Crohn's disease in Spain. Eur. J. Gastroenterol. Hepatol. 15: 355-362 (2003).
Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421: 177-182 (2003). *
Etzioni A. Immune deficiency and autoimmunity. Autoimmun. Rev. 2: 364-369 (2003).
Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 37: 897-901 (2003). *
Evans WE. Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut 52 Suppl. 2: ii10-ii18 (2003). *
Everson GT, Trotter JF, Kugelmas M, Forman L. Immunosuppression in liver transplantation. Minerva Chir. 58: 725-740 (2003).
Ezaki T, Watanabe M, Inoue N, Kanai T, Ogata H, Iwao Y, Ishii H, Hibi T. A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers. Cancer Res. 63: 3747-3749 (2003). *
Ezekowitz RA. Role of the mannose-binding lectin in innate immunity. J. Infect. Dis. 187 Suppl. 2: S335-S339 (2003). *
Faber KN, Muller M, Jansen PL. Drug transport proteins in the liver. Adv. Drug Deliv. Rev. 55: 107-124 (2003). *
Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat. Rev. Immunol. 3: 63-72 (2003).
Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin. Exp. Immunol. 131: 90-101 (2003). *
Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am. J. Hum. Genet. 72: 1560-1564 (2003). *
Falk Symposium No 134 + Falk Workshop (Berlin, Germany), June 12-14, 2003 (http://www.falkfoundation.com/pdf/FSK134e.pdf). New Findings on Pathogenesis and Progress in Management of Inflammatory Bowel Diseases. Falk Congress Short Reports (2003). *
Falkowska-Podstawka M, Wernicki A. Heat shock proteins in health and disease. Pol. J. Vet. Sci. 6: 61-70 (2003).
Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB, Theise ND. Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J. Hepatol. 39: 357-364 (2003). *
Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4: 1206-1212 (2003). *
Fallone CA, Tran S, Semret M, Discepola F, Behr M, Barkun AN. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment. Pharmacol. Ther. 17: 453-458 (2003). *
Falorni A. Immunologic and genetic aspects of latent autoimmune diabetes in the adult. Minerva Endocrinol. 28: 297-312 (2003).
Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr. Pharm. Des. 9: 1973-1980 (2003).
Fan LY, Zhong RQ, Tu XQ, Zhu Y, Gong CL, Zhou L, Zhao ZX, Ralph F, Thomas P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune liver diseases on Chinese. Zhonghua Yi Xue Za Zhi 83: 1852-1855 (2003).
Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24: 1541-1548 (2003). *
Fantry L. Gastrointestinal infections in the immunocompromised host. Curr. Opin. Gastroenterol. 19: 37-41 (2003).
Farnier M, Salko T, Isaacsohn JL, Troendle AJ, Dejager S, Gonasun L. Effects of baseline level of triglycerides on changes in lipid levels from combined fluvastatin + fibrate (bezafibrate, fenofibrate, or gemfibrozil). Am. J. Cardiol. 92: 794-797 (2003). *
Farrell RJ. Epidermal growth factor for ulcerative colitis. N. Engl. J. Med. 349: 395-397 (2003). *
Farrell RJ, Kelleher D. Glucocorticoid resistance in inflammatory bowel disease. J. Endocrinol. 178: 339-346 (2003). *
Fasano A. Celiac disease - how to handle a clinical chameleon. N. Engl. J. Med. 348: 2568-2570 (2003). *
Fassas A, Kazis A. High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis. J. Hematother. Stem Cell Res. 12: 701-711 (2003).
Fatma OS, Sarper DA, Dilek E, Emel OA, Semra A, Dilek KS, Mahmut C. HLA-DRB1 association in Turkish psoriasis vulgaris patients. Swiss Med. Wkly. 133: 541-543 (2003). *
Faust D, Menge F, Armbruster FP, Lembcke B, Stein J. Increased serum bone sialoprotein concentrations in patients with Crohn's disease. Z. Gastroenterol. 41: 243-247 (2003).
Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech. Dev. 120: 117-130 (2003). *
Favre C, Gerard A, Clauzier E, Pontarotti P, Olive D, Nunes JA. DOK4 and DOK5: new dok-related genes expressed in human T cells. Genes Immun. 4: 40-45 (2003). *
Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum. Immunol. 64: 816-822 (2003).
Feagan BG. Maintenance therapy for inflammatory bowel disease. Am. J. Gastroenterol. 98: S6-S17 (2003). *
Feferman T, Im SH, Fuchs S, Souroujon MC. Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 140: 153-158 (2003).
Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 48: 1956-1963 (2003). *
Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J. Int. Med. Res. 31: 537-551 (2003).
Feld J, Heathcote E. Epidemiology of autoimmune liver disease. J. Gastroenterol. Hepatol. 18: 1118-1128 (2003). *
Felderbauer P, Hoffmann P, Einwachter H, Bulut K, Ansorge N, Schmitz F, Schmidt WE. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol. 3: 34 (2003). *
Feldmann H, Jones S, Klenk HD, Schnittler HJ. Ebola virus: from discovery to vaccine. Nat. Rev. Immunol. 3: 677-685 (2003).
Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125: 437-443 (2003). *
Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39: 978-983 (2003). *
Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 38: 210-217 (2003). *
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol. Int. 23: 61-66 (2003). *
Felldin M, Friman S, Olausson M, Backman L, Castedal M, Larsson B, Henriksson BA, Siewert-Delle A. Liver dialysis using MARS in acute hepatic failure. Promising results in a pilot setting. Lakartidningen 100: 3836-3838, 3841 (2003).
Fellermann K, Luhmann D, Stange EF. Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Con argument. Inflamm. Bowel Dis. 9: 198-201 (2003). *
Fellermann K, Wehkamp J, Herrlinger KR, Stange EF. Crohn's disease: a defensin deficiency syndrome? Eur. J. Gastroenterol. Hepatol. 15: 627-634 (2003). *
Felley C, Michetti P. Engineered lymphocytes to treat dinitrobenzene sulphonic acid colitis in mice. Eur. J. Gastroenterol. Hepatol. 15: 1253-1255 (2003).
Fenwick SW, Toogood GJ, Lodge JP, Hull MA. The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology 125: 716-729 (2003). *
Ferenci P. How to identify the genetic basis of gastrointestinal and liver diseases? Gut 52 Suppl. 2: ii6-ii9 (2003). *
Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 23: 139-142 (2003). *
Fernandes J, Reshef A, Patton L, Ayuso R, Reese G, Lehrer SB. Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed Orthodox Jews. Clin. Exp. Allergy 33: 956-961 (2003). *
Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Anti-inflammatory role for intracellular dimeric immunoglobulin A by neutralization of lipopolysaccharide in epithelial cells. Immunity 18: 739-749 (2003). *
Fernandez P, Guillen MI, Gomar F, Alcaraz MJ. Expression of heme oxygenase-1 and regulation by cytokines in human osteoarthritic chondrocytes. Biochem. Pharmacol. 66: 2049-2052 (2003). *
Fernandez-Aguilar JL, Bondia Navarro JA, Santoyo Santoyo J, Suarez-Munoz MA, Perez-Daga A, Ramirez Plaza C, Mera Velasco S, de la Fuente Perucho A. Calibrated portacaval H-graft shunt in variceal hemorrhage. Long-term results. Hepatogastroenterology 50: 2000-2004 (2003).
Fernandez-Checa JC. Alcohol-induced liver disease: when fat and oxidative stress meet. Ann. Hepatol. 2: 69-75 (2003). *
Fernandez-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26: 1362-1368 (2003). *
Fernandez-Vozmediano JM, Armario-Hita JC, Gonzalez-Cabrerizo A. Sjogren-Larsson syndrome: treatment with topical calcipotriol. Pediatr. Dermatol. 20: 179-180 (2003). *
Ferrandez A, Prescott S, Burt RW. COX-2 and colorectal cancer. Curr. Pharm. Des. 9: 2229-2251 (2003).
Ferreira MA. Cytokine expression in allergic inflammation: systematic review of in vivo challenge studies. Mediators Inflamm. 12: 259-267 (2003). *
Ferreiros-Vidal I, Amarelo J, Barros F, Carracedo A, Gomez-Reino JJ, Gonzalez A. Lack of association of ankylosing spondylitis with the most common NOD2 susceptibility alleles to Crohn's disease. J. Rheumatol. 30: 102-104 (2003).
Ferreiros-Vidal I, Barros F, Pablos JL, Carracedo A, Gomez-Reino JJ, Gonzalez A. CARD15/NOD2 analysis in rheumatoid arthritis susceptibility. Rheumatology (Oxford) 42: 1380-1382 (2003). *
Ferreiros-Vidal I, Garcia-Meijide J, Carreira P, Barros F, Carracedo A, Gomez-Reino JJ, Gonzalez A. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus. Rheumatology (Oxford) 42: 570-574 (2003). *
Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 125: 795-804 (2003). *
Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. J. Hepatol. 38: 387-394 (2003). *
Fidder HH, Olschwang S, Avidan B, Zouali H, Lang A, Bardan E, Picard O, Bar-Meir S, Colombel JF, Chowers Y. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients. Am. J. Med. Genet. 121A: 240-244 (2003). *
Field AC, Bloch MF, Bellon B. Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells. J. Autoimmun. 21: 201-212 (2003).
Field EA, Allan RB. Oral ulceration - aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment. Pharmacol. Ther. 18: 949-962 (2003). *
Filippi J, Eyraud E, Al-Jaouni R, Schneider SM, Hebuterne X. Food intake and micronutrient status in patients with Crohn's disease. Clin. Nutr. 22: S34 (2003). *
Filippone A, Ambrosini R, Fuschi M, Marinelli T, Pinto D, Maggialetti A. Clinical impact of MR cholangiopancreatography in patients with biliary disease. Radiol. Med. (Torino) 105: 27-35 (2003).
Finesilver AG. Newer approaches to the treatment of rheumatoid arthritis. WMJ 102: 34-37 (2003).
Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr. Opin. Crit. Care 9: 143-151 (2003).
Finn OJ. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641 (2003). *
Fiocchi C. More answers and more questions in inflammatory bowel disease. Curr. Opin. Gastroenterol. 19: 325-326 (2003).
Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract. Res. Clin. Gastroenterol. 17: 711-724 (2003).
Fiorucci S, Antonelli E, Brancaleone V, Sanpaolo L, Orlandi S, Distrutti E, Acuto G, Clerici C, Baldoni M, Del Soldato P, Morelli A. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. J. Hepatol. 39: 932-939 (2003). *
Fiorucci S, Antonelli E, Morelli A. Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver. Dig. Liver Dis. 35 Suppl. 2: S61-S69 (2003).
Firneisz G, Zehavi I, Vermes C, Hanyecz A, Frieman JA, Glant TT. Identification and quantification of disease-related gene clusters. Bioinformatics 19: 1781-1786 (2003). *
Fischer M, You M, Matsumoto M, Crabb DW. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J. Biol. Chem. 278: 27997-28004 (2003). *
Fisher SA, Lanchbury JS, Lewis CM. Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. Arthritis Rheum. 48: 1200-1206 (2003). *
Fisher SA, Moody A, Mirza MM, Cuthbert AP, Hampe J, Macpherson A, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex disease. Ann. Hum. Genet. 67: 377-390 (2003). *
Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, Descamps V. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br. J. Dermatol. 149: 1018-1022 (2003). *
Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, Suffredini AF. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660 (2003). *
Flanders KC, Burmester JK. Medical applications of transforming growth factor-beta. Clin. Med. Res. 1: 13-20 (2003). *
Fleischmann R, Shealy D. Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis. Mol. Intervent. 3: 310-318 (2003). *
Fleming KA. Histology and brush cytology for diagnosis of bile duct carcinoma in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 92. October 15-16 (2003). *
Floch MH. Probiotics, irritable bowel syndrome, and inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 283-288 (2003).
Flodstrom-Tullberg M. Viral infections: their elusive role in regulating susceptibility to autoimmune disease. Microbes Infect. 5: 911-921 (2003). *
Floreani A. Preventative therapy in primary biliary cirrhosis. Clin. Liver Dis. 7: 911-921 (2003).
Floreani A, Baragiotta A, Guido M. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment. Dig. Liver Dis. 35: 128-129 (2003).
Floreani A, Baragiotta A, Leone MG, Baldo V, Naccarato R. Primary biliary cirrhosis and hepatitis C virus infection. Am. J. Gastroenterol. 98: 2757-2762 (2003). *
Flores-Villanueva PO, Hendel H, Caillat-Zucman S, Rappaport J, Burgos-Tiburcio A, Bertin-Maghit S, Ruiz-Morales JA, Teran ME, Rodriguez-Tafur J, Zagury JF. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J. Immunol. 170: 1925-1929 (2003). *
Flori L, Kumulungui B, Aucan C, Esnault C, Traore AS, Fumoux F, Rihet P. Linkage and association between Plasmodium falciparum blood infection levels and chromosome 5q31-q33. Genes Immun. 4: 265-268 (2003). *
Flourie B, Moussata D, Nancey S, Bonvoisin S, Benahmed M, Descos L. Cancer and inflammatory bowel diseases. Gastroenterol. Clin. Biol. 27: S104-S111 (2003).
Flynn M. Noninfectious liver disorders: adult autoimmune hepatitis. Nurse Pract. 28: 28-31 (2003).
Fociani P, Carsana L, Zerbi P, Ferri A, Sampietro GM, Vago G. Histopathological differential diagnosis in inflammatory bowel diseases. Ann. Ital. Chir. 74: 641-649 (2003).
Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853 (2003). *
Fofi C, Nicoletti MC, Onetti-Muda A, Giulio S. Focal segmental glomerulosclerosis with IgA deposits in a patient with ulcerative colitis. G. Ital. Nefrol. 20: 641-644 (2003).
Fogden E, Neuberger J. Alternative medicines and the liver. Liver Int. 23: 213-220 (2003). *
Fogel EL, Sherman S, Park SH, McHenry L, Lehman GA. Therapeutic biliary endoscopy. Endoscopy 35: 156-163 (2003).
Folwaczny C, Glas J, Torok HP. Crohn's disease: an immunodeficiency? Eur. J. Gastroenterol. Hepatol. 15: 621-626 (2003). *
Folwaczny M, Glas J, Torok HP, Fricke K, Folwaczny C. Prevalence of the chemokine receptor CCR5-Delta32 gene mutation in periodontal disease. Clin. Immunol. 109: 325-329 (2003). *
Fonarow GC. Aggressive treatment of atherosclerosis: the time is now. Cleve. Clin. J. Med. 70: 431-434, 437438, 440 (2003).
Fontana S, Moratto D, Mangal S, De Francesco M, Vermi W, Ferrari S, Facchetti F, Kutukculer N, Fiorini C, Duse M, Das PK, Notarangelo LD, Plebani A, Badolato R. Functional defects of dendritic cells in patients with CD40 deficiency. Blood 102: 4099-4106 (2003). *
Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336 (2003). *
Forbes A, Cartwright A, Marchant S, McIntyre P, Newton M. Review article: oral, modified-release mesalazine formulations - proprietary versus generic. Aliment. Pharmacol. Ther. 17: 1207-1214 (2003). *
Forbes JR, Gros P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102: 1884-1892 (2003). *
Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv. Pediatr. 50: 245-267 (2003).
Forestier M, Banninger R, Reichen J, Solioz M. Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. Biochim. Biophys. Acta 1638: 29-34 (2003). *
Fornoni A, Lenz O, Striker LJ, Striker GE. Glucose induces clonal selection and reversible dinucleotide repeat expansion in mesangial cells isolated from glomerulosclerosis-prone mice. Diabetes 52: 2594-2602 (2003). *
Foroncewicz B, Mucha K, Paczek L, Oldakowska-Jedynak U, Gornicka B, Zieniewicz K, Nyckowski P, Krawczyk M. Anti-CD25 and tacrolimus therapy may not prevent early primary biliary cirrhosis recurrence after liver transplantation: two case reports. Transplant. Proc. 35: 2310-2312 (2003). *
Forrest CM, Gould SR, Darlington LG, Stone TW. Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv. Exp. Med. Biol. 527: 395-400 (2003).
Fortuna VA, Martucci RB, Trugo LC, Borojevic R. Hepatic stellate cells uptake of retinol associated with retinol-binding protein or with bovine serum albumin. J. Cell. Biochem. 90: 792-805 (2003). *
Foster BC, Vandenhoek S, Hana J, Krantis A, Akhtar MH, Bryan M, Budzinski JW, Ramputh A, Arnason JT. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 10: 334-342 (2003).
Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr. Opin. Ophthalmol. 14: 395-398 (2003).
Foster JE, Gott K, Schuyler MR, Kozak W, Tesfaigzi Y. LPS-induced neutrophilic inflammation and Bcl-2 expression in metaplastic mucous cells. Am. J. Physiol. Lung Cell Mol. Physiol. 285: L405-L414 (2003). *
Foster RA, Zander DS, Mergo PJ, Valentine JF. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm. Bowel Dis. 9: 308-315 (2003). *
Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H. A comparative study between T regulatory type 1 and CD4(+)CD25(+) T cells in the control of inflammation. J. Immunol. 171: 5018-5026 (2003). *
Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, Rhein L, Collins JL, Willson TM, Mangelsdorf DJ, Elias PM, Feingold KR. Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J. Invest. Dermatol. 120: 246-255 (2003). *
Fox IJ. Hepatocyte transplantation: clinical aspects. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 37. October 20 - 21 (2003). *
Franca AV, Valerio HM, Trevisan M, Escanhoela C, Seva-Pereira T, Zucoloto S, Martinelli A, Soares EC. Fine needle aspiration biopsy for improving the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytol. 47: 332-336 (2003).
Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124: 9-17 (2003). *
Franceschi RT, Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88: 446-454 (2003). *
Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65: 261-311 (2003). *
Frangolias DD, Ruan J, Wilcox PJ, Davidson AG, Wong LT, Berthiaume Y, Hennessey R, Freitag A, Pedder L, Corey M, Sweezey N, Zielenski J, Tullis E, Sandford AJ. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. Am. J. Respir. Cell. Mol. Biol. 29: 390-396 (2003). *
Frank C, Gonzalez MM, Oinonen C, Dunlop TW, Carlberg C. Characterization of DNA complexes formed by the nuclear receptor constitutive androstane receptor. J. Biol. Chem. 278: 43299-43310 (2003). *
Franklin GM, Nelson L. Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy. Neurology 61: 1032-1034 (2003).
Fraser JS, Engel W, Ellis HJ, Moodie SJ, Pollock EL, Wieser H, Ciclitira PJ. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 52: 1698-1702 (2003). *
Frauendorf E, von Goessel H, May E, Marker-Hermann E. HLA-B27-restricted T cells from patients with ankylosing spondylitis recognize peptides from B*2705 that are similar to bacteria-derived peptides. Clin. Exp. Immunol. 134: 351-359 (2003). *
Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol. Dis. 30: 288-297 (2003). *
Freeman HJ. Natural history and clinical behavior of Crohn's disease extending beyond two decades. J. Clin. Gastroenterol. 37: 216-219 (2003).
Freeman HJ. Temporal and geographic evolution of longstanding Crohn's disease over more than 50 years. Can. J. Gastroenterol. 17: 696-700 (2003). *
Freeman ML. Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr. Gastroenterol. Rep. 5: 145-153 (2003).
Freeman ML, Sielaff TD. A modern approach to malignant hilar biliary obstruction. Rev. Gastroenterol. Disord. 3: 187-201 (2003). *
Freeman RB. MELD/PELD: one year later. Transplant. Proc. 35: 2425-2427 (2003). *
Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 289: 2554-2559 (2003). *
Freie B, Li X, Ciccone SL, Nawa K, Cooper S, Vogelweid C, Schantz L, Haneline LS, Orazi A, Broxmeyer HE, Lee SH, Clapp DW. Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 102: 4146-4152 (2003). *
Freitas M, Tavan E, Cayuela C, Diop L, Sapin C, Trugnan G. Host-pathogens cross-talk. Indigenous bacteria and probiotics also play the game. Biol. Cell 95: 503-506 (2003). *
Fridell JA, Bond GJ, Mazariegos GV, Orenstein DM, Jain A, Sindhi R, Finder JD, Molmenti E, Reyes J. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J. Pediatr. Surg. 38: 1152-1156 (2003).
Friedewald SM, Molmenti EP, DeJong MR, Hamper UM. Vascular and nonvascular complications of liver transplants: sonographic evaluation and correlation with other imaging modalities and findings at surgery and pathology. Ultrasound Q. 19: 71-85 (2003).
Friedman S, Odze RD, Farraye FA. Management of neoplastic polyps in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 260-266 (2003). *
Friedman SL. Hepatic fibrogenesis. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 24. October 20 - 21 (2003). *
Friedman SL. Liver fibrosis - from bench to bedside. J. Hepatol. 38 Suppl. 1: S38-S53 (2003). *
Friedman SL. Hepatic stellate cell biology and fibrosis - from Hans Popper to the present. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 76-77. October 17 - 19 (2003). *
Friedrich M, Sterry W, Asadullah K. Novel developments in the systemic treatment of psoriasis. J. Dtsch. Dermatol. Ges. 1: 12-21 (2003).
Friedrich RE, Heiland M, El-Moawen A, Dogan A, Von Schrenck T, Loning T. Oral lichen planus in patients with chronic liver diseases. Infection 31: 383-386 (2003).
Frieri M. Identification of masqueraders of autoimmune disease in the office. Allergy Asthma Proc. 24: 421-429 (2003).
Frilling A. Standards of visceral organ procurement. Zentralbl. Chir. 128: 804-815 (2003).
Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17: 2386-2392 (2003). *
Fruhwirth M, Janecke AR, Muller T, Carlton VE, Kronenberg F, Offner F, Knisely AS, Geleff S, Song EJ, Simma B, Konigsrainer A, Margreiter R, van der Hagen CB, Eiklid K, Aagenaes O, Bull L, Ellemunter H. Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome. J. Pediatr. 142: 441-447 (2003). *
Frulloni L, Castellani C, Bovo P, Vaona B, Calore B, Liani C, Mastella G, Cavallini G. Natural history of pancreatitis associated with cystic fibrosis gene mutations. Dig. Liver Dis. 35: 179-185 (2003).
Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 9: 748-753 (2003). *
Fu T, Kashireddy P, Borensztajn J. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E. Biochem. J. 373: 941-947 (2003). *
Fuchs M. Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challenges. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G551-G557 (2003). *
Fuchtenbusch M, Vogel A, Achenbach P, Gummer M, Ziegler AG, Albert E, Standl E, Manns MP. Lupus-like panniculitis in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Exp. Clin. Endocrinol. Diabetes 111: 288-293 (2003).
Fuentealba IC, Aburto EM. Animal models of copper-associated liver disease. Comp. Hepatol. 2: 5 (2003). *
Fujii K, Miyashita T, Omata T, Kobayashi K, Takanashi J, Kouchi K, Yamada M, Kohno Y. Gorlin syndrome with ulcerative colitis in a Japanese girl. Am. J. Med. Genet. A. 121A: 65-68 (2003).
Fujii S, Fujimori T, Chiba T, Terano A. Efficacy of surveillance and molecular markers for detection of ulcerative colitis-associated colorectal neoplasia. J. Gastroenterol. 38: 1117-1125 (2003). *
Fujii T, Shiba M, Takatera H. A case of ammonium urate urolithiasis with Crohn's disease. Hinyokika. Kiyo. 49: 615-617 (2003).
Fujimoto J. Reversal of liver cirrhosis by hepatocyte growth factor. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 41. October 20 - 21 (2003). *
Fujinaga J, Loiselle FB, Casey JR. Transport activity of chimaeric AE2-AE3 chloride/bicarbonate anion exchange proteins. Biochem. J. 371: 687-696 (2003). *
Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70 (2003). *
Fujiwara Y, Yokoyama M, Sawada R, Seyama Y, Ishii M, Tsutsumi S, Aburatani H, Hanaka S, Itakura H, Matsumoto A. Analysis of the comprehensive effects of polyunsaturated fatty acid on mRNA expression using a gene chip. J. Nutr. Sci. Vitaminol. (Tokyo) 49: 125-132 (2003).
Fukazawa T, Kikuchi S, Niino M, Yabe I, Miyagishi R, Fukaura H, Hamada T, Tashiro K. Susceptibility genes for multiple sclerosis. Nippon Rinsho 61: 1311-1316 (2003).
Fukuhara C, Tosini G. Peripheral circadian oscillators and their rhythmic regulation. Front. Biosci. 8: d642-d651 (2003).
Fukushima K, Yonezawa H, Fiocchi C. Inflammatory bowel disease-associated gene expression in intestinal epithelial cells by differential cDNA screening and mRNA display. Inflamm. Bowel Dis. 9: 290-301 (2003). *
Fuller SJ, Kumar P, Weltman M, Wiley JS. Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. Am. J. Hematol. 72: 31-33 (2003). *
Fulop T Jr, Larbi A, Dupuis G, Pawelec G. Ageing, autoimmunity and arthritis: perturbations of TCR signal transduction pathways with ageing - a biochemical paradigm for the ageing immune system. Arthritis Res. Ther. 5: 290-302 (2003). *
Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J. Rheumatol. 30: 2563-2571 (2003).
Fuss IJ. Cytokine network in inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2: 101-112 (2003).
Gaiva MH, Couto RC, Oyama LM, Couto GE, Silveira VL, Ribeiro EB, Nascimento CM. Diets rich in polyunsaturated fatty acids: effect on hepatic metabolism in rats. Nutrition 19: 144-149 (2003). *
Gallati S. Genetics of cystic fibrosis. Semin. Respir. Crit. Care Med. 24: 629-638 (2003).
Galle PR, Schuchmann M, Strand D, Strand S. Fas (CD95) mediated apoptosis in liver disease. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 18. October 20 - 21 (2003). *
Galman C, Ostlund-Lindqvist AM, Bjorquist A, Schreyer S, Svensson L, Angelin B, Rudling M. Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency. FASEB J. 17: 265-267 (2003). *
Galvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc. Natl. Acad. Sci. U.S.A. 100: 15276-15279 (2003). *
Galvao Da Silva AP, Jacysyn JF, De Almeida Abrahamsohn I. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response. Immunology 108: 230-237 (2003). *
Galvez J, Garrido M, Rodriguez-Cabezas ME, Ramis I, de Medina FS, Merlos M, Zarzuelo A. The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. Inflamm. Bowel Dis. 9: 363-371 (2003). *
Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15: 430-435 (2003).
Game X, Malavaud B, Alric L, Mouzin M, Sarramon JP, Rischmann P. Infliximab treatment of Crohn disease ileovesical fistula. Scand. J. Gastroenterol. 38: 1097-1098 (2003). *
Gammell P, O'Driscoll L, Clynes M. Characterisation of BHK-21 cells engineered to secrete human insulin. Cytotechnology 41: 11-21 (2003). *
Gan H, Ouyang Q, Chen Y, Liang F. The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 20: 268-272 (2003).
Gan SI, Beck PL. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am. J. Gastroenterol. 98: 2363-2371 (2003). *
Gant TW, Baus PR, Clothier B, Riley J, Davies R, Judah DJ, Edwards RE, George E, Greaves P, Smith AG. Gene expression profiles associated with inflammation, fibrosis, and cholestasis in mouse liver after griseofulvin. EHP Toxicogenomics 111: 37-43 (2003).
Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102: 783-788 (2003). *
Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720 (2003). *
Gao J, Lin Y, Qiu C, Liu Y, Ma Y, Liu Y. Association between HLA-DQA1, -DQB1 gene polymorphisms and susceptibility to asthma in northern Chinese subjects. Chin. Med. J. (Engl.) 116: 1078-1082 (2003).
Garbo GM, Vicente MG, Fingar V, Kessel D. Effects of ursodeoxycholic acid on photodynamic therapy in a murine tumor model. Photochem. Photobiol. 78: 407-410 (2003).
Garchon HJ. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man. J. Autoimmun. 21: 105-110 (2003).
Garcia AL, Ruhl R, Herz U, Koebnick C, Schweigert FJ, Worm M. Retinoid- and carotenoid-enriched diets influence the ontogenesis of the immune system in mice. Immunology 110: 180-187 (2003). *
Garcia C, Biller BM, Klibanski A. The role of the clinical laboratory in the diagnosis of Cushing syndrome. Am. J. Clin. Pathol. 120: S38-S45 (2003).
Garcia Cuerpo E. Nanobacteria and urinary system lithiasis. Arch. Esp. Urol. 56: 191-192 (2003).
Garcia Herola A, Nos P, Hinijosa J, Hoyos M, Moles J, Carmona E, Puig N, Sanchez-Cuenca J, Ponce J, Berenguer J. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease. Rev. Esp. Enferm. Dig. 95: 755-759 (2003).
Garcia-Leiva J, Rios-Vaca A, Torre-Delgadillo A. Antibodies and physiopathogeny of autoimmune hepatitis. Rev. Invest. Clin. 55: 577-582 (2003).
Garcia-Perez MA, Paz-Artal E, Corell A, Moreno A, Lopez-Goyanes A, Garcia-Martin F, Vazquez R, Pacho A, Romo E, Allende LM. Mutations of CD40 ligand in two patients with hyper-IgM syndrome. Immunobiology 207: 285-294 (2003).
Garcia-Porrua C, Gonzalez-Gay MA. Successful response to infliximab in a patient with undifferentiated spondyloarthropathy coexisting with polyarteritis nodosa-like cutaneous vasculitis. Clin. Exp. Rheumatol. 21 (6 Suppl. 32): S138 (2003).
Garcia-Ramos G, Tellez-Zenteno JF, Zapata-Zuniga M, Yamamoto-Furusho JK, Ruiz-Morales JA, Villarreal-Garza C, Vargas-Alarcon G, Estanol B, Llorente L, Granados J. HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis. Eur. J. Neurol. 10: 707-710 (2003). *
Garcia-Tsao G. Portal hypertension. Curr. Opin. Gastroenterol. 19: 250-258 (2003).
Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R, Vinh DC. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect. Dis. 3: 148-155 (2003).
Garg S, Mehta S, Dormans JP. An atypical presentation of Langerhans cell histiocytosis of the cervical spine in a child. Spine 28: E445-E448 (2003).
Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol. Immunol. 40: 73-84 (2003). *
Garrido Serrano A, Guerrero Igea F. Atypical endoscopic appearance in ulcerative colitis. Rev. Esp. Enferm. Dig. 95: 664-665 (2003).
Gasbarrini A, Carloni E, Gasbarrini G, Menard A. Helicobacter pylori and extragastric diseases - other Helicobacters. Helicobacter 8 Suppl. 1: 68-76 (2003).
Gasbarrini G, Mingrone G, Giancaterini A, De Gaetano A, Scarfone A, Capristo E, Calvani M, Caso V, Greco AV. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Hepatogastroenterology 50: 1385-1389 (2003).
Gasche C, Alizadeh BZ, Pena AS. Genotype-phenotype correlations: how many disorders constitute inflammatory bowel disease? Eur. J. Gastroenterol. Hepatol. 15: 599-606 (2003). *
Gassull MA. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig. Dis. 21: 220-227 (2003).
Gause A, Schnabel A. Rheumatology 2003-part I: research news concerning pathogenesis, epidemiology, diagnosis, and therapy of chronic inflammatory joint diseases. Med. Klin. (Munich) 98: 523-533 (2003).
Gause WC, Urban JF, Stadecker MJ. The immune response to parasitic helminths: insights from murine models. Trends Immunol. 24: 269-277 (2003). *
Gawenis LR, Franklin CL, Simpson JE, Palmer BA, Walker NM, Wiggins TM, Clarke LL. cAMP inhibition of murine intestinal Na/H exchange requires CFTR-mediated cell shrinkage of villus epithelium. Gastroenterology 125: 1148-1163 (2003). *
Gaya DR, Thorburn D, Oien KA, Morris AJ, Stanley AJ. Hepatic granulomas: a 10 year single centre experience. J. Clin. Pathol. 56: 850-853 (2003). *
Gearry R, Barclay M, Gardiner S, Zhang M. 6-Thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MP. N. Z. Med. J. 116: U531 (2003). *
Gearry RB, Barclay ML, Burt MJ, Collett JA, Chapman BA, Roberts RL, Kennedy MA. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 18: 395-400 (2003). *
Geboes K, De Hertogh G. Indeterminate colitis. Inflamm. Bowel Dis. 9: 324-331 (2003). *
Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3: 721-732 (2003). *
Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C, Stremmel W. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102: 371-376 (2003). *
Geier A, Dietrich CG, Gerloff T, Haendly J, Kullak-Ublick GA, Stieger B, Meier PJ, Matern S, Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 1609: 87-94 (2003). *
Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, Gartung C. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354 (2003). *
Geier A, Gartung C, Dietrich CG, Lammert F, Wasmuth HE, Matern S. Diagnosis of cholestatic disorders. Med. Klin. (Munich) 98: 499-509 (2003).
Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J. Gastroenterol. 9: 2681-2685 (2003). *
Geier A, Mertens PR, Gerloff T, Dietrich CG, En-Nia A, Kullak-Ublick GA, Karpen SJ, Matern S, Gartung C. Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. Biochem. Biophys. Res. Commun. 309: 612-618 (2003). *
Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin. Drug Saf. 2: 113-122 (2003).
Geissler M. DNA-based immunotherapy. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 43. October 20 - 21 (2003). *
Geissmann F, Revy P, Brousse N, Lepelletier Y, Folli C, Durandy A, Chambon P, Dy M. Retinoids regulate survival and antigen presentation by immature dendritic cells. J. Exp. Med. 198: 623-634 (2003). *
Gelbmann CM, Leeb SN, Vogl D, Maendel M, Herfarth H, Scholmerich J, Falk W, Rogler G. Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts. Gut 52: 1448-1456 (2003). *
Gelder CM, Williams OM, Hart KW, Wall S, Williams G, Ingrams D, Bull P, Bunce M, Welsh K, Marshall SE, Borysiewicz L. HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J. Virol. 77: 1927-1939 (2003). *
Gendrot C, Bacq Y, Brechot MC, Lansac J, Andres C. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J. Med. Genet. 40: e32 (2003). *
Gene E, Calvet X, Azagra R, Gisbert JP. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Aliment. Pharmacol. Ther. 17: 1137-1143 (2003). *
Gentzsch M, Cui L, Mengos A, Chang XB, Chen JH, Riordan JR. The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins. J. Biol. Chem. 278: 6440-6449 (2003). *
Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP. Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin. Sci. (Lond.) 105: 213-218 (2003). *
Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, Sitthimonchai S, Frank N. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat. Res. 523-524: 163-172 (2003).
German JB, Roberts MA, Watkins SM. Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids. J. Nutr. 133: 2078S-2083S (2003). *
Gerner EW, Ignatenko NA, Besselsen DG. Preclinical models for chemoprevention of colon cancer. Recent Results Cancer Res. 163: 58-71 (2003).
Gershwin ME, Van de Water J, Leung P, Ansari AA, Coppel RL. The pathobiology and the cause of primary biliary cirrhosis. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 36-37. September 12 - 13 (2003). *
Gershwin ME, Van de WaterJ, Leung P, Ansari AA, Coppel RL. Primary biliary cirrhosis: from induction through destruction. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 18. October 15-16 (2003). *
Geubel AP, Sempoux C, Rahier J. Bile duct disorders. Clin. Liver Dis. 7: 295-309 (2003).
Gewirtz AT. Intestinal epithelial Toll-like receptors: to protect. And serve? Curr. Pharm. Des. 9: 1-5 (2003).
Gezer S. Antiphospholipid syndrome. Dis. Mon. 49: 696-741 (2003).
Ghanchi FD, Rembacken BJ. Inflammatory bowel disease and the eye. Surv. Ophthalmol. 48: 663-676 (2003). *
Gharagozlou P, Demirci H, David Clark J, Lameh J. Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacol. 3: 1 (2003). *
Gheorghe L, Gheorghe C, Badea M, Vadan R, Parvulescu I, Toader C, Tugui L, Papuc O, Ionescu R, Preda C, Calin I, Diculescu M. Infliximab for Crohn's disease in clinical practice: the experience of a single center in Romania. Rom. J. Gastroenterol. 12: 7-13 (2003).
Ghirardi M, Di Fabio F, Mariani PP, Nascimbeni R, Salerni B. Surgery in severe ulcerative colitis: our experience. Ann. Ital. Chir. 74: 543-546 (2003).
Ghoreschi K, Mrowietz U, Rocken M. A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses. J. Mol. Med. 81: 471-480 (2003). *
Ghoreschi K, Rocken M. Immunopathogenesis of psoriasis. J. Dtsch. Dermatol. Ges. 1: 524-532 (2003).
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlondorff D, Plewig G, Sander CA, Rocken M. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 9: 40-46 (2003). *
Ghosh S. Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease:the role of natalizumab. Expert Opin. Biol. Ther. 3: 995-1000 (2003).
Ghosh S, Goldin E, Gordon FH, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnalek P, Zadorova Z, Palmer T, Donoghue S; Natalizumab Pan-European Study Group. Natalizumab for active Crohn's disease. N. Engl. J. Med. 348: 24-32 (2003). *
Giallourakis C, Stoll M, Miller K, Hampe J, Lander ES, Daly MJ, Schreiber S, Rioux JD. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am. J. Hum. Genet. 73: 205-211 (2003). *
Giannini E, Botta F, Testa R. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 125: 993-994 (2003). *
Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum. Immunol. 64: 930-935 (2003).
Giedraitis V, Modin H, Callander M, Landtblom AM, Fossdal R, Stefansson K, Hillert J, Gulcher J. Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun. 4: 559-563 (2003). *
Gil A. Is eicosapentaenoic acid useful in the treatment of ulcerative colitis in children? J. Pediatr. Gastroenterol. Nutr. 37: 536-537 (2003). *
Gilde AJ, Van Bilsen M. Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle. Acta Physiol. Scand. 178: 425-434 (2003). *
Gines P. Refractory ascites and hepatorenal syndrome. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 97-98. October 17 - 19 (2003). *
Gionchetti P, Amadini C, Rizzello F, Venturi A, Poggioli G, Campieri M. Diagnosis and treatment of pouchitis. Best Pract. Res. Clin. Gastroenterol. 17: 75-87 (2003).
Gionchetti P, Rizzello F, Habal F, Morselli C, Amadini C, Romagnoli R, Campieri M. Standard treatment of ulcerative colitis. Dig. Dis. 21: 157-167 (2003).
Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209 (2003). *
Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 12: 970-979 (2003). *
Girardin F, Rentsch KM, Schwab MA, Maggiorini M, Pauli-Magnus C, Kullak-Ublick GA, Meier PJ, Fattinger K. Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts. Clin. Pharmacol. Ther. 74: 341-352 (2003). *
Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300: 1584-1587 (2003). *
Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872 (2003). *
Girardin SE, Hugot JP, Sansonetti PJ. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol. 24: 652-658 (2003). *
Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, Sansonetti PJ, Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278: 41702-41708 (2003). *
Gisbert JP, Ducons J, Gomollon F, Dominguez-Munoz JE, Borda F, Mino G, Jimenez I, Vazquez MA, Santolaria S, Gallego S, Iglesias J, Pastor G, Hervas A, Pajares JM. Validation of the 13C-urea breath test for the initial diagnosis of Helicobacter pylori infection and to confirm eradication after treatment. Rev. Esp. Enferm. Dig. 95: 121-126 (2003).
Gisbert JP, Gonzalez-Guijarro L, Cara C, Pajares JM, Moreno-Otero R. Thiopurine methyltransferase activity in patients with autoimmune hepatitis. Med. Clin. (Barc.) 121: 481-484 (2003).
Gisbert JP, Jones EA, Pajares JM, Moreno-Otero R. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Aliment. Pharmacol. Ther. 17: 17-27 (2003). *
Gisbert JP, Luna M, Mate J, Gonzalez-Guijarro L, Cara C, Pajares JM. Thiopurine methyltransferase activity and myelosuppression in inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Med. Clin. (Barc.) 121: 1-5 (2003).
Gisbert JP, Pajares JM. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy. Rev. Esp. Enferm. Dig. 95: 220-228 (2003).
Gisbert JP, Pajares JM. Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter 8: 159-167 (2003).
Gisler SM, Pribanic S, Bacic D, Forrer P, Gantenbein A, Sabourin LA, Tsuji A, Zhao ZS, Manser E, Biber J, Murer H. PDZK1: I. A major scaffolder in brush borders of proximal tubular cells. Kidney Int. 64: 1733-1745 (2003). *
Gitlin JD. Wilson disease. Gastroenterology 125: 1868-1877 (2003). *
Gladman DD, Farewell VT, Pellett F, Schentag C, Rahman P. HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs. Hum. Immunol. 64: 887-889 (2003).
Glas J, Torok HP, Simperl C, Konig A, Martin K, Schmidt F, Schaefer M, Schiemann U, Folwaczny C. The Delta 32 mutation of the chemokine-receptor 5 gene neither is correlated with chronic hepatitis C nor does it predict response to therapy with interferon-alpha and ribavirin. Clin. Immunol. 108: 46-50 (2003). *
Glas J, Torok HP, Unterhuber H, Radlmayr M, Folwaczny C. The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin. Immunol. 106: 197-200 (2003). *
Glaser S, Alvaro D, Roskams T, Phinizy JL, Stoica G, Francis H, Ueno Y, Barbaro B, Marzioni M, Mauldin J, Rashid S, Mancino MG, LeSage G, Alpini G. Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G683-G694 (2003). *
Glaser S, Alvaro D, Ueno Y, Francis H, Marzioni M, Phinizy JL, Baumann B, Mancino MG, Venter J, LeSage G, Alpini G. Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. Liver Int. 23: 78-88 (2003). *
Glehen O, Mithieux F, Traverse-Glehen A, Isaac S, Bienvenu J, Francois Y, Chung R, Gilly FN. Enteral immunotherapy in the treatment of chronic enterocolitis in interleukin-10-deficient mice. Hepatogastroenterology 50: 670-675 (2003).
Glossop JR, Nixon NB, Dawes PT, Hassell AB, Mattey DL. No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis. J. Rheumatol. 30: 1406-1409 (2003).
Godard B, Ten Kate L, Evers-Kiebooms G, Ayme S. Population genetic screening programmes: principles, techniques, practices, and policies. Eur. J. Hum. Genet. 11 Suppl. 2: S49-S87 (2003). *
Goedecke V, Crane AM, Jaakkola E, Kaluza W, Laiho K, Weeks DE, Wilson J, Kauppi M, Kaarela K, Tuomilehto J, Wordsworth BP, Brown MA. Interleukin 10 polymorphisms in ankylosing spondylitis. Genes Immun. 4: 74-76 (2003). *
Goel A, Chang DK, Ricciardiello L, Gasche C, Boland CR. A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells. Clin. Cancer Res. 9: 383-390 (2003). *
Goel A, Christian CL. Gastric antral vascular ectasia (watermelon stomach) in a patient with Sjogren's syndrome. J. Rheumatol. 30: 1090-1092 (2003).
Goering PL. The road to elucidating the mechanism of manganese-bilirubin-induced cholestasis. Toxicol. Sci. 73: 216-219 (2003). *
Goerres MS, Meijer JWR, Wahab PJ, Kerckhaert JAM, Groenen PJTA, Van Krieken JHJM, Mulder CJJ. Azathioprine and prednisone combination therapy in refractory Coeliac disease. Aliment. Pharmacol. Ther. 18: 487-494 (2003). *
Goertz B, Fassbender WJ, Williams JC, Marzeion AM, Bretzel RG, Stracke H, Berliner MN. Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin. Exp. Rheumatol. 21: 333-339 (2003).
Goetz M, Lehr HA, Neurath MF, Galle PR, Orth T. Long-term evaluation of a rat model of chronic cholangitis resembling human primary sclerosing cholangitis. Scand. J. Immunol. 58: 533-540 (2003). *
Goffe B, Cather JC. Etanercept: an overview. J. Am. Acad. Dermatol. 49: S105-S111 (2003).
Goh J, O'Morain CA. Review article: nutrition and adult inflammatory bowel disease. Aliment. Pharmacol. Ther. 17: 307-320 (2003). *
Goh NS, McDonald CE, MacGregor DP, Pretto JJ, Brodie GN. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Respirology 8: 91-94 (2003). *
Gohar S, Desai D, Joshi A, Bhaduri A, Deshpande R, Balkrishna C, Chawla M, Rodrigues C, Joshi VR. Autoimmune hepatitis: a study of 50 patients. Indian J. Gastroenterol. 22: 140-142 (2003). *
Goicovich E, Molina C, Perez P, Aguilera S, Fernandez J, Olea N, Alliende C, Leyton C, Romo R, Leyton L, Gonzalez MJ. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 48: 2573-2584 (2003). *
Golby SJ, Spencer J. Where do IgA plasma cells in the gut come from? Gut 51: 150-151 (2003). *
Goldstein ES, Rubin PH. Endoscopic therapy for inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 237-243 (2003).
Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch. Biochem. Biophys. 420: 185-193 (2003). *
Gollan JL. Morbus Wilson. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 91-92. October 17 - 19 (2003). *
Gollnick H. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 63: 1579-1596 (2003).
Golovnova EV, Il'chenko LIu, Tsaregorodtseva TM, Serova TI, Gudkova RV, Shepeleva SD, Tkachev VD. Primary biliary cirrhosis: 12-year experience in observation. Ter. Arkh. 75: 26-30 (2003).
Golpe R, Mateos A, Perez-Valcarcel J, Lapena JA, Garcia-Figueiras R, Blanco J. Multiple pulmonary nodules in a patient with Crohn's disease. Respiration 70: 306-309 (2003). *
Gomez-Lira M, Bonamini D, Castellani C, Unis L, Cavallini G, Assael BM, Pignatti PF. Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients. Eur. J. Hum. Genet. 11: 543-546 (2003). *
Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD; BIOBADASER Group. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum. 48: 2122-2127 (2003). *
Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3: 642-655 (2003). *
Gonzalez S, Martinez-Borra J, Lopez-Larrea C. Cloning and characterization of human complement component C7 promoter. Genes Immun. 4: 54-59 (2003). *
Gonzalez S, Rodrigo L, Martinez-Borra J, Lopez-Vazquez A, Fuentes D, Nino P, Cadahia V, Saro C, Dieguez MA, Lopez-Larrea C. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am. J. Gastroenterol. 98: 1101-1016 (2003). *
Gonzalez-Buitrago JM, Gonzalez C, Hernando M, Carrasco R, Sanchez A, Navajo JA, Papisch W. Antibodies to centromere antigens measured by an automated enzyme immunoassay. Clin. Chim. Acta 328: 135-138 (2003). *
Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin. Arthritis Rheum. 33: 38-48 (2003). *
Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog. Biophys. Mol. Biol. 81: 1-44 (2003). *
Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc. Natl. Acad. Sci. U.S.A. 100: 223-228 (2003). *
Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA. Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol. Endocrinol. 17: 386-394 (2003). *
Goossens D, Jonkers D, Stobberingh E, van den Bogaard A, Russel M, Stockbrugger R. Probiotics in gastroenterology: indications and future perspectives. Scand. J. Gastroenterol. Suppl. 239: 15-23 (2003). *
Gopal DV, Corless CL, Rabkin JM, Olyaei AJ, Rosen HR. Graft failure from severe recurrent primary sclerosing cholangitis following orthotopic liver transplantation. J. Clin. Gastroenterol. 37: 344-347 (2003).
Gopal DV, Pfau PR, Lucey MR. Endoscopic management of biliary complications after orthotopic liver transplantation. Curr. Treat. Options Gastroenterol. 6: 509-515 (2003).
Gordon JN, Goggin PM. Thalidomide and its derivatives: emerging from the wilderness. Postgrad. Med. J. 79: 127-132 (2003). *
Gordon JN, MacDonald TT. Biological therapy in Crohn's disease. Hosp. Med. 64: 708-712 (2003).
Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35 (2003).
Gore JI, Surawicz C. Severe acute diarrhea. Gastroenterol. Clin. North Am. 32: 1249-1267 (2003).
Gores GJ. Apoptosis and liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 25. September 12 - 13 (2003). *
Gores GJ. Cholangiocarcinoma: preventing invasion as anti-cancer strategy. J. Hepatol. 38: 671-673 (2003). *
Gores GJ. A spotlight on cholangiocarcinoma. Gastroenterology 125: 1536-1538 (2003). *
Gorman C, Leandro M, Isenberg D. B cell depletion in autoimmune disease. Arthritis Res. Ther. 5 Suppl. 4: S17-S21 (2003). *
Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL 2nd, McGovern RM, Sloan JA, Cha SS, Persing DH. TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol. Oncol. 88: 326-332 (2003).
Goto K, Sugiyama K, Sugiura T, Ando T, Mizutani F, Terabe K, Ban K, Togari H. Bile salt export pump gene mutations in two Japanese patients with progressive familial intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 36: 647-650 (2003). *
Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum. 48: 2240-2245 (2003). *
Gottlieb AB. Infliximab for psoriasis. J. Am. Acad. Dermatol. 49: S112-S117 (2003).
Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, Gaspari AA, Ling M, Weinstein GD, Nayak A, Gordon KB, Zitnik R. A randomized trial of etanercept as monotherapy for psoriasis. Arch. Dermatol. 139: 1627-1632 (2003). *
Gotto AM Jr. Risks and benefits of continued aggressive statin therapy. Clin. Cardiol. 26: III3-III12 (2003).
Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L. The biology of IGE and the basis of allergic disease. Annu. Rev. Immunol. 21: 579-628 (2003). *
Graefe SE, Meyer BS, Muller-Myhsok B, Ruschendorf F, Drosten C, Laue T, Steeg C, Nurnberg P, Fleischer B. Murine susceptibility to Chagas' disease maps to chromosomes 5 and 17. Genes Immun. 4: 321-325 (2003). *
Graf GA, Yu L, Li WP, Gerard R, Tuma PL, Cohen JC, Hobbs HH. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J. Biol. Chem. 278: 48275-48282 (2003). *
Graf J, Webb A, Davis J. The use of topical tacrolimus (FK506/protopic) in cutaneous manifestations of autoimmune diseases. J. Clin. Rheumatol. 9: 310-315 (2003).
Grahnquist L, Chapman SC, Hvidsten S, Murphy MS. Evaluation of 99mTc-HMPAO leukocyte scintigraphy in the investigation of pediatric inflammatory bowel disease. J. Pediatr. 143: 48-53 (2003). *
Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res. Ther. 5 Suppl. 4: S22-S27 (2003). *
Granato A, Gores G, Vilei MT, Tolando R, Ferraresso C, Muraca M. Bilirubin inhibits bile acid induced apoptosis in rat hepatocytes. Gut 52: 1774-1778 (2003). *
Granel B, Philip N, Serratrice J, Ene N, Grateau G, Dode C, Cuisset L, Disdier P, Berbis P, Delpech M, Weiller PJ. CIAS1 mutation in a patient with overlap between Muckle-Wells and chronic infantile neurological cutaneous and articular syndromes. Dermatology 206: 257-259 (2003).
Grant WB, Strange RC, Garland CF. Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J. Cosmet. Dermatol. 2: 86-98 (2003).
Granucci F, Zanoni I, Feau S, Ricciardi-Castagnoli P. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J. 22: 2546-2551 (2003). *
Granvil CP, Yu AM, Elizondo G, Akiyama TE, Cheung C, Feigenbaum L, Krausz KW, Gonzalez FJ. Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. Drug Metab. Dispos. 31: 548-558 (2003). *
Gras M, van Kemenade FJ, van Maarsseveen AC, Alberts C. Sarcoidosis: immunopathogenesis and the potential of immunotherapy. Ned. Tijdschr. Geneeskd. 147: 150-155 (2003).
Grasset L, Guy C, Ollagnier M. Cyclines and acne: pay attention to adverse drug reactions! A recent literature review. Rev. Med. Interne. 24: 305-316 (2003).
Grattagliano I, Giudetti AM, Grattagliano V, Palmieri VO, Gnoni GV, Lapadula G, Palasciano G, Vendemiale G. Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment. Eur. J. Clin. Invest. 33: 868-874 (2003). *
Graziadei IW, Obermoser GE, Sepp NT, Erhart KH, Vogel W. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus 12: 409-412 (2003). *
Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. U.S.A. 100: 10878-10883 (2003). *
Greenbaum L. Hippatitis rex. Lancet 362: 2032 (2003). *
Greenstein RJ. Is Crohn's disease caused by a Mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect. Dis. 3: 507-514 (2003).
Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 5: liver disease. Br. Dent. J. 195: 71-73 (2003). *
Greenwood M, Meechan JG. General medicine and surgery for dental practitioners. Part 3: gastrointestinal system. Br. Dent. J. 194: 659-663 (2003).
Gregersen PK, Brehrens TW. Fine mapping the phenotype in autoimmune disease: the promise and pitfalls of DNA microarray technologies. Genes Immun. 4: 175-176 (2003). *
Grendell JH. Genetic factors in pancreatitis. Curr. Gastroenterol. Rep. 5: 105-109 (2003).
Grieco A, Caminiti G, Doglietto GB, Miele L, Gasbarrini G. "Tear-drop shaped" HCC. Ann. Hepatol. 2: 140 (2003). *
Griffin DE. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3: 493-502 (2003).
Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23: 117-145 (2003). *
Griffiths AM. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary. Inflamm. Bowel Dis. 9: 389-391 (2003). *
Grimes DS. Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Gut 52: 155 (2003). *
Grip O, Janciauskiene S, Lindgren S. Macrophages in inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2: 155-160 (2003).
Groeneweg M, Hartwig NG, Poerink-Stockschläder AB, Schweizer JJ, Bijleveld CM, Bredius RG. Two children with severe recurrent infections and the X-linked hyper-IgM syndrome. Ned. Tijdschr. Geneeskd. 147: 1024-1028 (2003).
Groeneweg M, Lankester AC, Bredius RG. From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome. Ned. Tijdschr. Geneeskd. 147: 1009-1011 (2003).
Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 100: 9452-9457 (2003). *
Grompe M. The role of bone marrow derived stem cells in liver injury responses. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 35. October 20 - 21 (2003). *
Grompe M. The role of bone marrow stem cells in liver regeneration. Semin. Liver Dis. 23: 363-372 (2003).
Gronowitz E, Pitkanen S, Kjellmer I, Heikinheimo M, Strandvik B. Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis. Acta Paediatr. 92: 1267-1271 (2003). *
Gross JB Jr, Kumar N. Simultaneous occurrence of PSC and MS in a patient. Dig. Dis. Sci. 48: 1397 (2003). *
Grotowski M, Wojtun S. CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer. Pol. Merkur. Lekarski. 14: 327-330 (2003).
Grover JK, Yadav S, Vats V, Joshi YK. Cyclo-oxygenase 2 inhibitors: emerging roles in the gut. Int. J. Colorectal Dis. 18: 279-291 (2003). *
Gruchy SE, Fardy JM. A meta-analysis of ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Am. J. Gastroenterol. 98: S90 (2003). *
Grunhage F, Fischer HP, Sauerbruch T, Reichel C. Drug- and toxin-induced hepatotoxicity. Z. Gastroenterol. 41: 565-578 (2003).
Gu YH, Kodama H, Du SL, Gu QJ, Sun HJ, Ushijima H. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease. Clin. Genet. 64: 479-484 (2003). *
Guanabens N, Pares A, Ros I, Alvarez L, Pons F, Caballeria L, Monegal A, Martinez de Osaba MJ, Roca M, Peris P, Rodes J. Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. Am. J. Gastroenterol. 98: 2268-2274 (2003). *
Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 361: 512-519 (2003). *
Guarner F, Malagelada JR. Role of bacteria in experimental colitis. Best Pract. Res. Clin. Gastroenterol. 17: 793-804 (2003).
Guengerich FP. Cytochromes P450, drugs, and diseases. Mol. Intervent. 3: 194-204 (2003). *
Guerini FR, Ferrante P, Losciale L, Caputo D, Lombardi ML, Pirozzi G, Luongo V, Sudomoina MA, Andreewski TV, Alekseenkov AD, Boiko AN, Gusev EI, Favorova OO. Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology 61: 520-526 (2003).
Guicciardi ME, Gores GJ. AIP1: a new player in TNF signaling. J. Clin. Invest. 111: 1813-1815 (2003). *
Guicciardi ME, Gores GJ. Targeted use of siRNA in animal models of hepatic damage: an innovative therapy for acute liver failure. J. Hepatol. 39: 883-885 (2003). *
Guichelaar MM, Benson JT, Malinchoc M, Krom RA, Wiesner RH, Charlton MR. Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am. J. Transplant. 3: 885-890 (2003). *
Guidat A, Fleyfel M, Vallet B, Desreumaux P, Levron JC, Gambiez L, Colombel JF, Scherpereel P. Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases. Eur. J. Anaesthesiol. 20: 957-962 (2003).
Guilford WG, Matz ME. The nutritional management of gastrointestinal tract disorders in companion animals. N. Z. Vet. J. 51: 284-291 (2003).
Guimbaud R, Selves J. Detection of hereditary non-polyposis colon cancer (HNPCC). J. Chir. (Paris) 140: 317-323 (2003).
Guma M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olive A. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J. Clin. Endocrinol. Metab. 88: 2141-2146 (2003). *
Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, Sinal CJ. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278: 45062-45071 (2003). *
Guo HH, Loeb LA. Tumbling down a different pathway to genetic instability. J. Clin. Invest. 112: 1793-1795 (2003). *
Guo L, Li X, Enosawa S, Harihara Y, Funeshima N, Kimura H, Fujino M, Makuuchi M, Suzuki S. Prolongation of liver xenograft survival by adenovirus vector-mediated CTLA-4Ig gene transfer. Transpl. Immunol. 11: 155-162 (2003).
Guo XH, Zhao MH, Gao Y, Wang SF, Gao Y. Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents. Zhonghua Yi Xue Za Zhi 83: 932-935 (2003).
Gupta A, Neogi R, Mukherjea M, Mukhopadhyay A, Roychoudhury S, Senapati A, Gangopadhyay PK, Ray K. DNA linkage based diagnosis of Wilson disease in asymptomatic siblings. Indian J. Med. Res. 118: 208-214 (2003).
Gupta M, Nikitina-Zake L, Zarghami M, Landin-Olsson M, Kockum I, Lernmark A, Sanjeevi CB. Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes mellitus in Sweden. Hum. Immunol. 64: 553-561 (2003).
Gupta S. Hepatocyte transplantation: basic aspects of cell engraftment and proliferation. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 36. October 20 - 21 (2003). *
Gupta S, Chiplunkar S, Gupta A, Gollapudi S. Increased spontaneous, tumor necrosis factor receptor- and CD95 (Fas)-mediated apoptosis in cord blood T-cell subsets from Turner's syndrome. Genes Immun. 4: 239-243 (2003). *
Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol. Int. 23: 104-107 (2003). *
Guslandi M. Helicobacter pylori infection in patients with inflammatory bowel disease. Am. J. Gastroenterol. 98: 2570-2571 (2003). *
Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 15: 697-698 (2003).
Gutierrez O, Akamatsu T, Cardona H, Graham DY, El-Zimaity HM. Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am. J. Gastroenterol. 98: 1266-1270 (2003). *
Gyorfy A, Kovacs T, Szegedi I, Olah E, Kiss C. Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med. Pediatr. Oncol. 40: 135-136 (2003).
Ha SJ, Kim JS, Myung JW, Lee HJ, Kim JW. Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia. J. Dermatol. Sci. 31: 135-141 (2003).
Haag M. Essential fatty acids and the brain. Can. J. Psychiatry 48: 195-203 (2003).
Haagsma EB, Van Den Berg AP, Kleibeuker JH, Slooff MJ, Dijkstra G. Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. Aliment. Pharmacol. Ther. 18: 33-44 (2003). *
Haaning Andersen AD, Lange M, Lillevang ST. Allelic variation of the inducible costimulator (ICOS) gene: detection of polymorphisms, analysis of the promoter region, and extended haplotype estimation. Tissue Antigens 61: 276-285 (2003). *
Haas S. Venous thromboembolism in medical patients-the scope of the problem. Semin. Thromb. Hemost. 29 Suppl. 1: 17-22 (2003).
Haas S, Theuerkauf I, Kuhnen A, Wickesberg A, Fischer HP. Langerhans' cell histiocytosis of the liver. Differential diagnosis of a rare chronic destructive sclerosing cholangitis. Pathologe 24: 119-123 (2003).
Haberman AM, Shlomchik MJ. Reassessing the function of immune-complex retention by follicular dendritic cells. Nat. Rev. Immunol. 3: 757-764 (2003). *
Habermann JK, Upender MB, Roblick UJ, Kruger S, Freitag S, Blegen H, Bruch HP, Schimmelpenning H, Auer G, Ried T. Pronounced chromosomal instability and multiple gene amplifications characterize ulcerative colitis-associated colorectal carcinomas. Cancer Genet. Cytogenet. 147: 9-17 (2003).
Habior A, Lewartowska A, Orlowska J, Zych W, Sankowska M, Bauer A, Butruk E. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur. J. Gastroenterol. Hepatol. 15: 159-164 (2003).
Haderslev KV, Jeppesen PB, Sorensen HA, Mortensen PB, Staun M. Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 52: 653-658 (2003). *
Hadj Kacem H, Rebai A, Kaffel N, Masmoudi S, Abid M, Ayadi H. PDS is a new susceptibility gene to autoimmune thyroid diseases: association and linkage study. J. Clin. Endocrinol. Metab. 88: 2274-2280 (2003). *
Hadjigogos K, Marinaki P. Autoimmune hepatitis and the antiphospholipid antibody syndrome. A case report. Panminerva Med. 45: 223-224 (2003).
Hagen EA, Lautenbach E, Olthoff K, Blumberg EA. Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation. Am. J. Transplant. 3: 902-905 (2003). *
Hahn-Zoric M, Hytonen AM, Hanson LA, Nilsson LA, Padyukov L. Association of -1087 IL10 and -308 TNFA gene polymorphisms with serological markers of coeliac disease. J. Clin. Immunol. 23: 291-296 (2003). *
Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, Holzhutter HG, Kloetzel PM, Kaufmann SH, Mollenkopf HJ. MAPPP: MHC class I antigenic peptide processing prediction. Appl. Bioinformatics 2: 155-158 (2003).
Halff G, Speeg KV, Washburn K, Esterl R, Abrahamian G, Mejia A, Nichols L, Neigut D, Dodd G, Cigarroa F. Liver transplantation at the University of Texas Health Science Center/University Hospital in San Antonio. Clin. Transpl. 2003: 247-253 (2003).
Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124: 1767-1773 (2003). *
Hall RJ, Hollis-Moffatt JE, Merriman ME, Green RA, Baker D, Merriman TR. An autoimmune diabetes locus (Idd21) on mouse chromosome 18. Mamm. Genome 14: 335-339 (2003). *
Hall RJ, Merriman ME, Green RA, Markham VH, Smyth DJ, Heward JM, Jennings CE, Braithwaite AW, Cundy T, Darlow BA, Gow PJ, Harrison AA, Highton J, Hunt PJ, Manning P, Pokorny V, Scott RS, Taylor BJ, Willis JA, Yeoman S, McLean L, Gough SC, Pearce SH, et al. The deleted in colorectal carcinoma (DCC) gene 201 R-->G polymorphism: no evidence for genetic association with autoimmune disease. Eur. J. Hum. Genet. 11: 840-844 (2003). *
Hallden G, Kirn D. Oncolytic replication selective adenoviruses as cytocidal therapeutics for cancer. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 42. October 20 - 21 (2003). *
Haller C, Kemmler G, Judmair G, Rathner G, Kinzl H, Richter R, Gunther V. Social network and social support in patients with chronic inflammatory bowel disease. Z. Psychosom. Med. Psychother. 49: 36-48 (2003).
Hallert C, Bjorck I, Nyman M, Pousette A, Granno C, Svensson H. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm. Bowel Dis. 9: 116-121 (2003). *
Hamajima N, Shibata A, Katsuda N, Matsuo K, Ito H, Saito T, Tajima K, Tominaga S. Subjects with TNF-A-857TT and -1031TT genotypes showed the highest Helicobacter pylori seropositive rate compared with those with other genotypes. Gastric Cancer 6: 230-236 (2003).
Hamaoui E, Hamaoui M. Nutritional assessment and support during pregnancy. Gastroenterol. Clin. North Am. 32: 59-121, v (2003). *
Hampe J, Heymann K, Krawczak M, Schreiber S. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int. J. Colorectal Dis. 18: 413-417 (2003). *
Han GM, Chen SL, Shen N, Ye S, Bao CD, Gu YY. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun. 4: 177-186 (2003). *
Hanada S, Harada M, Koga H, Kawaguchi T, Taniguchi E, Kumashiro R, Ueno T, Ueno Y, Ishii M, Sakisaka S, Sata M. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver Int. 23: 3-11 (2003). *
Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin. Gastroenterol. Hepatol. 1: 28-35 (2003). *
Hanauer SB. Factoring in growth factors for treatment of inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 485 (2003).
Hanauer SB. Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis. Am. J. Gastroenterol. 98: 215-216 (2003). *
Hanauer SB. Assessing the risk of lymphomas in inflammatory bowel disease. Rev. Gastroenterol. Disord. 3: 50-51 (2003). *
Hanauer SB. Crohn's disease: step up or top down therapy. Best Pract. Res. Clin. Gastroenterol. 17: 131-137 (2003). *
Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev. Gastroenterol. Disord. 3: 81-92 (2003). *
Hanck C, Schneider A, Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Best Pract. Res. Clin. Gastroenterol. 17: 613-623 (2003).
Handa R. Spondylo-arthropathies. J. Indian Med. Assoc. 101: 514, 516, 518 (2003).
Handa T, Nagai S, Ito I, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Mishima M. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism affects lymphocyte profiles in bronchoalveolar lavage of patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 20: 190-196 (2003).
Handschin C, Meyer UA. Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 55: 649-673 (2003). *
Haneline LS, Li X, Ciccone SL, Hong P, Yang Y, Broxmeyer HE, Lee SH, Orazi A, Srour EF, Clapp DW. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. Blood 101: 1299-1307 (2003). *
Hansen A, Lipsky PE, Dorner T. New concepts in the pathogenesis of Sjogren syndrome: many questions, fewer answers. Curr. Opin. Rheumatol. 15: 563-570 (2003).
Hansen TK, Thiel S, Knudsen ST, Gravholt CH, Christiansen JS, Mogensen CE, Poulsen PL. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J. Clin. Endocrinol. Metab. 88: 4857-4861 (2003). *
Hanyecz A, Bardos T, Berlo SE, Buzas E, Nesterovitch AB, Mikecz K, Glant TT. Induction of arthritis in SCID mice by T cells specific for the "shared epitope" sequence in the G3 domain of human cartilage proteoglycan. Arthritis Rheum. 48: 2959-2973 (2003). *
Harada K, Isse K, Tsuneyama K, Ohta H, Nakanuma Y. Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int. 23: 94-100 (2003). *
Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, Nakanuma Y. Lipopolysaccharide activates nuclear factor-kappaB through Toll-like receptors and related molecules in cultured biliary epithelial cells. Lab. Invest. 83: 1657-1667 (2003). *
Harada K, Ozaki S, Sudo Y, Tsuneyama K, Ohta H, Nakanuma Y. Osteopontin is involved in the formation of epithelioid granuloma and bile duct injury in primary biliary cirrhosis. Pathol. Int. 53: 8-17 (2003). *
Harada M, Kumemura H, Sakisaka S, Shishido S, Taniguchi E, Kawaguchi T, Hanada S, Koga H, Kumashiro R, Ueno T, Suganuma T, Furuta K, Namba M, Sugiyama T, Sata M. Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line. Int. J. Mol. Med. 11: 293-298 (2003).
Harada T, Koyama I, Kasahara T, Alpers DH, Komoda T. Heat shock induces intestinal-type alkaline phosphatase in rat IEC-18 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G255-G262 (2003). *
Harbige LS. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38: 323-341 (2003).
Hardy ML, Coulter I, Morton SC, Favreau J, Venuturupalli S, Chiappelli F, Rossi F, Orshansky G, Jungvig LK, Roth EA, Suttorp MJ, Shekelle P. S-Adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease. Evid. Rep. Technol. Assess. 64: 1-3 (2003).
Haristoy X, Angioi-Duprez K, Duprez A, Lozniewski A. Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice. Antimicrob. Agents Chemother. 47: 3982-3984 (2003). *
Harnad S. Open access to peer-reviewed research through author/institution self-archiving: maximizing research impact by maximizing online access. J. Postgrad. Med. 49: 337-342 (2003). *
Harney S, Newton J, Milicic A, Brown MA, Wordsworth BP. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 42: 171-174 (2003). *
Harney SM, Newton JL, Wordsworth BP. Molecular genetics of rheumatoid arthritis. Curr. Opin. Pharmacol. 3: 280-285 (2003).
Harp JA. Parasitic infections of the gastrointestinal tract. Curr. Opin. Gastroenterol. 19: 31-36 (2003).
Harpavat M, Keljo DJ. Perspectives on osteoporosis in pediatric inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 225-232 (2003).
Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur. J. Gastroenterol. Hepatol. 15: 1281-1285 (2003).
Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J. Hepatol. 38 Suppl. 1: S14-S23 (2003). *
Hasegawa T, Sakurai K, Kambayashi Y, Saniabadi AR, Nagamoto H, Tsukada K, Takahashi A, Kuwano H, Nakano M. Effects of OPC-6535 on lipopolysaccharide-induced acute liver injury in the rat: involvement of superoxide and tumor necrosis factor-alpha from hepatic macrophages. Surgery 134: 818-826 (2003). *
Hashigucci K, Niizeki H, Naruse T, Ota M, Inamoto N, Nishikawa T, Inoko H. A clinical feature associated with polymorphisms of the TNF region in Japanese patients with palmoplantar pustulosis. Hum. Immunol. 64: 530-537 (2003).
Hashimoto H, Green J, Iwao Y, Sakurai T, Hibi T, Fukuhara S. Reliability, validity, and responsiveness of the Japanese version of the Inflammatory Bowel Disease Questionnaire. J. Gastroenterol. 38: 1138-1143 (2003). *
Hashkes PJ, Shajrawi I. Sarcoid-related uveitis occurring during etanercept therapy. Clin. Exp. Rheumatol. 21: 645-646 (2003).
Hasler P, Zouali M. Subversion of B lymphocyte signaling by infectious agents. Genes Immun. 4: 95-103 (2003). *
Hasler WL. The irritable bowel syndrome during pregnancy. Gastroenterol. Clin. North Am. 32: 385-406, viii (2003). *
Hassan AB, Nikitina-Zake L, Padyukov L, Karlsson G, Gupta M, Lundberg IE, Sanjeevi CB. MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients. Hum. Immunol. 64: 290-296 (2003).
Hassoun Z, Gores GJ. Treatment of hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 1: 10-18 (2003). *
Haston CK, Tsui LC. Loci of intestinal distress in cystic fibrosis knockout mice. Physiol. Genomics 12: 79-84 (2003). *
Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand. J. Gastroenterol. 38: 1055-1058 (2003). *
Hatoum OA, Miura H, Binion DG. The vascular contribution in the pathogenesis of inflammatory bowel disease. Am. J. Physiol. Heart Circ. Physiol. 285: H1791-H1796 (2003). *
Hattori E, Okumoto K, Adachi T, Takeda T, Ito J, Sugahara K, Watanabe H, Saito K, Saito T, Togashi H, Kawata S. Possible contribution of circulating interleukin-10 (IL-10) to anti-tumor immunity and prognosis in patients with unresectable hepatocellular carcinoma. Hepatol. Res. 27: 309-314 (2003).
Hawn TR, Verbon A, Lettinga KD, Zhao LP, Li SS, Laws RJ, Skerrett SJ, Beutler B, Schroeder L, Nachman A, Ozinsky A, Smith KD, Aderem A. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J. Exp. Med. 198: 1563-1572 (2003). *
Hay JE. Osteoporosis in liver diseases and after liver transplantation. J. Hepatol. 38: 856-865 (2003). *
Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl. 9: 737-740 (2003). *
Hayashi T, Faustman DL. Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Recent Prog. Horm. Res. 58: 131-153 (2003).
Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3: 233-242 (2003). *
Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-grand) 49: 277-300 (2003).
Hazama S, Oka M, Hinoda Y. Polymorphism in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 42-46 (2003).
He D, Barnes S, Falany CN. Rat liver bile acid CoA:amino acid N-acyltransferase: expression, characterization, and peroxisomal localization. J. Lipid Res. 44: 2242-2249 (2003). *
He JQ, Chan-Yeung M, Becker AB, Dimich-Ward H, Ferguson AC, Manfreda J, Watson WT, Sandford AJ. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 4: 385-389 (2003). *
Head KA, Jurenka JS. Inflammatory bowel disease. Part 1: ulcerative colitis - pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 8: 247-283 (2003). *
Heathcote EJ. Primary biliary cirrhosis: historical perspective. Clin. Liver Dis. 7: 735-740 (2003).
Heathcote EJ. Primary biliary cirrhosis. Clin. Liver Dis. 7: xi-xii (2003). *
Heathcote J. Overlap syndromes - outlier syndromes and changing diagnoses. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 39-41. October 15-16 (2003). *
Heaton N. Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection. Liver Transpl. 9: S26-S28 (2003). *
Hebert MF, Wacher VJ, Roberts JP, Benet LZ. Pharmacokinetics of cyclosporine pre- and post-liver transplantation. J. Clin. Pharmacol. 43: 38-42 (2003). *
Hecker M, Bohnert A, Konig IR, Bein G, Hackstein H. Novel genetic variation of human interleukin-21 receptor is associated with elevated IgE levels in females. Genes Immun. 4: 228-233 (2003). *
Heesen M, Schippers EF, Bloemeke B, Kunz D, van Dissel JT. Cytokine response to endotoxin in individuals heterozygous for the Delta32 mutation of chemokine receptor CCR5. Cytokine 21: 195-199 (2003).
Heffron TG, Smallwood GA, Oakley B, Pillen T, Welch D, Connor K, Martinez E, Romero R, Stieber AC. Adult and pediatric liver transplantation for autoimmune hepatitis. Transplant. Proc. 35: 1435-1436 (2003). *
Heffron TG, Smallwood GA, Ramcharan T, Davis L, Connor K, Martinez E, Stieber AC. Duct-to-duct biliary anastomosis for patients with sclerosing cholangitis undergoing liver transplantation. Transplant. Proc. 35: 3006-3007 (2003). *
Hegazi RA, Mady HH, Melhem MF, Sepulveda AR, Mohi M, Kandil HM. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm. Bowel Dis. 9: 230-236 (2003). *
Hegedus T, Sessler T, Scott R, Thelin W, Bakos E, Varadi A, Szabo K, Homolya L, Milgram SL, Sarkadi B. C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins. Biochem. Biophys. Res. Commun. 302: 454-461 (2003). *
Heidemann J, Spinelli KS, Otterson MF, Binion DG. Case report: magnetic resonance imaging in the diagnosis of epidural abscess complicating perirectal fistulizing Crohn's disease. Inflamm. Bowel Dis. 9: 122-124 (2003). *
Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico L, Levy M et al. The DNA sequence and analysis of human chromosome 14. Nature 421: 601-607 (2003). *
Heiligenhaus A, Mingels A, Neudorf U, Ganser G. Juvenile idiopathic arthritis and uveitis: screening and anti-inflammatory therapy. Klin. Monatsbl. Augenheilkd. 220: 738-753 (2003).
Hein WR, Griebel PJ. A road less travelled: large animal models in immunological research. Nat. Rev. Immunol. 3: 79-84 (2003). *
Heine H, Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int. Arch. Allergy Immunol. 130: 180-192 (2003).
Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun. 4: 82-85 (2003). *
Held W, Coudert JD, Zimmer J. The NK cell receptor repertoire: formation, adaptation and exploitation. Curr. Opin. Immunol. 15: 233-237 (2003).
Heldt C, Listing J, Sozeri O, Blasing F, Frischbutter S, Muller B. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis. Arthritis Rheum. 48: 2779-2787 (2003). *
Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Farkkila M, Krusius T, Kontula K. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 52: 558-562 (2003). *
Heller AR, Theilen HJ, Koch T. Fish or chips? News Physiol. Sci. 18: 50-54 (2003). *
Heller F, Duchmann R. Intestinal flora and mucosal immune responses. Int. J. Med. Microbiol. 293: 77-86 (2003).
Hellerbrand C, Poppl A, Hartmann A, Scholmerich J, Lock G. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. Clin. Gastroenterol. Hepatol. 1: 279-284 (2003). *
Hellier S, Frodsham AJ, Hennig BJ, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, Thomas HC, Thursz M, Hill AV. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38: 1468-1476 (2003). *
Hellmich B, Ehlers S, Csernok E, Gross WL. Update on the pathogenesis of Churg-Strauss syndrome. Clin. Exp. Rheumatol. 21: S69-S77 (2003).
Helmby H, Grencis RK. Contrasting roles for IL-10 in protective immunity to different life cycle stages of intestinal nematode parasites. Eur. J. Immunol. 33: 2382-2390 (2003). *
Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35: 349-356 (2003). *
Hempfling W, Dilger K, Beuers U. Ursodeoxycholic acid - adverse effects and drug interactions. Aliment. Pharmacol. Ther. 18: 963-972 (2003). *
Hempfling W, Grunhage F, Dilger K, Reichel C, Beuers U, Sauerbruch T. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis. Hepatology 38: 196-202 (2003). *
Henderson CJ, Wolf CR. Transgenic analysis of human drug-metabolizing enzymes: preclinical drug development and toxicology. Mol. Intervent. 3: 331-343 (2003). *
Heneghan MA, Tuttle-Newhall JE, Suhocki PV, Muir AJ, Morse M, Bornstein JD, Sylvestre PB, Collins B, Kuo PC, Rockey DC. De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. Am. J. Transplant. 3: 634-638 (2003). *
Hensen P, Asadullah K, Windemuth C, Ruschendorf F, Huffmeier U, Stander M, Schmitt-Egenolf M, Wienker TF, Reis A, Traupe H. Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis. Br. J. Dermatol. 149: 381-385 (2003). *
Hensen P, Windemuth C, Huffmeier U, Ruschendorf F, Stadelmann A, Hoppe V, Fenneker D, Stander M, Schmitt-Egenolf M, Wienker TF, Traupe H, Reis A. Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci. Exp. Dermatol. 12: 490-496 (2003). *
Hentgen V, Granel B, Dode C, Cuisset L, Delpech M, Grateau G. Tumor necrosis factor receptor superfamily 1A-associated periodic syndrome (TRAPS). Rev. Med. Interne. 24: 781-785 (2003).
Hentgen V, Reinert P. TNF receptor-associated periodic syndrome (TRAPS): clinical aspects and physiopathology of a rare familial disease. Arch. Pediatr. 10: 45-53 (2003).
Hentze MW. RNA biology. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 17. October 20 - 21 (2003). *
Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 206: 24-28 (2003).
Herbon N, Werner M, Braig C, Gohlke H, Dutsch G, Illig T, Altmuller J, Hampe J, Lantermann A, Schreiber S, Bonifacio E, Ziegler A, Schwab S, Wildenauer D, van den Boom D, Braun A, Knapp M, Reitmeir P, Wjst M. High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics 81: 510-518 (2003). *
Herek O, Yilmaz M, Demir S, Akbulut M. The effects of intestinal ischemia on the levels of serum immunoglobulin A in rats. Pediatr. Surg. Int. 19: 601-604 (2003). *
Herendeen JM, Lindley C. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann. Pharmacother. 37: 1664-1674 (2003). *
Herfarth H, Goke M, Hellerbrand C, Muhlbauer M, Vogl D, Scholmerich J, Rogler G. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int. J. Colorectal Dis. 18: 401-405 (2003). *
Herfarth H, Messmann H. Low grade dysplasia in ulcerative colitis. Z. Gastroenterol. 41: 351-353 (2003).
Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipilä I, Akerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62: 162-169 (2003). *
Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol. 21: 107-137 (2003). *
Hermoso MA, Cidlowski JA. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life 55: 497-504 (2003).
Herr AB, Ballister ER, Bjorkman PJ. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423: 614-620 (2003). *
Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3: 405-412 (2003). *
Herrine SK. Drug-induced liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF. Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment. Pharmacol. Ther. 17: 1459-1464 (2003). *
Hershman MJ. Developments in understanding and management of inflammatory bowel disease. Hosp. Med. 64: 702 (2003).
Hertz R, Ben-Haim N, Petrescu AD, Kalderon B, Berman I, Eldad N, Schroeder F, Bar-Tana J. Rescue of MODY-1 by agonist ligands of hepatocyte nuclear factor-4alpha. J. Biol. Chem. 278: 22578-22585 (2003). *
Hesse S, Barthel H, Hermann W, Murai T, Kluge R, Wagner A, Sabri O, Eggers B. Regional serotonin transporter availability and depression are correlated in Wilson's disease. J. Neural. Transm. 110: 923-933 (2003). *
Heuman DM, Mihas A. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology 125: 992-993 (2003). *
Hewitt EW, Lehner PJ. The ABC-transporter signature motif is required for peptide translocation but not peptide binding by TAP. Eur. J. Immunol. 33: 422-427 (2003). *
Hiasa Y, Tokumoto Y, Furukawa S, Takeshita E, Matsui H, Michitaka K, Horiike N, Onji M. Two cases of asymptomatic primary biliary cirrhosis with ascites. Nippon Shokakibyo Gakkai Zasshi 100: 1400-1404 (2003).
Hibbeln JR, Makino KK, Martin CE, Dickerson F, Boronow J, Fenton WS. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol. Psychiatry 53: 431-441 (2003). *
Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 23: 513-522 (2003).
Hibi T, Inoue N, Ogata H, Naganuma M. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J. Gastroenterol. 38 Suppl. 15: 36-42 (2003).
Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J. Gastroenterol. 38: 740-746 (2003). *
Hicken BL, Calhoun DC, Tucker DC. Genetic testing for hemochromatosis: attitudes and acceptability among young and older adults. Genet. Test. 7: 235-239 (2003).
Higashi N, Senoo H. Distribution of vitamin A-storing lipid droplets in hepatic stellate cells in liver lobules - a comparative study. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 271: 240-248 (2003).
Higgins PD, Fontana RJ. Liver transplantation in acute liver failure. Panminerva. Med. 45: 85-94 (2003).
Higuchi H, Gores GJ. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G734-G738 (2003). *
Higuchi H, Gores GJ. Mechanisms of liver injury: an overview. Curr. Mol. Med. 3: 483-490 (2003).
Hikami K, Tsuchiya N, Yabe T, Tokunaga K. Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population. Genes Immun. 4: 160-167 (2003). *
Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A, Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Gut 52: 1432-1434 (2003). *
Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171: 538-541 (2003). *
Hillebrands JL, van der Werf N, Klatter FA, Bruggeman CA, Rozing J. Role of peritoneal macrophages in cytomegalovirus-induced acceleration of autoimmune diabetes in BB-rats. Clin. Dev. Immunol. 10: 133-139 (2003).
Hiller S, Kohl A, Fiorito F, Herrmann T, Wider G, Tschopp J, Grutter MG, Wuthrich K. NMR structure of the apoptosis- and inflammation-related NALP1 pyrin domain. Structure 11: 1199-1205 (2003). *
Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C et al. The DNA sequence of human chromosome 7. Nature 424: 157-164 (2003). *
Hilsden RJ, Verhoef MJ, Best A, Pocobelli G. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. BMC Gastroenterol. 3: 10 (2003). *
Hines ME 2nd, Styer EL. Preliminary characterization of chemically generated Mycobacterium avium subsp. paratuberculosis cell wall deficient forms (spheroplasts). Vet. Microbiol. 95: 247-258 (2003). *
Hino T, Kumashiro R, Ide T, Koga Y, Ishii K, Tanaka E, Morita Y, Hisamochi A, Murashima S, Tanaka K, Ogata K, Kuwahara R, Sata M. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. Int. J. Mol. Med. 11: 749-755 (2003).
Hinshelwood MM, Repa JJ, Shelton JM, Richardson JA, Mangelsdorf DJ, Mendelson CR. Expression of LRH-1 and SF-1 in the mouse ovary: localization in different cell types correlates with differing function. Mol. Cell. Endocrinol. 207: 39-45 (2003).
Hiramatsu J, Kataoka M, Nakata Y, Okazaki K, Tada S, Tanimoto M, Eishi Y. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 20: 197-203 (2003).
Hirano F, Kobayashi A, Makino I. Inhibition of TNF-alpha-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs. Int. Immunopharmacol. 3: 225-232 (2003).
Hirano K, Shiratori Y, Komatsu Y, Yamamoto N, Sasahira N, Toda N, Isayama H, Tada M, Tsujino T, Nakata R, Kawase T, Katamoto T, Kawabe T, Omata M. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin. Gastroenterol. Hepatol. 1: 453-464 (2003). *
Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J. Am. Coll. Cardiol. 42: 1429-1437 (2003). *
Hirayama K, Yokoi Y, Sakaguchi T, Nakamura T, Kashiwabara H, Sunayama K, Nakamura S. Platelet-activating factor, a critical mediator in the pathogenesis of dextran sulfate sodium-induced colitis in rats. Dis. Colon Rectum 46: 100-110 (2003).
Hirota M, Kuwata K, Ohmuraya M, Ogawa M. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene. JOP 4: 83-88 (2003). *
Hisamatsu T, Suzuki M, Podolsky DK. Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. J. Biol. Chem. 278: 32962-32968 (2003). *
Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124: 993-1000 (2003). *
Hise AG, Hazlett FE, Bockarie MJ, Zimmerman PA, Tisch DJ, Kazura JW. Polymorphisms of innate immunity genes and susceptibility to lymphatic filariasis. Genes Immun. 4: 524-527 (2003). *
Ho GT, Moodie FM, Satsangi J. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52: 759-766 (2003). *
Ho SC, Goh SS, Khoo DH. Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 13: 523-528 (2003).
Hoda F, Green RM. Hepatic canalicular membrane transport of bile salt in C57L/J and AKR/J mice: implications for cholesterol gallstone formation. J. Membr. Biol. 196: 9-14 (2003). *
Hodgkinson CP, Ye S. Microarray analysis of peroxisome proliferator-activated receptor-gamma induced changes in gene expression in macrophages. Biochem. Biophys. Res. Commun. 308: 505-510 (2003). *
Hodgson H. Liver cells: biology to therapeutics. Clin. Med. 3: 161-165 (2003). *
Hoefnagels MA, van Leusen R, de Vries RA. Three patients with weight loss as a result of sarcoidosis presenting as liver disease. Ned. Tijdschr. Geneeskd. 147: 2453-2457 (2003).
Hoehe MR, Timmermann B, Lehrach H. Human inter-individual DNA sequence variation in candidate genes, drug targets, the importance of haplotypes and pharmacogenomics. Curr. Pharm. Biotechnol. 4: 351-378 (2003).
Hoentjen F, Harmsen HJ, Braat H, Torrice CD, Mann BA, Sartor RB, Dieleman LA. Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice. Gut 52: 1721-1727 (2003). *
Hoeve MA, de Boer T, Langenberg DM, Sanal O, Verreck FA, Ottenhoff TH. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur. J. Immunol. 33: 3393-3397 (2003). *
Hofer KN. Oral budesonide in the management of Crohn's disease. Ann. Pharmacother. 37: 1457-1464 (2003).
Hoffmann JC, Pawlowski NN, Kuhl AA, Hohne W, Zeitz M. Animal models of inflammatory bowel disease: an overview. Pathobiology 70: 121-130 (2003).
Hofmann AF. Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 52: 1239-1241 (2003). *
Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, Kartalou M, Hussain SP, Roth RB, Zhou X, Mechanic LE, Zurer I, Rotter V, Samson LD, Harris CC. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J. Clin. Invest. 112: 1887-1894 (2003). *
Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. U.S.A. 100: 143-148 (2003). *
Hogenboom S, Romeijn GJ, Houten SM, Baes M, Wanders RJ, Waterham HR. Peroxisome deficiency does not result in deficiency of enzymes involved in cholesterol biosynthesis. Adv. Exp. Med. Biol. 544: 329-330 (2003).
Hogg KG, Kumkate S, Mountford AP. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int. Immunol. 15: 1451-1459 (2003). *
Hojo M, Sano N, Takikawa H. Effects of lipopolysaccharide on the biliary excretion of bile acids and organic anions in rats. J. Gastroenterol. Hepatol. 18: 815-821 (2003). *
Hokama A, Kinjo F, Sugama R, Kobashigawa K, Matayoshi R, Yonamine Y, Tomiyama R, Sunagawa T, Kawane M, Saito A. Gastrointestinal: duodenal Crohn's disease. J. Gastroenterol. Hepatol. 18: 1425 (2003). *
Holick MF. Vitamin D: a millenium perspective. J. Cell Biochem. 88: 296-307 (2003). *
Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res. 164: 3-28 (2003).
Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin. Proc. 78: 1457-1459 (2003). *
Hollander D. Inflammatory bowel diseases and brain-gut axis. J. Physiol. Pharmacol. 54 Suppl. 4: 183-190 (2003). *
Holm AM, Aukrust P, Aandahl EM, Muller F, Tasken K, Froland SS. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency - involvement of protein kinase A type I. J. Immunol. 170: 5772-5777 (2003). *
Holm SJ, Carlen LM, Mallbris L, Stahle-Backdahl M, O'Brien KP. Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp. Dermatol. 12: 435-444 (2003). *
Holmlund JT. Applying antisense technology: Affinitak(TM) and other antisense oligonucleotides in clinical development. Ann. N. Y. Acad. Sci. 1002: 244-251 (2003). *
Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X, Grimaldi PA. Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim. Biophys. Acta 1633: 43-50 (2003). *
Holt JA, Luo G, Billin AN, Bisi J, McNeill YY, Kozarsky KF, Donahee M, Wang da Y, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17: 1581-1591 (2003). *
Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M. Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease. Z. Gastroenterol. 41: 11-17 (2003).
Holtmann MH, Neurath MF. Transplanting the genetic susceptibility to Crohn's disease. Gut 52: 1394-1396 (2003). *
Holtmann MM. RDP-58 (SangStat Medical). IDrugs 6: 1188-1194 (2003).
Holtmeier W. Compartmentalization g/d T cells and their putative role in mucosal immunity. Crit. Rev. Immunol. 23: 473-488 (2003).
Holubar S, Hyman N. Continence alterations after ileal pouch-anal anastomosis do not diminish quality of life. Dis. Colon Rectum 46: 1489-1491 (2003).
Homaidan FR, Chakroun I, El-Sabban ME. Regulation of nuclear factor-kappaB in intestinal epithelial cells in a cell model of inflammation. Mediators Inflamm. 12: 277-283 (2003). *
Hommes D. Discussion on predictors of response to infliximab in patients with Crohn's disease. Gastroenterology 124: 2002-2003 (2003). *
Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52: 144-151 (2003). *
Hommes DW, van Deventer SJ. Infliximab therapy in Crohn's disease: safety issues. Neth. J. Med. 61: 100-104 (2003). *
Hommes DW, van Deventer SJ. Targeting tumor necrosis factor-alpha in inflammatory bowel disease: why, how, and when? Curr. Opin. Gastroenterol. 19: 350-357 (2003).
Homolya L, Varadi A, Sarkadi B. Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17: 103-114 (2003).
Honda T, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Toyoda H, Ishiguro H, Ogawa S, Takeshima K, Kawachi T, Hibi T, Hayashi K, Katano Y, Fukuda Y, Goto H. Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT. Hepatol. Res. 27: 315-322 (2003).
Honeckman A. Current concepts in the treatment of canine chronic hepatitis. Clin. Tech. Small Anim. Pract. 18: 239-244 (2003).
Honey K, Rudensky AY. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3: 472-482 (2003).
Hong MY, Chapkin RS, Davidson LA, Turner ND, Morris JS, Carroll RJ, Lupton JR. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr. Cancer 46: 44-51 (2003).
Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278: 14677-14687 (2003). *
Hong SP, Park SW, Chung JP, Chung JB, Kang JK, Kim J, Kim MJ, Park YN, Song SY. Autoimmune pancreatitis with effective steroid therapy. Yonsei Med. J. 44: 534-538 (2003). *
Honkakoski P, Sueyoshi T, Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35: 172-182 (2003).
Hooijberg JH, Peters GJ, Assaraf YG, Kathmann I, Priest DG, Bunni MA, Veerman AJ, Scheffer GL, Kaspers GJ, Jansen G. The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem. Pharmacol. 65: 765-771 (2003). *
Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4: 269-273 (2003). *
Hooper-van Veen T, Schrijver HM, Zwiers A, Crusius JB, Knol DL, Kalkers NF, Laine ML, Barkhof F, Pena AS, Polman CH, Uitdehaag BM. The interleukin-1 gene family in multiple sclerosis susceptibility and disease course. Mult. Scler. 9: 535-539 (2003). *
Hopkins TA, Sugden MC, Holness MJ, Kozak R, Dyck JR, Lopaschuk GD. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 285: H270-H276 (2003). *
Hopman WP, de Jong DJ, Naber AH, Jansen JB. Tumour necrosis factor alpha antibody affects gastrin release in Crohn disease. Scand. J. Gastroenterol. 38: 522-525 (2003). *
Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front. Biosci. 8: e437-e443 (2003).
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061 (2003). *
Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81: 331-371 (2003).
Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111: 1262-1267 (2003). *
Horton JD, Shimomura I, Ikemoto S, Bashmakov Y, Hammer RE. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J. Biol. Chem. 278: 36652-36660 (2003). *
Horton KM, Lawler LP, Fishman EK. CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease. Radiographics 23: 1561-1567 (2003). *
Hosono A, Ozawa A, Kato R, Ohnishi Y, Nakanishi Y, Kimura T, Nakamura R. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci. Biotechnol. Biochem. 67: 758-764 (2003). *
Houchen CW. FGF-20: FGFs - they keep growing and growing and growing! Inflamm. Bowel Dis. 9: 133 (2003).
Houghton WC. Betaine and nonalcoholic steatohepatitis. Am. J. Gastroenterol. 98: 2803 (2003). *
House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra A. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann. Surg. Oncol. 10: 882-889 (2003). *
Houten SM, Frenkel J, Waterham HR. Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell. Mol. Life Sci. 60: 1118-1134 (2003). *
Howard M, Fischer H, Roux J, Santos BC, Gullans SR, Yancey PH, Welch WJ. Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function. J. Biol. Chem. 278: 35159-35167 (2003). *
Howard PJ, Murphy GM. Bile acid stress in the mother and baby unit. Eur. J. Gastroenterol. Hepatol. 15: 317-321 (2003).
Howard TD, Postma DS, Jongepier H, Moore WC, Koppelman GH, Zheng SL, Xu J, Bleecker ER, Meyers DA. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112: 717-722 (2003). *
Hrstic I, Ostojic R, Rustemovic N, Opacic M, Cukovic-Cavka S, Barbaric-Babic V. Primary sclerosing cholangitis: case report of a young patient with an atypical diagnostic process in complications of the disease. Med. Arh. 57: 29-32 (2003).
Hsu C, Chen CN, Chen LT, Wu CY, Yang PM, Lai MY, Lee PH, Cheng AL. Low-dose thalidomide treatment for advanced hepatocellular carcinoma. Oncology 65: 242-249 (2003).
Hsu HC, Mountz JD. Origin of late-onset autoimmune disease. Immunol. Allergy Clin. North Am. 23: 65-82, vi (2003).
Hsu HC, Zhang HG, Li L, Yi N, Yang PA, Wu Q, Zhou J, Sun S, Xu X, Yang X, Lu L, Van Zant G, Williams RW, Allison DB, Mountz JD. Age-related thymic involution in C57BL/6J x DBA/2J recombinant-inbred mice maps to mouse chromosomes 9 and 10. Genes Immun. 4: 402-410 (2003). *
Hsueh WC, St Jean PL, Mitchell BD, Pollin TI, Knowler WC, Ehm MG, Bell CJ, Sakul H, Wagner MJ, Burns DK, Shuldiner AR. Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 52: 550-557 (2003). *
Hu X, Li S, Wu J, Xia C, Lala DS. Liver X receptors interact with corepressors to regulate gene expression. Mol. Endocrinol. 17: 1019-1026 (2003). *
Hu X, Peek R, Plomp A, ten Brink J, Scheffer G, van Soest S, Leys A, de Jong PT, Bergen AA. Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum. Invest. Ophthalmol. Vis. Sci. 44: 1824-1829 (2003). *
Hu X, Plomp A, Wijnholds J, Ten Brink J, van Soest S, van den Born LI, Leys A, Peek R, de Jong PT, Bergen AA. ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum. Eur. J. Hum. Genet. 11: 215-224 (2003). *
Hu X, Plomp AS, van Soest S, Wijnholds J, de Jong PT, Bergen AA. Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv. Ophthalmol. 48: 424-438 (2003). *
Huang CF, Wang CL, Huang YF, Hsieh KS, Yang KD. Hyper-IgM syndrome complicated with interstitial pneumonia and peritonitis. Chang Gung Med. J. 26: 53-59 (2003).
Huang L, Zhao A, Lew JL, Zhang T, Hrywna Y, Thompson JR, de Pedro N, Royo I, Blevins RA, Pelaez F, Wright SD, Cui J. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J. Biol. Chem. 278: 51085-51090 (2003). *
Huang SM, Wu TJ, Lee TD, Yang EK, Shaw CK, Yeh CC. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people. Tissue Antigens 61: 154-158 (2003). *
Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115: 565-576 (2003). *
Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD. Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 100: 4156-4161 (2003). *
Huang YT, Hsu YC, Chen CJ, Liu CT, Wei YH. Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J. Biomed. Sci. 10: 170-178 (2003). *
Hubscher SG. Iron overload, inflammation and fibrosis in genetic haemochromatosis. J. Hepatol. 38: 521-525 (2003). *
Hug MJ, Tamada T, Bridges RJ. CFTR and bicarbonate secretion by epithelial cells. News Physiol. Sci. 18: 38-42 (2003). *
Hughes DE, Stolz DB, Yu S, Tan Y, Reddy JK, Watkins SC, Diehl AM, Costa RH. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage. Hepatology 37: 1414-1424 (2003). *
Hughes DK. Nuclear medicine and infection detection: the relative effectiveness of imaging with (111)In-oxine-, (99m)Tc-HMPAO-, and (99m)Tc-stannous fluoride colloid-labeled leukocytes and with (67)Ga-citrate. J. Nucl. Med. Technol. 31: 196-201 (2003). *
Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP. Crohn's disease: the cold chain hypothesis. Lancet 362: 2012-2015 (2003). *
Hugot JP, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, Montague S, Gassull M, Christensen S, Finkel Y, Gower-Rousseau C, Modigliani R, Zouali H, Lesage S, Chamaillard M, Macry J, Thomas G, Victor JM; GETAID. Clustering of Crohn's disease within affected sibships. Eur. J. Hum. Genet. 11: 179-184 (2003). *
Hugot JP, Zouali H, Lesage S. Lessons to be learned from the NOD2 gene in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 15: 593-597 (2003). *
Huhn RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME, Kimball J, Greene A, Hansmann K, Gratwohl A, Young N, Barrett AJ, Dunbar CE. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 101: 71-77 (2003). *
Hui AY, Friedman SL. Molecular basis of hepatic fibrosis. Expert Rev. Mol. Med. 5: 1-23 (2003).
Huic D, Vukovic J, Senecic-Cala I, Dodig D. Splenic atrophy as complication of ulcerative colitis diagnosed by antigranulocyte antibodies labeled with tc-99m-pertechnetate. Croat. Med. J. 44: 767-769 (2003).
Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr. Opin. Rheumatol. 15: 61-69 (2003).
Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230-232 (2003). *
Hulzebos CV, Wolters H, Plosch T, Kramer W, Stengelin S, Stellaard F, Sauer PJ, Verkade HJ, Kuipers F. Cyclosporin A and enterohepatic circulation of bile salts in rats: decreased cholate synthesis but increased intestinal reabsorption. J. Pharmacol. Exp. Ther. 304: 356-363 (2003). *
Hunter JO. Endoscopic hydrostatic dilatation of intestinal strictures in Crohn's disease. Dig. Liver Dis. 35: 851-852 (2003).
Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, Hengartner H, Zinkernagel RM. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4: 343-349 (2003). *
Huppa JB, Davis MM. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3: 973-983 (2003).
Huster D, Hoppert M, Lutsenko S, Zinke J, Lehmann C, Mossner J, Berr F, Caca K. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines. Gastroenterology 124: 335-345 (2003). *
Huster D, Lutsenko S. The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein. J. Biol. Chem. 278: 32212-32218 (2003). *
Hyams JS. Infliximab treatment of Crohn's disease in children: it's time to not go retro(spective). Am. J. Gastroenterol. 98: 5-6 (2003). *
Iannello S, Cavaleri A, Milazzo P, Cantarella S, Belfiore F. Low fasting serum triglyceride level as a precocious marker of autoimmune disorders. MedGenMed. 5: 20 (2003). *
Iannone F, Falappone P, Pannarale G, Gentile A, Grattagliano V, Covelli M, Lapadula G. Microscopic polyangiitis associated with primary biliary cirrhosis. J. Rheumatol. 30: 2710-2712 (2003).
Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am. J. Respir. Crit. Care Med. 167: 1225-1231 (2003). *
Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, Imaizumi M, Oshima K, Usa T, Uotani S, Ejima E, Yamasaki H, Ashizawa K, Yamaguchi Y, Eguchi K. Interleukin-10 gene promoter region polymorphisms in patients with type 1 diabetes and autoimmune thyroid disease. Ann. N. Y. Acad. Sci. 1005: 344-347 (2003). *
Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, Takahashi R, Kuwahara H, Fujita N, Kita A, Imaizumi M, Oshima K, Usa T, Uotani S, Ejima E, Yamasaki H, Ashizawa K, Yamaguchi Y, Eguchi K. Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease. Ann. N. Y. Acad. Sci. 1005: 436-439 (2003). *
Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Yatoh S, Iizuka Y, Tomita S, Ohashi K, Takahashi A, Sone H, Gotoda T, Osuga J, Ishibashi S, Yamada N. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol. Endocrinol. 17: 1255-1267 (2003). *
Iellem A, Colantonio L, D'Ambrosio D. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells. Eur. J. Immunol. 33: 1488-1496 (2003). *
Igarashi H, Aoyagi Y, Suda T, Mita Y, Kawai K. Studies on the correlation among the fucosylation index, concentration of alpha-fetoprotein and des-gamma-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma. Hepatol. Res. 27: 280-288 (2003).
Iida A, Ozaki K, Ohnishi Y, Tanaka T, Nakamura Y. Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21. J. Hum. Genet. 48: 476-479 (2003). *
Iizasa H, Genda N, Kitano T, Tomita M, Nishihara K, Hayashi M, Nakamura K, Kobayashi S, Nakashima E. Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice. J. Pharm. Sci. 92: 569-576 (2003). *
Ikeda S, Kudsk KA, Fukatsu K, Johnson CD, Le T, Reese S, Zarzaur BL. Enteral feeding preserves mucosal immunity despite in vivo MAdCAM-1 blockade of lymphocyte homing. Ann. Surg. 237: 677-685 (2003). *
Ikeda Y, Akbar SM, Matsui H, Murakami H, Onji M. Depletion and decreased function of antigen-presenting dendritic cells caused by lymphocytapheresis in ulcerative colitis. Dis. Colon Rectum 46: 521-528 (2003).
Ikuma M, Geibel J, Binder HJ, Rajendran VM. Characterization of Cl-HCO3 exchange in basolateral membrane of rat distal colon. Am. J. Physiol. Cell Physiol. 285: C912-C921 (2003). *
Illig T, Bongardt F, Schopfer A, Holle R, Muller S, Rathmann W, Koenig W, Meisinger C, Wichmann HE, Kolb H; KORA Study Group. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52: 2861-2864 (2003). *
Iltanen S, Maki M, Collin P, Mustalahti K, Kaukinen K, Partanen J, Hulkkonen J, Hurme M, Aittoniemi J. The association between mannan-binding lectin gene alleles and celiac disease. Am. J. Gastroenterol. 98: 2808-2809 (2003). *
Imadome K, Shirakata M, Shimizu N, Nonoyama S, Yamanashi Y. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc. Natl. Acad. Sci. U.S.A. 100: 7836-7840 (2003). *
Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, Nagendran V, Wood P, Glastre C, Sarrot-Reynauld F, Hermine O, Forveille M, Revy P, Fischer A, Durandy A. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J. Clin. Invest. 112: 136-142 (2003). *
Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4: 1023-1028 (2003). *
Imai T. Functional genetic dissection of nuclear receptor signalling in obesity, diabetes and liver regeneration using spatiotemporally controlled somatic mutagenesis in the mouse. Keio. J. Med. 52: 198-203 (2003). *
Imose M, Nagaki M, Naiki T, Osawa Y, Brenner DA, Asano T, Hayashi H, Kato T, Moriwaki H. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Liver Int. 23: 386-396 (2003). *
Inadomi JM. Update on the cost-effectiveness of screening for colorectal neoplasia. Curr. Opin. Gastroenterol. 19: 44-50 (2003).
Inadomi JM. Cost-effectiveness of colorectal cancer surveillance in ulcerative colitis. Scand. J. Gastroenterol. Suppl. 237: 17-21 (2003). *
Indriethason OS, Palsson R, Eethvarethsson VO. The role of omega-3 polyunsaturated fatty acids in clinical medicine. Laeknabladid. 89: 199-211 (2003).
Infante AJ, Baillargeon J, Kraig E, Lott L, Jackson C, Hammerling GJ, Raju R, David C. Evidence of a diverse T cell receptor repertoire for acetylcholine receptor, the autoantigen of myasthenia gravis. J. Autoimmun. 21: 167-174 (2003).
Ingram DA, Wenning MJ, Shannon K, Clapp DW. Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells. Blood 101: 1984-1986 (2003). *
Inman CK, Shore P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J. Biol. Chem. 278: 48684-48689 (2003). *
Innis SM, Davidson AG, Chen A, Dyer R, Melnyk S, James SJ. Increased plasma homocysteine and S-adenosylhomocysteine and decreased methionine is associated with altered phosphatidylcholine and phosphatidylethanolamine in cystic fibrosis. J. Pediatr. 143: 351-356 (2003). *
Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3: 371-382 (2003). *
Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512 (2003). *
International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am. J. Hum. Genet. 73: 430-437 (2003). *
Inui S, Lee YF, Chang E, Shyr CR, Chang C. Differential and bi-directional regulation between TR2/TR4 orphan nuclear receptors and a specific ligand mediated-peroxisome proliferator-activated receptor alpha in human HaCaT keratinocytes. J. Dermatol. Sci. 31: 65-71 (2003).
Invernizzi P, Battezzati PM, Crosignani A, Perego F, Poli F, Morabito A, De Arias AE, Scalamogna M, Zuin M, Podda M. Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis. J. Hepatol. 38: 401-406 (2003). *
Ioachim E, Michael M, Katsanos C, Demou A, Tsianos EV. The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices. Histol. Histopathol. 18: 75-82 (2003).
Ioannou GN, Kowdley KV. Iron, HFE mutations, and hepatocellular carcinoma: is hepatic iron a carcinogen? Clin. Gastroenterol. Hepatol. 1: 246-248 (2003). *
Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38: 123-132 (2003). *
Iredale JP. Regulating hepatic inflammation: pathogen-associated molecular patterns take their toll. Hepatology 37: 979-982 (2003). *
Ishibashi H, Nakamura M, Shimoda S, Gershwin ME. T cell immunity and primary biliary cirrhosis. Autoimmun. Rev. 2: 19-24 (2003).
Ishikawa T, Kasamatsu S, Hagiwara Y, Mitomo H, Kato R, Sumino Y. Expression and functional characterization of human ABC transporter ABCG2 variants in insect cells. Drug Metab. Pharmacokinet. 18: 194-202 (2003). *
Ismail Y, Muhamad A. Protean manifestations of gastrointestinal tuberculosis. Med. J. Malaysia 58: 345-349 (2003).
Ismair MG, Stanca C, Ha HR, Renner EL, Meier PJ, Kullak-Ublick GA. Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol. Res. 26: 343-347 (2003).
Isomoto H, Fukuda Y, Bando Y, Machida I, Machida H, Omagari K, Mizuta Y, Murase K, Fukushima T, Murata I, Kohno S. Pure red cell aplasia associated with parvovirus B19 infection in a patient with ulcerative colitis. Dig. Dis. Sci. 48: 2104-2107 (2003). *
Isomoto H, Furusu H, Onizuka Y, Kawaguchi Y, Mizuta Y, Maeda T, Kohno S. Colonic involvement by adult T-cell leukemia/lymphoma mimicking ulcerative colitis. Gastrointest. Endosc. 58: 805-808 (2003).
Ito H. IL-6 and Crohn's disease. Curr. Drug Targets Inflamm. Allergy 2: 125-30 (2003).
Ito H. Anti-interleukin-6 therapy for Crohn's disease. Curr. Pharm. Des. 9: 295-305 (2003).
Ito T. Physiological function of ABCG1. Drug News Perspect. 16: 490-492 (2003).
Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 13: 43-47 (2003). *
Itoh S, Kanazuka A, Akimoto T. Combined treatment with ursodeoxycholic acid and pioglitazone in a patient with NASH associated with type 2 diabetes and psoriasis. Dig. Dis. Sci. 48: 2182-2186 (2003). *
Itzkowitz SH. Fingerprinting the colon? Inflamm. Bowel Dis. 9: 338-339 (2003). *
Ivanyi J. Milan Hasek and the discovery of immunological tolerance. Nat. Rev. Immunol. 3: 591-597 (2003). *
Iwahori T, Matsuura T, Maehashi H, Sugo K, Saito M, Hosokawa M, Chiba K, Masaki T, Aizaki H, Ohkawa K, Suzuki T. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 37: 665-673 (2003). *
Iwai M, Harada Y, Ishii M, Tanaka S, Muramatsu A, Mori T, Nakashima T, Okanoue T, Hirohata S. Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin. Rheumatol. 22: 234-236 (2003). *
Iwanaga Y, Davey MP, Martin TM, Planck SR, DePriest ML, Baugh MM, Suing CM, Rosenbaum JT. Cloning, sequencing and expression analysis of the mouse NOD2/CARD15 gene. Inflamm. Res. 52: 272-276 (2003). *
Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T. Detection of anti-SS-A/Ro and anti-SS-B/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sjogren's syndrome. Nihon Rinsho Meneki Gakkai Kaishi 26: 346-354 (2003).
Iwasaki N, Cox NJ, Wang YQ, Schwarz PE, Bell GI, Honda M, Imura M, Ogata M, Saito M, Kamatani N, Iwamoto Y. Mapping genes influencing type 2 diabetes risk and BMI in Japanese subjects. Diabetes 52: 209-213 (2003). *
Iwata M, Eshima Y, Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15: 1017-1025 (2003). *
Izumi Y, Tanaka S, Hidaka Y, Shimaoka Y, Tatsumi KI, Takano T, Kaneko A, Oku K, Amino N. Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies. Am. J. Reprod. Immunol. 50: 355-362 (2003). *
Jaaskelainen T, Ryhanen S, Maenpaa PH. 9-cis Retinoic acid accelerates calcitriol-induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells. J. Cell. Biochem. 89: 1164-1176 (2003). *
Jabbar A, Chang WK, Dryden GW, McClave SA. Gut immunology and the differential response to feeding and starvation. Nutr. Clin. Pract. 18: 461-482 (2003).
Jablonska-Kaszewska I, Dabrowska E, Jurowiecka AD, Falklewicz B. Treatment of Wilson's disease. Med. Sci. Monit. 9 Suppl. 3: 5-8 (2003).
Jablonska-Kaszewska I, Droblnska-Jurowiecka A, Dabrowska E, Trocha H. Results of treatment of Wilson's disease - own observations. Med. Sci. Monit. 9 Suppl. 3: 9-14 (2003).
Jackson AU, Galecki AT, Burke DT, Miller RA. Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable T cell subsets. Genes Immun. 4: 30-39 (2003). *
Jacob SE, Martin LK, Kerdel FA. Cutaneous Wegener's granulomatosis (malignant pyoderma) in a patient with Crohn's disease. Int. J. Dermatol. 42: 896-898 (2003). *
Jacobi A, Manger B, Schuler G, Hertl M. Therapeutic application of TNF-alpha inhibitors infliximab and etanercept in inflammatory skin disorders. J. Dtsch. Dermatol. Ges. 1: 259-372 (2003).
Jaeckel E, Manns MP. The role of autoantigens and autoantibodies in PBC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 28. October 15-16 (2003). *
Jagadeesh D, Syngal S. Genetic testing for hereditary nonpolyposis colorectal cancer. Curr. Opin. Gastroenterol. 19: 57-63 (2003).
Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation 75: 1020-1025 (2003).
Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin. Liver Dis. 23: 271-282 (2003).
Jalan R, Shawcross D, Davies N. The molecular pathogenesis of hepatic encephalopathy. Int. J. Biochem. Cell Biol. 35: 1175-1181 (2003). *
Jalouli M, Carlsson L, Ameen C, Linden D, Ljungberg A, Michalik L, Eden S, Wahli W, Oscarsson J. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology 144: 101-109 (2003). *
Jamain S, Betancur C, Giros B, Leboyer M, Bourgeron T. Genetics of autism: from genome scans to candidate genes. Med. Sci. (Paris) 19: 1081-1090 (2003).
Jamerson BD, Krishnan KR, Roberts J, Krishen A, Modell JG. Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacol. Bull. 37: 67-78 (2003).
James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab. Dispos. 31: 1499-1506 (2003). *
James MJ, Proudman SM, Cleland LG. Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukot. Essent. Fatty Acids 68: 399-405 (2003). *
James OFW. Epidemiology of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 17. October 15-16 (2003). *
James SP. 19. Immunologic, gastroenterologic, and hepatobiliary disorders. J. Allergy Clin. Immunol. 111: S645-S658 (2003). *
James SY, Lin F, Kolluri SK, Dawson MI, Zhang XK. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. Cancer Res. 63: 3531-3538 (2003). *
Janosikova B, Pavlikova M, Kocmanova D, Vitova A, Vesela K, Krupkova L, Kahleova R, Krijt J, Kraml P, Hyanek J, Zvarova J, Andel M, Kozich V. Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. Mol. Genet. Metab. 79: 167-175 (2003). *
Jansen G, Scheper RJ, Dijkmans BA. Multidrug resistance proteins in rheumatoid arthritis, role in disease-modifying antirheumatic drug efficacy and inflammatory processes: an overview. Scand. J. Rheumatol. 32: 325-336 (2003).
Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int. 23: 315-322 (2003). *
Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC; European Group for the Study of Vascular Disorders of the Liver. Budd-Chiari syndrome: a review by an expert panel. J. Hepatol. 38: 364-371 (2003). *
Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16: 637-646 (2003). *
Janssens S, Burns K, Vercammen E, Tschopp J, Beyaert R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett. 548: 103-107 (2003). *
Jaruga B, Hong F, Sun R, Radaeva S, Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J. Immunol. 171: 3233-3244 (2003). *
Jarvinen HJ. Genetic testing for polyposis: practical and ethical aspects. Gut 52 Suppl. 2: ii19-ii22 (2003). *
Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 76: 1599-1603 (2003).
Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C, Damle A, Xiao X, Chen D, Lum RF, Monteiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS, Ward R, Kastner DL, Wilder RL, et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48: 906-916 (2003). *
Jazayeri M, Bakayev V, Adibi P, Haghighi Rad F, Zakeri H, Kalantar E, Zali MR. Frequency of HFE gene mutations in Iranian beta-thalassaemia minor patients. Eur. J. Haematol. 71: 408-411 (2003). *
Jazrawi SF, Zaman A, Muhammad Z, Rabkin JM, Corless CL, Olyaei A, Biggs A, Ham J, Chou S, Rosen HR. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs. Liver Transpl. 9: 377-382 (2003). *
Jefferies H, Bot J, Coster J, Khalil A, Hall JC, McCauley RD. The role of glutathione in intestinal dysfunction. J. Invest. Surg. 16: 315-323 (2003).
Jennings JS, Howdle PD. New developments in celiac disease. Curr. Opin. Gastroenterol. 19: 118-129 (2003).
Jensen BA, Leeman RJ, Schlezinger JJ, Sherr DH. Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study. Environ. Health 2: 16 (2003). *
Jewell DP. Genes and immunopathology. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 57. September 12 - 13 (2003). *
Jeyarajah DR, Kielar ML, Frantz N, Lindberg G, Lu CY. Infection by Gram-negative organisms via the biliary route results in greater mortality than portal venous infection. Clin. Diagn. Lab. Immunol. 10: 664-669 (2003). *
Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124: 1488-1499 (2003). *
Jia D, Otsuki M. Bezafibrate, a peroxisome proliferator-activated receptor (PPAR)-alpha activator, prevents pancreatic degeneration in obese and diabetic rats. Pancreas 26: 286-291 (2003).
Jiang J, He M. Clinical features of primary biliary cirrhosis and treatment of it by integrated traditional Chinese and western medicine. Zhong Xi Yi Jie He Xue Bao 1: 99-102 (2003).
Jiang XH, Fang XY, Zhong RQ, Wang XP, Hu Y, Kong XT. Development of an enzyme immune assay for detecting M2 autoantibodies specific for primary biliary cirrhosis. Hepatobiliary Pancreat. Dis. Int. 2: 290-294 (2003). *
Jiang XH, Li N, Li JS. Intestinal permeability in patients after surgical trauma and effect of enteral nutrition versus parenteral nutrition. World J. Gastroenterol. 9: 1878-1880 (2003). *
Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT. Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J. Gastroenterol. 9: 1352-1355 (2003). *
Jiang YG, Wang YM, Liu TH, Liu J. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J. Gastroenterol. 9: 2221-2225 (2003). *
Jimenez-Saenz M, Villar-Rodriguez JL, Torres Y, Carmona I, Salas-Herrero E, Gonzalez-Vilches J, Herrerias-Gutierrez JM. Biliary tract disease: a rare manifestation of eosinophilic gastroenteritis. Dig. Dis. Sci. 48: 624-627 (2003). *
Jin LH, Kim DW, Eum WS, Yoon CS, Jang SH, Choi HS, Choi SH, Kim YH, Kim SY, Jung MR, Kang TC, Won MH, Lee HY, Kang JH, Kwon OS, Cho SW, Lee KS, Park J, Choi SY. Human liver catalase: cloning, expression and characterization of monoclonal antibodies. Mol. Cells 15: 381-386 (2003). *
Jin Y, Teng W, Ben S, Xiong X, Zhang J, Xu S, Shugart YY, Jin L, Chen J, Huang W. Genome-wide scan of Graves' disease: evidence for linkage on chromosome 5q31 in Chinese Han pedigrees. J. Clin. Endocrinol. Metab. 88: 1798-1803 (2003). *
Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, Kimura R, Miyagi T, Mochizuki K, Sasaki Y, Hayashi N. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104: 354-361 (2003). *
Jo Y, Matsumoto T, Mibu R, Iida M. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis? Dis. Colon Rectum 46: S3-S9 (2003).
Jo Y, Matsumoto T, Yada S, Fujisawa K, Esaki M, Onai N, Matsushima K, Iida M. CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease. Clin. Exp. Immunol. 132: 332-338 (2003). *
Johansson S, Lie BA, Cambon-Thomsen A, Pociot F, Nerup J, Kockum I, Thorsby E, Undlien DE. No evidence of type 1 diabetes susceptibility genes in the region centromeric of the HLA complex. Hum. Immunol. 64: 951-959 (2003).
Johansson S, Lie BA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Thorsby E, Undlien DE. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 61: 344-351 (2003). *
Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I, Akselsen HE, Thorsby E, Undlien DE. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun. 4: 46-53 (2003). *
Johansson-Lindbom B, Svensson M, Wurbel MA, Malissen B, Márquez G, Agace W. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 198: 963-969 (2003). *
Johnson CD, Harmsen WS, Wilson LA, Maccarty RL, Welch TJ, Ilstrup DM, Ahlquist DA. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 125: 311-319 (2003). *
Johnson CD, Toledano AY, Herman BA, Dachman AH, McFarland EG, Barish MA, Brink JA, Ernst RD, Fletcher JG, Halvorsen RA Jr, Hara AK, Hopper KD, Koehler RE, Lu DS, Macari M, Maccarty RL, Miller FH, Morrin M, Paulson EK, Yee J, Zalis M. Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology 125: 688-695 (2003). *
Johnson S. Do mitochondria regulate cellular iron homeostasis through citric acid and haem production? Implications for cancer and other diseases. Med. Hypotheses 60: 106-111 (2003). *
Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ. Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J. Bone Miner. Res. 18: 376-380 (2003).
Johnstone RF, Dolen WK, Hoffman HM. A large kindred with familial cold autoinflammatory syndrome. Ann. Allergy Asthma Immunol. 90: 233-237 (2003).
Jones BJ. Recent developments in the delivery of home parenteral nutrition in the UK. Proc. Nutr. Soc. 62: 719-725 (2003). *
Jones DE. Addison's other disease: primary biliary cirrhosis as a model autoimmune disease. Clin. Med. 3: 351-356 (2003). *
Jones DE. Pathogenesis of primary biliary cirrhosis. J. Hepatol. 39: 639-648 (2003). *
Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin. Liver Dis. 7: 841-864 (2003).
Jones DEJ. Is microchimaerism an etiological factor of PBC? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 21-22. October 15-16 (2003). *
Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R, Das S. Arachidonic acid and colorectal carcinogenesis. Mol. Cell. Biochem. 253: 141-149 (2003). *
Jones SA, Parks DJ, Kliewer SA. Cell-free ligand binding assays for nuclear receptors. Methods Enzymol. 364: 53-71 (2003).
Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders AE, Lamers CH, Masclee AA. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut 52: 109-115 (2003). *
Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren's syndrome. Curr. Rheumatol. Rep. 5: 311-316 (2003).
Jonuleit H, Adema G, Schmitt E. Immune regulation by regulatory T cells: implications for transplantation. Transpl. Immunol. 11: 267-276 (2003).
Joo SS, Kang HC, Won TJ, Lee DI. Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1beta and nitric oxide in rat microglia. Arch. Pharm. Res. 26: 1067-1073 (2003).
Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 48: 339-347 (2003). *
Joplin R. Infectious etiology of primary biliary cirrhosis? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 19-20. October 15-16 (2003). *
Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219 (2003). *
Juan J, Estiarte R, Colome E, Artes M, Jimenez FJ, Alonso J. Burden of illness of Crohn's disease in Spain. Dig. Liver Dis. 35: 853-861 (2003).
Jubelirer SJ, Wells JB, Emmett M, Broce M. Incidence of colorectal cancer in West Virginia from 1993-1999: an update by gender, age, subsite and stage. W.V. Med. J. 99: 182-186 (2003).
Jude BA, Pobezinskaya Y, Bishop J, Parke S, Medzhitov RM, Chervonsky AV, Golovkina TV. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4: 573-578 (2003). *
Jun HS, Yoon JW. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19: 8-31 (2003). *
Jung D, Kullak-Ublick GA. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 37: 622-631 (2003). *
Jung YS, Kwak HE, Choi KH, Kim YC. Effect of acute ethanol administration on S-amino acid metabolism: increased utilization of cysteine for synthesis of taurine rather than glutathione. Adv. Exp. Med. Biol. 526: 245-252 (2003).
Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Single-nucleotide polymorphisms (SNPs) in human beta-defensin 1: high-throughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J. Clin. Microbiol. 41: 90-96 (2003). *
Justice CM, Miller NH, Marosy B, Zhang J, Wilson AF. Familial idiopathic scoliosis: evidence of an X-linked susceptibility locus. Spine 28: 589-594 (2003).
Jyrkkarinne J, Makinen J, Gynther J, Savolainen H, Poso A, Honkakoski P. Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor. J. Med. Chem. 46: 4687-4695 (2003). *
Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, Canard JM, Fritsch J, Rey JF, Burtin P. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest. Endosc. 57: 178-182 (2003). *
Kabashima K, Sakata D, Nagamachi M, Miyachi Y, Inaba K, Narumiya S. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9: 744-749 (2003). *
Kabelitz D, Wesch D. Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit. Rev. Immunol. 23: 339-370 (2003).
Kabesch M, Peters W, Carr D, Leupold W, Weiland SK, von Mutius E. Association between polymorphisms in caspase recruitment domain containing protein 15 and allergy in two German populations. J. Allergy Clin. Immunol. 111: 813-817 (2003). *
Kabesch M, Tzotcheva I, Carr D, Hofler C, Weiland SK, Fritzsch C, von Mutius E, Martinez FD. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J. Allergy Clin. Immunol. 112: 893-898 (2003). *
Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin. Biochem. 36: 203-210 (2003). *
Kadokawa Y, Omagari K, Matsuo I, Otsu Y, Yamamoto U, Nishino T, Ohba K, Miyazaki M, Harada T, Taguchi T, Kohno S. Primary sclerosing cholangitis associated with lupus nephritis: a rare association. Dig. Dis. Sci. 48: 911-914 (2003). *
Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R. Molecular mechanism of insulin resistance and obesity. Exp. Biol. Med. (Maywood) 228: 1111-1117 (2003). *
Kadry Z, Mullhaupt B, Renner EL, Bauerfeind P, Schanz U, Pestalozzi BC, Studer G, Zinkernagel R, Clavien PA. Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. Transplantation 76: 1003-1006 (2003).
Kageyama F, Takehira Y, Yamada M, Murohisa G, Hirasawa K, Kataoka H, Iwaoka Y, Iwaizumi M, Kawata K, Hamaya Y, Nakamura A, Makino S, Hirano M, Kitagawa M, Ikematsu Y, Ozawa T, Yasumi K, Kobayashi Y. A case of intrahepatic biliary papillomatosis associated with autoimmune hepatitis. Nippon Shokakibyo Gakkai Zasshi 100: 1322-1327 (2003).
Kahan BD. Individuality: the barrier to optimal immunosuppression. Nat. Rev. Immunol. 3: 831-838 (2003). *
Kahana DD, Cass O, Jessurun J, Schwarzenberg SJ, Sharp H, Khan K. Sclerosing cholangitis associated with Trichosporon infection and natural killer cell deficiency in an 8-year-old girl. J. Pediatr. Gastroenterol. Nutr. 37: 620-623 (2003). *
Kahl S, Zimmermann S, Genz I, Glasbrenner B, Pross M, Schulz HU, Mc Namara D, Schmidt U, Malfertheiner P. Risk factors for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am. J. Gastroenterol. 98: 2448-2453 (2003). *
Kaiserling E, Krober S, Geleff S. Lymphatic vessels in the colonic mucosa in ulcerative colitis. Lymphology 36: 52-61 (2003).
Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E. Characteristics of nanobacteria and their possible role in stone formation. Urol. Res. 31: 47-54 (2003).
Kakizaki S, Ishikawa T, Koyama Y, Yamada H, Kobayashi R, Sohara N, Otsuka T, Takagi H, Mori M. Primary biliary cirrhosis complicated with sigmoid colonic varices: the usefulness of computed tomographic angiography. Abdom. Imaging 28: 831-834 (2003).
Kakizoe T. Chemoprevention of cancer - focusing on clinical trials. Jpn. J. Clin. Oncol. 33: 421-442 (2003). *
Kakko S, Kelloniemi J, von Rohr P, Hoeschele I, Tamminen M, Brousseau ME, Kesaniemi YA, Savolainen MJ. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis 166: 285-290 (2003).
Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, Ghaderi A. Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease. Autoimmunity 36: 313-316 (2003).
Kaletha K, Chodorowski Z, Anand IS, Rybakowska I, Nagel-Starczynowska G. Lipoproteins HDL and coronary artery disease: a molecular mechanism of fibrate. Przegl. Lek. 60: 223-225 (2003).
Kalfa VC, Roberts RL, Stiehm ER. The syndrome of chronic mucocutaneous candidiasis with selective antibody deficiency. Ann. Allergy Asthma Immunol. 90: 259-264 (2003).
Kalicinski PJ, Ismail H, Jankowska I, Kaminski A, Pawlowska J, Drewniak T, Markiewicz M, Szymczak M. Surgical treatment of progressive familial intrahepatic cholestasis: comparison of partial external biliary diversion and ileal bypass. Eur. J. Pediatr. Surg. 13: 307-311 (2003).
Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur. J. Immunol. 33: 798-805 (2003). *
Kalish RS, Gilhar A. Alopecia areata: autoimmunity - the evidence is compelling. J. Investig. Dermatol. Symp. Proc. 8: 164-167 (2003). *
Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol. 3: 15-20 (2003).
Kam I. Cadaveric versus living donor liver transplantation - analysis of costs. Transplant. Proc. 35: 971 (2003).
Kamata Y, Kamimura T, Yoshio T, Hirata D, Masuyama J, Isoda N, Kanai N, Minota S. Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report. Ryumachi 43: 667-671 (2003).
Kamath PS, Kim WR. Is the change in MELD score a better indicator of mortality than baseline MELD score? Liver Transpl. 9: 19-21 (2003). *
Kamihira T, Shimoda S, Harada K, Kawano A, Handa M, Baba E, Tsuneyama K, Nakamura M, Ishibashi H, Nakanuma Y, Gershwin ME, Harada M. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology 125: 1379-1387 (2003). *
Kaminen N, Hannula-Jouppi K, Kestila M, Lahermo P, Muller K, Kaaranen M, Myllyluoma B, Voutilainen A, Lyytinen H, Nopola-Hemmi J, Kere J. A genome scan for developmental dyslexia confirms linkage to chromosome 2p11 and suggests a new locus on 7q32. J. Med. Genet. 40: 340-345 (2003). *
Kamisako T, Ogawa H. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats: effects of diosgenin and ethinyl estradiol. Hepatol. Res. 26: 348-352 (2003).
Kamisako T, Ogawa H. Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatol. Res. 25: 99-104 (2003).
Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am. J. Gastroenterol. 98: 2811-2812 (2003). *
Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am. J. Gastroenterol. 98: 2694-2699 (2003). *
Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 38: 982-984 (2003). *
Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, Egawa N, Nakajima H. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 52: 683-687 (2003). *
Kanagawa S, Morinobu A, Koshiba M, Kageyama G, Hayashi N, Yoshino S, Tokano Y, Hashimoto H, Kumagai S. Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus. Lupus 12: 258-265 (2003).
Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, Watanabe M. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163 (2003). *
Kanai T, Uraushihara K, Totsuka T, Okazawa A, Hibi T, Oshima S, Miyata T, Nakamura T, Watanabe M. Macrophage-derived IL-18 targeting for the treatment of Crohn's disease. Curr. Drug Targets Inflamm. Allergy 2: 131-136 (2003).
Kanauchi O, Mitsuyama K, Araki Y, Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Des. 9: 333-346 (2003).
Kanda T, Yokosuka O, Imazeki F, Saisho H. Bezafibrate treatment: a new medical approach for PBC patients? J. Gastroenterol. 38: 573-578 (2003). *
Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol. Clin. North Am. 32: 323-340 (2003). *
Kane S, Altschuler EL, Kast RE. Crohn's disease remission on bupropion. Gastroenterology 125: 1290 (2003). *
Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Med. 114: 39-43 (2003). *
Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis. Clin. Gastroenterol. Hepatol. 1: 170-173 (2003). *
Kane SV, Bjorkman DJ. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review. Rev. Gastroenterol. Disord. 3: 210-218 (2003). *
Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am. J. Gastroenterol. 98: 1309-1314 (2003). *
Kankonkar S, Jeyanti G, Singhal BS, Shankarkumar U. Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India. Hum. Immunol. 64: 478-482 (2003).
Kankuri E, Hamalainen M, Hukkanen M, Salmenpera P, Kivilaakso E, Vapaatalo H, Moilanen E. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand. J. Gastroenterol. 38: 186-192 (2003). *
Kanno K, Tazuma S, Niida S, Chayama K. Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. Hepatol. Res. 26: 157-163 (2003).
Kantarci A, Van Dyke TE. Lipoxins in chronic inflammation. Crit. Rev. Oral Biol. Med. 14: 4-12 (2003). *
Kantarci OH, Hebrink DD, Achenbach SJ, Atkinson EJ, Waliszewska A, Buckle G, McMurray CT, de Andrade M, Hafler DA, Weinshenker BG. CTLA4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol. 134: 133-141 (2003).
Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 61: 238-240 (2003).
Kanz MF, Dugas TR, Liu H, Santa Cruz V. Glutathione depletion exacerbates methylenedianiline toxicity to biliary epithelial cells and hepatocytes in rats. Toxicol. Sci. 74: 447-456 (2003). *
Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3: 984-993 (2003). *
Karaman A, Demirbilek S, Sezgin N, Gurbuz N, Gurses I. Protective effect of polyunsaturated phosphatidylcholine on liver damage induced by biliary obstruction in rats. J. Pediatr. Surg. 38: 1341-1347 (2003).
Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, Ciclitira PJ, Sollid LM, Partanen J; European Genetics Cluster on Celiac Disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum. Immunol. 64: 469-477 (2003).
Karjalainen J, Hulkkonen J, Nieminen MM, Huhtala H, Aromaa A, Klaukka T, Hurme M. Interleukin-10 gene promoter region polymorphism is associated with eosinophil count and circulating immunoglobulin E in adult asthma. Clin. Exp. Allergy 33: 78-83 (2003). *
Karlsson T, Vahlquist A, Kedishvili N, Torma H. 13-cis-Retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem. Biophys. Res. Commun. 303: 273-278 (2003). *
Karvonen AL. Treatment of cholestatic liver diseases. Duodecim. 119: 533-539 (2003).
Kasahara Y, Kaneko H, Fukao T, Terada T, Asano T, Kasahara K, Kondo N. Hyper-IgM syndrome with putative dominant negative mutation in activation-induced cytidine deaminase. J. Allergy Clin. Immunol. 112: 755-760 (2003). *
Kashif W, Siddiqi N, Dincer AP, Dincer HE, Hirsch S. Proteinuria: how to evaluate an important finding. Cleve. Clin. J. Med. 70: 535-537, 541-544, 546-547 (2003).
Kassam A, Miao B, Young PR, Mukherjee R. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J. Biol. Chem. 278: 10028-10032 (2003). *
Katabi N, Albores-Saavedra J. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis. Am. J. Surg. Pathol. 27: 349-355 (2003).
Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, Mayumi T. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 124: 1315-1324 (2003). *
Kato S, Kamagata S, Asakura T, Ozawa K, Nio M, Ohi R, Munakata M, Iinuma K. A newly developed small-caliber videoduodenoscope for endoscopic retrograde cholangiopancreatography in children. J. Clin. Gastroenterol. 37: 173-176 (2003).
Katoh M. WNT2 and human gastrointestinal cancer (review). Int. J. Mol. Med. 12: 811-816 (2003).
Katsanos KH, Christodoulou DK, Zioga A, Tsianos EV. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence? Inflamm. Bowel Dis. 9: 279 (2003). *
Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 9: 34-40 (2003). *
Katznelson L, Fairfield WP, Zeizafoun N, Sands BE, Peppercorn MA, Rosenthal DI, Klibanski A. Effects of growth hormone secretion on body composition in patients with Crohn's disease. J. Clin. Endocrinol. Metab. 88: 5468-5672 (2003). *
Kaunitz JD, Akiba Y. Acid-sensing protective mechanisms of duodenum. J. Physiol. Pharmacol. 54 Suppl. 4: 19-26 (2003). *
Kaur G, Rapthap CC, Xavier M, Saxena R, Choudhary VP, Reuben SK, Mehra NK. Distribution of C282Y and H63D mutations in the HFE gene in healthy Asian Indians and patients with thalassaemia major. Natl. Med. J. India 16: 309-310 (2003).
Kavanaugh A, Keystone EC. The safety of biologic agents in early rheumatoid arthritis. Clin. Exp. Rheumatol. 21 (5 Suppl. 31): S203-S208 (2003).
Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Hara M, Kotake S, Kitamura Y, Kamatani N. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 48: 186-192 (2003). *
Kawahata H, Kikkawa T, Higashibata Y, Sakuma T, Huening M, Sato M, Sugimoto M, Kuriyama K, Terai K, Kitamura Y, Nomura S. Enhanced expression of Runx2/PEBP2alphaA/CBFA1/AML3 during fracture healing. J. Orthop. Sci. 8: 102-108 (2003).
Kawai K, Michitaka K, Miyauchi S, Sano M, Abe M, Ninomiya T, Matsuura B, Masumoto T, Akbar SM, Horiike N, Onji M. Acute-onset autoimmune hepatitis treated with living donor-liver transplantation. Intern. Med. 42: 158-162 (2003). *
Kawai M, Otake Y, Hara Y. High-molecular-mass isoform of aminopeptidase N/CD13 in serum from cholestatic patients. Clin. Chim. Acta 330: 141-149 (2003). *
Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278: 9435-9440 (2003). *
Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K, Kawajiri K. Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol. Pharmacol. 63: 524-531 (2003). *
Kawanishi M, Yoshida Y, Sakaguchi I, Nagano F, Kato K, Miyake H. Cerebral venous sinus thrombosis in a patient with ulcerative colitis. J. Stroke Cerebrovasc. Dis. 12: 271-275 (2003).
Kawashima M, Miossec P. Heterogeneity of response of rheumatoid synovium cell subsets to interleukin-18 in relation to differential interleukin-18 receptor expression. Arthritis Rheum. 48: 631-637 (2003). *
Kay MA. Hepatic gene transfer. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 49. October 20 - 21 (2003). *
Kazama H, Usui S, Okazaki M, Hosoi T, Ito H, Orimo H. Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes. Diabetes Res. Clin. Pract. 59: 181-189 (2003).
Kefalas CH. Gastroduodenal Crohn's disease. Proc. Bayl. Univ. Med. Cent. 16: 147-151 (2003).
Kehlen A, Pachnio A, Thiele K, Langner J. Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6. Arthritis Res. Ther. 5: R186-R192 (2003). *
Keighley MR, Stockbrugger RW. Inflammatory bowel disease. Aliment. Pharmacol. Ther. 18 Suppl. 3: 66-70 (2003).
Keim V. Identification of patients with genetic risk factors of pancreatitis: impact on treatment and cancer prevention. Dig. Dis. 21: 346-350 (2003).
Keim V, Witt H, Bauer N, Bodeker H, Rosendahl J, Teich N, Mossner J. The course of genetically determined chronic pancreatitis. JOP 4: 146-154 (2003). *
Keino H, Sakai J, Usui M. Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 241: 777-778 (2003). *
Keller BM, Aebischer CC, Kraemer R, Schoni MH. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation. J. Cyst. Fibros. 2: 76-83 (2003).
Keller JJ, Giardiello FM. Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol. Ther. 2: S140-S149 (2003). *
Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 300: 1527-1528 (2003). *
Kempuraj D, Frydas S, Kandere K, Madhappan B, Letourneau R, Christodoulou S, Boucher W, Riccioni G, Conti P, Theoharides TC. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16: 95-97 (2003).
Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, Rogers A, Sculpher M, Thompson D. A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol. Assess. 7: 1-126 (2003). *
Kennedy A, Robinson A, Hann M, Thompson D, Wilkin D; The North-West Region Gastrointestinal Research Group. A cluster-randomised controlled trial of a patient-centred guidebook for patients with ulcerative colitis: effect on knowledge, anxiety and quality of life. Health Soc. Care Community 11: 64-72 (2003).
Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J. Immunol. 170: 1481-1489 (2003). *
Kerry JE, Marshall C, Griffiths PA, Scott BB, Griffiths G. White cell scanning for inflammatory bowel disease: are biochemical markers useful referral criteria? Nucl. Med. Commun. 24: 1145-1148 (2003).
Kershenobich Stalnikowitz D, Weissbrod AB. Liver fibrosis and inflammation. A review. Ann. Hepatol. 2: 159-163 (2003). *
Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52: 720-728 (2003). *
Kew S, Banerjee T, Minihane AM, Finnegan YE, Muggli R, Albers R, Williams CM, Calder PC. Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am. J. Clin. Nutr. 77: 1287-1295 (2003). *
Keystone EC, Haraoui B, Bykerk VP. Role of infliximab in the treatment of early rheumatoid arthritis. Clin. Exp. Rheumatol. 21 (5 Suppl. 31): S200-S202 (2003).
Khakoo SI, Brooks CR. MHC class I receptors on natural killer cells: on with the old and in with the new. Clin. Sci. (Lond.) 105: 127-140 (2003). *
Khalili K, Metser U, Wilson SR. Hilar biliary obstruction: preliminary results with Levovist-enhanced sonography. AJR Am. J. Roentgenol. 180: 687-693 (2003). *
Khan SA, Davidson BR, Goldin R, Pereira S, Rosenberg WMC, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H. GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHOLANGIOCARCINOMA - CONSENSUS DOCUMENT. (http://www.basl.org.uk/cholan.pdf) (2003). *
Khan SA, Vanden Heuvel JP. Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review). J. Nutr. Biochem. 14: 554-667 (2003). *
Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R. Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J. Rheumatol. 30: 1248-1252 (2003).
Khanna M, Shirodkar MA, Gottlieb AB. Etanercept therapy in patients with autoimmunity and hepatitis C. J. Dermatolog. Treat. 14: 229-232 (2003).
Khare M, Rodriguez M, David CS. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Int. Immunol. 15: 535-546 (2003). *
Khare S, Cerda S, Wali RK, von Lintig FC, Tretiakova M, Joseph L, Stoiber D, Cohen G, Nimmagadda K, Hart J, Sitrin MD, Boss GR, Bissonnette M. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res. 63: 3517-3523 (2003). *
Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342 (2003). *
Khettry U, Anand N, Faul PN, Lewis WD, Pomfret EA, Pomposelli J, Jenkins RL, Gordon FD. Liver transplantation for primary biliary cirrhosis: a long-term pathologic study. Liver Transpl. 9: 87-96 (2003). *
Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum. Pathol. 34: 1127-1136 (2003). *
Khoo AL, Tham LS, Lee KH, Lim GK. Acute liver failure with concurrent bupropion and carbimazole therapy. Ann. Pharmacother. 37: 220-223 (2003).
Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J. Lipid Res. 44: 1728-1736 (2003). *
Khubchandani RP, D'Souza S. Antiphospholipid antibody syndrome as a cause of Budd-Chiari syndrome. Indian Pediatr. 40: 907-908 (2003).
Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246 (2003). *
Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, Nagata T. Calprotectin release from human neutrophils is induced by Porphyromonas gingivalis lipopolysaccharide via the CD-14-Toll-like receptor-nuclear factor kappaB pathway. J. Periodontal Res. 38: 557-563 (2003). *
Kiechle FL, Holland-Staley CA. Genomics, transcriptomics, proteomics, and numbers. Arch. Pathol. Lab. Med. 127: 1089-1097 (2003). *
Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14: 389-396 (2003). *
Kikuchi K, Tanaka A, Miyakawa H, Kawashima Y, Kawaguchi N, Matsushita M, Gershwin ME. Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis. Hepatol. Res. 26: 87-90 (2003).
Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat. Rev. Immunol. 3: 159-167 (2003). *
Kilding R, Akil M, Till S, Amos R, Winfield J, Iles MM, Wilson AG. A biologically important single nucleotide polymorphism within the Toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 340-342 (2003).
Kilic SS, Oral HB, Budak F, Aydogdu H, Yavascaoglu B, Goral G. Immunoglobulin subclasses and HLA alleles in immunoglobulin A deficiency. Indian J. Pediatr. 70: 389-392 (2003).
Kilpatrick DC. Introduction to mannan-binding lectin. Biochem. Soc. Trans. 31: 745-747 (2003). *
Kim EH, Mok JW, Bang DS, Lee ES, Lee SN, Park KS. Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet's disease. J. Korean Med. Sci. 18: 415-418 (2003). *
Kim EY, Shin CH, Yang SW. Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease. Autoimmunity 36: 177-181 (2003).
Kim GD, Kim MH, Hyung CH, Song JW, Choi JJ, Kim JK, Lee TH, Kim WJ, Koh SJ, Lee SS, Lee SK, Seo DW, Min YI, Jun SY, Yu ES. A case of liver transplantation for primary sclerosing cholangitis. Korean J. Gastroenterol. 42: 431-435 (2003).
Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM, Reitman ML, Yakar S, Stannard B, Heron-Milhavet L, Wheeler MB, LeRoith D. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 52: 1770-1778 (2003). *
Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 17: 895-904 (2003). *
Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Jeong SW, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125: 708-715 (2003). *
Kim JA, Choi SC, Yun KJ, Kim DK, Han MK, Seo GS, Yeom JJ, Kim TH, Nah YH, Lee YM. Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm. Bowel Dis. 9: 224-229 (2003). *
Kim JD, Choi BK, Bae JS, Lee UH, Han IS, Lee HW, Youn BS, Vinay DS, Kwon BS. Cloning and characterization of GITR ligand. Genes Immun. 4: 564-569 (2003). *
Kim JE, Kim KS, Seo JK. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease. Korean J. Gastroenterol. 42: 297-302 (2003).
Kim JJ, Kim JG, Kwon DH. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 8: 202-206 (2003). *
Kim JU, Chang HK, Lee SS, Kim JW, Kim KT, Lee SW, Chung WT. Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease and rheumatic diseases with vasculitis. Ann. Rheum. Dis. 62: 1083-1087 (2003). *
Kim MS, Shigenaga J, Moser A, Feingold K, Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278: 8988-8995 (2003). *
Kim RB. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur. J. Clin. Invest. 33 Suppl. 2: 1-5 (2003).
Kim TG, Pyo CW, Hur SS, Kim YK, Hwang HY, Youn JI, Kim TY. Polymorphisms of tumor necrosis factor (TNF) alpha and beta genes in Korean patients with psoriasis. Arch. Dermatol. Res. 295: 8-13 (2003). *
Kim TH, Kim BG, Shin HD, Kim JW, Kim CG, Kim JS, Jung HC, Song IS. Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Korean J. Gastroenterol. 42: 377-386 (2003).
Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park do J. A C/T polymorphism in the 5'-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13: 919-925 (2003).
Kim WR. Pretransplantation disease severity and posttransplantation outcome. Liver Transpl. 9: 124-125 (2003). *
Kim YI. Role of folate in colon cancer development and progression. J. Nutr. 133: 3731S-3739S (2003). *
Kim YK, Pyo CW, Hur SS, Kim TY, Kim TG. No associations of CTLA-4 and ICAM-1 polymorphisms with psoriasis in the Korean population. J. Dermatol. Sci. 33: 75-77 (2003).
Kimbrough RD, Krouskas CA. Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol. Rev. 22: 217-233 (2003).
Kimura R, Nishioka T, Ishida T. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes Immun. 4: 356-361 (2003). *
King AL, Moodie SJ, Fraser JS, Curtis D, Reid E, Dearlove AM, Ciclitira PJ. Coeliac disease: investigation of proposed causal variants in the CTLA4 gene region. Eur. J. Immunogenet. 30: 427-432 (2003). *
King K, Moody A, Fisher SA, Mirza MM, Cuthbert AP, Hampe J, Sutherland-Craggs A, Sanderson J, MacPherson AJ, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel disease. Eur. J. Immunogenet. 30: 187-190 (2003). *
Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun. 4: 455-457 (2003). *
Kinikli G, Ates A, Turgay M, Akay G, Kinikli S, Tokgoz G. HLA-DRB1 genes and disease severity in rheumatoid arthritis in Turkey. Scand. J. Rheumatol. 32: 277-280 (2003).
Kinney T, Rawlins M, Kozarek R, France R, Patterson D. Immunomodulators and "on demand" therapy with infliximab in Crohn's disease: clinical experience with 400 infusions. Am. J. Gastroenterol. 98: 608-612 (2003). *
Kinnman N, Francoz C, Barbu V, Wendum D, Rey C, Hultcrantz R, Poupon R, Housset C. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83: 163-173 (2003).
Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J. Immunol. 170: 5793-5798 (2003). *
Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, Shimosegawa T. HLA-B genotype in Japanese patients with Crohn's disease. Dis. Colon Rectum 46: S10-S14 (2003).
Kiortsis DN, Nikas S, Hatzidimou K, Tsianos E, Elisaf MS. Lipid-lowering drugs and serum liver enzymes: the effects of body weight and baseline enzyme levels. Fundam. Clin. Pharmacol. 17: 491-494 (2003). *
Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J. Gastroenterol. Hepatol. 18: 1272-1282 (2003). *
Kirsner JB. Commentary on the 1958 National Institutes of Health conference on "New frontiers in ulcerative colitis". Inflamm. Bowel Dis. 9: 61-69 (2003). *
Kishimoto H, Hamada K, Saunders M, Backman S, Sasaki T, Nakano T, Mak TW, Suzuki A. Physiological functions of Pten in mouse tissues. Cell Struct. Funct. 28: 11-21 (2003). *
Kishimoto T, Hamazaki T, Yasui M, Sasabe M, Okamura T, Sakata N, Inoue M, Yagi K, Kawa K. Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis. Int. J. Hematol. 78: 453-456 (2003).
Kita H. Primary biliary cirrhosis and E. coli-induced pyelonephritis; are infectious agents related to the pathogenesis of primary biliary cirrhosis? Intern. Med. 42: 1063-1064 (2003). *
Kita H, Ansari AA, He XS, Lian ZX, Van de Water J, Coppel RL, Luketic V, Kaplan M, Inamori H, Isoda N, Sugano K, Imawari M, Gershwin ME. Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosis. J. Autoimmun. 21: 175-182 (2003). *
Kita H, He XS, Gershwin ME. Application of tetramer technology in studies on autoimmune diseases. Autoimmun. Rev. 2: 43-49 (2003).
Kita H, Nalbandian G, Keeffe EB, Coppel RL, Gershwin ME. Pathogenesis of primary biliary cirrhosis. Clin. Liver Dis. 7: 821-839 (2003).
Kitada H, Miyata M, Nakamura T, Tozawa A, Honma W, Shimada M, Nagata K, Sinal CJ, Guo GL, Gonzalez FJ, Yamazoe Y. Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J. Biol. Chem. 278: 17838-17844 (2003). *
Kitchens RL, Thompson PA, Munford RS, O'Keefe GE. Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J. Lipid Res. 44: 2339-2348 (2003). *
Kiyici M, Gulten M, Gurel S, Nak SG, Dolar E, Savci G, Adim SB, Yerci O, Memik F. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can. J. Gastroenterol. 17: 713-718 (2003). *
Kizilisik AT, Grewal HP, Shokouh-Amiri MH, Vera SR, Hathaway DK, Gaber AO. Impact of long-term immunosuppressive therapy on psychosocial and physical well being in liver transplant recipients. Prog. Transplant. 13: 278-283 (2003).
Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate. Mol. Cancer Res. 1: 855-862 (2003). *
Klapman JB, Ene-Stroescu D, Becker MA, Hanauer SB. A lupus-like syndrome associated with infliximab therapy. Inflamm. Bowel Dis. 9: 176-178 (2003). *
Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33: 655-780 (2003).
Klebl FH, Bataille F, Bertea CR, Herfarth H, Hofstadter F, Scholmerich J, Rogler G. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm. Bowel Dis. 9: 302-307 (2003). *
Klebl FH, Bregenzer N, Rogler G, Straub RH, Scholmerich J, Andus T. Treatment of pouchitis with dehydroepiandrosterone (DHEA) - a case report. Z. Gastroenterol. 41: 1087-1090 (2003).
Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 101: 545-551 (2003). *
Kleideiter E, Friedrich U, Mohring A, Walker S, Horing E, Maier K, Fritz P, Thon KP, Klotz U. Telomerase activity in chronic inflammatory bowel disease. Dig. Dis. Sci. 48: 2328-2332 (2003). *
Klein D, Einspanier R, Bolder U, Jeschke MG. Differences in the hepatic signal transcription pathway and cytokine expression between thermal injury and sepsis. Shock 20: 536-543 (2003). *
Klein R, Goller S, Bianchi L. Nodular regenerative hyperplasia (NRH) of the liver - a manifestation of 'organ-specific antiphospholipid syndrome'? Immunobiology 207: 51-57 (2003).
Klein W, Tromm A, Griga T, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand. J. Gastroenterol. 38: 834-836 (2003). *
Kleinau S. The impact of Fc receptors on the development of autoimmune diseases. Curr. Pharm. Des. 9: 1861-1870 (2003).
Kliewer SA. The nuclear pregnane X receptor regulates xenobiotic detoxification. J. Nutr. 133: 2444S-2447S (2003). *
Kliewer SA. Anthrax mounts a nuclear attack on glucocorticoid signaling. Trends Pharmacol. Sci. 24: 558-559 (2003).
Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62: 296-307 (2003). *
Klomp AE, Juijn JA, van der Gun LT, van den Berg IE, Berger R, Klomp LW. The N-terminus of the human copper transporter 1 (hCTR1) is localized extracellularly, and interacts with itself. Biochem. J. 370: 881-889 (2003). *
Klomp AE, van de Sluis B, Klomp LW, Wijmenga C. The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. J. Hepatol. 39: 703-709 (2003). *
Klump B, Hsieh CJ, Dette S, Holzmann K, Kiebetalich R, Jung M, Sinn U, Ortner M, Porschen R, Gregor M. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease. Clin. Cancer Res. 9: 1773-1778 (2003). *
Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, Wright M, Chiaramonte M, Graves M, Thomas HC, Hill AV, Thursz MR. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 4: 411-419 (2003). *
Knight BL, Patel DD, Humphreys SM, Wiggins D, Gibbons GF. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. J. Lipid Res. 44: 2049-2058 (2003). *
Knolle P. Immunological functions. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 23. October 20 - 21 (2003). *
Knutson D, Greenberg G, Cronau H. Management of Crohn's disease - a practical approach. Am. Fam. Physician 68: 707-714 (2003). *
Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. J. Pharmacol. Exp. Ther. 305: 173-179 (2003). *
Kobayashi K, Bang Lu Y, Xian Li M, Nishi I, Hsiao KJ, Choeh K, Yang Y, Hwu WL, Reichardt JK, Palmieri F, Okano Y, Saheki T. Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol. Genet. Metab. 80: 356-359 (2003). *
Kobayashi M, Kweon MN, Kuwata H, Schreiber RD, Kiyono H, Takeda K, Akira S. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111: 1297-1308 (2003). *
Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J. Artif. Organs 6: 236-244 (2003).
Koch KL, Frissora CL. Nausea and vomiting during pregnancy. Gastroenterol. Clin. North Am. 32: 201-234, vi (2003). *
Kocher O, Pal R, Roberts M, Cirovic C, Gilchrist A. Targeted disruption of the PDZK1 gene by homologous recombination. Mol. Cell. Biol. 23: 1175-1180 (2003). *
Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, Krieger M. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J. Biol. Chem. 278: 52820-52825 (2003). *
Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister HW, Kirschning CJ. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J. Immunol. 170: 438-444 (2003). *
Koffeman GI, van Gemert WG, George EK, Veenendaal RA. Classification, epidemiology and aetiology. Best Pract. Res. Clin. Gastroenterol. 17: 879-893 (2003). *
Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, Leslie EM, Cole SP, Bear CE. CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J. 22: 1981-1989 (2003). *
Koike M, Sekigawa I, Ogawa K, Iida N, Oshimi K. Ursodeoxycholic acid treatment of idiopathic thrombocytopenic purpura with liver dysfunction. Eur. J. Haematol. 71: 391-392 (2003). *
Koinuma K, Togashi K, Konishi F, Kirii Y, Horie H, Okada M, Nagai H. Localized giant inflammatory polyposis of the cecum associated with distal ulcerative colitis. J. Gastroenterol. 38: 880-883 (2003). *
Kojima E, Kimura K, Noda Y, Kobayashi G, Itoh K, Fujita N. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J. Gastroenterol. 38: 603-607 (2003).
Kojima H, Nies AT, Konig J, Hagmann W, Spring H, Uemura M, Fukui H, Keppler D. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J. Hepatol. 39: 693-702 (2003). *
Kok T, Bloks VW, Wolters H, Havinga R, Jansen PL, Staels B, Kuipers F. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem. J. 369: 539-547 (2003). *
Kok T, Hulzebos CV, Wolters H, Havinga R, Agellon LB, Stellaard F, Shan B, Schwarz M, Kuipers F. Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. J. Biol. Chem. 278: 41930-41937 (2003). *
Kok T, Wolters H, Bloks VW, Havinga R, Jansen PL, Staels B, Kuipers F. Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse. Gastroenterology 124: 160-171 (2003). *
Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, Lazo JS. 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278: 13244-13256 (2003). *
Kolivras A, De Maubeuge J, Andre J, Song M. Thalidomide in refractory vulvar ulcerations associated with Crohn's disease. Dermatology 206: 381-383 (2003).
Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic. Biol. Med. 34: 1006-1016 (2003).
Kong YC, Flynn JC, Wan Q, David CS. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease. Autoimmunity 36: 397-404 (2003).
Kongtawelert P, Tangkijvanich P, Ong-Chai S, Poovorawan Y. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma. World J. Gastroenterol. 9: 2178-2181 (2003). *
Konikoff FM. Gallstones - approach to medical management. MedGenMed. 5: 8 (2003). *
Konikoff FM, Leikin-Frenkel A, Goldiner I, Michowitz M, Brezowski E, Harats D, Gilat T. Biliary and systemic effects of fatty acid bile acid conjugates. Eur. J. Gastroenterol. Hepatol. 15: 649-655 (2003).
Koning F. The molecular basis of celiac disease. J. Mol. Recognit. 16: 333-336 (2003). *
Kono M, Oshitani N, Sawa Y, Watanabe K, Kamata N, Oiso R, Inagawa M, Kawachiya T, Kawashima D, Sogawa M, Jinno Y, Higuchi K, Matsumoto T, Arakawa T. Crohn's disease complicated by adult-onset Still's disease. J. Gastroenterol. 38: 891-895 (2003). *
Konrad A, Seibold F. Response of cutaneous Crohn's disease to infliximab and methotrexate. Dig. Liver Dis. 35: 351-356 (2003).
Kopp T, Lenz P, Bello-Fernandez C, Kastelein RA, Kupper TS, Stingl G. IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity. J. Immunol. 170: 5438-5444 (2003). *
Koreck A, Pivarcsi A, Dobozy A, Kemeny L. The role of innate immunity in the pathogenesis of acne. Dermatology 206: 96-105 (2003).
Korelitz BI. Is there any remaining role for methotrexate for Crohn's disease? Dig. Liver Dis. 35: 610-611 (2003).
Korendowych E, Dixey J, Cox B, Jones S, McHugh N. The influence of the HLA-DRB1 rheumatoid arthritis shared epitope on the clinical characteristics and radiological outcome of psoriatic arthritis. J. Rheumatol. 30: 96-101 (2003).
Korkina L, Suprun M, Petrova A, Mikhal'chik E, Luci A, De Luca C. The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe vera against dextran sulfate-induced ulcerative colitis in rats. Biofactors 18: 255-264 (2003).
Korman U, Kantarci F, Selcuk D, Cetinkaya S, Kurugoglu S, Mihmanli I. Enteroclysis in obscure gastrointestinal system hemorrhage of small bowel origin. Turk. J. Gastroenterol. 14: 243-249 (2003). *
Korn JH. Scleroderma: a treatable disease. Cleve. Clin. J. Med. 70: 954, 956, 958 (2003). *
Kornbluth A. Is there still a role for cyclosporine in the treatment of inflammatory bowel disease? Pro argument. Inflamm. Bowel Dis. 9: 194-197 (2003). *
Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur. Respir. J. 22: 709-711 (2003). *
Koruk M, Ozkilic S, Savas MC, Celen Z, Kadayifci A, Ozkilic C. Evaluation of hepatic functions and biliary dynamics in patients with liver cirrhosis by quantitative scintigraphy. Hepatogastroenterology 50: 1803-1805 (2003).
Kosco-Vilbois MH. Are follicular dendritic cells really good for nothing? Nat. Rev. Immunol. 3: 764-769 (2003). *
Kosor E, Gagro A, Drazenovic V, Kuzman I, Jeren T, Rakusic S, Rabatic S, Markotic A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacic V, Gjenero-Margan I, Kaic B, Mlinaric-Galinovic G, Kastelan A, Dekaris D. MHC tetramers: tracking specific immunity. Acta Med. Croatica 57: 255-259 (2003).
Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur. J. Pediatr. 162: 177-179 (2003).
Kosters A, Frijters RJ, Schaap FG, Vink E, Plosch T, Ottenhoff R, Jirsa M, De Cuyper IM, Kuipers F, Groen AK. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J. Hepatol. 38: 710-716 (2003). *
Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim. Biophys. Acta 1637: 1-19 (2003). *
Kotler DP. Human immunodeficiency virus and pregnancy. Gastroenterol. Clin. North Am. 32: 437-448, ix (2003). *
Kotulski M, Pawlak J, Hevelke P, Krawczyk M. Assessment of early graft function in relation to different preservation fluids - preliminary results. Ann. Transplant. 8: 31-35 (2003).
Kountouras J, Kouklakis G, Zavos C, Chatzopoulos D, Moschos J, Molyvas E, Zavos N. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences. Can. J. Gastroenterol. 17: 249-258 (2003). *
Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J. Viral Hepat. 10: 335-342 (2003).
Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Kouroumalis EA. Serum laminin and collagen IV in inflammatory bowel disease. J. Clin. Pathol. 56: 817-820 (2003). *
Koutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Kouroumalis EA. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int. J. Colorectal Dis. 18: 254-259 (2003). *
Kovacevic I, Zekan M. Wilson's disease. Acta Med. Croatica 57: 227-235 (2003).
Kovacs L, Papos M, Takacs R, Roka R, Csenke Z, Kovacs A, Varkonyi T, Pajor L, Pavics L, Pokorny G. Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 21: 697-703 (2003).
Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424: 801-805 (2003). *
Kovarik JM, Burtin P. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin. Emerg. Drugs 8: 47-62 (2003).
Kowdley KV. UDCA to prevent colon cancer in PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 86. October 15-16 (2003). *
Koyama T, Tsukamoto H, Masumoto K, Himeji D, Hayashi K, Harada M, Horiuchi T. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology (Oxford) 42: 980-985 (2003). *
Koyano S, Saito Y, Nagano M, Maekawa K, Kikuchi Y, Murayama N, Fujino T, Ozawa S, Nakajima T, Matsumoto K, Saito H, Sawada J. Functional analysis of three genetic polymorphisms in the glucocorticoid receptor gene. J. Pharmacol. Exp. Ther. 307: 110-116 (2003). *
Kozaiwa K, Sugawara K, Smith MF Jr, Carl V, Yamschikov V, Belyea B, McEwen SB, Moskaluk CA, Pizarro TT, Cominelli F, McDuffie M. Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 125: 477-490 (2003). *
Kozarek RA, France RE, Gluck M, Brandabur JJ, Mergener KD, Patterson DJ. Primary sclerosing cholangitis in a tertiary referral center: this is not your father's oldsmobile. Gastrointest. Endosc. 57: AB203 (2003).
Krach K, Badenhoop K, Tonjes RR. The IDDM-associated solitary retroviral promoters DQ-LTR3 and DQ-LTR13 have a distinct impact on the expression of selected DQB1 genes in different cell lines in vitro. Immunogenetics 55: 521-529 (2003). *
Kraemer DM, Kraus MR, Kneitz C, Tony HP. Nucleoporin p62 antibodies in a case of mixed connective tissue disease. Clin. Diagn. Lab. Immunol. 10: 329-331 (2003). *
Krahenbuhl L, Lang C, Ludes S, Seiler C, Schafer M, Zimmermann A, Krahenbuhl S. Reduced hepatic glycogen stores in patients with liver cirrhosis. Liver Int. 23: 101-109 (2003). *
Kralovicova J, Hammarstrom L, Plebani A, Webster AD, Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170: 2765-2775 (2003). *
Kramer JA, Blomme EA, Bunch RT, Davila JC, Jackson CJ, Jones PF, Kolaja KL, Curtiss SW. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Toxicol. Pathol. 31: 417-431 (2003). *
Kramer JA, LeDeaux J, Butteiger D, Young T, Crankshaw C, Harlow H, Kier L, Bhat BG. Transcription profiling in rat liver in response to dietary docosahexaenoic acid implicates stearoyl-coenzyme a desaturase as a nutritional target for lipid lowering. J. Nutr. 133: 57-66 (2003). *
Kramers C, Adema GJ, Korte M, Deinum J. Familial hyperactivity of angiotensin-converting enzyme (ACE). Ned. Tijdschr. Geneeskd. 147: 507-510 (2003).
Krasko A, Deshpande K, Bonvino S. Liver failure, transplantation, and critical care. Crit. Care Clin. 19: 155-183 (2003).
Kreimer-Erlacher H, Seidl H, Back B, Cerroni L, Kerl H, Wolf P. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. J. Invest. Dermatol. 120: 676-682 (2003). *
Kren BT, Yin WX, Steer CJ. Gene repair as a viable approach to gene therapy. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 50-51. October 20 - 21 (2003). *
Kretowski A, Wawrusiewicz N, Mironczuk K, Mysliwiec J, Kretowska M, Kinalska I. Intercellular adhesion molecule 1 gene polymorphisms in Graves' disease. J. Clin. Endocrinol. Metab. 88: 4945-4949 (2003). *
Kriegel MA, Huffmeier U, Scherb E, Scheidig C, Geiler T, Kalden JR, Reis A, Lorenz HM. Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: implications for pathogenesis. Arthritis Rheum. 48: 2386-2388 (2003). *
Kroesen S, Widmer AF, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 42: 617-621 (2003). *
Kroetz DL, Pauli-Magnus C, Hodges LM, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Carlson EJ, Herskowitz I, Giacomini KM, Clark AG; Pharmacogenetics of Membrane Transporters Investigators. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 13: 481-494 (2003).
Krok KL, Lichtenstein GR. Nutrition in Crohn disease. Curr. Opin. Gastroenterol. 19: 148-153 (2003).
Krowka MJ. The hepato- and portopulmonary hypertension syndromes. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 99. October 17 - 19 (2003). *
Kruchkovich J, Blickstein I. Autoimmune hepatitis during pregnancy. Harefuah. 142: 503-507, 567 (2003).
Kruger E, Kuckelkorn U, Sijts A, Kloetzel PM. The components of the proteasome system and their role in MHC class I antigen processing. Rev. Physiol. Biochem. Pharmacol. 148: 81-104 (2003).
Kruidenier L, Kuiper I, Lamers CB, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J. Pathol. 201: 28-36 (2003). *
Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J. Pathol. 201: 7-16 (2003). *
Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J. Pathol. 201: 17-27 (2003). *
Kruidenier L, van Meeteren ME, Kuiper I, Jaarsma D, Lamers CB, Zijlstra FJ, Verspaget HW. Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Radic. Biol. Med. 34: 753-765 (2003).
Kruis W, Bar-Meir S, Feher J, Mickisch O, Mlitz H, Faszczyk M, Chowers Y, Lengyele G, Kovacs A, Lakatos L, Stolte M, Vieth M, Greinwald R. The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine. Clin. Gastroenterol. Hepatol. 1: 36-43 (2003). *
Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 17: 225-234 (2003).
Kryczka W, Walewska-Zielecka B, Dutkiewicz E. Acute seronegative hepatitis C manifesting itself as adult giant cell hepatitis - a case report and review of literature. Med. Sci. Monit. 9 Suppl. 3: 29-31 (2003).
Ku NO, Darling JM, Krams SM, Esquivel CO, Keeffe EB, Sibley RK, Lee YM, Wright TL, Omary MB. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc. Natl. Acad. Sci. U.S.A. 100: 6063-6068 (2003). *
Kube D, Mormann M, Tomiuk J, Rieth H, Hua TD, Kremsner PG, Vockerodt M. Simultaneous analysis of interleukin-10 gene microsatellites and single-nucleotide polymorphisms in parallel with tumour necrosis factor and interferon-gamma short tandem repeats by fluorescence-based polymerase chain reaction. Genes Immun. 4: 459-468 (2003). *
Kubryn I, Mlynarski W, Trippenbach-Dulska H, Szalecki M, Lisowicz L, Surdej B, Pilecki O, Heinrich A, Wyka K, Perenc M, Bodalski J. Alleles of HLA-DQB1 and familial aggregation of type 1 diabetes. Med. Wieku. Rozwoj. 7: 157-164 (2003).
Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3: 454-462 (2003). *
Kuenzli S, Saurat JH. Peroxisome proliferator-activated receptors in cutaneous biology. Br. J. Dermatol. 149: 229-236 (2003). *
Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Weisdorf-Schindele S, San Pablo W Jr, Perrault J, Park R, Yaffe M, Brown C, Rivera-Bennett MT, Halabi I, Martinez A, Blank E, Werlin SL, Rudolph CD, Binion DG. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J. Pediatr. 143: 525-531 (2003). *
Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 9: 727-732 (2003). *
Kuipers S, Aerts PC, Cluysenaer OJ, Bartelink AK, Ezekowitz RA, Bax WA, Salimans M, Vandyk H. A case of familial meningococcal disease due to deficiency in mannose-binding lectin (MBL). Adv. Exp. Med. Biol. 531: 351-355 (2003).
Kuisma J, Mentula S, Luukkonen P, Jarvinen H, Kahri A, Farkkila M. Factors associated with ileal mucosal morphology and inflammation in patients with ileal pouch-anal anastomosis for ulcerative colitis. Dis. Colon Rectum 46: 1476-1483 (2003).
Kulczycki LL, Kostuch M, Bellanti JA. A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations. Am. J. Med. Genet. 116A: 262-267 (2003). *
Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. J. Pediatr. 142: 631-636 (2003). *
Kullak-Ublick GA. ABC transporter regulation by bile acids: where PXR meets FXR. J. Hepatol. 39: 628-630 (2003). *
Kullak-Ublick GA, Becker MB. Regulation of drug and bile salt transporters in liver and intestine. Drug Metab. Rev. 35: 305-317 (2003).
Kullak-Ublick GA, Jung D, Meier PJ. Role of nuclear receptors in hepatic and intestinal drug transport. Dtsch. Med. Wochenschr. 128: 389-393 (2003).
Kullberg MC, Andersen JF, Gorelick PL, Caspar P, Suerbaum S, Fox JG, Cheever AW, Jankovic D, Sher A. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc. Natl. Acad. Sci. U.S.A. 100: 15830-15835 (2003). *
Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: case report and review. Gastrointest. Endosc. 57: 118-120 (2003).
Kumagai S, Jikimoto T, Saegusa J. Pathological roles of oxidative stress in autoimmune diseases. Rinsho Byori 51: 126-132 (2003).
Kunkel EJ, Butcher EC. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829 (2003). *
Kunkel EJ, Campbell DJ, Butcher EC. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 10: 313-323 (2003).
Kunkel EJ, Kim CH, Lazarus NH, Vierra MA, Soler D, Bowman EP, Butcher EC. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111: 1001-1010 (2003). *
Kunstmann E, Hardt C, Crabtree JE, Suerbaum S, Epplen JT. Helicobacter pylori infection: CagA-specific antibodies are associated with clinical outcome, but not with HLA-class II polymorphisms of the host. Int. J. Med. Microbiol. 292: 537-540 (2003).
Kunzelmann K, Mall M. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics. Am. J. Respir. Med. 2: 299-309 (2003).
Kupcova V, Turecky L, Detkova Z, Prikazska M, Keleova A. Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease. Physiol. Res. 52: 89-93 (2003). *
Kupper TS. Immunologic targets in psoriasis. N. Engl. J. Med. 349: 1987-1990 (2003). *
Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3: 801-812 (2003). *
Kurbegov AC, Setchell KD, Haas JE, Mierau GW, Narkewicz M, Bancroft JD, Karrer F, Sokol RJ. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 125: 1227-1234 (2003). *
Kurdow R, Marks HG, Kraemer-Hansen H, Luttges J, Kremer B, Henne-Bruns D. Recurrence of primary biliary cirrhosis after orthotopic liver transplantation. Hepatogastroenterology 50: 322-325 (2003).
Kurie JM, Lotan R, Lee JJ, Lee JS, Morice RC, Liu DD, Xu XC, Khuri FR, Ro JY, Hittelman WN, Walsh GL, Roth JA, Minna JD, Hong WK. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J. Natl. Cancer Inst. 95: 206-214 (2003). *
Kurihara T, Maeda A, Shigemoto M, Yamashita K, Kamatani N. Efficacy of bezafibrate in a patient with primary sclerosing cholangitis. J. Gastroenterol. 38: 300-301 (2003). *
Kurokawa M, Hirai H. Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Cancer Sci. 94: 841-846 (2003). *
Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 110: 2040-2044 (2003).
Kuroki F, Matsumoto T, Iida M. Selenium is depleted in Crohn's disease on enteral nutrition. Dig. Dis. 21: 266-270 (2003).
Kurtovic J, Riordan S. Clinical aspects of primary biliary cirrhosis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 31-32. October 15-16 (2003). *
Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, Al-Saab S, Naiman SC. Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor. Eur. J. Haematol. 71: 396-398 (2003). *
Kurz AK. Non-invasive imaging: Ultrasound and duplex. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 38. October 17 - 19 (2003). *
Kutukculer N, Aksoylar S, Kansoy S, Cetingul N, Notarangelo LD. Outcome of hematopoietic stem cell transplantation in hyper-IgM syndrome caused by CD40 deficiency. J. Pediatr. 143: 141-142 (2003). *
Kutukculer N, Moratto D, Aydinok Y, Lougaris V, Aksoylar S, Plebani A, Genel F, Notarangelo LD. Disseminated Cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J. Pediatr. 142: 194-196 (2003). *
Kuwata H, Watanabe Y, Miyoshi H, Yamamoto M, Kaisho T, Takeda K, Akira S. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102: 4123-4129 (2003). *
Kuwata K, Hirota M, Nishimori I, Otsuki M, Ogawa M. Mutational analysis of the pancreatic secretory trypsin inhibitor gene in familial and juvenile pancreatitis in Japan. J. Gastroenterol. 38: 365-370 (2003). *
Kvasnicka F, Biba B, Sevcik R, Voldrich M, Kratka J. Analysis of the active components of silymarin. J. Chromatogr. A. 990: 239-245 (2003).
Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, Graham DY. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47: 2169-2178 (2003). *
Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann. Intern. Med. 138: 807-811 (2003). *
Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM. Summaries for patients. Tumor necrosis factor antagonists and heart failure. Ann. Intern. Med. 138: I48 (2003). *
Kwon J, Farrell R. Probiotics and inflammatory bowel disease. BioDrugs 17: 179-186 (2003).
Kwon YD, Lee HS, Park CH, Jeen YT, Chun HJ, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH. A case of auto-immune hepatitis associated with primary Sjogren's syndrome. Taehan Kan Hakhoe Chi 9: 25-30 (2003).
Kyburz D, Gay S. Toll-like receptors direct antimicrobial immune responses - and driving arthritis? Curr. Rheumatol. Rep. 5: 407-408 (2003).
Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis NE, Dalekos GN. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J. Hepatol. 39: 679-685 (2003). *
La Regina M, Nucera G, Diaco M, Manna R, Gasbarrini G. Differential diagnosis of periodic fevers. Arch. Dis. Child. 88: 92 (2003). *
Lachter J, Isseroff HN, Yasin K, Keidar Z, Israel O. Radiolabeled leukocyte imaging in inflammatory bowel disease: a prospective blinded evaluation. Hepatogastroenterology 50: 1439-1441 (2003).
Ladas EJ, Kelly KM. Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer? J. Altern. Complement. Med. 9: 411-416 (2003). *
Laffi G, Gentilini P, Romanelli RG, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. Dig. Liver Dis. 35: 660-663 (2003).
Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, Tontonoz P. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. U.S.A. 100: 5419-5424 (2003). *
Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 23: 2182-2191 (2003). *
Laflamme N, Echchannaoui H, Landmann R, Rivest S. Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria. Eur. J. Immunol. 33: 1127-1138 (2003). *
Lage H. ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int. J. Antimicrob. Agents 22: 188-199 (2003). *
Laghi A, Borrelli O, Paolantonio P, Dito L, Buena de Mesquita M, Falconieri P, Passariello R, Cucchiara S. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut 52: 393-397 (2003). *
Lai K, Harnish DC, Evans MJ. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. J. Biol. Chem. 278: 36418-36429 (2003). *
Laine L, Hanauer SB. Considerations in the management of steroid-dependent Crohn's disease. Gastroenterology 125: 906-910 (2003). *
Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Epidemiology of inflammatory bowel diseases in Veszprem county of Western Hungary between 1977 and 2001. Orv. Hetil. 144: 1819-1827 (2003).
Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J. Gastroenterol. 9: 2300-2307 (2003). *
Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Extra-intestinal manifestation of IBD in Veszprem county (of Hungary): results of a 25-years follow-up study. Orv. Hetil. 144: 1965-1975 (2003).
Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125: 47-57 (2003). *
Lam RS, App EM, Nahirney D, Szkotak AJ, Vieira-Coelho MA, King M, Duszyk M. Regulation of Cl- secretion by alpha2-adrenergic receptors in mouse colonic epithelium. J. Physiol. 548: 475-484 (2003). *
Lamarque D, Nhieu JT, Breban M, Bernardeau C, Martin-Garcia N, Szepes Z, Delchier JC, Whittle B, Claudepierre P. Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis. J. Rheumatol. 30: 2428-2436 (2003).
Lamb DJ, El-Sankary W, Ferns GA. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 167: 177-185 (2003).
Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, Schuetz EG. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther. 307: 906-922 (2003). *
Lambert G, Amar MJ, Guo G, Brewer HB Jr, Gonzalez FJ, Sinal CJ. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem. 278: 2563-2570 (2003). *
Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2: 133-139 (2003).
Lambley J, Ho YH. Mesenteric vein thrombosis after proctocolectomy for inflammatory bowel disease. Dis. Colon Rectum 46: 1715 (2003).
Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat. Rev. Immunol. 3: 994-1003 (2003). *
Lamhamedi-Cherradi SE, Zheng S, Hilliard BA, Xu L, Sun J, Alsheadat S, Liou HC, Chen YH. Transcriptional regulation of type I diabetes by NF-kappa B. J. Immunol. 171: 4886-4892 (2003). *
Lamhonwah AM, Skaug J, Scherer SW, Tein I. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem. Biophys. Res. Commun. 301: 98-101 (2003). *
Lammert F, Marschall HU, Matern S. Intrahepatic cholestasis of pregnancy. Curr. Treat. Options Gastroenterol. 6: 123-132 (2003).
Lampert JM, Holzschuh J, Hessel S, Driever W, Vogt K, von Lintig J. Provitamin A conversion to retinal via the beta,beta-carotene-15,15'-oxygenase (bcox) is essential for pattern formation and differentiation during zebrafish embryogenesis. Development 130: 2173-2186 (2003). *
Lamprecht A. Multiparticulate systems in the treatment of inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2: 137-144 (2003).
Lamprecht P, Bruhl H, Erdmann A, Holl-Ulrich K, Csernok E, Seitzer U, Mack M, Feller AC, Reinhold-Keller E, Gross WL, Muller A. Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis. Clin. Immunol. 108: 1-7 (2003). *
Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 3: 601-614 (2003). *
Lamps LW, Madhusudhan KT, Havens JM, Greenson JK, Bronner MP, Chiles MC, Dean PJ, Scott MA. Pathogenic Yersinia DNA is detected in bowel and mesenteric lymph nodes from patients with Crohn's disease. Am. J. Surg. Pathol. 27: 220-227 (2003).
Landa Garrido L, Huaman Munnte J, Valencia Caballero V, Lozano Miranda Z, Nago Nago A. Hereditary hemochromatosis. Rev. Gastroenterol. Peru 23: 302-306 (2003).
Landes N, Birringer M, Brigelius-Flohe R. Homologous metabolic and gene activating routes for vitamins E and K. Mol. Aspects Med. 24: 337-344 (2003).
Landes N, Pfluger P, Kluth D, Birringer M, Ruhl R, Bol GF, Glatt H, Brigelius-Flohe R. Vitamin E activates gene expression via the pregnane X receptor. Biochem. Pharmacol. 65: 269-273 (2003). *
Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F; Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 63: 3560-3566 (2003). *
Landrier JF, Grober J, Demydchuk J, Besnard P. FXRE can function as an LXRE in the promoter of human ileal bile acid-binding protein (I-BABP) gene. FEBS Lett. 553: 299-303 (2003). *
Lang B, Dale RC, Vincent A. New autoantibody mediated disorders of the central nervous system. Curr. Opin. Neurol. 16: 351-357 (2003).
Lang L. HIPAA challenges to clinical research. Gastroenterology 125: 1298 (2003). *
Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone 32: 297-310 (2003). *
Lange EM, Gillanders EM, Davis CC, Brown WM, Campbell JK, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Giri V, Dimmer JB, Montie JE, Trent JM, Cooney KA. Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 57: 326-334 (2003).
Lange S, Bosaeus I, Jennische E, Johansson E, Lundgren BK, Lonnroth I. Food-induced antisecretory factor activity is correlated with small bowel length in patients with intestinal resections. APMIS 111: 985-988 (2003). *
Langman MJ. The burdens imposed by Crohn's disease: messages for clinicians? Dig. Liver Dis. 35: 849-850 (2003).
Lankarani KB. Use of mycophenolate mofetil in the treatment of primary sclerosing cholangitis. J. Clin. Gastroenterol. 36: 86 (2003).
Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 73: 49-56 (2003). *
Lanzini A, De Tavonatti MG, Panarotto B, Scalia S, Mora A, Benini F, Baisini O, Lanzarotto F. Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut 52: 1371-1375 (2003). *
Lapierre P, Johanet C, Alvarez F. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Eur. J. Immunol. 33: 1869-1878 (2003). *
Lasek W, Owczarczyk-Skoczynska M, Pilecki S, Serafin Z, Miegoc H. Hydrocolonic sonography in the diagnostics of ulcerative colitis. Przegl. Lek. 60: 806-809 (2003).
Lashner BA. Motion - colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: arguments for the motion. Can. J. Gastroenterol. 17: 119-121 (2003). *
Lashner BA. Clinical advances in ulcerative colitis. American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course, October 10 - 15, 2003, Baltimore, Maryland (2003).
Lashner BA. When should prophylactic colectomy be considered in patients with ulcerative colitis? Cleve. Clin. J. Med. 70: 221-222 (2003). *
Lashner BA. Use with caution: 6MP in pregnancy. Inflamm. Bowel Dis. 9: 277 (2003). *
Lashner BA, Bauer WM, Rybicki LA, Goldblum JR. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis. Am. J. Gastroenterol. 98: 1423-1427 (2003). *
Latruffe N, Vamecq J, Cherkaoui Malki M. Genetic-dependency of peroxisomal cell functions - emerging aspects. J. Cell. Mol. Med. 7: 238-248 (2003). *
Lau AH, Thomson AW. Dendritic cells and immune regulation in the liver. Gut 52: 307-314 (2003). *
Laurenius A, Wangberg B, Lange S, Jennische E, Lundgren BK, Bosaeus I. Antisecretory factor counteracts secretory diarrhoea of endocrine origin. Clin. Nutr. 22: 549-552 (2003). *
Laurinavicius A, Gruodyte E, Priluckiene J, Razukeviciene L, Supranaviciene L, Salkus G. Potential causes of antigenemia in the patients with an immune complex-mediated membranoproliferative glomerulonephritis in Lithuania. Medicina (Kaunas) 39 Suppl. 1: 28-32 (2003).
Lavie L, Lotan R, Hochberg I, Herer P, Lavie P, Levy AP. Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome. Sleep 26: 592-595 (2003).
Lavy A, Naveh Y, Coleman R, Mokady S, Werman MJ. Dietary Dunaliella bardawil, a beta-carotene-rich alga, protects against acetic acid-induced small bowel inflammation in rats. Inflamm. Bowel Dis. 9: 372-379 (2003). *
Lawrance IC, Wu F, Leite AZ, Willis J, West GA, Fiocchi C, Chakravarti S. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 125: 1750-1761 (2003). *
Lazaridis KN. Primary sclerosing cholangitis. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 43. September 12 - 13 (2003). *
Lazaridis KN, LaRusso NF. Bile formation: do not ignore the role of plasma membrane-cytoskeleton linking proteins. Hepatology 37: 218-220 (2003). *
Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ, Silverman EK, Martinez F, Weiss ST. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81: 85-91 (2003). *
Lebenthal E, Lebenthal Y. Probiotics: a therapeutic concept awaiting recognition. Zh. Mikrobiol. Epidemiol. Immunobiol. 4: 88-90 (2003).
Lebreton G, Fatome A. Management of severe acute colitis. J. Chir. (Paris) 140: 201-210 (2003).
Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol. Psychiatry 8: 114-117 (2003). *
Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 3: 147-158 (2003). *
Leckel K, Blaheta RA, Markus BH. State of hepatocyte transplantation: a risk or a chance? Zentralbl. Chir. 128: 283-290 (2003).
Lecomte T, Contou JF, Beaugerie L, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine. Dis. Colon Rectum 46: 1469-1475 (2003).
Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM, Curtiss LK. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302: 453-457 (2003). *
Lee CS, Lee YJ, Liu HF, Su CH, Chang SC, Wang BR, Chen TL, Liu TL. Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin. Rheumatol. 22: 221-224 (2003). *
Lee EB, Kim JY, Lee YJ, Park MH, Song YW. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum. Immunol. 64: 614-620 (2003).
Lee HS, Chung YH, Kim TG, Kim TH, Jun JB, Jung S, Bae SC, Yoo DH. Independent association of HLA-DR and FCgamma receptor polymorphisms in Korean patients with systemic lupus erythematosus. Rheumatology (Oxford) 42: 1501-1507 (2003). *
Lee JC, Chen MJ, Chang CH, Tiai YF, Lin PW, Lai HS, Wang ST. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Hepatogastroenterology 50: 1269-1273 (2003).
Lee JH, Choi JH, Namkung W, Hanrahan JW, Chang J, Song SY, Park SW, Kim DS, Yoon JH, Suh Y, Jang IJ, Nam JH, Kim SJ, Cho MO, Lee JE, Kim KH, Lee MG. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum. Mol. Genet. 12: 2321-2332 (2003). *
Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, Hwang DH. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44: 479-486 (2003). *
Lee K, Berthiaume F, Stephanopoulos GN, Yarmush ML. Profiling of dynamic changes in hypermetabolic livers. Biotechnol. Bioeng. 83: 400-415 (2003). *
Lee K, Berthiaume F, Stephanopoulos GN, Yarmush ML. Induction of a hypermetabolic state in cultured hepatocytes by glucagon and H2O2. Metab. Eng. 5: 221-229 (2003). *
Lee MR, Kim YJ, Hwang DY, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lim HJ, Ahn KS, Cho JS, Chae KR, Kim YK. An in vitro bioassay for xenobiotics using the SXR-driven human CYP3A4/lacZ reporter gene. Int. J. Toxicol. 22: 207-213 (2003).
Lee SH, Prince JE, Rais M, Kheradmand F, Shardonofsky F, Lu H, Beaudet AL, Smith CW, Soong L, Corry DB. Differential requirement for CD18 in T-helper effector homing. Nat. Med. 9: 1281-1286 (2003). *
Lee VS, Morgan JN, Tan AG, Pandharipande PV, Krinsky GA, Barker JA, Lo C, Weinreb JC. Celiac artery compression by the median arcuate ligament: a pitfall of end-expiratory MR imaging. Radiology 228: 437-442 (2003). *
Lee WI, Zhu Q, Gambineri E, Jin Y, Welcher AA, Ochs HD. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis. J. Allergy Clin. Immunol. 112: 958-964 (2003). *
Lee WM. Acute liver failure in the United States. Semin. Liver Dis. 23: 217-226 (2003).
Lee WM. Drug-induced hepatotoxicity. N. Engl. J. Med. 349: 474-485 (2003). *
Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand. J. Rheumatol. 32: 235-239 (2003).
Lee YM, Kaplan MM. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. Am. J. Gastroenterol. 98: 205-208 (2003). *
Leeb SN, Vogl D, Gunckel M, Kiessling S, Falk W, Goke M, Scholmerich J, Gelbmann CM, Rogler G. Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology 125: 1341-1354 (2003). *
Lefevre C, Audebert S, Jobard F, Bouadjar B, Lakhdar H, Boughdene-Stambouli O, Blanchet-Bardon C, Heilig R, Foglio M, Weissenbach J, Lathrop M, Prud'homme JF, Fischer J. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum. Mol. Genet. 12: 2369-2378 (2003). *
Lefkowitch JH. Hepatobiliary pathology. Curr. Opin. Gastroenterol. 19: 185-193 (2003).
Lehmann FS. Pathophysiology of inflammatory bowel disease. Ther. Umsch. 60: 127-132 (2003).
Lehmann HW, Knoll A, Kuster RM, Modrow S. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum. 48: 1631-1638 (2003). *
Lehours P. Helicobacter pylori and the others. Gastroenterol. Clin. Biol. 27: 367-373 (2003).
Lehrer SB, Ayuso R, Reese G. Seafood allergy and allergens: a review. Mar. Biotechnol. (N.Y.) 5: 339-348 (2003). *
Leigh MW. Primary ciliary dyskinesia. Semin. Respir. Crit. Care Med. 24: 653-662 (2003).
Leloup JC, Goldbeter A. Toward a detailed computational model for the mammalian circadian clock. Proc. Natl. Acad. Sci. U.S.A. 100: 7051-7056 (2003). *
Lemon SC, Zapka JG, Estabrook B, Erban S, Luckmann R. Screening for colorectal cancer on the front line. Am. J. Gastroenterol. 98: 915-923 (2003). *
Lemonde HA, Custard EJ, Bouquet J, Duran M, Overmars H, Scambler PJ, Clayton PT. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut 52: 1494-1499 (2003). *
Lemyze M, Tavernier JY, Chevalon B, Lamblin C. Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease. Rev. Mal. Respir. 20: 773-776 (2003).
Lenaerts C, Lapierre C, Patriquin H, Bureau N, Lepage G, Harel F, Marcotte J, Roy CC. Surveillance for cystic fibrosis-associated hepatobiliary disease: early ultrasound changes and predisposing factors. J. Pediatr. 143: 343-350 (2003). *
Lengeling RW, Mitros FA, Brennan JA, Schulze KS. Ulcerative ileitis encountered at ileo-colonoscopy: likely role of nonsteroidal agents. Clin. Gastroenterol. Hepatol. 1: 160-169 (2003). *
Lennartsson A, Pieters K, Ullmark T, Vidovic K, Gullberg U. AML-1, PU.1, and Sp3 regulate expression of human bactericidal/permeability-increasing protein. Biochem. Biophys. Res. Commun. 311: 853-863 (2003). *
Leon F, Roldan E, Sanchez L, Camarero C, Bootello A, Roy G. Human small-intestinal epithelium contains functional natural killer lymphocytes. Gastroenterology 125: 345-356 (2003). *
Leonardi CL. Overview of psoriasis: update on current and emerging treatment options. Manag. Care 12: S3-S9 (2003).
Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, Sung JJ. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment. Pharmacol. Ther. 17: 1465-1470 (2003). *
Leshem RN. Inflammatory bowel disease support groups: a primer for gastroenterology nurses. Gastroenterol. Nurs. 26: 246-250 (2003).
Leslie WD, Bernstein CN, Leboff MS; American Gastroenterological Association Clinical Practice Commitee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125: 941-966 (2003). *
Lester S, Danda D, Cavill D, Pile K, Downie-Doyle S, Rischmueller M. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjogren's syndrome. Arthritis Rheum. 48: 3293-3294 (2003). *
Leung PS, Park O, Matsumura S, Ansari AA, Coppel RL, Gershwin ME. Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin. Dev. Immunol. 10: 227-233 (2003). *
Leung PS, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, Ansari AA, Coppel RL, Lam KS, Gershwin ME. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J. Immunol. 170: 5326-5332 (2003). *
Leuschner U. Combination therapy in primary biliary cirrhosis and overlap syndromes. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 52-53. October 15-16 (2003). *
Leuschner U. Primary biliary cirrhosis - presentation and diagnosis. Clin. Liver Dis. 7: 741-758 (2003).
Levanon D, Brenner O, Otto F, Groner Y. Runx3 knockouts and stomach cancer. EMBO Rep. 4: 560-564 (2003). *
Levenstein S. Stress and ulcerative colitis: convincing the doubting Thomases. Am. J. Gastroenterol. 98: 2112-2115 (2003). *
Levin L, Tomer Y. The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun. Rev. 2: 377-386 (2003).
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Multiple sclerosis and Epstein-Barr virus. JAMA 289: 1533-1536 (2003). *
Levitsky J, Hart J, Cohen SM, Te HS. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl. 9: 733-736 (2003). *
Levy C, Lindor KD. Management of primary biliary cirrhosis. Curr. Treat. Options Gastroenterol. 6: 493-498 (2003).
Levy C, Lindor KD. Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin. Liver Dis. 7: 901-910 (2003).
Levy C, Lindor KD. Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis. Curr. Treat. Options Gastroenterol. 6: 93-103 (2003).
Levy C, Lindor KD. Current management of primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 38: S24-S37 (2003). *
Levy C, Lindor KD. Drug-induced cholestasis. Clin. Liver Dis. 7: 311-330 (2003).
Levy O, Canny G, Serhan CN, Colgan SP. Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia. Biochem. Soc. Trans. 31: 795-800 (2003). *
Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch. Dis. Child. 88: 517-519 (2003). *
Lewis J, Speers T. Misleading media reporting? The MMR story. Nat. Rev. Immunol. 3: 913-918 (2003). *
Lewis JD. How safe are the safest IBD drugs? Gastroenterology 124: 1986-1987 (2003). *
Lewis JD. The many faces of low-grade dysplasia. Gastroenterology 125: 1531-1533 (2003). *
Lewis JD, Schoenfeld P, Lichtenstein GR. An evidence-based approach to studies of the natural history of gastrointestinal diseases: recurrence of symptomatic Crohn's disease after surgery. Clin. Gastroenterol. Hepatol. 1: 229-236 (2003). *
Lewis KC, Hochadel JF, Zech LA Jr. A systems modeling approach to the study of retinoid function: implications for evaluation of retinoids in cancer chemoprevention and/or chemotherapy. Adv. Exp. Med. Biol. 537: 301-316 (2003).
Lewis M, Howdle PD. The neurology of liver failure. QJM 96: 623-633 (2003). *
Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology 61: 1174-1178 (2003).
Lewis MB, Howdle PD. Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors. Liver Transpl. 9: 1145-1148 (2003). *
Li A, Zhu X, Brown B, Craft CM. Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells. Invest. Ophthalmol. Vis. Sci. 44: 996-1007 (2003). *
Li B, Yang FC, Clapp DW, Chun KT. Enforced expression of CUL-4A interferes with granulocytic differentiation and exit from the cell cycle. Blood 101: 1769-1776 (2003). *
Li CF, He XH, Teng Q, Jiang ZF. Association of HLA-A, B, and DR haplotypes with genotype in Chinese children with systemic lupus erythematosus. Zhonghua Er Ke Za Zhi 41: 422-425 (2003).
Li D. Omega-3 fatty acids and non-communicable diseases. Chin. Med. J. (Engl.) 116: 453-458 (2003).
Li J, Gran B, Zhang GX, Ventura ES, Siglienti I, Rostami A, Kamoun M. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J. Neurol. Sci. 215: 95-103 (2003). *
Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, Harris HE, Czura CJ, Wang H, Ulloa L, Wang H, Warren HS, Moldawer LL, Fink MP, Andersson U, Tracey KJ, Yang H. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 9: 37-45 (2003). *
Li L, Xu X, Lu F, Zhao N. Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats. Chin. Med. J. (Engl.) 116: 1099-1103 (2003).
Li M, Zhang YH, Qin J. Treatment of Wilson's disease with penicillamine and zinc salts: a follow-up study. Zhonghua Er Ke Za Zhi 41: 119-122 (2003).
Li MY, Ryan P, Batey RG. Traditional Chinese medicine prevents inflammation in CCl4-related liver injury in mice. Am. J. Chin. Med. 31: 119-127 (2003).
Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J. Exp. Med. 197: 1501-1510 (2003). *
Li S, Zhang ZW, Guan YF. On the bile acid receptor FXR. Sheng Li Ke Xue Jin Zhan 34: 314-318 (2003).
Li X, Plett PA, Yang Y, Hong P, Freie B, Srour EF, Orschell CM, Clapp DW, Haneline LS. Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control. Blood 102: 2081-2084 (2003). *
Li Z, Diehl AM. Innate immunity in the liver. Curr. Opin. Gastroenterol. 19: 565-571 (2003).
Li Z, Engelhardt JF. Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer. Reprod. Biol. Endocrinol. 1: 83 (2003). *
Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37: 343-350 (2003). *
Li-Weber M, Krammer PH. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol. 3: 534-543 (2003). *
Lian JB, Javed A, Zaidi SK, Lengner C, Montecino M, Van Wijnen AJ, Stein JL, Stein GS. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukaryot. Gene Expr. 14: 1-42 (2003).
Liangas G, Morton JR, Henry RL. Mirth-triggered asthma: is laughter really the best medicine? Pediatr. Pulmonol. 36: 107-112 (2003).
Liangpunsakul S, Agarwal D, Horlander JC, Kieff B, Chalasani N. Positron emission tomography for detecting occult hepatocellular carcinoma in hepatitis C cirrhotics awaiting for liver transplantation. Transplant. Proc. 35: 2995-2997 (2003). *
Liangpunsakul S, Chalasani N. Treatment of nonalcoholic fatty liver disease. Curr. Treat. Options Gastroenterol. 6: 455-463 (2003).
Liao CH, Huang JL. Juvenile ankylosing spondylitis with uveitis. Asian Pac. J. Allergy Immunol. 21: 69-71 (2003).
Licata A. Osteoporosis in men: suspect secondary disease first. Cleve. Clin. J. Med. 70: 247-254 (2003).
Lich JD, Jayne JA, Zhou D, Elliott JF, Blum JS. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. J. Immunol. 171: 853-859 (2003). *
Lichtenstein GR. Evaluation of bone mineral density in inflammatory bowel disease: current safety focus. Am. J. Gastroenterol. 98: S24-S30 (2003). *
Lidar M, Langevitz P, Livneh A, Weiss P, Yosepovich A. Sclerosing cholangitis associated with systemic sarcoidosis. J. Clin. Gastroenterol. 36: 84-85 (2003).
Lieber CS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res. Health 27: 220-231 (2003).
Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J. Clin. Gastroenterol. 37: 336-339 (2003).
Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3: 361-370 (2003).
Liepa GU, Basu H. C-reactive proteins and chronic disease: what role does nutrition play? Nutr. Clin. Pract. 18: 227-233 (2003).
Lim CH, Axon AT. Low-grade dysplasia: nonsurgical treatment. Inflamm. Bowel Dis. 9: 270-272 (2003). *
Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad. Med. J. 79: 307-312 (2003). *
Lin AE, Terry SF, Lerner B, Anderson R, Irons M. Participation by clinical geneticists in genetic advocacy groups. Am. J. Med. Genet. 119A: 89-92 (2003).
Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33: 626-638 (2003). *
Lin DC. Probiotics as functional foods. Nutr. Clin. Pract. 18: 497-506 (2003). *
Lin JH, Liu ZH, Lv FJ, Fu YG, Fan XL, Li SY, Lu JM, Liu XY, Xu AL. Molecular analyses of HLA-DRB1, -DPB1, and -DQB1 in Jing ethnic minority of Southwest China. Hum. Immunol. 64: 830-834 (2003).
Lin M, Zhang M, Abraham M, Smith SM, Napoli JL. Mouse retinal dehydrogenase 4 (RALDH4), molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cells. J. Biol. Chem. 278: 9856-9861 (2003). *
Lind DL, Choudhry S, Ung N, Ziv E, Avila PC, Salari K, Ha C, Lovins EG, Coyle NE, Nazario S, Casal J, Torres A, Rodriguez-Santana JR, Matallana H, Lilly CM, Salas J, Selman M, Boushey HA, Weiss ST, Chapela R, Ford JG, Rodriguez-Cintron W, et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 168: 1312-1316 (2003). *
Lindell M. Expression of genes encoding for drug metabolism in the small intestine. Acta Universitatis Upsaliensis; Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 297; ISBN-91-554-5753-3 (2003). *
Lindell M, Karlsson MO, Lennernas H, Pahlman L, Lang MA. Variable expression of CYP and Pgp genes in the human small intestine. Eur. J. Clin. Invest. 33: 493-499 (2003). *
Linden A. Rationale for targeting interleukin-17 in the lungs. Curr. Opin. Investig. Drugs 4: 1304-1312 (2003).
Lindner P, Norrby J, Olausson M, Rizell M, Cahlin C, Friman S. Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transplant. Proc. 35: 811-812 (2003). *
Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun. 4: 234-238 (2003). *
Lionetti P, Bronzini F, Salvestrini C, Bascietto C, Canani RB, De Angelis GL, Guariso G, Martelossi S, Papadatou B, Barabino A. Response to infliximab is related to disease duration in paediatric Crohn's disease. Aliment. Pharmacol. Ther. 18: 425-431 (2003). *
Lipscomb JC, Teuschler LK, Swartout J, Popken D, Cox T, Kedderis GL. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Risk Anal. 23: 1221-1238 (2003).
Lipsitch M, Bergstrom CT, Antia R. Effect of human leukocyte antigen heterozygosity on infectious disease outcome: the need for allele-specific measures. BMC Med. Genet. 4: 2 (2003). *
Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350-354 (2003). *
Litman T, Skovsgaard T, Stein WD. Pumping of drugs by P-glycoprotein: a two-step process? J. Pharmacol. Exp. Ther. 307: 846-853 (2003). *
Liu CL, Fan ST, Lo CM, Tam PK, Saing H, Wei WI, Yong BH, Tsoi NS, Wong J. Live donor liver transplantation for fulminant hepatic failure in children. Liver Transpl. 9: 1185-1190 (2003). *
Liu HH, Chen KH, Shih YP, Lui WY, Wong FH, Chen YM. Characterization of reduced expression of glycine N-methyltransferase in cancerous hepatic tissues using two newly developed monoclonal antibodies. J. Biomed. Sci. 10: 87-97 (2003).
Liu J, Beller DI. Distinct pathways for NF-kappa B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J. Immunol. 170: 4489-4496 (2003). *
Liu J, Cao S, Herman LM, Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 198: 1265-1276 (2003). *
Liu J, Manheimer E, Tsutani K, Gluud C. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am. J. Gastroenterol. 98: 538-544 (2003). *
Liu L, Mei QB, Zhou SY, Han FH, Long Y, Liu JY, Li C, Meng JR, Wang ZP. Effects of tanguticum maxim polysaccharide on ulcerative colitis induced by TNBS in rats. Zhongguo Zhong Yao Za Zhi 28: 246-249 (2003).
Liu L, Wang ZP, Xu CT, Pan BR, Mei QB, Long Y, Liu JY, Zhou SY. Effects of Rheum tanguticum polysaccharide on TNBS-induced colitis and CD4+T cells in rats. World J. Gastroenterol. 9: 2284-2288 (2003). *
Liu LY, Jarjour NN, Busse WW, Kelly EA. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J. Allergy Clin. Immunol. 112: 556-562 (2003).
Liu PY, Chen JH, Li YH, Wu HL, Shi GY. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb. Haemost. 90: 132-139 (2003).
Liu SP, Dong WG, Wu DF, Luo HS, Yu JP. Protective effect of angelica sinensis polysaccharide on experimental immunological colon injury in rats. World J. Gastroenterol. 9: 2786-2790 (2003). *
Liu V, Mackool B. Mycophenolate in dermatology. J. Dermatolog. Treat. 14: 203-211 (2003).
Liu XQ, Zhang YF, Liu TT, Gu XF, Hsiao KJ, Bao KR, Yu LH. Genotype and phenotype correlation in Chinese patients with Wilson's disease. Zhonghua Er Ke Za Zhi 41: 35-38 (2003).
Liu Y, Binz J, Numerick MJ, Dennis S, Luo G, Desai B, MacKenzie KI, Mansfield TA, Kliewer SA, Goodwin B, Jones SA. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 112: 1678-1687 (2003). *
Liu Y, Zhu B, Wang X, Luo L, Li P, Paty DW, Cynader MS. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J. Neuroimmunol. 139: 27-35 (2003).
Lizardi-Cervera J, Almeda P, Guevara L, Uribe M. Hepatic encephalopathy: a review. Ann. Hepatol. 2: 122-130 (2003). *
Llor X, Pons E, Roca A, Alvarez M, Mane J, Fernandez-Banares F, Gassull MA. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin. Nutr. 22: 71-79 (2003).
Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstet. Gynecol. 188: 1348-1353 (2003).
Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J. Hepatol. 38 Suppl. 1: S136-S149 (2003). *
Lo FS, Lee YJ, Huang CY, Lin CH, Chang SC, Dang CW, Liu HF. Polymorphism in the transmembrane region of the major histocompatibility complex class I chain-related gene A: association of five GCT repetitions with Graves' disease in children. Thyroid 13: 839-843 (2003).
Locardi E, Boer J, Modlinger A, Schuster A, Holzmann B, Kessler H. Synthesis and structure-activity relationship of mannose-based peptidomimetics selectively blocking integrin alpha4beta7 binding to mucosal addressin cell adhesion molecule-1. J. Med. Chem. 46: 5752-5762 (2003). *
Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol. Dial. Transplant. 18: 1272-1280 (2003). *
Lochner M, Forster I. Anti-interleukin-18 therapy in murine models of inflammatory bowel disease. Pathobiology 70: 164-169 (2003).
Lofberg R. Review article: medical treatment of mild to moderately active Crohn's disease. Aliment. Pharmacol. Ther. 17 Suppl. 2: 18-22 (2003). *
Loftus EV Jr. Does monitoring prevent cancer in inflammatory bowel disease? J. Clin. Gastroenterol. 36: S79-S83 (2003).
Loftus EV Jr. Mortality in inflammatory bowel disease: peril and promise. Gastroenterology 125: 1881-1883 (2003). *
Loftus EV Jr, Achenbach SJ, Sandborn WJ, Tremaine WJ, Oberg AL, Melton LJ 3rd. Risk of fracture in ulcerative colitis: a population-based study from Olmsted county, Minnesota. Clin. Gastroenterol. Hepatol. 1: 465-473 (2003). *
Logan AC. Omega-3 fatty acids and acne. Arch. Dermatol. 139: 941-942 (2003). *
Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern. Med. Rev. 8: 410-425 (2003). *
Logan RF, van Staa TP. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 52: 1530 (2003). *
Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, Del Vecchio Blanco C. Glutathione supplementation improves oxidative damage in experimental colitis. Dig. Liver Dis. 35: 635-641 (2003).
Lohi H, Lamprecht G, Markovich D, Heil A, Kujala M, Seidler U, Kere J. Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains. Am. J. Physiol. Cell. Physiol. 284: C769-C779 (2003). *
Lohmann CH, Schwartz Z, Liu Y, Li Z, Simon BJ, Sylvia VL, Dean DD, Bonewald LF, Donahue HJ, Boyan BD. Pulsed electromagnetic fields affect phenotype and connexin 43 protein expression in MLO-Y4 osteocyte-like cells and ROS 17/2.8 osteoblast-like cells. J. Orthop. Res. 21: 326-334 (2003). *
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33: 177-182 (2003). *
Lohr HF, Pingel S, Weyer S, Fritz T, Galle PR. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand. J. Immunol. 57: 384-390 (2003). *
Lohse AW. Other extra-hepatic and extra-intestinal diseases in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 78. October 15-16 (2003). *
Loncar MB, Al-azzeh ED, Sommer PS, Marinovic M, Schmehl K, Kruschewski M, Blin N, Stohwasser R, Gott P, Kayademir T. Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide. Gut 52: 1297-1303 (2003). *
Londei M, Quaratino S, Maiuri L. Celiac disease: a model autoimmune disease with gene therapy applications. Gene Ther. 10: 835-843 (2003). *
Long R, Gardam M. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. CMAJ 168: 1153-1156 (2003). *
Longo WE. The specialty of colon and rectal surgery: its impact on patient care and role in academic medicine. Yale J. Biol. Med. 76: 63-77 (2003). *
Longshore SJ, Hollandsworth K. Acne vulgaris: one treatment does not fit all. Cleve. Clin. J. Med. 70: 670, 672-674, 677-678 (2003). *
Longworth L, Young T, Buxton MJ, Ratcliffe J, Neuberger J, Burroughs A, Bryan S. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Liver Transpl. 9: 1295-1307 (2003). *
Lopez-Granados E, Cambronero R, Ferreira A, Fontan G, Garcia-Rodriguez MC. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome. Clin. Exp. Immunol. 133: 123-131 (2003). *
Lopez-Hoyos M, Marquina R, Tamayo E, Gonzalez-Rojas J, Izui S, Merino R, Merino J. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum. 48: 2353-2361 (2003). *
Lopez-Nevot MA, Ramal L, Jimenez-Alonso J, Martin J. The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 42: 113-116 (2003). *
Loraine AE, Helt GA, Cline MS, Siani-Rose MA. Exploring alternative transcript structure in the human genome using blocks and InterPro. J. Bioinform. Comput. Biol. 1: 289-306 (2003).
Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 3: 991-1002 (2003). *
Loria P, Lonardo A, Leonardi F, Fontana C, Carulli L, Verrone AM, Borsatti A, Bertolotti M, Cassani F, Bagni A, Muratori P, Ganazzi D, Bianchi FB, Carulli N. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig. Dis. Sci. 48: 2173-2181 (2003). *
Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's thyroiditis. Pediatr. Endocrinol. Rev. 1 Suppl. 2: 205-211 (2003).
Lotze MT, DeMarco RA. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4: 1405-1409 (2003).
Loudianos G, Kostic V, Solinas P, Lovicu M, Dessi V, Svetel M, Major T, Cao A. Characterization of the molecular defect in the ATP7B gene in Wilson disease patients from Yugoslavia. Genet. Test. 7: 107-112 (2003).
Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 52: 552-557 (2003). *
Louis M, Rauch J, Armstrong M, Fitzcharles MA. Induction of autoantibodies during prolonged treatment with infliximab. J. Rheumatol. 30: 2557-2562 (2003).
Louka AS, Lie BA, Talseth B, Ascher H, Ek J, Gudjonsdottir AH, Sollid LM. Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles. Immunogenetics 55: 339-343 (2003). *
Louka AS, Moodie SJ, Karell K, Bolognesi E, Ascher H, Greco L, Momigliano-Richiardi P, Partanen J, Ciclitira PJ, Sollid LM; European Genetics Cluster on Celiac Disease. A collaborative European search for non-DQA1*05-DQB1*02 celiac disease loci on HLA-DR3 haplotypes: analysis of transmission from homozygous parents. Hum. Immunol. 64: 350-358 (2003).
Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 61: 105-117 (2003). *
Loureiro-Silva MR, Cadelina GW, Iwakiri Y, Groszmann RJ. A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats. J. Hepatol. 39: 940-946 (2003). *
Louw JA, Marks IN. The management of peptic ulcer disease. Curr. Opin. Gastroenterol. 19: 533-539 (2003).
Louzir B, Othmani S, Ben Abdelhafidh N; Groupe d'Etude du Lupus Erythematuex Systemique en Tunisie. Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases. Rev. Med. Interne. 24: 768-774 (2003).
Lovato P, Brender C, Agnholt J, Kelsen J, Kaltoft K, Svejgaard A, Eriksen KW, Woetmann A, Odum N. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J. Biol. Chem. 278: 16777-16781 (2003). *
Lowichik A, Book L. Pediatric celiac disease: clinicopathologic and genetic aspects. Pediatr. Dev. Pathol. 6: 470-483 (2003).
Lu J, Wang A, Ansari S, Hershberg RM, McKay DM. Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis. Gastroenterology 125: 1785-1795 (2003). *
Lu SC, Gukovsky I, Lugea A, Reyes CN, Huang ZZ, Chen L, Mato JM, Bottiglieri T, Pandol SJ. Role of S-adenosylmethionine in two experimental models of pancreatitis. FASEB J. 17: 56-58 (2003). *
Lu SY, Sui YF, Li ZS, Pan CE, Ye J, Zhang XM, Wang WY. The construction and expression of a hepatocellular carcinoma-specific superantigen SEA (D227A) expression vector. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 19: 353-356 (2003).
Luangsay S, Kasper LH, Rachinel N, Minns LA, Mennechet FJ, Vandewalle A, Buzoni-Gatel D. CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology 125: 491-500 (2003). *
Lubberts E. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Investig. Drugs 4: 572-577 (2003).
Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J. Immunol. 170: 2655-2662 (2003). *
Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 100: 15047-15052 (2003). *
Lucena JF, Herrero JI, Quiroga J, Sangro B, Garcia-Foncillas J, Zabalegui N, Sola J, Herraiz M, Medina JF, Prieto J. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 124: 1037-1042 (2003). *
Lucini S, Brun P, Gaspert A, Riehle HM, Schulthess G. Elevated liver values of uncertain origin. Schweiz. Rundsch. Med. Prax. 92: 288-293 (2003).
Lucotte G, Dieterlen F. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection. Infect. Genet. Evol. 3: 293-295 (2003).
Lucotte G, Smets P. CCR5-Delta32 allele frequencies in Ashkenazi Jews. Genet. Test. 7: 333-337 (2003). *
Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ. Autoantibodies to tissue transglutaminase in Sjogren's syndrome and related rheumatic diseases. J. Rheumatol. 30: 2613-2619 (2003).
Luhder F, Huang Y, Dennehy KM, Guntermann C, Muller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hunig T. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists. J. Exp. Med. 197: 955-966 (2003). *
Luisetti M, Franco Pignatti P. Genetics of idiopathic disseminated bronchiectasis. Semin. Respir. Crit. Care Med. 24: 179-184 (2003).
Luka Z, Wagner C. Effect of naturally occurring mutations in human glycine N-methyltransferase on activity and conformation. Biochem. Biophys. Res. Commun. 312: 1067-1072 (2003). *
Lukacs GL, Durie PR. Pharmacologic approaches to correcting the basic defect in cystic fibrosis. N. Engl. J. Med. 349: 1401-1404 (2003). *
Luman W, Ng KL. Audit of investigations in patients with iron deficiency anaemia. Singapore Med. J. 44: 504-510 (2003).
Lundin KE, Farstad IN, Sollid LM. Coeliac disease - new clinical findings and diagnostic tools. Tidsskr. Nor. Laegeforen. 123: 3226-3229 (2003).
Lundin KE, Sollid LM. Gliadin peptide specific intestinal T cells in coeliac disease. Gut 52: 162 (2003). *
Luomala M, Lehtimaki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I. Promoter polymorphism of IL-10 and severity of multiple sclerosis. Acta Neurol. Scand. 108: 396-400 (2003).
Lupp A, Karge E, Hopf H, Machts H, Oelschlager H, Fleck C. Fibrates and their newly synthesized glycinate or glycinate-methylester derivatives: comparison of the interactions with liver cytochrome P450 dependent monooxygenase- and oxidase-functions in vitro. Exp. Toxicol. Pathol. 54: 433-440 (2003).
Lustig MJ, Cunningham ET Jr. Use of immunosuppressive agents in uveitis. Curr. Opin. Ophthalmol. 14: 399-412 (2003).
Luxon BA. Autoimmune hepatitis. Making sense of all those antibodies. Postgrad. Med. 114: 79-82, 85-88 (2003).
Lykavieris P, van Mil S, Cresteil D, Fabre M, Hadchouel M, Klomp L, Bernard O, Jacquemin E. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J. Hepatol. 39: 447-452 (2003). *
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N. Engl. J. Med. 348: 919-932 (2003). *
Ma J, Nakajima T, Iida H, Iwasawa K, Terasawa K, Oonuma H, Jo T, Morita T, Imuta H, Suzuki J, Hirose K, Okuda Y, Yamada N, Nagai R, Omata M. Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells. Eur. J. Pharmacol. 464: 79-86 (2003). *
Macdonald DC, Leir SH, Brooks C, Sanders E, Lackie P, Rosenberg W. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines. Eur. J. Gastroenterol. Hepatol. 15: 1101-1110 (2003).
MacFarlane AJ, Burghardt KM, Kelly J, Simell T, Simell O, Altosaar I, Scott FW. A type 1 diabetes-related protein from wheat (Triticum aestivum). cDNA clone of a wheat storage globulin, Glb1, linked to islet damage. J. Biol. Chem. 278: 54-63 (2003). *
Mackenzie PI, Gregory PA, Gardner-Stephen DA, Lewinsky RH, Jorgensen BR, Nishiyama T, Xie W, Radominska-Pandya A. Regulation of UDP glucuronosyltransferase genes. Curr. Drug Metab. 4: 249-257 (2003).
MacLean AR, Lilly L, Cohen Z, O'Connor B, McLeod RS. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis. Dis. Colon Rectum 46: 1124-1128 (2003).
MacMaster JF, Dambach DM, Lee DB, Berry KK, Qiu Y, Zusi FC, Burke JR. An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm. Res. 52: 508-511 (2003). *
Maconi G, Carsana L, Fociani P, Sampietro BM, Ardizzone S, Cristaldi M, Parente F, Vago GL, Taschieri AM, Bianchi Porro G. Small bowel stenosis in Crohn's disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment. Pharmacol. Ther. 18: 749-756 (2003). *
Maconi G, Greco S, Parente F, Ardizzone S, Sampietro GM, Sartani A, Danelli P, Bianchi Porro G. Bowel ultrasound in Crohn's disease. Surgical importance. Ann. Ital. Chir. 74: 651-658 (2003).
MacQuillan GC, Neuberger J. Liver transplantation for primary biliary cirrhosis. Clin. Liver Dis. 7: 941-956, ix (2003).
Madsen L, Petersen RK, Sorensen MB, Jorgensen C, Hallenborg P, Pridal L, Fleckner J, Amri EZ, Krieg P, Furstenberger G, Berge RK, Kristiansen K. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 375: 539-549 (2003). *
Maeda T, Sepe P, Lahousse S, Tamaki S, Enjoji M, Wands JR, de la Monte SM. Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells. J. Hepatol. 38: 615-622 (2003). *
Maerten P, Liu Z, Ceuppens JL. Targeting of costimulatory molecules as a therapeutic approach in inflammatory bowel disease. BioDrugs 17: 395-411 (2003).
Maeyama K, Emi M, Chihara K. Role of PPARgamma in inflammatory response related to mast cells. Nippon Yakurigaku Zasshi 122: 325-330 (2003).
Mageed RA, Prud'homme GJ. Immunopathology and the gene therapy of lupus. Gene Ther. 10: 861-874 (2003).
Maggiore G, Caprai S. The liver in celiac disease. J. Pediatr. Gastroenterol. Nutr. 37: 117-1199 (2003). *
Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278: 17277-17283 (2003). *
Maglich JM, Sluder AE, Willson TM, Moore JT. Beyond the human genome: examples of nuclear receptor analysis in model organisms and potential for drug discovery. Am. J. Pharmacogenomics 3: 345-353 (2003).
Magrini L, Rotiroti G, Conti F, Viganego F, Alessandri C, Picardo V, Valesini G. Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids. Isr. Med. Assoc. J. 5: 825-826 (2003). *
Magro F, Dinis-Ribeiro M, Araujo FM, Pereira P, Fraga MC, Cunha-Ribeiro LM, Tome-Ribeiro A. High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 15: 1157-1163 (2003).
Mahadevan U. 6TG: when less is more than you bargained for. Inflamm. Bowel Dis. 9: 394-395 (2003). *
Mahadevan U. Runs in the family. Inflamm. Bowel Dis. 9: 72-73 (2003). *
Mahadevan U, Marion JF, Present DH. Fistula response to methotrexate in Crohn's disease: a case series. Aliment. Pharmacol. Ther. 18: 1003-1008 (2003). *
Mahady GB, Pendland SL, Stoia A, Chadwick LR. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother. Res. 17: 217-221 (2003).
Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes melitus. Indian J. Dermatol. Venereol. Leprol. 69: 105-108 (2003).
Mahoney EJ, Spiegel JH. Sjogren's disease. Otolaryngol. Clin. North Am. 36: 733-745 (2003).
Maier LM, Twells RC, Howson JM, Lam AC, Clayton DG, Smyth DJ, Savage D, Carson D, Patterson CC, Smink LJ, Walker NM, Burren OS, Nutland S, Rance H, Tuomilehto-Wolf E, Tuomilehto J, Guja C, Ionescu-Tirgoviste C, Undlien DE, Ronningen KS, Cucca F, Todd JA. Testing the possible negative association of type 1 diabetes and atopic disease by analysis of the interleukin 4 receptor gene. Genes Immun. 4: 469-475 (2003). *
Mailliard M, Casey C. Transplantation of hepatocytes to provide life support: feasibility for future therapy? Am. J. Gastroenterol. 98: 11 (2003). *
Mailliard ME, Gollan JL. Metabolic liver disease in the young adult. Best Pract. Res. Clin. Gastroenterol. 17: 307-322 (2003).
Maire F, Bienvenu T, Ngukam A, Hammel P, Ruszniewski P, Levy P. Frequency of CFTR gene mutations in idiopathic pancreatitis. Gastroenterol. Clin. Biol. 27: 398-402 (2003).
Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362: 30-37 (2003). *
Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat. Rev. Immunol. 3: 733-744 (2003). *
Majumdar R, Al Jumah M, Fraser M. 4193delC, a common mutation causing Wilson's disease in Saudi Arabia: rapid molecular screening of patients and carriers. Mol. Pathol. 56: 302-304 (2003). *
Mak TW. 'Order from disorder sprung': recognition and regulation in the immune system. Philos. Transact. A. Math. Phys. Eng. Sci. 361: 1235-50 (2003). *
Maki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Hopfl P, Knip M. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348: 2517-2524 (2003). *
Makinen J, Reinisalo M, Niemi K, Viitala P, Jyrkkarinne J, Chung H, Pelkonen O, Honkakoski P. Dual action of oestrogens on the mouse constitutive androstane receptor. Biochem. J. 376: 465-472 (2003). *
Makishima M. Lipid metabolism and nuclear receptors. Seikagaku 75: 391-395 (2003).
Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Docosahexaenoic acid and post-partum depression - is there a link? Asia Pac. J. Clin. Nutr. 12: S37 (2003).
Makrigiannis AP, Anderson SK. Regulation of natural killer cell function. Cancer Biol. Ther. 2: 610-616 (2003). *
Maksymowych WP, Reeve JP, Reveille JD, Akey JM, Buenviaje H, O'Brien L, Peloso PM, Thomson GT, Jin L, Russell AS. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum. 48: 2011-2018 (2003). *
Malaguarnera L, Simpore J, Prodi DA, Angius A, Sassu A, Persico I, Barone R, Musumeci S. A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun. 4: 570-574 (2003). *
Malangoni MA. Gastrointestinal surgery and pregnancy. Gastroenterol. Clin. North Am. 32: 181-200 (2003). *
Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J. Leukoc. Biol. 74: 961-965 (2003). *
Malfertheiner P, Kirchner T, Kist M, Leodolter A, Peitz U, Strobel S, Bohuschke M, Gatz G; BYK Advanced Gastric Ulcer Study Group. Helicobacter pylori eradication and gastric ulcer healing - comparison of three pantoprazole-based triple therapies. Aliment. Pharmacol. Ther. 17: 1125-1135 (2003). *
Malfertheiner P, Peitz U, Treiber G. What constitutes failure for Helicobacter pylori eradication therapy? Can. J. Gastroenterol. 17 Suppl. B: 53B-57B (2003).
Mall M, Gonska T, Thomas J, Schreiber R, Seydewitz HH, Kuehr J, Brandis M, Kunzelmann K. Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia. Pediatr. Res. 53: 608-618 (2003). *
Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst. Rev. 4: CD004514 (2003). *
Malumbres R, Lecanda J, Melero S, Ciesielczyk P, Prieto J, Medina JF. HNF1alpha upregulates the human AE2 anion exchanger gene (SLC4A2) from an alternate promoter. Biochem. Biophys. Res. Commun. 311: 233-240 (2003). *
Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol. Clin. North Am. 32: 967-995, viii (2003).
Mandekou-Lefaki I, Delli F, Teknetzis A, Euthimiadou R, Karakatsanis G. Low-dose schema of isotretinoin in acne vulgaris. Int. J. Clin. Pharmacol. Res. 23: 41-46 (2003).
Mandel L, Dehlinger N. Primary biliary cirrhosis and Sjogren's syndrome: case report. J. Oral Maxillofac. Surg. 61: 1358-1361 (2003). *
Mandel L, Sunwoo J. Primary Sjogren's syndrome. N.Y. State Dent. J. 69: 34-36 (2003).
Mandrusiak LM, Beitel LK, Wang X, Scanlon TC, Chevalier-Larsen E, Merry DE, Trifiro MA. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor. Hum. Mol. Genet. 12: 1497-1506 (2003). *
Manes S, del Real G, Martinez-A C. Pathogens: raft hijackers. Nat. Rev. Immunol. 3: 557-568 (2003).
Mangione RA, Patel PN. Caring for patients with celiac disease: the role of the pharmacist. J. Am. Pharm. Assoc. 48: e125-e135 (2003).
Mangnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver Int. 23: 124-138 (2003). *
Mankowski DC, Ekins S. Prediction of human drug metabolizing enzyme induction. Curr. Drug Metab. 4: 381-391 (2003).
Mann S. Melatonin for ulcerative colitis? Am. J. Gastroenterol. 98: 232-233 (2003). *
Mann SD, Pitt J, Springall RG, Thillainayagam AV. Clostridium difficile infection - an unusual cause of refractory pouchitis: report of a case. Dis. Colon Rectum. 46: 267-270 (2003).
Mann ST, Stracke H, Lange U, Klor HU, Teichmann J. Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas. Dig. Dis. Sci. 48: 533-538 (2003). *
Mannweiler S, Beham A, Langner C. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue. APMIS 111: 978-984 (2003).
Manolova IM. Anti-lactoferrin antibodies in patients with connective tissue diseases. Folia Med. (Plovdiv.) 45: 25-30 (2003).
Mansfield JC. Which 5-ASA? Gut 52: 771 (2003). *
Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Clin. Gastroenterol. Hepatol. 1: 122-128 (2003). *
Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 124: 1724-1732 (2003). *
Mao Y, Zhu CG, Boedeker EC. Foodborne enteric infections. Curr. Opin. Gastroenterol. 19: 11-22 (2003).
Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry 160: 996-998 (2003). *
Marder BA, Schroppel B, Lin M, Schiano T, Parekh R, Tomer Y, Murphy B. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am. J. Transplant. 3: 424-431 (2003). *
Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83: 337-376 (2003). *
Mareen P, Van De Walle S, Bernaert P, Vanhouteghem H, Dierick J. Antineutrophil cytoplasmic antibodies (ANCA) and small vessel vasculitis. Acta Clin. Belg. 58: 193-200 (2003).
Margalit M, Elinav H, Goldin E, Ilan Y. Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"? Harefuah. 142: 421-425 (2003).
Margenthaler JA, Landeros K, Kataoka M, Eilers M, Ku G, Flye MW. Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury. J. Surg. Res. 112: 102-110 (2003). *
Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62: 168-171 (2003). *
Marinaro M, Fasano A, De Magistris MT. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses. Infect. Immun. 71: 1897-1902 (2003). *
Marini M, Bamias G, Rivera-Nieves J, Moskaluk CA, Hoang SB, Ross WG, Pizarro TT, Cominelli F. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100: 8366-8371 (2003). *
Markowitz JF. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. Rev. Gastroenterol. Disord. 3 Suppl. 1: S23-S29 (2003). *
Marnila P, Rokka S, Rehnberg-Laiho L, Karkkainen P, Kosunen TU, Rautelin H, Hanninen ML, Syvaoja EL, Korhonen H. Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 8: 192-201 (2003). *
Marotta F, Naito Y, Minelli E, Tajiri H, Bertuccelli J, Wu CC, Min CH, Hotten P, Fesce E. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study. Hepatogastroenterology 50: 1914-1918 (2003).
Marsano LS, Mendez C, Hill D, Barve S, McClain CJ. Diagnosis and treatment of alcoholic liver disease and its complications. Alcohol Res. Health 27: 247-256 (2003). *
Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21: 71-105 (2003). *
Marsh S, McLeod HL. Crohn's disease: ethnic variation in CARD15 genotypes. Gut 52: 770 (2003). *
Martignoni ME, Kunze P, Friess H. Cancer cachexia. Mol. Cancer 2: 36 (2003). *
Martin Alcalde E, Cantero Blanco S, Sanchez Garcia FJ, Gomez Castillo JJ. New perspectives in the treatment of rheumatoid arthritis. Farm Hosp. 27: 360-370 (2003).
Martin AR, Villegas I, La Casa C, Alarcon de la Lastra C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur. J. Pharmacol. 481: 281-291 (2003). *
Martin R, Jarnagin W. Intrahepatic cholangiocarcinoma. Current management. Minerva Chir. 58: 469-478 (2003).
Martin TM, Doyle TM, Smith JR, Dinulescu D, Rust K, Rosenbaum JT. Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15). Am. J. Ophthalmol. 136: 933-935 (2003). *
Martin-Pagola A, Perez de Nanclares G, Vitoria JC, Bilbao JR, Ortiz L, Zubillaga P, Castano L. No association of CTLA4 gene with celiac disease in the Basque population. J. Pediatr. Gastroenterol. Nutr. 37: 142-145 (2003). *
Martinez A, Gual L, Fernandez-Arquero M, Nogales A, Ferreira A, Garcia-Rodriguez MC, Fontan G, de la Concha Ed EG. Epistatic effects occurring among susceptibility and protective MHC genes in IgA deficiency. Genes Immun. 4: 316-320 (2003). *
Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG. Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun. 4: 117-121 (2003). *
Martinez-Berriotxoa A, Ruiz-Irastorza G, Egurbide Arberas MV, Rueda Gutierrez M, Aguirre Errasti C. Plasma homocysteine levels in systemic lupus erythematosus. Med. Clin. (Barc.) 120: 681-685 (2003).
Martinez-Borra J, Gonzalez S, Santos-Juanes J, Sanchez del Rio J, Torre-Alonso JC, Lopez-Vazquez A, Blanco-Gelaz MA, Lopez-Larrea C. Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology (Oxford) 42: 1089-1092 (2003). *
Martinez-Chantar ML, Latasa MU, Varela-Rey M, Lu SC, Garcia-Trevijano ER, Mato JM, Avila MA. L-Methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine. J. Biol. Chem. 278: 19885-19890 (2003). *
Martinez-Mir A, Zlotogorski A, Ott J, Gordon D, Christiano AM. Genetic linkage studies in alopecia areata. J. Investig. Dermatol. Symp. Proc. 8: 199-203 (2003). *
Martucci S, Fraser JS, Biagi F, Corazza GR, Ciclitira PJ, Ellis HJ. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system. Eur. J. Gastroenterol. Hepatol. 15: 1293-1298 (2003).
Marucci L, Alpini G, Glaser SS, Alvaro D, Benedetti A, Francis H, Phinizy JL, Marzioni M, Mauldin J, Venter J, Baumann B, Ugili L, LeSage G. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G290-G301 (2003). *
Marucci L, Macarri G, Benedetti A. Cholestasis. Recent diagnostic and therapeutic acquisitions. Recenti Prog. Med. 94: 19-24 (2003).
Maruyama S. Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer. Nippon Rinsho 61 Suppl. 7: 379-382 (2003).
Marzioni M, LeSage GD, Glaser S, Patel T, Marienfeld C, Ueno Y, Francis H, Alvaro D, Tadlock L, Benedetti A, Marucci L, Baiocchi L, Phinizy JL, Alpini G. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G837-G852 (2003). *
Marzo-Ortega H, McGonagle D, O'Connor P, Emery P. Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis. Ann. Rheum. Dis. 62: 74-76 (2003). *
Mas A, Rodes J, Sunyer L, Rodrigo L, Planas R, Vargas V, Castells L, Rodriguez-Martinez D, Fernandez-Rodriguez C, Coll I, Pardo A; Spanish Association for the Study of the Liver Hepatic Encephalopathy Cooperative Group. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial. J. Hepatol. 38: 51-58 (2003). *
Masaki T, Fukunaga A, Tohyama M, Koda Y, Okuda S, Maeda N, Kanda F, Yasukawa M, Hashimoto K, Horikawa T, Ueda M. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm. Venereol. 83: 128-131 (2003).
Mascarenhas MR. Treatment of gastrointestinal problems in cystic fibrosis. Curr. Treat. Options Gastroenterol. 6: 427-441 (2003).
Masci E, Mariani A, Curioni S, Testoni PA. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 35: 830-834 (2003).
Masclee AA, Vu MK. Gallbladder motility in inflammatory bowel diseases. Dig. Liver Dis. 35 Suppl. 3: S35-S38 (2003).
Massarotti M, Marasini B, Marchesoni A, Arreghini M, Biondi ML. Polymorphism in the stromelysin 1 (matrix metalloproteinase 3) promoter gene and severity of rheumatoid arthritis: comment on the article by Constantin et al. Arthritis Rheum. 48: 2695-2696 (2003). *
Mastroeni P, Menager N. Development of acquired immunity to Salmonella. J. Med. Microbiol. 52: 453-459 (2003). *
Masuda H, Takahashi Y, Asai S, Takayama T. Distinct gene expression of osteopontin in patients with ulcerative colitis. J. Surg. Res. 111: 85-90 (2003). *
Masumoto T, Horiike N, Abe M, Kumaki T, Matsubara H, Fazle Akbar SM, Michitaka K, Hyodo I, Onji M. Diagnosis of drug-induced liver injury in Japanese patients by criteria of Consensus Meetings in Europe. Hepatol. Res. 25: 1-7 (2003). *
Mata A, Llach J, Bordas JM, Feu F, Pellise M, Fernandez-Esparrach G, Gines A, Pique JM. Role of capsule endoscopy in patients with obscure digestive bleeding. Gastroenterol. Hepatol. 26: 619-623 (2003).
Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal disease. Nutr. Clin. Pract. 18: 507-516 (2003). *
Materna V, Lage H. Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient. J. Hum. Genet. 48: 484-486 (2003). *
Matheson PJ, Hurt RT, Mittel OF, Wilson MA, Spain DA, Garrison RN. Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum. J. Surg. Res. 110: 360-370 (2003). *
Mathews J, Rao S, Kumar BN. Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? J. Laryngol. Otol. 117: 212-214 (2003).
Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm. Bowel Dis. 9: 351-355 (2003). *
Matousovic K, Martinek V. IgA nephropathy. Use of modern laboratory methods and renal biopsy for diagnosis. Vnitr. Lek. 49: 869-873 (2003).
Matri S, Boubaker J, Hamzaoui S, Bardi R, Ayed K, Filali A. The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases. Tunis. Med. 81: 289-294 (2003).
Matsubayashi H, Fukushima N, Sato N, Brune K, Canto M, Yeo CJ, Hruban RH, Kern SE, Goggins M. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol. Ther. 2: 652-655 (2003). *
Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, Tsuda S, Wada Y, Iwashita A, Kamachi S. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation. J. Gastroenterol. 38: 647-655 (2003). *
Matsumoto K, Kanmatsuse K. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy. Scand. J. Urol. Nephrol. 37: 164-171 (2003).
Matsumoto N, Yoshida T, Okayasu I. High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis. Cancer Res. 63: 6158-6161 (2003). *
Matsumoto T, Jo Y, Mibu R, Hirahashi M, Yao T, Iida M. Multiple microcarcinoids in a patient with long standing ulcerative colitis. J. Clin. Pathol. 56: 963-965 (2003). *
Matsumoto T, Nakamura S, Jo Y, Yao T, Iida M. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am. J. Gastroenterol. 98: 1827-1833 (2003). *
Matsunaga S, Maruyama T, Yamada S, Motohashi Y, Shigihara T, Shimada A, Saruta T. Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) P22 Phox C242T gene polymorphism in type 1 diabetes. Ann. N. Y. Acad. Sci. 1005: 324-327 (2003). *
Matsuno K, Adachi Y, Yamamoto H, Goto A, Arimura Y, Endo T, Itoh F, Imai K. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J. Gastroenterol. 38: 348-354 (2003). *
Matsushima-Nishiwaki R, Okuno M, Takano Y, Kojima S, Friedman SL, Moriwaki H. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid. Carcinogenesis 24: 1353-1359 (2003). *
Matsushita T, Yagi T, Hardin JA, Cragun JD, Crow FW, Bergen HR 3rd, Gores GJ, Nyberg SL. Apoptotic cell death and function of cryopreserved porcine hepatocytes in a bioartificial liver. Cell Transplant. 12: 109-121 (2003).
Matsuzawa J, Sugimura K, Matsuda Y, Takazoe M, Ishizuka K, Mochizuki T, Seki SS, Yoneyama O, Bannnai H, Suzuki K, Honma T, Asakura H. Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut 52: 75-78 (2003). *
Matta H, Sun Q, Moses G, Chaudhary PM. Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-kappaB activation. J. Biol. Chem. 278: 52406-52411 (2003). *
Mattiuz EL, Ponsler GD, Barbuch RJ, Wood PG, Mullen JH, Shugert RL, Li Q, Wheeler WJ, Kuo F, Conrad PC, Sauer JM. Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog. Drug Metab. Dispos. 31: 88-97 (2003). *
Matysiak-Budnik T, Candalh C, Dugave C, Namane A, Cellier C, Cerf-Bensussan N, Heyman M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology 125: 696-707 (2003). *
Maxwell KN, Soccio RE, Duncan EM, Sehayek E, Breslow JL. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid Res. 44: 2109-2119 (2003). *
May A, Nachbar L, Wardak A, Yamamoto H, Ell C. Double-balloon enteroscopy: preliminary experience in patients with obscure gastrointestinal bleeding or chronic abdominal pain. Endoscopy 35: 985-991 (2003).
Mayer J, Meese EU. Presence of dUTPase in the various human endogenous retrovirus K (HERV-K) families. J. Mol. Evol. 57: 642-649 (2003). *
Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J. Immunol. 171: 4837-4843 (2003). *
Mayer L. Mucosal immunity. Pediatrics 111: 1595-1600 (2003). *
Mayer L. Redefining autoimmunity. Gastroenterology 125: 1574 (2003). *
Mayo MJ. Primary biliary cirrhosis: the future. Clin. Liver Dis. 7: 957-969 (2003).
Mazur W, Gonciarz M, Kajdy M, Mazurek U, Jurzak M, Wilczok T, Gonciarz Z. Blood serum glutathione alpha S-transferase (alpha GST) activity during antiviral therapy in patients with chronic hepatitis C. Med. Sci. Monit. 9 Suppl. 3: 44-48 (2003).
Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, van de Wal Y, Kooy Y, Koning F, Auricchio S, Troncone R. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 52: 57-62 (2003). *
Mazzon E, Cuzzocrea S. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis. Cell. Mol. Biol. (Noisy-le-grand) 49: 45-57 (2003).
McAlister VC, Badovinac K, Fenton SS, Greig PD. Transplantation in Canada: review of the last decade from the Canadian Organ Replacement Register. Clin. Transpl. 2003: 101-108 (2003).
McCafferty MH. Advances in the surgical treatment of colon and rectal cancer. J. Ky. Med. Assoc. 101: 394-401 (2003).
McClain KL, Laud P, Wu WS, Pollack MS. Langerhans cell histiocytosis patients have HLA Cw7 and DR4 types associated with specific clinical presentations and no increased frequency in polymorphisms of the tumor necrosis factor alpha promoter. Med. Pediatr. Oncol. 41: 502-507 (2003). *
McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70: 253-257 (2003). *
McClean P, Davison SM. Neonatal liver failure. Semin. Neonatol. 8: 393-401 (2003).
McCluskey J, Kanaan C, Diviney M. Nomenclature and serology of HLA class I and class II alleles. Curr. Protoc. Immunol. Appendix 1: 1S (2003).
McCole DF, Barrett KE. Epithelial transport and gut barrier function in colitis. Curr. Opin. Gastroenterol. 19: 578-582 (2003).
McCullough ML, Robertson AS, Chao A, Jacobs EJ, Stampfer MJ, Jacobs DR, Diver WR, Calle EE, Thun MJ. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control 14: 959-970 (2003). *
McCune CA, Ravine D, Worwood M, Jackson HA, Evans HM, Hutton D. Screening for hereditary haemochromatosis within families and beyond. Lancet 362: 1897-1898 (2003). *
McDiarmid SV, Anand R; SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report. Clin. Transpl. 2003: 119-130 (2003).
McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R. Alopecia areata susceptibility in rodent models. J. Investig. Dermatol. Symp. Proc. 8: 182-187 (2003). *
McFarland EG. Another new look at the small bowel: feasibility of three-dimensional magnetic resonance imaging to evaluate Crohn's disease. Inflamm. Bowel Dis. 9: 134-135 (2003). *
McFarlane IG. Autoimmune markers and their role in the pathogenesis of PSC. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 70. October 15-16 (2003). *
McGovern DP, van Heel DA, Negoro K, Ahmad T, Jewell DP. Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. Am. J. Hum. Genet. 73: 1465-1466 (2003). *
McGrath K, Slivka A. Gastroenterologic emergencies: diagnosis and management. Gastroenterol. Clin. N. Am. 32: xi-xii (2003). *
McGrath-Hanna NK, Greene DM, Tavernier RJ, Bult-Ito A. Diet and mental health in the Arctic: is diet an important risk factor for mental health in circumpolar peoples? - a review. Int. J. Circumpolar Health 62: 228-241 (2003).
McGuire JJ. Anticancer antifolates: current status and future directions. Curr. Pharm. Des. 9: 2593-2613 (2003).
McInnis MG, Lan TH, Willour VL, McMahon FJ, Simpson SG, Addington AM, MacKinnon DF, Potash JB, Mahoney AT, Chellis J, Huo Y, Swift-Scanlan T, Chen H, Koskela R, Stine OC, Jamison KR, Holmans P, Folstein SE, Ranade K, Friddle C, Botstein D, Marr T, et al. Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol. Psychiatry 8: 288-298 (2003). *
McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361: 1671-1676 (2003). *
McLeod RS. Surgery for inflammatory bowel diseases. Dig. Dis. 21: 168-179 (2003).
McManus R, Kelleher D. Celiac disease - the villain unmasked? N. Engl. J. Med. 348: 2573-2574 (2003). *
McMillan L, Butcher SK, Pongracz J, Lord JM. Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br. J. Cancer 88: 748-753 (2003). *
McMinn JR Jr, Cohen S, Moore J, Lilly S, Parkhurst J, Tarantino MD, Terrell DR, George JN. Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am. J. Hematol. 73: 135-140 (2003). *
McRae CA, Prince MI, Hudson M, Day CP, James OF, Jones DE. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology 125: 591-596 (2003). *
McShane D, Davies JC, Davies MG, Bush A, Geddes DM, Alton EW. Airway surface pH in subjects with cystic fibrosis. Eur. Respir. J. 21: 37-42 (2003). *
Mealey KL, Northrup NC, Bentjen SA. Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. J. Am. Vet. Med. Assoc. 223: 1453-1455, 1434 (2003).
Mebius RE. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3: 292-303 (2003). *
Medina JF, Recalde S, Prieto J, Lecanda J, Saez E, Funk CD, Vecino P, van Roon MA, Ottenhoff R, Bosma PJ, Bakker CT, Oude Elferink RP. Anion exchanger 2 is essential for spermiogenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 100: 15847-15852 (2003). *
Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res. 92: 1254-1261 (2003). *
Megraud F. Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What's new? Can. J. Gastroenterol. 17 Suppl. B: 49B-52B (2003).
Megraud F, Lamouliatte H. Review article: the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 17: 1333-1343 (2003). *
Mehling A, Beissert S. Dendritic cells under investigation in autoimmune disease. Crit. Rev. Biochem. Mol. Biol. 38: 1-21 (2003). *
Mehra NK, Kaur G. MHC-based vaccination approaches: progress and perspectives. Expert Rev. Mol. Med. 5: 1-17 (2003).
Mehta DS, Wurster AL, Whitters MJ, Young DA, Collins M, Grusby MJ. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170: 4111-4118 (2003). *
Meier R, Burri E, Steuerwald M. The role of nutrition in diarrhoea syndromes. Curr. Opin. Clin. Nutr. Metab. Care 6: 563-567 (2003).
Meier-Abt PJ. Transport and metabolic functions. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 21-22. October 20 - 21 (2003). *
Mekus F, Laabs U, Veeze H, Tummler B. Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs. Hum. Genet. 112: 1-11 (2003). *
Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment. Pharmacol. Ther. 17: 857-870 (2003). *
Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin. Exp. Immunol. 134: 127-137 (2003). *
Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, Cucchiara S, Andria G. Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr. 92: 1415-1421 (2003). *
Mellai M, Giordano M, D'Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, Leone M, Ferro I, Liguori M, Trojano M, Ballerini C, Massacesi L, Cannoni S, Bomprezzi R, Momigliano-Richiardi P. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum. Immunol. 64: 274-284 (2003).
Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170: 1406-1415 (2003). *
Mendez-Sanchez N, Chavez-Tapia NC, Uribe M. New molecular features of cholestatic diseases of the liver. Rev. Invest. Clin. 55: 546-556 (2003).
Mendez-Sanchez N, Motola-Kuba D, Bahena-Aponte J, Chavez-Tapia N, Pichardo-Bahena R, Uribe M. Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report. Ann. Hepatol. 2: 183-185 (2003). *
Mendez-Sanchez N, Vega R, Cortes R, Corona R, Pichardo-Bahena R, Uribe M. Hepatic Echinococcus granulosus. A case report. Ann. Hepatol. 2: 99-100 (2003). *
Mendonca CO, Burden AD. Current concepts in psoriasis and its treatment. Pharmacol. Ther. 99: 133-147 (2003).
Mendoza JL, Murillo LS, Fernandez L, Pena AS, Lana R, Urcelay E, Cruz-Santamaria DM, de la Concha EG, Diaz-Rubio M, Garcia-Paredes J. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand. J. Gastroenterol. 38: 1235-1240 (2003). *
Mendoza ME, Monte MJ, Serrano MA, Pastor-Anglada M, Stieger B, Meier PJ, Medarde M, Marin JJ. Physiological characteristics of allo-cholic acid. J. Lipid Res. 44: 84-92 (2003). *
Meneu-Diaz JC, Moreno Gonzalez E, Moreno Elola-Olaso A, Lopez EV, Nuno Vazquez J, Jimenez C, Turrion V, Loinaz C, Gomez R, Abradelo M. Liver recipients undergoing hepatic transplantation and subsequent retransplantation: a comparison between clinical characteristics. Hepatogastroenterology 50: 2143-2148 (2003).
Menon KV, Angulo P, Boe GM, Lindor KD. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis. Am. J. Gastroenterol. 98: 889-892 (2003). *
Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, Asnafi V, Colombel JF, Cugnenc PH, Ruemmele FM, McIntyre E, Brousse N, Cellier C, Cerf-Bensussan N. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125: 730-745 (2003). *
Merendino RA, Di Pasquale G, Sturniolo GC, Ruello A, Albanese V, Minciullo PL, Di Mauro S, Gangemi S. Relationship between IL-18 and sICAM-1 serum levels in patients affected by coeliac disease: preliminary considerations. Immunol. Lett. 85: 257-260 (2003).
Merger M, Herfarth H, Scholmerich J, Andus T, Farber L. Discussion on the biologic therapy of inflammatory bowel disease. Gastroenterology 124: 2005-2006 (2003).
Merlin JL, Gautier H, Barberi-Heyob M, Teiten MH, Guillemin F. The multidrug resistance modulator SDZ-PSC 833 potentiates the photodynamic activity of chlorin e6 independently of P-glycoprotein in multidrug resistant human breast adenocarcinoma cells. Int. J. Oncol. 22: 733-739 (2003). *
Merlo CA, Boyle MP. Modifier genes in cystic fibrosis lung disease. J. Lab. Clin. Med. 141: 237-241 (2003). *
Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, Miller A, McHugh PJ, Chapman RW, Pointon JJ, Wimhurst VL, Livesey KJ, Tanphaichitr V, Rochette J, Robson KJ. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 12: 2241-2247 (2003). *
Mertz HR. Functional disorders of the gastrointestinal tract. Preface. Gastroenterol. Clin. North Am. 32: xi-xii (2003). *
Mesotten D, Van den Berghe G, Liddle C, Coulter S, McDougall F, Baxter RC, Delhanty PJ. Growth hormone modulation of the rat hepatic bile transporter system in endotoxin-induced cholestasis. Endocrinology 144: 4008-4017 (2003). *
Messini F. Helicobacter pylori and hepatobiliary diseases. Clin. Ter. 154: 55-56 (2003).
Mete N, Yilmaz F, Gulbahar O, Aydin A, Sin A, Kokuludag A, Yuce G, Sebik F. Allopurinol hypersensitivity syndrome as a cause of hepatic centrilobular hemorrhagic necrosis. J. Investig. Allergol. Clin. Immunol. 13: 281-283 (2003).
Meyenberger Ch, Fantin AC. Biliary stents. Ther. Umsch. 60: 225-232 (2003).
Meyer O. Evaluating inflammatory joint disease: how and when can autoantibodies help? Joint Bone Spine 70: 433-447 (2003).
Meyers RL, Book LS, O'Gorman MA, Jackson WD, Black RE, Johnson DG, Matlak ME. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J. Pediatr. Surg. 38: 406-411 (2003). *
Mi LZ, Devarakonda S, Harp JM, Han Q, Pellicciari R, Willson TM, Khorasanizadeh S, Rastinejad F. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol. Cell 11: 1093-1100 (2003). *
Miakotkin VA, Moshnina MA, Krylov MIu, Guseva IA, Sharapova EP, Alekseeva LI. A search for genes of predisposition to rheumatoid arthritis. Vestn. Ross. Akad. Med. Nauk. 7: 27-30 (2003).
Mic FA, Molotkov A, Benbrook DM, Duester G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc. Natl. Acad. Sci. U.S.A. 100: 7135-7140 (2003). *
Michalik L, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member. Curr. Opin. Lipidol. 14: 129-135 (2003).
Michalska Z, Radowska D, Staike P, Sikorska K, Lakomy A, Witczak-Malinowska K, Bakowska A, Stolarczyk J, Trocha H, Pawiak A, Kowalik M. Autoimmune hepatitis in the material of Department and Regional Hospital of Infectious Diseases in Gdansk. Med. Sci. Monit. 9 Suppl. 3: 49-54 (2003).
Micheau O. Cellular FLICE-inhibitory protein: an attractive therapeutic target? Expert Opin. Ther. Targets 7: 559-573 (2003).
Michel O, LeVan TD, Stern D, Dentener M, Thorn J, Gnat D, Beijer ML, Cochaux P, Holt PG, Martinez FD, Rylander R. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in human beings. J. Allergy Clin. Immunol. 112: 923-929 (2003). *
Micu AL, Miksys S, Sellers EM, Koop DR, Tyndale RF. Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism. J. Pharmacol. Exp. Ther. 306: 941-947 (2003). *
Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 103: 455-465 (2003). *
Miehsler W, Gasche C. Standard therapy of Crohn's disease. Dig. Dis. 21: 146-156 (2003).
Mieli-Vergani G, Mowat A. Primary sclerosing cholangitis in pediatrics: what is different? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 79. October 15-16 (2003). *
Mieli-Vergani G, Vergani D. Autoimmune liver disease in children. Ann. Acad. Med. Singapore 32: 239-243 (2003). *
Mikamo E, Harada S, Nishikawa J, Nishihara T. Endocrine disruptors induce cytochrome P450 by affecting transcriptional regulation via pregnane X receptor. Toxicol. Appl. Pharmacol. 193: 66-72 (2003). *
Mikuls TR, Weaver AL. Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis. Curr. Rheumatol. Rep. 5: 270-277 (2003).
Miles EA, Aston L, Calder PC. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures. Clin. Exp. Allergy 33: 624-632 (2003). *
Milkiewicz P, Chilton AP, Hubscher SG, Elias E. Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Gut 52: 300-303 (2003). *
Milkiewicz P, Gallagher R, Chambers J, Eggington E, Weaver J, Elias E. Obstetric cholestasis with elevated gamma glutamyl transpeptidase: incidence, presentation and treatment. J. Gastroenterol. Hepatol. 18: 1283-1286 (2003). *
Millatt LJ, Bocher V, Fruchart JC, Staels B. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochim. Biophys. Acta 1631: 107-118 (2003). *
Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann. Surg. 238: 697-702 (2003). *
Miller KK. Mechanisms by which nutritional disorders cause reduced bone mass in adults. J. Womens Health (Larchmt.) 12: 145-150 (2003).
Mills CC, Amin M, Manisali M. Salivary duct fistula and recurrent buccal space infection: a complication of Crohn's disease. J. Oral Maxillofac. Surg. 61: 1485-1487 (2003).
Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H. Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur. J. Haematol. 71: 403-407 (2003). *
Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin. Genet. 64: 36-47 (2003). *
Milovic V, Turchanowa L. Polyamines and colon cancer. Biochem. Soc. Trans. 31: 381-383 (2003). *
Mimouni D, Anhalt GJ, Kouba DJ, Nousari HC. Infliximab for peristomal pyoderma gangrenosum. Br. J. Dermatol. 148: 813-816 (2003). *
Min KM, Kim PH. Macrophage-derived TGF-beta1 induces IgA isotype expression. Mol. Cells 16: 245-250 (2003). *
Minagar A, Long A, Ma T, Jackson TH, Kelley RE, Ostanin DV, Sasaki M, Warren AC, Jawahar A, Cappell B, Alexander JS. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10: 299-307 (2003).
Mindikoglu AL, Anantharaju A, Hartman GG, Li SD, Villanueva J, Van Thiel DH. Prochlorperazine-induced cholestasis in a patient with alpha-1 antitrypsin deficiency. Hepatogastroenterology 50: 1338-1340 (2003).
Miniello S, Nacchiero M, Testini M, Tomasicchio N, Cristallo G, Lissidini G, Bonomo GM. Urgent ulcerative colitis: our experience. Ann. Ital. Chir. 74: 547-553 (2003).
Minuk GY. Hepatic regeneration: if it ain't broke, don't fix it. Can. J. Gastroenterol. 17: 418-424 (2003). *
Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48: 594-601 (2003). *
Miquel C, Fourquier P, P De Saint-Maur P, Prevot S. A complicated ulcerative colitis. Ann. Pathol. 23: 451-452 (2003).
Mira MT, Alcais A, di Pietrantonio T, Thuc NV, Phuong MC, Abel L, Schurr E. Segregation of HLA/TNF region is linked to leprosy clinical spectrum in families displaying mixed leprosy subtypes. Genes Immun. 4: 67-73 (2003). *
Mircheff AK. Sjogrens syndrome as failed local immunohomeostasis: prospects for cell-based therapy. Ocul. Surf. 1: 160-179 (2003).
Miron D, Fink D, Hashkes PJ. Kawasaki disease in an infant following immunisation with hepatitis B vaccine. Clin. Rheumatol. 22: 461-463 (2003). *
Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J, Mansfield J, Donaldson P, Macpherson AJ, Forbes A, Schreiber S, Lewis CM, Mathew CG. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am. J. Hum. Genet. 72: 1018-1022 (2003). *
Misra S, Varticovski L, Arias IM. Mechanisms by which cAMP increases bile acid secretion in rat liver and canalicular membrane vesicles. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G316-G324 (2003). *
Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet 361: 1447-1455 (2003). *
Miura S, Yoshioka T, Furuichi K, Tanaka T, Kichikawa K, Ohishi H. Mechanical properties of biliary metallic stents: an experimental comparison. Nippon Igaku Hoshasen Gakkai Zasshi 63: 201-209 (2003).
Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, Shibuya A, Amaki S, Miyakawa H. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J. Autoimmun. 20: 247-254 (2003). *
Miyakawa H, Kawashima Y, Kitazawa E, Kawaguchi N, Kato T, Kikuchi K, Imai E, Fujikawa H, Hashimoto E, Schlumberger W. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J. Autoimmun. 21: 77-82 (2003). *
Miyamoto M, Haruma K, Yoshihara M, Hiyama T, Sumioka M, Nishisaka T, Tanaka S, Chayama K. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig. Dis. Sci. 48: 968-975 (2003). *
Miyata M. Functional analysis of drug metabolizing enzymes using gene knockout animals. Yakugaku Zasshi 123: 569-576 (2003).
Miyazono K, Suzuki H, Imamura T. Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci. 94: 230-234 (2003). *
Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm. Bowel Dis. 9: 246-259 (2003). *
Mizoguchi E, Xavier RJ, Reinecker HC, Uchino H, Bhan AK, Podolsky DK, Mizoguchi A. Colonic epithelial functional phenotype varies with type and phase of experimental colitis. Gastroenterology 125: 148-161 (2003). *
Mizuta Y, Isomoto H, Kadokawa Y, Akazawa Y, Chin S, Kanazawa Y, Takeshima F, Omagari K, Murase K, Sawai T, Nakagoe T, Murata I, Kohno S. Immune thrombocytopenic purpura in patients with ulcerative colitis. J. Gastroenterol. 38: 884-890 (2003). *
Mochizuki M, Amemiya S, Kobayashi K, Kobayashi K, Shimura Y, Ishihara T, Nakagomi Y, Onigata K, Tamai S, Kasuga A, Nanazawa S. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 26: 843-847 (2003). *
Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann. Pharmacother. 37: 1622-1624 (2003).
Mohamed HS, Ibrahim ME, Miller EN, Peacock CS, Khalil EA, Cordell HJ, Howson JM, El Hassan AM, Bereir RE, Blackwell JM. Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun. 4: 351-355 (2003). *
Mohan MP, Ramesh TC. Multiple autoimmune syndrome. Indian J. Dermatol. Venereol. Leprol. 69: 298-299 (2003). *
Mohan R, Heyman RA. Orphan nuclear receptor modulators. Curr. Top. Med. Chem. 3: 1637-1647 (2003).
Mohr L. Suicide gene therapy. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 44. October 20 - 21 (2003). *
Mohty M, Morbelli S, Isnardon D, Sainty D, Arnoulet C, Gaugler B, Olive D. All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells. Br. J. Haematol. 122: 829-836 (2003).
Mok JW, Lee YJ, Kim JY, Lee EB, Song YW, Park MH, Park KS. Association of MICA polymorphism with rheumatoid arthritis patients in Koreans. Hum. Immunol. 64: 1190-1194 (2003).
Molberg O, Solheim Flaete N, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, Kjersti Uhlen A, Sollid LM. Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology 125: 337-344 (2003). *
Moles JP, Hadi JC, Guilhou JJ. High prevalence of an IgG response against murine leukemia virus (MLV) in patients with psoriasis. Virus Res. 94: 97-101 (2003). *
Molina MF, Sanchez-Reus I, Iglesias I, Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol. Pharm. Bull. 26: 1398-1402 (2003). *
Moller DE, Berger JP. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3: S17-S21 (2003).
Molmenti EP, Squires RH, Nagata D, Roden JS, Molmenti H, Fasola CG, Prestidge C, D'Amico L, Casey D, Sanchez EQ, Goldstein RM, Levy MF, Benser M, McPhail W, Andrews W, Andersen JA, Klintmalm GB. Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr. Transplant. 7: 93-97 (2003). *
Molnar B, Sipos F, Galamb O, Tulassay Z. Molecular detection of circulating cancer cells. Role in diagnosis, prognosis and follow-up of colon cancer patients. Dig. Dis. 21: 320-325 (2003).
Molotkov A, Duester G. Genetic evidence that retinaldehyde dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol dehydrogenase Adh1 in metabolism of retinol to retinoic acid. J. Biol. Chem. 278: 36085-36090 (2003). *
Mombo LE, Lu CY, Ossari S, Bedjabaga I, Sica L, Krishnamoorthy R, Lapoumeroulie C. Mannose-binding lectin alleles in sub-Saharan Africans and relation with susceptibility to infections. Genes Immun. 4: 362-367 (2003). *
Monteiro RC, Van De Winkel JG. IgA Fc receptors. Annu. Rev. Immunol. 21: 177-204 (2003). *
Monteleone G, Holloway J, Salvati VM, Pender SL, Fairclough PD, Croft N, MacDonald TT. Activated STAT4 and a functional role for IL-12 in human Peyer's patches. J. Immunol. 170: 300-307 (2003). *
Montgomery SM, Wakefield AJ, Ekbom A. Sex-specific risks for pediatric onset among patients with Crohn's disease. Clin. Gastroenterol. Hepatol. 1: 303-309 (2003). *
Moody DB, Porcelli SA. Intracellular pathways of CD1 antigen presentation. Nat. Rev. Immunol. 3: 11-22 (2003).
Moody JL, Pereira CG, Magil A, Fritzler MJ, Jirik FR. Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice. Genes Immun. 4: 60-66 (2003). *
Moon C, Soria JC, Jang SJ, Lee J, Obaidul Hoque M, Sibony M, Trink B, Chang YS, Sidransky D, Mao L. Involvement of aquaporins in colorectal carcinogenesis. Oncogene 22: 6699-6703 (2003). *
Moore JT, Moore LB, Maglich JM, Kliewer SA. Functional and structural comparison of PXR and CAR. Biochim. Biophys. Acta 1619: 235-238 (2003). *
Moore PK, Marshall M. Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig. Liver Dis. 35 Suppl. 2: S49-S60 (2003).
Moorman PG, Grubber JM, Millikan RC, Newman B. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14: 915-922 (2003). *
Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am. J. Gastroenterol. 98: 2594-2604 (2003). *
Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC, Cipolletta E, Mazzilli MC. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum. Immunol. 64: 297-301 (2003).
Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424: 88-93 (2003). *
Morelli MS, Zucker SD. A role for the appendix in inflammatory bowel disease? Cut it out. Gastroenterology 125: 1270-1272 (2003). *
Moreno C, Sanchez-Ibarrola A. Toll type receptors: molecular bases of the relationship between innate and adaptation responses of the immune system. Rev. Med. Univ. Navarra 47: 29-33 (2003).
Moreno M, Molina H, Amigo L, Zanlungo S, Arrese M, Rigotti A, Miquel JF. Hepatic overexpression of caveolins increases bile salt secretion in mice. Hepatology 38: 1477-1488 (2003). *
Morgenstern I, Raijmakers MT, Peters WH, Hoensch H, Kirch W. Homocysteine, cysteine, and glutathione in human colonic mucosa: elevated levels of homocysteine in patients with inflammatory bowel disease. Dig. Dis. Sci. 48: 2083-2090 (2003). *
Mori T, Ono K, Hakozaki M, Kochi H. Epitope mapping on E1alpha subunit of pyruvate dehydrogenase complex with autoantibodies of patients with primary biliary cirrhosis. Liver Int. 23: 355-362 (2003). *
Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med. 35: 772-781 (2003).
Morini S, Hassan C, Lorenzetti R, Zullo A, Cerro P, Winn S, Giustini M, Taggi F. Long-term outcome of endoscopic pneumatic dilatation in Crohn's disease. Dig. Liver Dis. 35: 893-897 (2003).
Morishita A, Murota M, Fujita J, Wu F, Kurokohchi K, Masaki T, Arima K, Watanabe S, Kuriyama S. Autoreactive helper T cells specific for cytokeratin 19 in patients with autoimmune hepatitis. Hepatol. Res. 25: 415-422 (2003).
Moro MA, Hurtado O, Cardenas A, Romera C, Madrigal JL, Fernandez-Tome P, Leza JC, Lorenzo P, Lizasoain I. Expression and function of tumour necrosis factor-alpha-converting enzyme in the central nervous system. Neurosignals 12: 53-58 (2003).
Morpurgo E, Petras R, Kimberling J, Ziegler C, Galandiuk S. Characterization and clinical behavior of Crohn's disease initially presenting predominantly as colitis. Dis. Colon Rectum 46: 918-924 (2003).
Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag HB, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann. Intern. Med. 138: 627-633 (2003). *
Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174 (2003). *
Moses S. Pruritus. Am. Fam. Physician 68: 1135-1142 (2003). *
Motamed M, Laugharne D, Bradley PJ. Management of chronic parotitis: a review. J. Laryngol. Otol. 117: 521-526 (2003).
Motiwala AS, Strother M, Amonsin A, Byrum B, Naser SA, Stabel JR, Shulaw WP, Bannantine JP, Kapur V, Sreevatsan S. Molecular epidemiology of Mycobacterium avium subsp. paratuberculosis: evidence for limited strain diversity, strain sharing, and identification of unique targets for diagnosis. J. Clin. Microbiol. 41: 2015-2026 (2003). *
Motojima K, Seto K. Fibrates and statins rapidly and synergistically induce pyruvate dehydrogenase kinase 4 mRNA in the liver and muscles of mice. Biol. Pharm. Bull. 26: 954-958 (2003). *
Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170: 3939-3943 (2003). *
Mottino AD, Veggi LM, Wood M, Roman JM, Vore M. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis. J. Pharmacol. Exp. Ther. 307: 306-313 (2003). *
Mottram PL. Past, present and future drug treatment for rheumatoid arthritis and systemic lupus erythematosus. Immunol. Cell. Biol. 81: 350-353 (2003). *
Moum B. 5-Aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease. Tidsskr. Nor. Laegeforen. 123: 2565-2567 (2003).
Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3: 331-341 (2003). *
Mowat AM. Coeliac disease - a meeting point for genetics, immunology, and protein chemistry. Lancet 361: 1290-1292 (2003). *
Mowat AM, Donachie AM, Parker LA, Robson NC, Beacock-Sharp H, McIntyre LJ, Millington O, Chirdo F. The role of dendritic cells in regulating mucosal immunity and tolerance. Novartis Found. Symp. 252: 291-302 (2003).
Moxon DR, Hong K, Brown RD, Venu RP. Selective intrahepatic ductal cannulation during ERCP with a sphincterotome. Gastrointest. Endosc. 57: 738-743 (2003). *
Mpandi M, Otten LA, Lavanchy C, Acha-Orbea H, Finke D. Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle. J. Virol. 77: 9369-9377 (2003). *
Muckenthaler M, Roy CN, Custodio AO, Minana B, deGraaf J, Montross LK, Andrews NC, Hentze MW. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34: 102-107 (2003). *
Mudter J, Neurath MF. The role of signal transducers and activators of transcription in T inflammatory bowel diseases. Inflamm. Bowel Dis. 9: 332-337 (2003). *
Mudter J, Neurath MF. Mucosal T cells: mediators or guardians of inflammatory bowel disease? Curr. Opin. Gastroenterol. 19: 343-349 (2003).
Mudter J, Wirtz S, Galle PR, Neurath MF. A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis. Pathobiology 70: 170-176 (2003).
Mugnier B, Balandraud N, Darque A, Roudier C, Roudier J, Reviron D. Polymorphism at position -308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis. Arthritis Rheum. 48: 1849-1852 (2003). *
Muhlfeld A, Kubitz R, Dransfeld O, Haussinger D, Wettstein M. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. Arch. Biochem. Biophys. 413: 32-40 (2003). *
Mukherjee KK, Chhabra R, Khosla VK. Raised intracranial pressure in hepatic encephalopathy. Indian J. Gastroenterol. 22 Suppl. 2: S62-S65 (2003).
Mulcahy G, O'Neill S, Donnelly S, Dalton JP. Helminths at mucosal barriers - interaction with the immune system. Adv. Drug Deliv. Rev. 56: 853-868 (2003). *
Mulinari-Brenner F, Bergfeld WF. Hair loss: diagnosis and management. Cleve. Clin. J. Med. 70: 705-706, 709-710, 712 (2003). *
Mullenbach R, Linton KJ, Wiltshire S, Weerasekera N, Chambers J, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J. Med. Genet. 40: e70 (2003). *
Muller H, Plasilova M, Russell AM, Heinimann K. Genetic predisposition as a basis for chemoprevention, surgical and other interventions in colorectal cancer. Recent Results Cancer Res. 163: 235-247 (2003).
Muller M, Kersten S. Nutrigenomics: goals and strategies. Nat. Rev. Genet. 4: 315-322 (2003). *
Muller O. Identification of colon cancer patients by molecular diagnosis. Dig. Dis. 21: 315-319 (2003).
Mullhaupt B, Kullak-Ublick GA, Ambuhl PM, Stocker R, Renner EL. Successful use of the Molecular Adsorbent Recirculating System (MARS) in a patient with primary biliary cirrhosis (PBC) and treatment refractory pruritus. Hepatol. Res. 25: 442-446 (2003).
Munakata W, Liu Q, Shimoyama T, Sawaya M, Umeda T, Sugawara K. Ecabet sodium attenuates reactive oxygen species produced by neutrophils after priming with bacterial lipopolysaccharides. Luminescence 18: 330-333 (2003). *
Mungall AJ, Palmer SA, Sims SK, Edwards CA, Ashurst JL, Wilming L, Jones MC et al. The DNA sequence and analysis of human chromosome 6. Nature 425: 805-811 (2003). *
Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther. 18 Suppl. 2: 1-5 (2003). *
Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am. J. Gastroenterol. 98: 431-437 (2003). *
Muratori P, Muratori L, Guidi M, Maccariello S, Pappas G, Ferrari R, Gionchetti P, Campieri M, Bianchi FB. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin. Exp. Immunol. 132: 473-476 (2003). *
Murillo LS, Morre SA, Pena AS. Role of the CARD15 gene in the pathogenesis of Crohn disease: phenotypic classification and prognostic implications. Scand. J. Gastroenterol. 38: 1107-1114 (2003). *
Murillo LS, Morre SA, Pena AS. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today (Barc.) 39: 415-438 (2003).
Murota M, Watanabe S, Fujita J, Ohtsuki Y, Wu F, Yoshida S, Kita Y, Funakoshi F, Masaki T, Kurokohchi K, Uchida N, Ishida T, Kuriyama S. Aberrant cytokeratin expression and high susceptibility to apoptosis in autoimmune hepatitis. Hepatol. Res. 25: 271-280 (2003).
Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957 (2003). *
Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology 125: 1492-1502 (2003). *
Murray KF, Lam D, Kowdley KV. Current and future therapy in haemochromatosis and Wilson's disease. Expert Opin. Pharmacother. 4: 2239-2251 (2003).
Murumagi A, Vahamurto P, Peterson P. Characterization of regulatory elements and methylation pattern of the autoimmune regulator (AIRE) promoter. J. Biol. Chem. 278: 19784-19790 (2003). *
Musialik J, Michalkiewicz J, Petelenz M, Mazurek U, Mazur W, Madalinski K, Gonciarz Z. Reduction of CD45RA isoform expression and decrease in CD4 and CD8 receptor density in lymphocytes of patients with primary biliary cirrhosis. Scand. J. Gastroenterol. 38: 421-426 (2003). *
Muto M, Ohmura A, Hamamoto Y, Konishi Y, Shiozawa S, Youn JI, Tanifuji J, Furuya K, Sasazuki T, Ogawa H. Generalized pustular psoriasis: strategy for identification of psoriasis susceptibility gene. Arch. Dermatol. Res. 295 Suppl. 1: S60-S62 (2003). *
Muzes G. Possible role of mucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases. Orv. Hetil. 144: 1441-1446 (2003).
Nagata Y, Uto H, Hasuike S, Ido A, Hayashi K, Eto T, Hamakawa T, Tanaka K, Tsubouchi H. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease. Intern. Med. 42: 967-970 (2003). *
Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C. The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J. Allergy Clin. Immunol. 112: 729-734 (2003). *
Nagy J, Vincze Z, Folhoffer A, Horvath A, Csak T, Zelko R. Pathogenesis and treatment of Wilson's disease. Acta Pharm. Hung. 73: 237-241 (2003).
Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann. Pharmacother. 37: 1256-1265 (2003).
Nahon S, Lahmek P, Massard J, Lesgourgues B, Mariaud de Serre N, Traissac L, Bodiguel V, Adotti F, Delas N. Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association? Helicobacter 8: 573-577 (2003). *
Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol. Pharmacol. 63: 732-741 (2003). *
Naito T, Ogasawara H, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Maruyama N. Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J. Clin. Immunol. 23: 371-376 (2003). *
Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T, Yoshida N, Minami M, Kita M, Imanishi J, Yoshikawa T. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J. Gastroenterol. Hepatol. 18: 560-569 (2003). *
Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J. Am. Acad. Dermatol. 48: 805-821 (2003).
Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171: 6173-6177 (2003). *
Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U.S.A. 100: 5986-5990 (2003). *
Nakagawa N, Osanai S, Ide H, Nishigaki Y, Takahashi S, Nakano H, Ohsaki Y, Kikuchi K, Tokusashi Y, Obata H. Severe pulmonary hypertension associated with primary Sjogren's syndrome. Intern. Med. 42: 1248-1252 (2003). *
Nakagawa T, Ma BY, Uemura K, Oka S, Kawasaki N, Kawasaki T. Role of mannan-binding protein, MBP, in innate immunity. Anticancer Res. 23: 4467-4471 (2003).
Nakajima A, Katayama K, Mayumi T. PPARgamma-gene therapy using an adenovirus vector for inflammatory bowel disease. Nippon Yakurigaku Zasshi 122: 309-316 (2003).
Nakajima T, Yamanoshita O, Kamijima M, Kishi R, Ichihara G. Generalized skin reactions in relation to trichloroethylene exposure: a review from the viewpoint of drug-metabolizing enzymes. J. Occup. Health 45: 8-14 (2003). *
Nakamura RM, Matsutani M, Barry M. Advances in clinical laboratory tests for inflammatory bowel disease. Clin. Chim. Acta 335: 9-20 (2003). *
Nakamura T, Nakamura R, Maruyama K, Fukazawa A, Uno A, Hayashi T, Higashi Y, Hosoda Y, Nakamura S. Refractory ulcerative colitis complicated by a cytomegaloviral infection requiring surgery: report of a case. Surg. Today. 34: 68-71 (2003).
Nakamura T, Suzuki Y, Koide H. Granulocyte and monocyte adsorption apheresis in a patient with antiglomerular basement membrane glomerulonephritis and active ulcerative colitis. Am. J. Med. Sci. 325: 296-398 (2003).
Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. Hyperhomocystinemia in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 37: 586-590 (2003). *
Nakanuma Y. Are esophagogastric varices a late manifestation in primary biliary cirrhosis? J. Gastroenterol. 38: 1110-1112 (2003). *
Nakase H, Okazaki K, Tabata Y, Chiba T. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. J. Gastroenterol. 38 Suppl. 15: 59-62 (2003).
Nakatsuka K, Nishizawa Y, Ralston SH. Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J. Bone Miner. Res. 18: 1381-1385 (2003).
Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, Nishimura Y. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem. Biophys. Res. Commun. 306: 16-25 (2003). *
Nakiri Y, Kaneko H, Morimoto S, Suzuki J, Tokano Y, Hashimoto H. Expression of NKB1 on peripheral T cells in patients with rheumatoid arthritis. Clin. Rheumatol. 22: 305-308 (2003). *
Nallani SC, Goodwin B, Maglich JM, Buckley DJ, Buckley AR, Desai PB. Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor. Drug Metab. Dispos. 31: 681-684 (2003). *
Namazi MR. Nicotinamide: a potential addition to the anti-psoriatic weaponry. FASEB J. 17: 1377-1379 (2003). *
Namkung W, Lee JA, Ahn W, Han W, Kwon SW, Ahn DS, Kim KH, Lee MG. Ca2+ activates cystic fibrosis transmembrane conductance regulator- and Cl--dependent HCO3 transport in pancreatic duct cells. J. Biol. Chem. 278: 200-207 (2003). *
Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr. Pract. 9: 307-309 (2003).
Nanavati SA, Ergun GA, Schwartz JT. Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis. Am. J. Gastroenterol. 98: 2333-2334 (2003). *
Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 284: G321-G327 (2003). *
Narang M, Penner JA, Williams D. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab). Am. J. Hematol. 74: 263-267 (2003). *
Naranjo-Rodriguez A, Solorzano-Peck G, Lopez-Rubio F, Calanas-Continente A, Galvez-Calderon C, Gonzalez-Galilea A, Hervas-Molina A. Isolated oesophageal involvement of Crohn's disease. Eur. J. Gastroenterol. Hepatol. 15: 1123-1126 (2003).
Narayanan BA, Narayanan NK, Simi B, Reddy BS. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res. 63: 972-979 (2003). *
Narisawa S, Huang L, Iwasaki A, Hasegawa H, Alpers DH, Millan JL. Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell Biol. 23: 7525-7530 (2003). *
Narisawa T, Fukaura Y. Prevention by intrarectal 5-aminosalicylic acid of N-methylnitrosourea-induced colon cancer in F344 rats. Dis. Colon Rectum 46: 900-903 (2003).
Narumiya S. Prostanoids in immunity: roles revealed by mice deficient in their receptors. Life Sci. 74: 391-395 (2003). *
Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 102: 2364-2372 (2003). *
Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, Dipersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol. Blood Marrow Transplant. 9: 583-591 (2003).
Natori S, Higuchi H, Contreras P, Gores GJ. The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl. 9: 278-284 (2003). *
Naumann UK, Kaser L, Vetter W. Ulcerative colitis. Schweiz. Rundsch. Med. Prax. 92: 1033-1035, 1062 (2003).
Naumann UK, Kaser L, Vetter W. Crohn disease. Schweiz. Rundsch. Med. Prax. 92: 933-935 (2003).
Navarro F, Hanauer SB. Treatment of inflammatory bowel disease: safety and tolerability issues. Am. J. Gastroenterol. 98: S18-S23 (2003). *
Nebreda J, Robert J, Pena M, Juan-Creix A, Charte A. Celiac colitis and ulcerative colitis. Rev. Esp. Enferm. Dig. 95: 813-814 (2003).
Neff GW, Montalbano M, Slapak-Green G, Meyer D, Berney T, Safdar K, Schiff ER, Tzakis AG. Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. Transplant. Proc. 35: 3029-3031 (2003).
Negoro K, McGovern DP, Kinouchi Y, Takahashi S, Lench NJ, Shimosegawa T, Carey A, Cardon LR, Jewell DP, van Heel DA. Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut 52: 541-546 (2003). *
Nejentsev S, Laaksonen M, Tienari PJ, Fernandez O, Cordell H, Ruutiainen J, Wikstrom J, Pastinen T, Kuokkanen S, Hillert J, Ilonen J. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum. Immunol. 64: 345-349 (2003).
Nelson G, Wilde GJ, Spiller DG, Kennedy SM, Ray DW, Sullivan E, Unitt JF, White MR. NF-kappaB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms. J. Cell. Sci. 116: 2495-2503 (2003). *
Nelson PN, Carnegie PR, Martin J, Davari Ejtehadi H, Hooley P, Roden D, Rowland-Jones S, Warren P, Astley J, Murray PG. Demystified. Human endogenous retroviruses. Mol. Pathol. 56: 11-18 (2003). *
Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461-2463 (2003). *
Nemetz A, Molnar T, Zagoni T, Kovacs A, Tulassay Z, Nagy F, Salvador Pena A. Phenotypes defined by the "Vienna Classification" in 100 Hungarian patients with Crohn's disease. Rev. Esp. Enferm. Dig. 95: 533-538, 527-533 (2003).
Nemoto T, Kubota K, Kita J, Shimoda M, Rokkaku K, Tagaya N, Fujiwara T, Sunakawa M. Unusual onset of chronic graft-versus-host disease after adult living-related liver transplantation from a homozygous donor. Transplantation 75: 733-736 (2003).
Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig. Liver Dis. 35: 571-576 (2003).
Nestel P. Metabolic syndrome: multiple candidate genes, multiple environmental factors - multiple syndromes? Int. J. Clin. Pract. Suppl. 134: 3-9 (2003).
Net M, Valero R, Almenara R, Deulofeu R, Lopez-Boado MA, Capdevila L, Barros P, Bombi JA, Agusti M, Adalia R, Ruiz A, Arce Y, Manyalich M, Garcia-Valdecasas JC. Hepatic preconditioning after prolonged warm ischemia by means of S-adenosyl-L-methionine administration in pig liver transplantation from non-heart-beating donors. Transplantation 75: 1970-1977 (2003).
Nettagul R, Visitsunthorn N, Vichyanond P. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies. J. Med. Assoc. Thai. 86: 686-692 (2003).
Neuberger J. Recurrence of autoimmune liver diseases after liver transplantation. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 47-48. September 12 - 13 (2003). *
Neuberger J. Liver transplantation for cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 113-121 (2003).
Neuberger J. Primary sclerosing cholangitis: indications for transplantation and recurrence. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 93-94. October 15-16 (2003). *
Neuberger J. Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence. J. Hepatol. 39: 142-148 (2003). *
Neuberger J. Liver transplantation for primary biliary cirrhosis. Autoimmun. Rev. 2: 1-7 (2003). *
Neuberger J. A healthy view of dying. BMJ 327: 207-208 (2003). *
Neuberger J. Recurrent primary biliary cirrhosis. Liver Transpl. 9: 539-546 (2003). *
Neuberger J, Farber L, Corrado M, O'Dell C. Living liver donation: a survey of the attitudes of the public in Great Britain. Transplantation 76: 1260-1264 (2003).
Neuberger J, Price D. Role of living liver donation in the United Kingdom. BMJ 327: 676-679 (2003). *
Neuhaus P. Organ shortage. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 112-113. October 17 - 19 (2003). *
Neuman MG. Cytokines - central factors in alcoholic liver disease. Alcohol Res. Health 27: 307-316 (2003). *
Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, Schonemann C, Menzel S, Klupp J, Neuhaus P. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 75: 132-137 (2003).
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38: 1008-10017 (2003). *
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR. Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J. Hepatol. 38: 434-440 (2003). *
Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219 (2003). *
Newman B, Rubin LA, Siminovitch KA. NOD2/CARD15 gene mutation is not associated with susceptibility to Wegener's granulomatosis. J. Rheumatol. 30: 305-307 (2003).
Newman B, Siminovitch K. Inflammatory bowel disease: Crohn's disease and the success of NODern genetics. Clin. Invest. Med. 26: 303-314 (2003).
Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, Wordsworth BP, Kwiatkowski D. The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype. Arthritis Rheum. 48: 90-96 (2003). *
Newton JL. Is osteoporosis a specific complication of primary biliary cirrhosis? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 34-35. October 15-16 (2003). *
Newton SE. Relationship between depression and work outcomes following liver transplantation: the nursing perspective. Gastroenterol. Nurs. 26: 68-72 (2003).
Ng B, Specks U, Offord KP, Matteson EL. Epidemiology of Wegener granulomatosis since the introduction of ANCA testing in Olmsted county, MN, 1990-1999. J. Clin. Rheumatol. 9: 387-388 (2003).
Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust. N. Z. J. Psychiatry 37: 78-84 (2003).
Nguyen DH, Taub DD. Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp. Cell. Res. 291: 36-45 (2003). *
Nicchitta CV. Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity. Nat. Rev. Immunol. 3: 427-432 (2003). *
Nickelson DE, Steiner JE Jr, Mehta N. Privacy protection for your patients: understanding the federal requirements. Cleve. Clin. J. Med. 70: 182, 184-186, 189-190 (2003).
Nicolaou KC, Evans RM, Roecker AJ, Hughes R, Downes M, Pfefferkorn JA. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. Org. Biomol. Chem. 1: 908-920 (2003).
Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34: 97-101 (2003). *
Nicolas I, Pons JA, Vargas A, Gallardo F, Albaladejo A, Nicolas JM. Ursodeoxycholic acid treatment shortens the course of cholestasis in two patients with benign recurrent intrahepatic cholestasis. Gastroenterol. Hepatol. 26: 421-423 (2003).
Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am. J. Perinatol. 20: 405-414 (2003).
Niederkorn JY. Mechanisms of immune privilege in the eye and hair follicle. J. Investig. Dermatol. Symp. Proc. 8: 168-172 (2003). *
Nielsen C, Hansen D, Husby S, Jacobsen BB, Lillevang ST. Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62: 492-497 (2003). *
Nielsen C, Husby S, Lillevang ST. Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease. Ugeskr. Laeger. 165: 917-920 (2003).
Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38: 180-185 (2003). *
Nieuwenhuizen WF, Pieters RH, Knippels LM, Jansen MC, Koppelman SJ. Is Candida albicans a trigger in the onset of coeliac disease? Lancet 361: 2152-2154 (2003). *
Nigam R, Bhatia E, Miao D, Yu L, Brozzetti A, Eisenbarth GS, Falorni A. Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians. Clin. Endocrinol. (Oxf.) 59: 593-598 (2003). *
Niho N, Takahashi M, Kitamura T, Shoji Y, Itoh M, Noda T, Sugimura T, Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res. 63: 6090-6095 (2003). *
Niizeki H, Yokoyama M, Inamoto N, Nishikawa T, Naruse T, Inoko H, Hashigucci K. Lack of association of the interleukin-1 receptor antagonist gene with palmoplantar pustulosis in Japanese. Eur. J. Immunogenet. 30: 249-252 (2003). *
Nijhout HF. On the association between genes and complex traits. J. Investig. Dermatol. Symp. Proc. 8: 162-163 (2003). *
Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67: 593-656 (2003). *
Nikas SN, Drosos AA. Onercept. Serono. Curr. Opin. Investig. Drugs 4: 1369-1376 (2003).
Nikolaus S, Rutgeerts P, Fedorak R, Steinhart AH, Wild GE, Theuer D, Mohrle J, Schreiber S. Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut 52: 1286-1290 (2003). *
Nikougoftar M, Farhadi M, Pourfathollah AA. P-glycoprotein quantitation in acute leukemia. Iran J. Allergy Asthma Immunol. 2: 57-60 (2003).
Nilsson I, Kornilovs'ka I, Lindgren S, Ljungh A, Wadstrom T. Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. J. Med. Microbiol. 52: 949-953 (2003). *
Ninomiya R, Matsuoka K, Moroi Y. Micelle formation of sodium chenodeoxycholate and solubilization into the micelles: comparison with other unconjugated bile salts. Biochim. Biophys. Acta 1634: 116-125 (2003). *
Nishiguchi S, Habu D, Kubo S, Shiomi S, Tatsumi N, Tamori A, Takeda T, Ogami M, Tanaka T, Hirohashi K, Kinoshita H, Nakatani T. Effects of alanine in patients with advanced primary biliary cirrhosis: preliminary report. Hepatol. Res. 25: 8-13 (2003). *
Nishiguchi S, Shiomi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Ochi H. Usefulness of per-rectal portal scintigraphy with technetium-99m pertechnetate for prognosis of primary biliary cirrhosis. Hepatogastroenterology 50: 1783-1786 (2003).
Nishiguchi S, Shiomi S, Kurooka H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Seki S, Ochi H. Portal hemodynamics in primary biliary cirrhosis as evaluated by per-rectal portal scintigraphy with Tc-99m pertechnetate. Hepatogastroenterology 50: 1535-1538 (2003).
Nishio Y, Noguchi E, Shibasaki M, Kamioka M, Ichikawa E, Ichikawa K, Umebayashi Y, Otsuka F, Arinami T. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun. 4: 515-517 (2003). *
Nissinen R, Paimela L, Julkunen H, Tienari PJ, Leirisalo-Repo M, Palosuo T, Vaarala O. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren syndrome. Scand. J. Rheumatol. 32: 337-342 (2003). *
Niv Y, Dickman R, Figer A, Abuksis G, Fraser G. Case-control study of screening colonoscopy in relatives of patients with colorectal cancer. Am. J. Gastroenterol. 98: 486-489 (2003). *
Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Specific fatty acids and human colorectal cancer: an overview. Cancer Detect. Prev. 27: 55-66 (2003). *
No authors listed. Abstracts of the 3rd International Meeting on Inflammatory Bowel Diseases: Clinical Implications of Pathophysiology. April 13-16, 2003, Capri, Italy. Inflamm. Bowel Dis. 9 Suppl. 1: S1-S44 (2003).
Nobili V. Mycophenolate mofetil in pediatric liver transplant patients with renal dysfunction: preliminary data. Pediatr. Transplant. 7: 454-457 (2003).
Noble B. Bone microdamage and cell apoptosis. Eur. Cell Mater. 6: 46-55 (2003).
Noble BS, Peet N, Stevens HY, Brabbs A, Mosley JR, Reilly GC, Reeve J, Skerry TM, Lanyon LE. Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am. J. Physiol. Cell Physiol. 284: C934-C943 (2003). *
Noguchi E, Nakayama J, Kamioka M, Ichikawa K, Shibasaki M, Arinami T. Insertion/deletion coding polymorphisms in hHAVcr-1 are not associated with atopic asthma in the Japanese population. Genes Immun. 4: 170-173 (2003). *
Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am. J. Gastroenterol. 98: 2289-2292 (2003). *
Nohara H, Inoue N, Hibi T, Okita K, Hinoda Y. Association between the interleukin-1 receptor antagonist polymorphism and ulcerative colitis with younger age at diagnosis. Immunol. Lett. 90: 53-57 (2003).
Nojima H, Carstens E. Quantitative assessment of directed hind limb scratching behavior as a rodent itch model. J. Neurosci. Methods 126: 137-143 (2003). *
Nojima H, Simons CT, Cuellar JM, Carstens MI, Moore JA, Carstens E. Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin. J. Neurosci. 23: 10784-10790 (2003). *
Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, Aizawa T, Saito A, Hayashi D, Hirata Y, Sugiyama T, Yamazaki T, Nagai R. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int. J. Cardiol. 92: 181-186 (2003).
Nomura E, Sato M, Suemizu H, Watanabe T, Kimura T, Yabuki K, Goto K, Ito N, Bahram S, Inoko H, Mizuki N, Ohno S, Kimura M. Hyperkeratosis and leukocytosis in transgenic mice carrying MHC class I chain-related gene B (MICB). Tissue Antigens 61: 300-307 (2003). *
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171: 3262-3269 (2003). *
Noponen-Hietala N, Kyllonen E, Mannikko M, Ilkko E, Karppinen J, Ott J, Ala-Kokko L. Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann. Rheum. Dis. 62: 1208-1214 (2003). *
Norris DA. How close are we to solving the puzzle? Review of the Alopecia Areata Research Workshop David Norris. J. Investig. Dermatol. Symp. Proc. 8: 222-225 (2003). *
Novitsky YW, Kercher KW, Czerniach DR, Litwin DE. Watermelon stomach: pathophysiology, diagnosis, and management. J. Gastrointest. Surg. 7: 652-661 (2003).
Nunez Martinez O, Clemente Ricote G, Garcia Monzon C. Role of cyclooxygenase-2 in the pathogenesis of chronic liver diseases. Med. Clin. (Barc.) 121: 743-748 (2003).
Nuttall KL, Palaty J, Lockitch G. Reference limits for copper and iron in liver biopsies. Ann. Clin. Lab. Sci. 33: 443-450 (2003).
Nyckowski P, Dudek K, Skwarek A, Zieniewicz K, Pawlak J, Patkowski W, Michalowicz B, Alsharabi A, Wroblewski T, Leowska E, Paczkowska A, Oldakowska-Jedynak U, Paczek L, Krawczyk M. Results of liver transplantation according to indications for orthotopic liver transplantation. Transplant. Proc. 35: 2265-2267 (2003). *
O'Callaghan NJ, Adams KE, van Heel DA, Cavanaugh JA. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population. Scand. J. Gastroenterol. 38: 533-534 (2003). *
O'Carroll RE, Couston M, Cossar J, Masterton G, Hayes PC. Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl. 9: 712-720 (2003). *
O'Connell CB, Mooseker MS. Native myosin-IXb is a plus-, not a minus-end-directed motor. Nat. Cell Biol. 5: 171-172 (2003). *
O’Farrelly C. Hepatic stem cells - potential for the future. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 49. September 12 - 13 (2003). *
O'Leary JJ. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol. Pathol. 56: 248 (2003). *
O'Neill LA. The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem. Soc. Trans. 31: 643-647 (2003). *
O'Neill LA, Brown Z, Ward SG. Toll-like receptors in the spotlight. Nat. Immunol. 4: 299 (2003). *
O'Neill LA, Dunne A, Edjeback M, Gray P, Jefferies C, Wietek C. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors. J. Endotoxin Res. 9: 55-59 (2003). *
O'Sullivan CE, Aksamit AJ, Harrington JR, Harmsen WS, Mitchell PS, Patel R. Clinical spectrum and laboratory characteristics associated with detection of herpes simplex virus DNA in cerebrospinal fluid. Mayo Clin. Proc. 78: 1347-1352 (2003). *
Oates JC, Levesque MC, Hobbs MR, Smith EG, Molano ID, Page GP, Hill BS, Weinberg JB, Cooper GS, Gilkeson GS. Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in African-Americans. J. Rheumatol. 30: 60-67 (2003).
Obermeier F, Dunger N, Strauch UG, Grunwald N, Herfarth H, Scholmerich J, Falk W. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin. Exp. Immunol. 134: 217-224 (2003). *
Obermeier F, Schwarz H, Dunger N, Strauch UG, Grunwald N, Scholmerich J, Falk W. OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice. Eur. J. Immunol. 33: 3265-3274 (2003). *
Ochiai K, Handharyani E, Umemura T. Idiopathic hepatic fibrosis with cholestasis in broiler chickens: immunohistochemistry of hepatic stellate cells. Avian Pathol. 32: 425-428 (2003).
Ochsenkuhn T, Marsteller I, Hay U, Diebold J, Paumgartner G, Goke B, Sackmann M. Does ursodeoxycholic acid change the proliferation of the colorectal mucosa? A randomized, placebo-controlled study. Digestion 68: 209-216 (2003).
Ochsenkuhn T, Sackmann M, Goke B. Inflammatory bowel diseases (IBD) - critical discussion of etiology, pathogenesis, diagnostics, and therapy. Radiologe 43: 1-8 (2003).
Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124: 1802-1808 (2003). *
Odeh M, Lavy A, Stermer E. Hydrocortisone-induced convulsions. J. Toxicol. Clin. Toxicol. 41: 995-997 (2003).
Odes HS, Smirnoff P, Guberman R, Pollak-Charcon S, Sperber AD, Fich A, Fraser GM, Schwartz B. Cystic fibrosis transmembrane conductance regulator and Na+ channel subunits mRNA transcripts, and Cl- efflux, show a different distribution in rat duodenum and colon. Acta Physiol. Scand. 178: 231-240 (2003). *
Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod. Pathol. 16: 347-358 (2003).
Offensperger WB. Antisense oligonucleotides. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 54-55. October 20 - 21 (2003). *
Offit PA, Hackett CJ. Addressing parents' concerns: do vaccines cause allergic or autoimmune diseases? Pediatrics 111: 653-659 (2003). *
Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin. Exp. Rheumatol. 21: 733-738 (2003).
Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, Chen T, Pertel T, Carnaud C, Bluestone JA, Lanier LL. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18: 41-51 (2003). *
Ogata H, Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9: 1107-1113 (2003).
Ogawa H, Fukushima K, Naito H, Funayama Y, Unno M, Takahashi K, Kitayama T, Matsuno S, Ohtani H, Takasawa S, Okamoto H, Sasaki I. Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflamm. Bowel Dis. 9: 162-170 (2003). *
Ogawa Y, Murata Y, Saibara T, Nishioka A, Kariya S, Yoshida S. Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate. Oncol. Rep. 10: 1473-1478 (2003).
Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nunez G. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52: 1591-1597 (2003). *
Ogura Y, Saab L, Chen FF, Benito A, Inohara N, Nunez G. Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease. Genomics 81: 369-377 (2003). *
Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K. A single-nucleotide substitution from C to T at position -1055 in the IL-13 promoter is associated with protection from severe malaria in Thailand. Genes Immun. 4: 528-531 (2003). *
Ohira H, Takiguchi J, Rai T, Shishido S, Sato Y. Two cases of primary biliary cirrhosis complicated with syringomyelia. Am. J. Gastroenterol. 98: 224-226 (2003). *
Ohki S, Terashima S, Sekikawa K, Takenoshita S, Gotoh M. Recent indications and methods of surgery for inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2: 113-118 (2003).
Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52: 79-83 (2003). *
Ohlsson S, Wieslander J, Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin. Exp. Immunol. 131: 528-535 (2003). *
Ohno N, Ota Y, Hatakeyama S, Yanagimoto S, Morisawa Y, Tsukada K, Koike K, Kimura S. A patient with E. coli-induced pyelonephritis and sepsis who transiently exhibited symptoms associated with primary biliary cirrhosis. Intern. Med. 42: 1144-1148 (2003). *
Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, Kodama T, Kashima K, Imanishi J. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter 8: 207-215 (2003). *
Ohta K, Omura K, Hirano K, Kanehira E, Ishikawa N, Kato Y, Kawakami K, Watanabe G. The effects of an additive small amount of a low residual diet against total parenteral nutrition-induced gut mucosal barrier. Am. J. Surg. 185: 79-85 (2003). *
Ohtani M, Azuma T, Yamazaki S, Yamakawa A, Ito Y, Muramatsu A, Dojo M, Yamazaki Y, Kuriyama M. Association of the HLA-DRB1 gene locus with gastric adenocarcinoma in Japan. Dig. Liver Dis. 35: 468-472 (2003).
Ohyama M, Vogel JC. Gene delivery to the hair follicle. J. Investig. Dermatol. Symp. Proc. 8: 204-206 (2003). *
Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, Tamiya G, Kimura A, Bahram S, Inoko H. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am. J. Hum. Genet. 72: 303-312 (2003). *
Okano N, Yamamoto K, Sakaguchi K, Miyake Y, Shimada N, Hakoda T, Terada R, Baba S, Suzuki T, Tsuji T. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol. Res. 25: 263-270 (2003).
Okkenhaug K, Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3: 317-330 (2003).
Okolicsanyi L, Groppo M, Floreani A, Morselli-Labate AM, Rusticali AG, Battocchia A, Colombo M, Galatola G, Gasbarrini G, Podda M, Ricci G, Rosina F, Zuin M. Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig. Liver Dis. 35: 325-331 (2003).
Olah I, Nagy N, Magyar A, Palya V. Esophageal tonsil: a novel gut-associated lymphoid organ. Poult. Sci. 82: 767-770 (2003). *
Oldakowska-Jedynak U, Niewczas M, Ziolkowski J, Mucha K, Foroncewicz B, Bartlomiejczyk I, Senatorski G, Wyzgal J, Krawczyk M, Zieniewicz K, Nyckowski P, Paczek L. Cytomegalovirus infection as a common complication following liver transplantation. Transplant. Proc. 35: 2295-2297 (2003). *
Olden KW. Irritable bowel syndrome: an overview of diagnosis and pharmacologic treatment. Cleve. Clin. J. Med. 70 Suppl. 2: S3-S7 (2003). *
Olesen M, Middelveld R, Bohr J, Tysk C, Lundberg JO, Eriksson S, Alving K, Jarnerot G. Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand. J. Gastroenterol. 38: 66-72 (2003). *
Oliveira CP, Gayotto LC, Tatai C, Della Nina BI, Lima ES, Abdalla DS, Lopasso FP, Laurindo FR, Carrilho FJ. Vitamin C and vitamin E in prevention of nonalcoholic fatty liver disease (NAFLD) in choline deficient diet fed rats. Nutr. J. 2: 9 (2003). *
Oliveira EM, Bar-Or A, Waliszewska AI, Cai G, Anderson DE, Krieger JI, Hafler DA. CTLA-4 dysregulation in the activation of myelin basic protein reactive T cells may distinguish patients with multiple sclerosis from healthy controls. J. Autoimmun. 20: 71-81 (2003).
Ollila J, Vihinen M. Stimulation-induced gene expression in Ramos B-cells. Genes Immun. 4: 343-350 (2003). *
Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33: 25-32 (2003). *
Olofsson P, Holmdahl R. Positional cloning of Ncf1 - a piece in the puzzle of arthritis genetics. Scand. J. Immunol. 58: 155-164 (2003). *
Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against MPP14, a 14 kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Acta Vet. Scand. 44: 287 (2003).
Olsson R. Small duct primary sclerosing cholangitis: a separate disease? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 62. October 15-16 (2003). *
Oltean S, Banerjee R. Nutritional modulation of gene expression and homocysteine utilization by vitamin B12. J. Biol. Chem. 278: 20778-29784 (2003). *
Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, Weinstein JS, Murray NG, Goldstein RM, Klintmalm GB. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 9: 117-123 (2003). *
Onaitis MW, Mantyh C. Ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: historical development and current status. Ann. Surg. 238: S42-S48 (2003).
Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL. IBD and genetics: new developments. Scand. J. Gastroenterol. Suppl. 239: 63-68 (2003). *
Orange JS, Geha RS. Finding NEMO: genetic disorders of NF-kappaB activation. J. Clin. Invest. 112: 983-985 (2003). *
Orbach H, Shoenfeld Y. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis. Harefuah. 142: 182-185, 239 (2003).
Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 512-517 (2003).
Orchel A, Parfiniewicz B, Lodowska J, Dzierzewicz Z, Weglarz L, Wilczok T. The effect of sulphasalazine and its metabolites on the colonic epithelial Caco-2 cells. Acta Pol. Pharm. 60: 106-108 (2003).
Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, Ida H, Kawakami A, Migita K, Eguchi K. Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome. Ann. Rheum. Dis. 62: 1117-1118 (2003). *
Oriuchi T, Hiwatashi N, Kinouchi Y, Takahashi S, Takagi S, Negoro K, Shimosegawa T. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J. Gastroenterol. 38: 942-953 (2003). *
Orlowski M, Stalke P, Michalska Z, Sikorska K, Witczak-Malinowska K, Eilert-Zygadlowska J, Stolarczyk J. Assessment of correlation between histopathologic changes of gastric mucosa according to Whitehead's classification and extent of liver damage according to Knodell's scale in patients with chronic hepatopathy. Med. Sci. Monit. 9 Suppl. 3: 60-63 (2003).
Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mossner J, Lochs H. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125: 1355-1363 (2003). *
Oselin K, Gerloff T, Mrozikiewicz PM, Pahkla R, Roots I. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes. Fundam. Clin. Pharmacol. 17: 463-469 (2003). *
Oshitani N, Hato F, Kitagawa S, Maeda K, Higuchi K, Matsumoto T, Arakawa T. Analysis of intestinal HLA-DR bound peptides and dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease. Int. J. Mol. Med. 11: 99-104 (2003). *
Oshitani N, Hato F, Kitagawa S, Watanabe K, Fujiwara Y, Higuchi K, Matsumoto T, Arakawa T. Distinct elevation of levels of anti-Caenorhabditis elegans antibody in sera of patients with inflammatory bowel disease. Clin. Diagn. Lab. Immunol. 10: 856-861 (2003). *
Oshitani N, Jinno Y, Sawa Y, Nakamura S, Matsumoto T, Nishiguchi S, Seki S, Higuchi K, Arakawa T. Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis? Hepatogastroenterology 50: 1830-1835 (2003).
Oshitani N, Watanabe K, Maeda K, Fujiwara Y, Higuchi K, Matsumoto T, Arakawa T. Differential expression of homing receptor CD103 on lamina propria lymphocytes and association of CD103 with epithelial adhesion molecules in inflammatory bowel disease. Int. J. Mol. Med. 12: 715-719 (2003).
Ostedgaard LS, Randak C, Rokhlina T, Karp P, Vermeer D, Ashbourne Excoffon KJ, Welsh MJ. Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia. Proc. Natl. Acad. Sci. U.S.A. 100: 1937-1942 (2003). *
Ota Y, Matsui T, Ono H, Uno H, Matake H, Tsuda S, Sakurai T, Yao T. Value of virtual computed tomographic colonography for Crohn's colitis: comparison with endoscopy and barium enema. Abdom. Imaging 28: 778-783 (2003).
Ottaviani F, Schindler A, Capaccio P, Petrone M, Porro GB. New therapy for orolaryngeal manifestations of Crohn's disease. Ann. Otol. Rhinol. Laryngol. 112: 37-39 (2003).
Otte JM, Kiehne K, Herzig KH. Antimicrobial peptides in innate immunity of the human intestine. J. Gastroenterol. 38: 717-726 (2003). *
Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124: 1866-1878 (2003). *
Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, Cheruvallath Z, Jackson D, Casari G, Koegl M, Paabo S, Mous J, Kremoser C, Deuschle U. Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol. Mol. Cell Biol. 23: 864-872 (2003). *
Otten LA, Tacchini-Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, Louis J, Steimle V, Reith W, Acha-Orbea H. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes. J. Immunol. 170: 1150-1157 (2003). *
Otto F, Lubbert M, Stock M. Upstream and downstream targets of RUNX proteins. J. Cell. Biochem. 89: 9-18 (2003). *
Otto SJ, de Groot RH, Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot. Essent. Fatty Acids 69: 237-243 (2003). *
Ouamrane L, Larrieu G, Gauthier B, Pineau T. RXR activators molecular signalling: involvement of a PPAR alpha-dependent pathway in the liver and kidney, evidence for an alternative pathway in the heart. Br. J. Pharmacol. 138: 845-854 (2003). *
Ouchi K, Suzuki Y, Shirakawa T, Kishi F. Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J. Infect. Dis. 187: 326-329 (2003). *
Oude Elferink RP. Cholestasis. Gut 52 Suppl. 2: ii42-ii48 (2003). *
Ourlin JC, Lasserre F, Pineau T, Fabre JM, Sa-Cunha A, Maurel P, Vilarem MJ, Pascussi JM. The small heterodimer partner interacts with the pregnane X receptor and represses its transcriptional activity. Mol. Endocrinol. 17: 1693-1703 (2003). *
Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc. Nutr. Soc. 62: 813-821 (2003). *
Owczarek D, Garlicka M, Pierzchala-Koziec K, Skulina D, Szulewski P. Met-enkephalin plasma concentration and content in liver tissue in patients with primary biliary cirrhosis. Przegl. Lek. 60: 461-466 (2003).
Owsley E, Chiang JY. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. Biochem. Biophys. Res. Commun. 304: 191-195 (2003). *
Ozaki H, Kinoshita K, Hori M. Mechanism of the intestinal dysmotility in the inflammatory bowel diseases: possible involvement of muscularis resident macrophages. Nippon Yakurigaku Zasshi 122: 46P-50P (2003).
Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K. Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. Hepatol. Res. 27: 289-301 (2003).
Ozaki M, Enosawa S, Suzuki S. Regenerative medicine in liver disease. Nippon Rinsho 61: 498-503 (2003).
Ozdil S, Demir K, Boztas G, Danalioglu A, Karaca C, Akyuz F, Aksoy N, Kaymakoglu S, Mungan Z, Besisik F, Cakaloglu Y, Okten A. Crohn's disease; analysis of 105 patients. Hepatogastroenterology 50 Suppl. 2: cclxxxvii-ccxci (2003).
Ozen S. Familial mediterranean fever: revisiting an ancient disease. Eur. J. Pediatr. 162: 449-454 (2003). *
Ozias MK, Schalinske KL. All-trans-retinoic acid rapidly induces glycine N-methyltransferase in a dose-dependent manner and reduces circulating methionine and homocysteine levels in rats. J. Nutr. 133: 4090-4094 (2003). *
Ozturk M. Differentiation and malignant transformation. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 25-27. October 20 - 21 (2003). *
Paavola-Sakki P, Ollikainen V, Helio T, Halme L, Turunen U, Lahermo P, Lappalainen M, Farkkila M, Kontula K. Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci. Eur. J. Hum. Genet. 11: 112-120 (2003). *
Pace F, Molteni P, Bollani S, Sarzi-Puttini P, Stockbrugger R, Porro GB, Drossman DA. Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand. J. Gastroenterol. 38: 1031-1038 (2003). *
Padhye U. Excess dietary iron is the root cause for increase in childhood autism and allergies. Med. Hypotheses 61: 220-222 (2003). *
Pagnoux C, Hayem G, Roux F, Palazzo E, Meyer O. Sclerosing cholangitis as a complication of Langerhans' cell histiocytosis. Rev. Med. Interne. 24: 324-327 (2003).
Paiva I, Gomes L, Ribeiro C, Carvalheiro M, Ruas MM. Autoimmune hypophysitis or lymphocytic hypophysitis. Acta Med. Port. 16: 459-463 (2003).
Pajares Garcia JM, Gisbert JP. Gastric carcinogenesis and Helicobacter pylori infection. Rev. Esp. Enferm. Dig. 95: 84-88 (2003).
Pajares Villarroya R, Castillo Grau P, Mancenido Marcos N, Navajas Leon FJ, Hervias Cruz D, Erdozain Sosa JC, Segura Cabral JM. Primary biliary cirrhosis and pregnancy: benefit of ursodeoxycholic acid therapy. Gastroenterol. Hepatol. 26: 615 (2003).
Palazzi C, D'Amico E, Pennese E, Petricca A. Normalization of methotrexate-induced high levels of serum transaminases after ursodeoxycholic acid administration in a rheumatoid arthritis patient. Rheumatology (Oxford) 42: 1266-1267 (2003). *
Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2: 736-746 (2003). *
Pallis AG, Vlachonikolis IG, Mouzas IA. Validation of a reliable instrument (QUOTE-IBD) for assessing the quality of health care in Greek patients with inflammatory bowel disease. Digestion 68: 153-160 (2003).
Pallone F, Del Vecchio Blanco G, Vavassori P, Monteleone I, Fina D, Monteleone G. Genetic and pathogenetic insights into inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 487-492 (2003).
Palmas C, Gabriele F, Conchedda M, Bortoletti G, Ecca AR. Causality or coincidence: may the slow disappearance of helminths be responsible for the imbalances in immune control mechanisms? J. Helminthol. 77: 147-153 (2003). *
Palmer CN, Young V, Ho M, Doney A, Belch JJ. Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum. 48: 854-855 (2003). *
Palmer E. Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 3: 383-391 (2003).
Pan D, Watson HK, Swigart C, Thomson JG, Honig SC, Narayan D. Microarray gene analysis and expression profiles of Dupuytren's contracture. Ann. Plast. Surg. 50: 618-622 (2003).
Panchal PC, Forman JS, Blumberg DR, Wilson KT. Helicobacter pylori infection: pathogenesis. Curr. Opin. Gastroenterol. 19: 4-10 (2003).
Panzer S, Seel E. Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review. Wien. Med. Wochenschr. 153: 417-420 (2003).
Papa A, Danese S, Armuzzi A, Gaetani E, Flex A, Pola P, Gasbarrini A. Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations. Gut 52: 1227-1228 (2003). *
Papadakis KA, Landers C, Prehn J, Kouroumalis EA, Moreno ST, Gutierrez-Ramos JC, Hodge MR, Targan SR. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile. J. Immunol. 171: 159-165 (2003). *
Papadakis KA, Treyzon L, Abreu MT, Fleshner PR, Targan SR, Vasiliauskas EA. Infliximab in the treatment of medically refractory indeterminate colitis. Aliment. Pharmacol. Ther. 18: 741-747 (2003). *
Papadimitriou JC, Cangro CB, Lustberg A, Khaled A, Nogueira J, Wiland A, Ramos E, Klassen DK, Drachenberg CB. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int. J. Surg. Pathol. 11: 295-302 (2003).
Papakostas GI, Alpert JE, Fava M. S-Adenosyl-methionine in depression: a comprehensive review of the literature. Curr. Psychiatry Rep. 5: 460-466 (2003).
Paradiso AM, Coakley RD, Boucher RC. Polarized distribution of HCO3- transport in human normal and cystic fibrosis nasal epithelia. J. Physiol. 548: 203-218 (2003). *
Parana R, Codes L, Andrade Z, Freitas LA, Santos-Jesus R, Reis M, Cotrim H, Cunha S, Trepo C. Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease? Int. J. Infect. Dis. 7: 222-230 (2003).
Pardi DS. Microscopic colitis. Mayo Clin. Proc. 78: 614-616 (2003). *
Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124: 889-893 (2003). *
Parente F, Greco S, Molteni M, Cucino C, Maconi G, Sampietro GM, Danelli PG, Cristaldi M, Bianco R, Gallus S, Bianchi Porro G. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment. Pharmacol. Ther. 18: 1009-1016 (2003). *
Pares A, Rodes J. Natural history of primary biliary cirrhosis. Clin. Liver Dis. 7: 779-794 (2003).
Parham P. Immunogenetics of killer-cell immunoglobulin-like receptors. Tissue Antigens 62: 194-200 (2003). *
Parham P, McQueen KL. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat. Rev. Immunol. 3: 108-122 (2003).
Pariser DM. Improving the standard of care for patients with psoriasis. Manag. Care 12: S18-S20 (2003).
Park DJ, Zhang W, Stoehlmacher J, Tsao-Wei D, Groshen S, Gil J, Yun J, Sones E, Mallik N, Lenz HJ. ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. Clin. Adv. Hematol. Oncol. 1: 162-166 (2003).
Park JS, Arcaroli J, Yum HK, Yang H, Wang H, Yang KY, Choe KH, Strassheim D, Pitts TM, Tracey KJ, Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284: C870-C879 (2003). *
Park Y, Moon Y, Chung HY. AIRE-1 (autoimmune regulator type 1) as a regulator of the thymic induction of negative selection. Ann. N. Y. Acad. Sci. 1005: 431-435 (2003). *
Parlak E, Dagli U, Alkim C, Disibeyaz S, Tunc B, Ulker A, sAhin B. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk. J. Gastroenterol. 14: 250-256 (2003). *
Parouchev A, Mahieu-Caputo D, Delgado JP, Andreoletti M, Dagher I, Leboulch P, Franco D, Di Santo J, Weber A. Reversible immortalization of human and primate liver progenitor cells and their transplantation into animal models. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 32-33. October 20 - 21 (2003). *
Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57: 677-701 (2003). *
Pasare C, Medzhitov R. Toll-like receptors: balancing host resistance with immune tolerance. Curr. Opin. Immunol. 15: 677-682 (2003).
Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036 (2003). *
Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J. Hepatobiliary Pancreat. Surg. 10: 282-287 (2003). *
Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ. Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. Mol. Endocrinol. 17: 42-55 (2003). *
Pascussi JM, Dvorak Z, Gerbal-Chaloin S, Assenat E, Maurel P, Vilarem MJ. Pathophysiological factors affecting CAR gene expression. Drug Metab. Rev. 35: 255-268 (2003).
Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, Vilarem MJ. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim. Biophys. Acta 1619: 243-253 (2003). *
Pasos-Altamirano G, Mendieta-Zeron H, Fuentes-Luiton E. Hemobilia. A case report. Ann. Hepatol. 2: 141-142 (2003). *
Pasricha JS. Pulse therapy as a cure for autoimmune diseases. Indian J. Dermatol. Venereol. Leprol. 69: 323-328 (2003).
Pastore C, Picchio GR, Galimi F, Fish R, Hartley O, Offord RE, Mosier DE. Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES. Antimicrob. Agents Chemother. 47: 509-517 (2003). *
Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J. Clin. Endocrinol. Metab. 88: 162-165 (2003). *
Patel NJ, Zamek-Gliszczynski MJ, Zhang P, Han YH, Jansen PL, Meier PJ, Stieger B, Brouwer KL. Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. Mol. Pharmacol. 64: 154-159 (2003). *
Patel SM, Falchuk K. Dexamethasone pulse steroids in ulcerative colitis - is it time for a change? Inflamm. Bowel Dis. 9: 213 (2003). *
Patel T. Aberrant local renin-angiotensin II responses in the pathogenesis of primary sclerosing cholangitis. Med. Hypotheses 61: 64-67 (2003). *
Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, Smoter P, Grodzicki M, Skwarek A, Ziolkowski J, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M. Biliary tract complications following liver transplantation. Transplant. Proc. 35: 2316-2317 (2003). *
Patt CH, Yoo HY, Dibadj K, Flynn J, Thuluvath PJ. Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program. Dig. Dis. Sci. 48: 797-801 (2003). *
Pauleau AL, Murray PJ. Role of nod2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell Biol. 23: 7531-7539 (2003). *
Pauli-Magnus C, Meier PJ. Pharmacogenetics of hepatocellular transporters. Pharmacogenetics 13: 189-198 (2003).
Paumgartner G. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. J. Hepatol. 39: 112-114 (2003). *
Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J. Investig. Dermatol. Symp. Proc. 8: 188-194 (2003). *
Pavai S, Yap SF. The clinical significance of elevated levels of serum CA 19-9. Med. J. Malaysia 58: 667-672 (2003).
Pavan A, Thomaseth K, Valerio A. Modeling population kinetics of free fatty acids in isolated rat hepatocytes using Markov Chain Monte Carlo. Ann. Biomed. Eng. 31: 854-866 (2003). *
Pavic S, Simonovic J, Boricic I, Svirtlih N. Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C. Srp. Arh. Celok. Lek. 131: 437-442 (2003).
Pavkovic M, Georgievski B, Cevreska L, Spiroski M, Efremov DG. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am. J. Hematol. 72: 147-149 (2003). *
Pavlenko VV, Iagoda AV. Synthesis of eicosanoids in the colonic mucosa in patients with ulcerative colitis. Klin. Med. (Mosk.) 81: 39-43 (2003).
Pavlovic-Calic N. Ulcerative colitis and Crohn's disease. Med. Arh. 57 (1 Suppl. 2): 85-86 (2003).
Pavoni DP, Roxo VM, Marquart Filho A, Petzl-Erler ML. Dissecting the associations of endemic pemphigus foliaceus (Fogo Selvagem) with HLA-DRB1 alleles and genotypes. Genes Immun. 4: 110-116 (2003). *
Pawar A, Botolin D, Mangelsdorf DJ, Jump DB. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J. Biol. Chem. 278: 40736-40743 (2003). *
Pawar A, Jump DB. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J. Biol. Chem. 278: 35931-35939 (2003). *
Pazzi P, Gamberini S, Buldrini P, Gullini S. Biliary sludge: the sluggish gallbladder. Dig. Liver Dis. 35 Suppl. 3: S39-S45 (2003).
Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot. Essent. Fatty Acids 69: 477-485 (2003). *
Pelle MT, Werth VP. Thalidomide in cutaneous lupus erythematosus. Am. J. Clin. Dermatol. 4: 379-387 (2003).
Pelletier G, Roulot D, Davion T, Masliah C, Causse X, Oberti F, Raabe JJ, Van Lemmens C, Labadie H, Serfaty L; URSOMAF Group. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Hepatology 37: 887-892 (2003). *
Pelletier SJ, Maraschio MA, Schaubel DE, Dykstra DM, Punch JD, Wolfe RA, Port FK, Merion RM. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin. Transpl. 2003: 77-88 (2003).
Pelli N, Setti M, Ceppa P, Toncini C, Indiveri F. Autoimmune hepatitis revealed by atorvastatin. Eur. J. Gastroenterol. Hepatol. 15: 921-924 (2003).
Pena A. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies. Rev. Esp. Enferm. Dig. 95: 749-751 (2003).
Pena AS. Genetics of inflammatory bowel diseases - past, present, and future. Dig. Dis. 21: 85-90 (2003).
Pena-Cruz V, Ito S, Dascher CC, Brenner MB, Sugita M. Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells. J. Invest. Dermatol. 121: 517-521 (2003). *
Pena-Quintana L, Torres-Galvan MJ, Deniz-Naranjo MC, Ortigosa-Castillo L, Ramos-Varela JC, Calvo-Hernandez F, Fiuza-Perez MD, Rodriguez-Gallego JC, Sanchez-Garcia F. Assessment of the DQ heterodimer test in the diagnosis of celiac disease in the Canary Islands (Spain). J. Pediatr. Gastroenterol. Nutr. 37: 604-608 (2003). *
Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol. 24: 584-588 (2003). *
Peng J, Liu C, Zhu K, Zhu Y, Yu Y, Li J, Hou M, Chen X, Xu C, Zhang M. The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR. Hum. Immunol. 64: 896-901 (2003).
Peng T, He S, Kruger M, Tang H, Wong-Staal F. Identification, validation and characterization of a novel cellular factor required for hepatitis C virus internal ribosome entry sitemediated translation. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 53. October 20 - 21 (2003). *
Percopo S, Babron MC, Whalen M, De Virgiliis S, Coto I, Clerget-Darpoux F, Landolfo F, Greco L. Saturation of the 5q31-q33 candidate region for coeliac disease. Ann. Hum. Genet. 67: 265-268 (2003). *
Perdriger A, Werner-Leyval S, Rollot-Elamrani K. The genetic basis for systemic lupus erythematosus. Joint Bone Spine 70: 103-108 (2003).
Pereira SP, Bain IM, Kumar D, Dowling RH. Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile. Aliment. Pharmacol. Ther. 17: 923-933 (2003). *
Perez C, Errazuriz I, Brockmann P, Gonzalez S, Cofre C. Eosinophilic pneumonia caused by mesalazine. Report of one case. Rev. Med. Chil. 131: 81-84 (2003).
Perez De Nanclares G, Bilbao JR, Calvo B, Vitoria JC, Vazquez F, Castano L. 5'-Insulin gene VNTR polymorphism is specific for type 1 diabetes: no association with celiac or Addison's disease. Ann. N. Y. Acad. Sci. 1005: 319-323 (2003). *
Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am. Fam. Physician 68: 1075-1082 (2003). *
Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum. Dis. Clin. North Am. 29: 123-143, vii (2003).
Perri AJ 3rd, Hsu S. A review of thalidomide's history and current dermatological applications. Dermatol. Online J. 9: 5 (2003). *
Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A. Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur. J. Hum. Genet. 11: 687-692 (2003). *
Perrot S, Calvez V, Escande JP, Dupin N, Marcelin AG. Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjogren's syndrome using degenerated consensus PCR primers. J. Clin. Virol. 28: 165-168 (2003).
Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 1060-1065 (2003).
Persson T, Monsef N, Andersson P, Bjartell A, Malm J, Calafat J, Egesten A. Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils. Clin. Exp. Allergy 33: 531-537 (2003). *
Peterlin BM, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 3: 97-107 (2003).
Peters JM, Aoyama T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice. Biochim. Biophys. Acta 1632: 80-89 (2003). *
Peters WH, te Morsche RH, Roelofs HM. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J. Hepatol. 38: 3-8 (2003).
Peterson JR, Hsu FC, Simkin PA, Wener MH. Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann. Rheum. Dis. 62: 1078-1082 (2003). *
Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, Gores GJ, Sessa WC, Simari RD. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol. 23: 1521-1527 (2003). *
Petraccia L, Onori P, Sferra R, Lucchetta MC, Liberati G, Grassi M, Gaudio E. MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications. Clin. Ter. 154: 325-335 (2003).
Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum. 48: 166-173 (2003). *
Petrie HT. Cell migration and the control of post-natal T-cell lymphopoiesis in the thymus. Nat. Rev. Immunol. 3: 859-866 (2003).
Petro TM. Modulation of IL-12 p35 and p40 promoter activity by smokeless tobacco extract is associated with an effect upon activation of NF-kappaB but not IRF transcription factors. Int. Immunopharmacol. 3: 735-745 (2003).
Petrovic S, Ma L, Wang Z, Soleimani M. Identification of an apical Cl-/HCO-3 exchanger in rat kidney proximal tubule. Am. J. Physiol. Cell Physiol. 285: C608-C617 (2003). *
Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am. J. Ophthalmol. 135: 879-884 (2003). *
Pezzilli R, Morselli-Labate AM, Mantovani V, Romboli E, Selva P, Migliori M, Corinaldesi R, Gullo L. Mutations of the CFTR gene in pancreatic disease. Pancreas 27: 332-336 (2003).
Phalipon A, Sansonetti PJ. Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development. Crit. Rev. Immunol. 23: 371-401 (2003).
Philip S, Kundu GC. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278: 14487-14497 (2003). *
Phillips JR, Angulo P, Lindor K. Recurrent idiopathic hepatitis: a new entity? J. Clin. Gastroenterol. 37: 267-269 (2003).
Phillips MJ, Azuma T, Meredith SL, Squire JA, Ackerley CA, Pluthero FG, Roberts EA, Superina RA, Levy GA, Marsden PA. Abnormalities in villin gene expression and canalicular microvillus structure in progressive cholestatic liver disease of childhood. Lancet 362: 1112-1119 (2003). *
Philpott S, Weiser B, Tarwater P, Vermund SH, Kleeberger CA, Gange SJ, Anastos K, Cohen M, Greenblatt RM, Kovacs A, Minkoff H, Young MA, Miotti P, Dupuis M, Chen CH, Burger H. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women. J. Infect. Dis. 187: 569-575 (2003). *
Pichardo-Bahena R, Almeda-Valdes P, Mendez-Sanchez N. Hepatic fascioliasis. Ann. Hepatol. 2: 182 (2003). *
Pienaar S, Eley BS, Hughes J, Henderson HE. X-linked hyper IgM (HIGM1) in an African kindred: the first report from South Africa. BMC Pediatr. 3: 12 (2003). *
Pietrangelo A. Hemochromatosis. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 89-90. October 17 - 19 (2003). *
Pietrangelo A. Haemochromatosis. Gut 52 Suppl. 2: ii23-ii30 (2003). *
Pignatti P, Ciapponi L, Galle P, Hansen MB, Massa M, Meazza C, Paonessa G, Novick D, Ciliberto G, Martini A, De Benedetti F. High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130. Clin. Exp. Immunol. 131: 355-363 (2003). *
Pihlaja H, Rantamaki T, Wikstrom J, Sumelahti ML, Laaksonen M, Ilonen J, Ruutiainen J, Pirttila T, Elovaara I, Reunanen M, Kuokkanen S, Peltonen L, Koivisto K, Tienari PJ. Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland. Genes Immun. 4: 138-146 (2003). *
Pikuleva I, Javitt NB. Novel sterols synthesized via the CYP27A1 metabolic pathway. Arch. Biochem. Biophys. 420: 35-39 (2003). *
Pilz I, von Weizsacker F, Glimm H, Peters C, von Kalle C. Evaluation of stem cell plasticity by clonal marking in a liver damage model. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 31. October 20 - 21 (2003). *
Pineau BC, Paskett ED, Chen GJ, Espeland MA, Phillips K, Han JP, Mikulaninec C, Vining DJ. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology 125: 304-310 (2003). *
Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol. Endocrinol. 17: 259-272 (2003). *
Piodi LP, Bardella M, Rocchia C, Cesana BM, Baldassarri A, Quatrini M. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J. Clin. Gastroenterol. 36: 22-25 (2003).
Pircher PC, Kitto JL, Petrowski ML, Tangirala RK, Bischoff ED, Schulman IG, Westin SK. Farnesoid X receptor regulates bile acid-amino acid conjugation. J. Biol. Chem. 278: 27703-27711 (2003). *
Pirzada O, Taylor C. Modifier genes and cystic fibrosis liver disease. Hepatology 37: 714 (2003). *
Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108: 155-160 (2003). *
Pitkanen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun. 4: 12-21 (2003). *
Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment. Pharmacol. Ther. 18: 451-471 (2003). *
Pituch H, Obuch-Woszczatynski P, Glinka D, Lazinska B, Meisel-Mikolajczyk F, Luczak M. Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002. Med. Dosw. Mikrobiol. 55: 253-258 (2003).
Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn's disease. Trends Mol. Med. 9: 218-222 (2003). *
Pleister A, Eckels DD. Cryptic infection and autoimmunity. Autoimmun. Rev. 2: 126-132 (2003).
Plesa A. Treatment of cholestatic liver disease. Rev. Med. Chir. Soc. Med. Nat. Iasi. 107: 733-736 (2003).
Pless RP. Recent differing expert opinions regarding the safety profile of hepatitis B vaccines: is there really a controversy? Expert Opin. Drug Saf. 2: 451-455 (2003).
Plevy S, Mayer L. Meeting summary: signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A. Inflamm. Bowel Dis. 9: 28-33 (2003). *
Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 63: 803-843 (2003).
Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin. Proc. 78: 1463-1470 (2003). *
Plotz PH. The autoantibody repertoire: searching for order. Nat. Rev. Immunol. 3: 73-78 (2003). *
Podgaetz E, Chan C; Liver transplant Team. Liver transplantation for Wilson's disease: our experience with review of the literature. Ann. Hepatol. 2: 131-134 (2003). *
Polese L, Angriman I, Scarpa M, Norberto L, Sturniolo GC, Cecchetto A, Ruffolo C, D'Amico DF. Role of CD40 and B7 costimulators in inflammatory bowel diseases. Acta Biomed. Ateneo. Parmense. 74 Suppl. 2: 65-70 (2003). *
Ponsioen CY. Incidence and prevalence of PSC around the world. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 61. October 15-16 (2003). *
Pooran N, Singh P, Bank S. Crohn's disease and risk of fracture: does thyroid disease play a role? World J. Gastroenterol. 9: 615-618 (2003). *
Poritz LS, Koltun WA. Surgical management of ulcerative colitis in the presence of primary sclerosing cholangitis. Dis. Colon Rectum 46: 173-178 (2003).
Portilla D. Energy metabolism and cytotoxicity. Semin. Nephrol. 23: 432-438 (2003).
Portmann B. Biliary pathology. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 47-48. October 17 - 19 (2003). *
Poupon R. Autoimmune overlapping syndromes. Clin. Liver Dis. 7: 865-878 (2003).
Poupon R. Molecular mechanisms of bile formation and cholestatic diseases. Bull. Acad. Natl. Med. 187: 1261-1274 (2003).
Poupon RE, Lindor KD, Pares A, Chazouilleres O, Poupon R, Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J. Hepatol. 39: 12-16 (2003). *
Powrie F, Maloy KJ. Immunology. Regulating the regulators. Science 299: 1030-1031 (2003). *
Powrie F, Read S, Mottet C, Uhlig H, Maloy K. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252: 92-98 (2003).
Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P; PANFIBROSIS Group. A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 38: 257-265 (2003). *
Poynard T, Thabut D, Chryssostalis A, Taieb J, Ratziu V. Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible? J. Hepatol. 38: 518-520 (2003). *
Pradhan VD, Badakere SS, Iyer YS, Kumar R, Almeida AF. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders. J. Postgrad. Med. 49: 5-9 (2003). *
Pradhan VD, Badakere SS, Pawar AR, Almeida AF. Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis. Indian J. Med. Sci. 57: 479-486 (2003).
Prado IB, dos Santos MH, Lopasso FP, Iriya K, Laudanna AA. Cholestasis in a murine experimental model: lesions include hepatocyte ischemic necrosis. Rev. Hosp. Clin. Fac. Med. Sao Paulo 58: 27-32 (2003).
Prajapati DN, Kim JP, Spinelli KS, Sudakoff G, Stewart ET, Komorowski RA, Telford GL, Binion DG. Case report: "popcorn" dystrophic ileal calcification in a patient with Crohn's disease. Inflamm. Bowel Dis. 9: 25-27 (2003). *
Prandota J. Possible pathomechanism of autoimmune hepatitis. Am. J. Ther. 10: 51-57 (2003).
Pratesi R, Gandolfi L, Martins RC, Tauil PL, Nobrega YK, Teixeira WA. Is the prevalence of celiac disease increased among epileptic patients? Arq. Neuropsiquiatr. 61: 330-334 (2003). *
Preitner N, Brown S, Ripperger J, Le-Minh N, Damiola F, Schibler U. Orphan nuclear receptors, molecular clockwork, and the entrainment of peripheral oscillators. Novartis Found. Symp. 253: 89-99 (2003).
Presanis JS, Kojima M, Sim RB. Biochemistry and genetics of mannan-binding lectin (MBL). Biochem. Soc. Trans. 31: 748-752 (2003). *
Present DH. Crohn's fistula: current concepts in management. Gastroenterology 124: 1629-1635 (2003). *
Price P, Bolitho P, Jaye A, Glasson M, Yindom LM, Sirugo G, Chase D, McDermid J, Whittle H. A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33,B58,DR3 haplotypes. Tissue Antigens 62: 72-75 (2003). *
Prieto J. Cytokine-mediated gene therapy of liver tumors. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 45-46. October 20 - 21 (2003). *
Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J. The promise of gene therapy in gastrointestinal and liver diseases. Gut 52 Suppl. 2: ii49-ii54 (2003). *
Prince MI, James OF. The epidemiology of primary biliary cirrhosis. Clin. Liver Dis. 7: 795-819 (2003).
Prince MI, Mitchison HC, Ashley D, Burke DA, Edwards N, Bramble MG, James OF, Jones DE. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment. Pharmacol. Ther. 17: 137-143 (2003). *
Principe A, Ercolani G, Bassi F, Paolucci U, Raspadori A, Turi P, Beltempo P, Grazi GL, Cavallari A. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepatogastroenterology 50: 1246-1249 (2003).
Priori R, Medda E, Conti F, Cassara EA, Danieli MG, Gerli R, Giacomelli R, Franceschini F, Manfredi A, Pietrogrande M, Stazi MA, Valesini G. Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. Lupus 12: 735-740 (2003).
Probert CS, Hearing SD, Schreiber S, Kuhbacher T, Ghosh S, Arnott ID, Forbes A. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 52: 998-1002 (2003). *
Proft T, Fraser JD. Bacterial superantigens. Clin. Exp. Immunol. 133: 299-306 (2003). *
Prohaszka Z. Heat shock proteins as chaperones of the immune response. The optimal stress of life. Orv. Hetil. 144: 1331-1339 (2003).
Puddu P, Puddu GM, Muscari A. Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression? Int. J. Cardiol. 90: 133-140 (2003).
Puebla Maestu A, Martin-Lorente JL, Lopez-Morante A, Garcia-Moran S, Yuguero Del Moral L, Arauzo Gonzalez A. Ulcerative colitis associated with idiopathic thrombocytopenic purpura. Gastroenterol. Hepatol. 26: 545-548 (2003).
Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, Emery PW, Sanders TA. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124: 1240-1248 (2003). *
Pufulete M, Emery PW, Sanders TA. Folate, DNA methylation and colo-rectal cancer. Proc. Nutr. Soc. 62: 437-445 (2003). *
Punzi L, Podswiadek M, D'Inca R, Zaninotto M, Bernardi D, Plebani M, Sturniolo GC. Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease. Ann. Rheum. Dis. 62: 1224-1226 (2003). *
Puylaert JB. Ultrasonography of the acute abdomen: gastrointestinal conditions. Radiol. Clin. North Am. 41: 1227-1242, vii (2003).
Puzanowska B, Prokopowicz D, Ziarko S, Radziwon P, Lapinski TW. The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland. Hepatogastroenterology 50: 1436-1438 (2003).
Pyo CW, Hur SS, Kim YK, Kim TY, Kim TG. Association of TAP and HLA-DM genes with psoriasis in Koreans. J. Invest. Dermatol. 120: 616-622 (2003). *
Qin JM, Fu XY, Li SJ, Liu SQ, Zeng JZ, Qiu XH, Wu MC, Wang HY. Gene and protein expressions of p28(GANK) in rat with liver regeneration. World J. Gastroenterol. 9: 2523-2527 (2003). *
Qiu DK, Ma X. Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients. J. Gastroenterol. Hepatol. 18: 63-67 (2003). *
Quan H, Present JW, Sutherland LR. Evaluation of educational programs in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 356-362 (2003). *
Queiro R, Torre JC, Gonzalez S, Lopez-Larrea C, Tinture T, Lopez-Lagunas I. HLA antigens may influence the age of onset of psoriasis and psoriatic arthritis. J. Rheumatol. 30: 505-507 (2003).
Queiroz DM, Oliveira AG, Guerra JB, Lima JC, Silva CP, Rocha GA. Helicobacter DNA in bile: correlation with hepato-biliary diseases. Aliment. Pharmacol. Ther. 18: 546-547 (2003). *
Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Tissue Antigens 61: 166-171 (2003). *
Quero Guillen JC, Carmona Soria I, Garcia Montes JM, Jimenez Saenz M, Herrerias Gutierrez JM. Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev. Esp. Enferm. Dig. 95: 135-142, 127-134 (2003).
Quintana AB, Rodriguez JV, Scandizzi AL, Guibert EE. The benefit of adding sodium nitroprusside (NPNa) or S-nitrosoglutathione (GSNO) to the University of Wisconsin solution (UW) to prevent morphological alterations during cold preservation/reperfusion of rat livers. Ann. Hepatol. 2: 84-91 (2003). *
Quondamcarlo C, Valentini G, Ruggeri M, Forlini G, Fenderico P, Rossi Z. Campylobacter jejuni enterocolitis presenting as inflammatory bowel disease. Tech. Coloproctol. 7: 173-177 (2003).
Qureshi MH, Harmsen AG, Garvy BA. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J. Immunol. 170: 1002-1009 (2003). *
Qureshi ST, Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 4: 87-94 (2003). *
Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am. J. Gastroenterol. 98: 1400-1409 (2003). *
Rabeneck L, El-Serag HB, Davila JA, Sandler RS. Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am. J. Gastroenterol. 98: 471-477 (2003). *
Rabinovitz M. Evolution of autoimmune hepatitis to sclerosing cholangitis. Hepatology 37: 946-947 (2003). *
Radaev S, Sun PD. Structure and function of natural killer cell surface receptors. Annu. Rev. Biophys. Biomol. Struct. 32: 93-114 (2003). *
Raddatz D, Legler T, Lynen R, Addicks N, Ramadori G. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Z. Gastroenterol. 41: 1069-1076 (2003).
Radovanovic-Dinic B, Nagorni A, Katic V, Bjelakovic G. Clinical extraintestinal manifestations of ulcerative colitis. Facta Universitatis Series: Medicine and Biology 10: 139-144 (2003). *
Radstake TR, Petit E, Pierlot C, van de Putte LB, Cornelis F, Barrera P. Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. J. Rheumatol. 30: 926-933 (2003).
Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 100: 4742-4747 (2003). *
Raghuram V, Hormuth H, Foskett JK. A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions. Proc. Natl. Acad. Sci. U.S.A. 100: 9620-9625 (2003). *
Rahbar A, Bostrom L, Lagerstedt U, Magnusson I, Soderberg-Naucler C, Sundqvist VA. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm. Bowel Dis. 9: 154-161 (2003). *
Rahman NU, Meng MV, Stoller ML. Infections and urinary stone disease. Curr. Pharm. Des. 9: 975-981 (2003).
Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, Peddle L, Schentag CT, Alderdice CA, Hamilton S, Khraishi M, Tobin Y, Hefferton D, Gladman DD. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am. J. Hum. Genet. 73: 677-681 (2003). *
Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J. Gastrointest. Surg. 7: 26-35 (2003).
Rahme E, Barkun AN, Toubouti Y, Bardou M. The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence. Gastroenterology 125: 404-412 (2003). *
Raijmakers MT, Roes EM, te Morsche RH, Steegers EA, Peters WH. Haptoglobin and its association with the HELLP syndrome. J. Med. Genet. 40: 214-216 (2003). *
Rajendra S, Kadir ZA, Karim N, Zain Z. Ulcerative colitis and motor neurone disease: causal or coincidental? Singapore Med. J. 44: 423-425 (2003).
Rajendran CP, Ledge SG, Rani KP, Madhavan R. Psoriatic arthritis. J. Assoc. Physicians India 51: 1065-1068 (2003).
Ralhan R, Kaur J. Retinoids as chemopreventive agents. J. Biol. Regul. Homeost. Agents 17: 66-91 (2003).
Rall GF. Measles virus 1998-2002: progress and controversy. Annu. Rev. Microbiol. 57: 343-367 (2003). *
Ram VJ. Therapeutic role of peroxisome proliferator-activated receptors in obesity, diabetes and inflammation. Prog. Drug Res. 60: 93-132 (2003).
Ram VJ. Therapeutic significance of peroxisome proliferator-activated receptor modulators in diabetes. Drugs Today (Barc.) 39: 609-632 (2003).
Ramalho AS, Beck S, Penque D, Gonska T, Seydewitz HH, Mall M, Amaral MD. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J. Med. Genet. 40: e88 (2003). *
Ramel B. Crisis of the scientific communication. Ugeskr. Laeger. 165: 3514-3518 (2003).
Ramkumar D, Schulze KS. Gastroduodenal motility. Curr. Opin. Gastroenterol. 19: 540-545 (2003).
Rammert Ch, Kullak-Ublick GA. Management of ulcerative colitis. Ther. Umsch. 60: 145-150 (2003).
Ramriez RA. Helicobacter pylori in Peru. Rev. Gastroenterol. Peru. 23: 11-13 (2003).
Ramsdell F, Ziegler SF. Transcription factors in autoimmunity. Curr. Opin. Immunol. 15: 718-724 (2003).
Randak C, Welsh MJ. An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR. Cell 115: 837-850 (2003). *
Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI, Kaestner KH, Lazar MA. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev. Cell 5: 657-663 (2003). *
Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3: 569-581 (2003). *
Rao BM, Girvin AT, Ciardelli T, Lauffenburger DA, Wittrup KD. Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity. Protein Eng. 16: 1081-1087 (2003). *
Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J. Leukoc. Biol. 74: 3-15 (2003). *
Rassa JC, Ross SR. Viruses and Toll-like receptors. Microbes Infect. 5: 961-968 (2003). *
Rath HC. Role of commensal bacteria in chronic experimental colitis: lessons from the HLA-B27 transgenic rat. Pathobiology 70: 131-138 (2003).
Rauh P, Rickes S, Fleischhacker M. Microsatellite alterations in free-circulating serum DNA in patients with ulcerative colitis. Dig. Dis. 21: 363-366 (2003).
Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3: 781-790 (2003). *
Rausa FM, Tan Y, Costa RH. Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding. Mol. Cell. Biol. 23: 437-449 (2003). *
Rayhorn N. PATIENT EDUCATION SERIES Patient-education guide: inflammatory bowel disease. Nursing 33: 54-55 (2003).
Rayner CK, McCormack G, Emmanuel AV, Kamm MA. Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis. Aliment. Pharmacol. Ther. 18: 303-308 (2003). *
Reboul MP, Laharie D, Amouretti M, Lacombe D, Iron A. Isolated idiopathic chronic pancreatitis associated with a compound heterozygosity for two mutations of the CFTR gene. Gastroenterol. Clin. Biol. 27: 821-824 (2003).
Reddy SI. Making a good thing last: the effect of intravenous hydrocortisone premedication on the immunogenicity of infliximab. Inflamm. Bowel Dis. 9: 339-340 (2003). *
Reddy SI, Burakoff R. Inflammatory bowel disease in African Americans. Inflamm. Bowel Dis. 9: 380-385 (2003). *
Reding R, Gras J, Sokal E, Otte JB, Davies HF. Steroid-free liver transplantation in children. Lancet 362: 2068-2070 (2003). *
Redinger RN. Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis. J. Lab. Clin. Med. 142: 7-20 (2003). *
Redinger RN. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: bile salts as ligands for nuclear hormone receptors. Can. J. Gastroenterol. 17: 265-271 (2003). *
Redinger RN. The coming of age of our understanding of the enterohepatic circulation of bile salts. Am. J. Surg. 185: 168-172 (2003). *
Rees JR, Longstaff A, Rigby HL, Smith DL, Dixon AR. An unusual cause for a colonic stricture: a case of Mycobacterium xenopi mimicking malignancy. Postgrad. Med. J. 79: 705-706 (2003). *
Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP. Bone density improves with disease remission in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 15: 1267-1273 (2003).
Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm. Bowel Dis. 9: 98-103 (2003). *
Rehman HU. Sjogren's syndrome. Yonsei. Med. J. 44: 947-954 (2003). *
Reich K, Westphal G, Konig IR, Mossner R, Schupp P, Gutgesell C, Hallier E, Ziegler A, Neumann C. Cytokine gene polymorphisms in atopic dermatitis. Br. J. Dermatol. 148: 1237-1241 (2003). *
Reichel PH, Seemann C, Csernok E, Schroder JM, Muller A, Gross WL, Schultz H. Bactericidal/permeability-increasing protein is expressed by human dermal fibroblasts and upregulated by interleukin 4. Clin. Diagn. Lab. Immunol. 10: 473-475 (2003). *
Reichen J. Gallstones - natural history and conservative management. Ther. Umsch. 60: 109-112 (2003).
Reichhart JM. TLR5 takes aim at bacterial propeller. Nat. Immunol. 4: 1159-1160 (2003). *
Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M, Wijnholds J, Borst P. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. U.S.A. 100: 9244-9249 (2003). *
Reimold AM. New indications for treatment of chronic inflammation by TNF-alpha blockade. Am. J. Med. Sci. 325: 75-92 (2003).
Reimund JM. Leptin and chronic inflammatory bowel disease: the human labyrinth. Gastroenterol. Clin. Biol. 27: 983-985 (2003).
Reinacher-Schick A, Schoeneck A, Graeven U, Schwarte-Waldhoff I, Schmiegel W. Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells. Carcinogenesis 24: 443-451 (2003). *
Reindl M, Lutterotti A, Ingram J, Schanda K, Gassner C, Deisenhammer F, Berger T, Lorenz E. Mutations in the gene for Toll-like receptor 4 and multiple sclerosis. Tissue Antigens 61: 85-88 (2003). *
Reinehr R, Graf D, Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. Gastroenterology 125: 839-853 (2003). *
Remes-Troche JM, Takahashi T, Velasco L, Garcia-Osogobio S, Uscanga L, Gamboa-Dominguez A, Santillan-Doherty P. Effect of ulcerative colitis in the bursting strength of colonic anastomoses in rats. J. Invest. Surg. 16: 335-343 (2003).
Remus N, Alcais A, Abel L. Human genetics of common mycobacterial infections. Immunol. Res. 28: 109-129 (2003).
Ren S, Marques D, Redford K, Hylemon PB, Gil G, Vlahcevic ZR, Pandak WM. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in the rat. Metabolism 52: 636-642 (2003). *
Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat. Rev. Immunol. 3: 667-676 (2003). *
Renault MA, Jalvy S, Belloc I, Pasquet S, Sena S, Olive M, Desgranges C, Gadeau AP. AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells. Circ. Res. 93: 674-681 (2003). *
Rendon-Mitchell B, Ochani M, Li J, Han J, Wang H, Yang H, Susarla S, Czura C, Mitchell RA, Chen G, Sama AE, Tracey KJ, Wang H. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 170: 3890-3897 (2003). *
Rennert J, Coffman JA, Mushegian AR, Robertson AJ. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol. Biol. 3: 4 (2003). *
Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52: 988-997 (2003). *
Reumaux D, de Boer M, Meijer AB, Duthilleul P, Roos D. Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO. J. Leukoc. Biol. 73: 841-849 (2003). *
Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel JF. Serological markers in inflammatory bowel diseases. Best Pract. Res. Clin. Gastroenterol. 17: 19-35 (2003). *
Rex DK. Colorectal cancer surveillance, screening, and colonoscopy. American College of Gastroenterology 68th Annual Scientific Meeting and Postgraduate Course, October 10 - 15, 2003, Baltimore, Maryland (2003).
Rex DK. Is virtual colonoscopy ready for widespread application? Gastroenterology 125: 608-610 (2003). *
Rhew EY, Ramsey-Goldman R, Buchman AL. Sjogren's syndrome in association with Crohn's disease. J. Clin. Gastroenterol. 37: 312-314 (2003).
Ricchi P, Pignata S, Iaffaioli RV, Daniele B. Cyclo-oxygenase inhibition in colorectal adenomas and cancer. J. Clin. Gastroenterol. 37: 281-287 (2003).
Ricchi P, Zarrilli R, Di Palma A, Acquaviva AM. Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br. J. Cancer 88: 803-807 (2003). *
Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160: 65-75 (2003). *
Rice LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve. Clin. J. Med. 70: 793-800 (2003).
Richardson B. DNA methylation and autoimmune disease. Clin. Immunol. 109: 72-79 (2003). *
Richardson CE, Morgan JM, Jasani B, Green JT, Rhodes J, Williams GT, Lindstrom J, Wonnacott S, Peel S, Thomas GA. Effect of smoking and transdermal nicotine on colonic nicotinic acetylcholine receptors in ulcerative colitis. QJM 96: 57-65 (2003). *
Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol. Clin. North Am. 32: 235-261 (2003). *
Richter-Hintz D, Their R, Steinwachs S, Kronenberg S, Fritsche E, Sachs B, Wulferink M, Tonn T, Esser C. Allelic variants of drug metabolizing enzymes as risk factors in psoriasis. J. Invest. Dermatol. 120: 765-770 (2003). *
Riegler G, Bossa F, Caserta L, Pera A, Tonelli F, Sturniolo GC, Oliva L, Contessini Avesani E, Poggioli G; IG-IBD Group. Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study. Dig. Liver Dis. 35: 628-634 (2003).
Riemann JF. Diagnostic laparoscopy. Endoscopy 35: 43-47 (2003).
Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D. Prometheus - a new extracorporeal system for the treatment of liver failure. J. Hepatol. 39: 984-990 (2003). *
Rifas L, Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum. 48: 993-1001 (2003). *
Riise T, Nortvedt MW, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 61: 1122-1124 (2003).
Riksen NP, Keuning JJ, Vreugdenhil G. Rituximab in the treatment of relapsing idiopathic thrombocytopenic purpura. Neth. J. Med. 61: 262-265 (2003). *
Riordan SM, Williams R. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin. Liver Dis. 23: 203-215 (2003).
Risch N, Tang H, Katzenstein H, Ekstein J. Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. Am. J. Hum. Genet. 72: 812-822 (2003). *
Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, Keppler D. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38: 374-384 (2003). *
Rivera-Espinosa L, Muriel P, Ordaz Gallo M, Perez-Urizar J, Palma-Aguirre A, Castaneda-Hernandez G. Ketorolac pharmacokinetics in experimental cirrhosis by bile duct ligation in the rat. Ann. Hepatol. 2: 175-181 (2003). *
Riyazi N, Spee J, Huizinga TW, Schreuder GM, de Vries RR, Dekker FW, Kloppenburg M. HLA class II is associated with distal interphalangeal osteoarthritis. Ann. Rheum. Dis. 62: 227-230 (2003). *
Rizzello F, Gionchetti P, Venturi A, Campieri M. Review article: medical treatment of severe ulcerative colitis. Aliment. Pharmacol. Ther. 17 Suppl. 2: 7-10 (2003). *
Roberts AB, Russo A, Felici A, Flanders KC. Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci. 995: 1-10 (2003). *
Roberts EA. Nonalcoholic steatohepatitis in children. Curr. Gastroenterol. Rep. 5: 253-259 (2003).
Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 37: 1475-1492 (2003). *
Robertson GR, Field J, Goodwin B, Bierach S, Tran M, Lehnert A, Liddle C. Transgenic mouse models of human CYP3A4 gene regulation. Mol. Pharmacol. 64: 42-50 (2003). *
Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin. Pharmacokinet. 42: 123-137 (2003).
Robinson CM, Shirey KA, Carlin JM. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. J. Interferon Cytokine Res. 23: 413-421 (2003). *
Robinson P, Okhuysen PC, Chappell CL, Weinstock JV, Lewis DE, Actor JK, White AC Jr. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J. Infect. Dis. 188: 290-296 (2003). *
Robinson WH, Steinman L, Utz PJ. Protein arrays for autoantibody profiling and fine-specificity mapping. Proteomics 3: 2077-2084 (2003). *
Robinson WH, Utz PJ, Steinman L. Genomic and proteomic analysis of multiple sclerosis. Opinion. Curr. Opin. Immunol. 15: 660-667 (2003). *
Robles R, Figueras J, Turrion VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Garcia-Valdelcasas JC, Lopez P, Gomez M, de Vicente E, Loinaz C, Santoyo J, Casanova D, Bernardos A, Fernandez JA, Marin C, Ramirez P, Bueno FS, Jaurrieta E, Parrilla P. Liver transplantation for hilar cholangiocarcinoma: Spanish experience. Transplant. Proc. 35: 1821-1822 (2003). *
Roblin X, Serre-Debeauvais F, Phelip JM, Bessard G, Bonaz B. Drug interaction between infliximab and azathioprine in patients with Crohn's disease. Aliment. Pharmacol. Ther. 18: 917-925 (2003). *
Rocca P, Cocuzza E, Rasetti R, Rocca G, Zanalda E, Bogetto F. Predictors of psychiatric disorders in liver transplantation candidates: logistic regression models. Liver Transpl. 9: 721-726 (2003). *
Rocha PN, Plumb TJ, Coffman TM. Eicosanoids: lipid mediators of inflammation in transplantation. Springer Semin. Immunopathol. 25: 215-227 (2003). *
Rockey DC. Update on treatment of portal hypertension. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Rodgers MS, Windsor JA, Koea JB, McCall JL. Laparoscopic staging of upper gastrointestinal malignancy. ANZ J. Surg. 73: 806-810 (2003). *
Rodriguez C, Carrion F, Marinovic MA, Chavez E, Preisler J, Pooley F, Futatani T, Ochs HD. X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case. Rev. Med. Chil. 131: 303-308 (2003).
Rodriguez HJ, Bass NM. Primary sclerosing cholangitis. Semin. Gastrointest. Dis. 14: 189-198 (2003).
Rodriguez-Caballero A, Garcia-Montero A, Bueno C, Orfao A. Flow cytometric analysis of cytokine responses in stimulated whole blood: simultaneous quantitation of TNF-alpha-secreting cells and soluble cytokines. Curr. Protoc. Cytom. Chapter 9: Unit 9.21 (2003).
Rodriguez-Garay EA. Cholestasis: human disease and experimental animal models. Ann. Hepatol. 2: 150-158 (2003). *
Roeb E, Purucker E, Gartung C, Geier A, Jansen B, Winograd R, Matern S. Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis. Scand. J. Gastroenterol. 38: 878-885 (2003).
Roesler KW, Schmider W, Kist M, Batsford S, Schiltz E, Oelke M, Tuczek A, Dettenborn T, Behringer D, Kreisel W. Identification of beta-subunit of bacterial RNA-polymerase - a non-species-specific bacterial protein - as target of antibodies in primary biliary cirrhosis. Dig. Dis. Sci. 48: 561-569 (2003). *
Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33: 21-22 (2003). *
Rogner UC, Avner P. Congenic mice: cutting tools for complex immune disorders. Nat. Rev. Immunol. 3: 243-252 (2003). *
Rogoveanu I, Saftoiu A, Cazacu S, Ciurea T. Color Doppler transabdominal ultrasonography for the assessment of the patients with inflammatory bowel disease during treatment. Rom. J. Gastroenterol. 12: 277-281 (2003).
Rogozina VA, Rumiantsev VG. Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis. Eksp. Klin. Gastroenterol. 1: 58-9, 183 (2003).
Rolla G. Is nitric oxide the ultimate mediator in hepatopulmonary syndrome? J. Hepatol. 38: 668-670 (2003). *
Rolo AP, Palmeira CM, Wallace KB. Mitochondrially mediated synergistic cell killing by bile acids. Biochim. Biophys. Acta 1637: 127-132 (2003). *
Romagnolo DF, Chirnomas RB, Ku J, Jeffy BD, Payne CM, Holubec H, Ramsey L, Bernstein H, Bernstein C, Kunke K, Bhattacharyya A, Warneke J, Garewal H. Deoxycholate, an endogenous tumor promoter and DNA damaging agent, modulates BRCA-1 expression in apoptosis-sensitive epithelial cells: loss of BRCA-1 expression in colonic adenocarcinomas. Nutr. Cancer 46: 82-92 (2003).
Roman ID, Fernandez-Moreno MD, Fueyo JA, Roma MG, Coleman R. Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicol. Sci. 71: 276-281 (2003). *
Romero R, Abramowsky CR, Pillen T, Smallwood GA, Heffron TG. Peripheral eosinophilia and eosinophilic gastroenteritis after pediatric liver transplantation. Pediatr. Transplant. 7: 484-488 (2003).
Romphruk AV, Oka A, Romphruk A, Tomizawa M, Choonhakarn C, Naruse TK, Puapairoj C, Tamiya G, Leelayuwat C, Inoko H. Corneodesmosin gene: no evidence for PSORS 1 gene in North-eastern Thai psoriasis patients. Tissue Antigens 62: 217-224 (2003). *
Rook GA, Martinelli R, Brunet LR. Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr. Opin. Allergy Clin. Immunol. 3: 337-342 (2003).
Roomans GM. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis. Am. J. Respir. Med. 2: 413-431 (2003).
Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J. Pathol. 200: 553-560 (2003). *
Ros JE, Roskams TA, Geuken M, Havinga R, Splinter PL, Petersen BE, LaRusso NF, van der Kolk DM, Kuipers F, Faber KN, Muller M, Jansen PL. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut 52: 1060-1067 (2003). *
Rosa N, Giamundo A, Jura A, Iaccarino G, Romano A. Mesalazine-associated benign intracranial hypertension in a patient with ulcerative colitis. Am. J. Ophthalmol. 136: 212-213 (2003). *
Rose T, Moreau JL, Eckenberg R, Theze J. Structural analysis and modeling of a synthetic interleukin-2 mimetic and its interleukin-2Rbeta2 receptor. J. Biol. Chem. 278: 22868-22876 (2003). *
Rose-John S, Schooltink H. CDP-870. Celltech/Pfizer. Curr. Opin. Investig. Drugs 4: 588-592 (2003).
Rosen HR, Prieto M, Casanovas-Taltavull T, Cuervas-Mons V, Guckelberger O, Muiesan P, Strong RW, Bechstein WO, O'Grady J, Zaman A, Chan B, Berenguer J, Williams R, Heaton N, Neuhaus P. Validation and refinement of survival models for liver retransplantation. Hepatology 38: 460-469 (2003). *
Rosen-Wolff A, Quietzsch J, Schroder H, Lehmann R, Gahr M, Roesler J. Two German CINCA (NOMID) patients with different clinical severity and response to anti-inflammatory treatment. Eur. J. Haematol. 71: 215-219 (2003). *
Rosenbaum JT, Planck SR, Davey MP, Iwanaga Y, Kurz DE, Martin TM. With a mere nod, uveitis enters a new era. Am. J. Ophthalmol. 136: 729-732 (2003). *
Rosenberg WM. Rating fibrosis progression in chronic liver diseases. J. Hepatol. 38: 357-360 (2003). *
Rosenfeld JM, Vargas R Jr, Xie W, Evans RM. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol. 17: 1268-1282 (2003). *
Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124: 1001-1009 (2003). *
Roskams TA, Libbrecht L, Desmet VJ. Progenitor cells in diseased human liver. Semin. Liver Dis. 23: 385-396 (2003).
Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 125: 452-459 (2003). *
Ross AC. Retinoid production and catabolism: role of diet in regulating retinol esterification and retinoic acid oxidation. J. Nutr. 133: 291S-296S (2003). *
Ross AM 4th, Anupindi SA, Balis UJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2003. A 14-year-old boy with ulcerative colitis, primary sclerosing cholangitis, and partial duodenal obstruction. N. Engl. J. Med. 348: 1464-1476 (2003). *
Rossman MD, Kreider ME. Is chronic beryllium disease sarcoidosis of known etiology? Sarcoidosis Vasc. Diffuse Lung Dis. 20: 104-109 (2003).
Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D; ACCESS Group. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am. J. Hum. Genet. 73: 720-735 (2003). *
Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 361: 1871-1872 (2003). *
Rost D, Herrmann T, Sauer P, Schmidts HL, Stieger B, Meier PJ, Stremmel W, Stiehl A. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Hepatology 38: 187-195 (2003). *
Roth DB. Restraining the V(D)J recombinase. Nat. Rev. Immunol. 3: 656-666 (2003).
Rothkrantz-Kos S, Drent M, Rutgers A, Heeringa P, De Vries J, van Dieijen-Visser MP, Cohen Tervaert JW. Relationship between myeloperoxidase promotor polymorphism and disease severity in sarcoidosis. Eur. J. Intern. Med. 14: 296-301 (2003).
Rottem M, Shoenfeld Y. Asthma as a paradigm for autoimmune disease. Int. Arch. Allergy Immunol. 132: 210-214 (2003).
Rougier P, Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann. Oncol. 14 Suppl. 2: ii3-5 (2003). *
Roulet A, Puel O, Gesta S, Lepage JF, Drag M, Soll M, Alvinerie M, Pineau T. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur. J. Pharmacol. 460: 85-91 (2003). *
Roussomoustakaki M, Dimoulios P, Chatzicostas C, Kritikos HD, Romanos J, Panayiotides JG, Kouroumalis EA. Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy. J. Gastroenterol. 38: 1000-1014 (2003). *
Rowland-Jones SL. Timeline: AIDS pathogenesis: what have two decades of HIV research taught us? Nat. Rev. Immunol. 3: 343-348 (2003).
Rowling MJ, Schalinske KL. Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. J. Nutr. 133: 3392-3398 (2003). *
Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann. Hum. Genet. 67: 471-485 (2003). *
Roy CN, Weinstein DA, Andrews NC. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr. Res. 53: 507-512 (2003). *
Roy-Chowdhury J, Locker J, Roy-Chowdhury N. Nuclear receptors orchestrate detoxification pathways. Dev. Cell 4: 607-608 (2003). *
Royet J, Reichhart JM. Detection of peptidoglycans by NOD proteins. Trends Cell Biol. 13: 610-614 (2003). *
Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J. Am. Soc. Nephrol. 14: 593-600 (2003). *
Rubio CA. Adenocarcinoma in inflammatory colorectal disease. Histological features pertinent to local tumour progression. Anticancer Res. 23: 4313-4318 (2003).
Rubio CA. Colorectal adenomas produce lysozyme. Anticancer Res. 23: 5165-5171 (2003).
Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol. 3: 544-556 (2003). *
Ruderman EM. Evaluation and management of psoriatic arthritis: the role of biologic therapy. J. Am. Acad. Dermatol. 49 (2 Suppl.): S125-S132 (2003).
Rudolph KL. Telomeres and telomerase in liver regeneration and cancer. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 19. October 20 - 21 (2003). *
Rudow DL, Russo MW, Hafliger S, Emond JC, Brown RS Jr. Clinical and ethnic differences in candidates listed for liver transplantation with and without potential living donors. Liver Transpl. 9: 254-259 (2003). *
Rueda B, Pascual M, Lopez-Nevot MA, Koeleman BP, Ortega E, Maldonado J, Lopez M, Martin J. Association of MICA-A5.1 allele with susceptibility to celiac disease in a family study. Am. J. Gastroenterol. 98: 359-362 (2003). *
Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 124: 1292-1299 (2003). *
Rulyak SJ, Saunders MD, Lee SD. Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease. J. Clin. Gastroenterol. 36: 234-237 (2003).
Runstadler JA, Saila H, Savolainen A, Leirisalo-Repo M, Aho K, Tuomilehto-Wolf E, Tuomilehto J, Seldin MF. Analysis of MHC region genetics in Finnish patients with juvenile idiopathic arthritis: evidence for different locus-specific effects in polyarticular vs pauciarticular subsets and a shared DRB1 epitope. Genes Immun. 4: 326-335 (2003). *
Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174 (2003). *
Russell SJ, Peng KW. Primer on medical genomics. Part X: Gene therapy. Mayo Clin. Proc. 78: 1370-1383 (2003). *
Russinko PJ, Agarwal S, Choi MJ, Kelty PJ. Obstructive nephropathy secondary to sulfasalazine calculi. Urology 62: 748 (2003).
Russo MW, Brown RS Jr. Ethical issues in living donor liver transplantation. Curr. Gastroenterol. Rep. 5: 26-30 (2003).
Russo MW, Sood A, Jacobson IM, Brown RS Jr. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am. J. Gastroenterol. 98: 2521-2527 (2003). *
Rutgeerts P, Lemmens L, Van Assche G, Noman M, Borghini-Fuhrer I, Goedkoop R. Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study. Aliment. Pharmacol. Ther. 17: 185-192 (2003). *
Rutgeerts P, Van Deventer S, Schreiber S. Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition. Aliment. Pharmacol. Ther. 17: 1435-1450 (2003). *
Rutgers A, Heeringa P, Tervaert JW. The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin. Exp. Rheumatol. 21 (6 Suppl. 32): S55-S63 (2003).
Ryan BM, Russel MG, Langholz E, Stockbrugger RW. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow. Am. J. Gastroenterol. 98: 1682-1687 (2003). *
Ryder SD; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52 Suppl. 3: iii1-iii8 (2003). *
Saadoun D, Deslandre CJ, Allanore Y, Pham XV, Kahan A. Sustained response to infliximab in 2 patients with refractory relapsing polychondritis. J. Rheumatol. 30: 1394-1395 (2003).
Sachar DB. Ten common errors in the management of inflammatory bowel disease. Inflamm. Bowel Dis. 9: 205-209 (2003). *
Sachar DB. 6-Mercaptopurine beats a bum rap. Gastroenterology 125: 610-612 (2003). *
Sachdeva K, Yan B, Chichester CO. Lipopolysaccharide and cecal ligation/puncture differentially affect the subcellular distribution of the pregnane X receptor but consistently cause suppression of its target genes CYP3A. Shock 19: 469-474 (2003). *
Sadler CH, Rutitzky LI, Stadecker MJ, Wilson RA. IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur. J. Immunol. 33: 880-888 (2003). *
Safe S, Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem. Res. Toxicol. 16: 807-816 (2003). *
Sahajpal A, Vollmer C, Pollett A, Gallinger S. Sclerosing pancreatitis presenting as a periampullary tumour. HPB (Oxford) 5: 268-272 (2003). *
Sahoo S, Hart J. Histopathological features of L-asparaginase-induced liver disease. Semin. Liver Dis. 23: 295-299 (2003).
Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am. J. Gastroenterol. 98: 112-117 (2003). *
Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Dig. Liver Dis. 35: 862-868 (2003).
Saibeni S, Vecchi M, Faioni EM, Franchi F, Rondonotti E, Borsi G, de Franchis R. Val34Leu factor XIII polymorphism in Italian patients with inflammatory bowel disease. Dig. Liver Dis. 35: 32-36 (2003).
Saito N, Courtois G, Chiba A, Yamamoto N, Nitta T, Hironaka N, Rowe M, Yamamoto N, Yamaoka S. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278: 46565-46575 (2003). *
Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J. Gastroenterol. 38: 229-237 (2003). *
Sakaeda T, Nakamura T, Okumura K. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 4: 397-410 (2003).
Sakaguchi S. The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J. Clin. Invest. 112: 1310-1312 (2003). *
Sakata H, Kawamura N, Horie T, Ohizumi H, Tamaki T, Kukita K, Meguro J, Yonekawa M, Saitoh M, Kawamura A. Successful treatment of ulcerative colitis with leukocytapheresis using non-woven polyester filter. Therap. Apher. Dial. 7: 536-539 (2003).
Sakhalkar HS, Dalal MK, Salem AK, Ansari R, Fu J, Kiani MF, Kurjiaka DT, Hanes J, Shakesheff KM, Goetz DJ. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 100: 15895-15900 (2003). *
Sako K, Imamura Y, Nishimata H, Tahara K, Kubozono O, Tsubouchi H. Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis. Hepatol. Res. 26: 327-329 (2003).
Sakrak O, Akpinar M, Bedirli A, Akyurek N, Aritas Y. Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage. Hepatogastroenterology 50: 1542-1546 (2003).
Sakugawa H, Nakasone H, Nakayoshi T, Yamashiro T, Maeshiro T, Kobashigawa K, Kinjo F, Saito A, Zukeran H, Nakanuma Y, Ohba K. Epidemiology of primary biliary cirrhosis among women with elevated gamma-glutamyl transpeptidase levels in Okinawa, Japan. Hepatol. Res. 26: 330-336 (2003).
Salem TA, El-Refaei MF, Badra GA. Study of antioxidant enzymes level and phagocytic activity in chronic liver disease patients. Egypt. J. Immunol. 10: 37-45 (2003).
Salky B. Severe gastroduodenal Crohn's disease: surgical treatment. Inflamm. Bowel Dis. 9: 129-130 (2003). *
Sampaio-Barros PD, Conde RA, Donadi EA, Kraemer MH, Persoli L, Coimbra IB, Costallat LT, Samara AM, Bertolo MB. Undifferentiated spondyloarthropathies in Brazilians: importance of HLA-B27 and the B7-CREG alleles in characterization and disease progression. J. Rheumatol. 30: 2632-2637 (2003).
Sampietro GM, Sartani A, Danelli P, Ghizzoni M, Sposito C, Maconi G, Parente E, Taschieri AM. Strictureplasty in the surgical treatment of complicated Crohn's disease. Ann. Ital. Chir. 74: 659-663 (2003).
Sams HH, Kiripolsky MG, Boyd AS, King LE Jr. Crohn's disease of the penis masquerading as pyoderma gangrenosum: a case report and review of the literature. Cutis. 72: 432-437 (2003).
Sanchez D, Tuckova L, Mothes T, Kreisel W, Benes Z, Tlaskalova-Hogenova H. Epitopes of calreticulin recognised by IgA autoantibodies from patients with hepatic and coeliac disease. J. Autoimmun. 21: 383-392 (2003). *
Sanchez EQ, Levy MF, Goldstein RM, Fasola CG, Tillery GW, Netto GJ, Watkins DL, Weinstein JS, Murray NG, Byers D, Christensen LL, Klintmalm GB. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation 76: 1583-1588 (2003).
Sanchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Rodriguez Garay EA, Mottino AD. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. J. Pharmacol. Exp. Ther. 306: 279-286 (2003). *
Sanchez-Pobre P, Solis-Herruzo J. Autoimmune cholangitis, nosological location. Rev. Esp. Enferm. Dig. 95: 791-794 (2003).
Sandborn WJ. Evidence-based treatment algorithm for mild to moderate Crohn's disease. Am. J. Gastroenterol. 98: S1-S5 (2003). *
Sandborn WJ. Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 501-505 (2003).
Sandborn WJ. Strategies for targeting tumour necrosis factor in IBD. Best Pract. Res. Clin. Gastroenterol. 17: 105-117 (2003). *
Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 125: 1508-1530 (2003). *
Sandborn WJ, Feagan BG. Review article: mild to moderate Crohn's disease - defining the basis for a new treatment algorithm. Aliment. Pharmacol. Ther. 18: 263-277 (2003). *
Sandborn WJ, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis. Aliment. Pharmacol. Ther. 17: 29-42 (2003). *
Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 125: 380-388 (2003). *
Sandborn WJ, Sands BE, Wolf DC, Valentine JF, Safdi M, Katz S, Isaacs KL, Wruble LD, Katz J, Present DH, Loftus EV Jr, Graeme-Cook F, Odenheimer DJ, Hanauer SB. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment. Pharmacol. Ther. 17: 1355-1364 (2003). *
Sandborn WJ, Yednock TA. Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin. Am. J. Gastroenterol. 98: 2372-2382 (2003). *
Sandhu BS, Sanyal AJ. Pregnancy and liver disease. Gastroenterol. Clin. North Am. 32: 407-436, ix (2003). *
Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N. Engl. J. Med. 348: 883-890 (2003). *
Sands BE, Arsenault JE, Rosen MJ, Alsahli M, Bailen L, Banks P, Bensen S, Bousvaros A, Cave D, Cooley JS, Cooper HL, Edwards ST, Farrell RJ, Griffin MJ, Hay DW, John A, Lidofsky S, Olans LB, Peppercorn MA, Rothstein RI, Roy MA, Saletta MJ, Shah SA, et al. Risk of early surgery for Crohn's disease: implications for early treatment strategies. Am. J. Gastroenterol. 98: 2712-2178 (2003). *
Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther. Apher. Dial. 7: 48-59 (2003).
Sans M, Tassies D, Pellise M, Espinosa G, Quinto L, Pique JM, Reverter JC, Panes J. The 4G/4G genotype of the 4G/5G polymorphism of the type-1 plasminogen activator inhibitor (PAI-1) gene is a determinant of penetrating behaviour in patients with Crohn's disease. Aliment. Pharmacol. Ther. 17: 1039-1047 (2003). *
Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ. Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc. Natl. Acad. Sci. U.S.A. 100: 3065-3070 (2003). *
Santana MA, Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J. Cell Physiol. 195: 392-401 (2003). *
Santini D, Vincenzi B, Massacesi C, Picardi A, Gentilucci UV, Esposito V, Liuzzi G, La Cesa A, Rocci L, Marcucci F, Montesarchio V, Groeger AM, Bonsignori M, Tonini G. S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury. Anticancer Res. 23: 5173-5179 (2003).
Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F. NF-kappaB expression in oral and cutaneous lichen planus. J. Pathol. 201: 466-472 (2003). *
Sapone A, Vaira D, Trespidi S, Perna F, Gatta L, Tampieri A, Ricci C, Cantelli-Forti G, Miglioli M, Biagi GL, Paolini M. The clinical role of cytochrome P450 genotypes in Helicobacter pylori management. Am. J. Gastroenterol. 98: 1010-1015 (2003). *
Sarkhosh K, Tredget EE, Karami A, Uludag H, Iwashina T, Kilani RT, Ghahary A. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J. Cell. Biochem. 90: 206-217 (2003). *
Sarkhosh K, Tredget EE, Li Y, Kilani RT, Uludag H, Ghahary A. Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3-dioxygenase expression of interferon-gamma-treated skin cells in a co-culture system. Wound Repair Regen. 11: 337-345 (2003).
Saro Gismera C, Riestra Menendez S, Sanchez Fernandez R, Milla Crespo A, Lacort Fernandez M, Arguelles Fernandez G, Chobak Z, Florido Mancheno JI, Anton Magarzo JL, Altadill Arregui A, Vizoso F, Pineda Garcia E, Fernandez de Ocariz Archs E, et al. Epidemiology in inflammatory bowel disease in five areas of Asturias, Spain. An. Med. Interna. 20: 232-238 (2003).
Sarrauste de Menthiere C, Terriere S, Pugnere D, Ruiz M, Demaille J, Touitou I. INFEVERS: the registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res. 31: 282-285 (2003). *
Sartor RB. Clinical applications of advances in the genetics of IBD. Rev. Gastroenterol. Disord. 3 Suppl. 1: S9-S17 (2003). *
Sartor RB. Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr. Opin. Gastroenterol. 19: 358-365 (2003).
Sartor RB. Innate immunity in the pathogenesis and therapy of IBD. J. Gastroenterol. 38 Suppl. 15: 43-47 (2003).
Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, Isik N, Serdaroglu P. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J. Neuroimmunol. 145: 127-134 (2003).
Sarzi-Puttini P, Ardizzone S, Manzionna G, Atzeni F, Colombo E, Antivalle M, Carrabba M, Bianchi-Porro G. Infliximab-induced lupus in Crohn's disease: a case report. Dig. Liver Dis. 35: 814-817 (2003).
Sasaki M, Bharwani S, Jordan P, Elrod JW, Grisham MB, Jackson TH, Lefer DJ, Alexander JS. Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic. Biol. Med. 35: 1679-1687 (2003).
Sasaki M, Bharwani S, Jordan P, Joh T, Manas K, Warren A, Harada H, Carter P, Elrod JW, Wolcott M, Grisham MB, Alexander JS. The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis. J. Pharmacol. Exp. Ther. 305: 78-85 (2003). *
Sasaki M, Huang SF, Chen MF, Jan YY, Yeh TS, Ishikawa A, Mollenhauer J, Poustka A, Tsuneyama K, Nimura Y, Oda K, Nakanuma Y. Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis. Dig. Dis. Sci. 48: 1234-1240 (2003). *
Sasaki M, Jordan P, Houghton J, Meng X, Itoh M, Joh T, Alexander JS. Transfection of IL-10 expression vectors into endothelial cultures attenuates alpha4beta7-dependent lymphocyte adhesion mediated by MAdCAM-1. BMC Gastroenterol. 3: 3 (2003). *
Sasaki M, Tsuneyama K, Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab. Invest. 83: 1403-1413 (2003).
Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct. Funct. 28: 105-112 (2003). *
Sato S, Hayakawa I, Hasegawa M, Fujimoto M, Takehara K. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J. Invest. Dermatol. 120: 542-547 (2003). *
Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, Suga T. Evaluation of hemodynamics in esophageal varices. Value of endoscopic color Doppler ultrasonography with a galactose-based contrast agent. Hepatol. Res. 25: 55-61 (2003). *
Satoh H, Moriyama N, Hara C, Yamada H, Horita S, Kunimi M, Tsukamoto K, Iso-O N, Inatomi J, Kawakami H, Kudo A, Endou H, Igarashi T, Goto A, Fujita T, Seki G. Localization of Na+-HCO3- cotransporter (NBC-1) variants in rat and human pancreas. Am. J. Physiol. Cell. Physiol. 284: C729-C737 (2003). *
Satomura K, Yin M, Shimizu S, Kato Y, Nagano T, Komeichi H, Ohsuga M, Katsuta Y, Aramaki T, Omoto Y. Increased chymase in livers with autoimmune disease: colocalization with fibrosis. J. Nippon Med. Sch. 70: 490-495 (2003).
Satsangi J, Morecroft J, Shah NB, Nimmo E. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract. Res. Clin. Gastroenterol. 17: 3-18 (2003).
Savander M, Ropponen A, Avela K, Weerasekera N, Cormand B, Hirvioja ML, Riikonen S, Ylikorkala O, Lehesjoki AE, Williamson C, Aittomaki K. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 52: 1025-1029 (2003). *
Savkur RS, Wu Y, Bramlett KS, Wang M, Yao S, Perkins D, Totten M, Searfoss G 3rd, Ryan TP, Su EW, Burris TP. Alternative splicing within the ligand binding domain of the human constitutive androstane receptor. Mol. Genet. Metab. 80: 216-226 (2003). *
Savouret JF, Berdeaux A, Casper RF. The aryl hydrocarbon receptor and its xenobiotic ligands: a fundamental trigger for cardiovascular diseases. Nutr. Metab. Cardiovasc. Dis. 13: 104-113 (2003).
Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T, Arakawa T. Comprehensive analysis of intestinal cytokine messenger RNA profile by real-time quantitative polymerase chain reaction in patients with inflammatory bowel disease. Int. J. Mol. Med. 11: 175-179 (2003).
Sawabe T, Horiuchi T, Koga R, Tsukamoto H, Kojima T, Harashima S, Kikuchi Y, Otsuka J, Mitoma H, Yoshizawa S, Niho Y, Watanabe T. Aberrant HS1 molecule in a patient with systemic lupus erythematosus. Genes Immun. 4: 122-131 (2003). *
Sawada K. Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease. Dis. Colon Rectum 46: S66-S77 (2003).
Sawada N, Murata M, Kikuchi K, Osanai M, Tobioka H, Kojima T, Chiba H. Tight junctions and human diseases. Med. Electron Microsc. 36: 147-156 (2003). *
Sawalha AH, Potts R, Schmid WR, Scofield RH, Harley JB. The genetics of primary Sjogren's syndrome. Curr. Rheumatol. Rep. 5: 324-332 (2003).
Sawcer S, Maranian M, Hensiek A, Roxburgh R, Gray J, Compston A. Crohn's associated NOD2 gene variants are not involved in determining susceptibility to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74: 1157 (2003). *
Sawczenko A, Lynn R, Sandhu BK. Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland. Arch. Dis. Child. 88: 990-994 (2003). *
Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch. Dis. Child. 88: 995-1000 (2003). *
Scalone O, Bonaventure C, Pasquier D, Faucheron JL. Should liver biopsy be systematic during surgery for ulcerative colitis? Gastroenterol. Clin. Biol. 27: 94-99 (2003).
Scarisbrick IA, Rodriguez M. Hit-Hit and Hit-Run: viruses in the playing field of multiple sclerosis. Curr. Neurol. Neurosci. Rep. 3: 265-271 (2003).
Scarpa M, Angriman I, Barollo M, Polese L, Ruffolo C, Bertin M, Pagano D, D'Amico DF. Risk factors for recurrence of stenosis in Crohn's disease. Acta Biomed. Ateneo. Parmense. 74 Suppl. 2: 80-83 (2003).
Scarpa R, Cosentini E, Manguso F, Oriente A, Peluso R, Atteno M, Ayala F, D'Arienzo A, Oriente P. Clinical and genetic aspects of psoriatic arthritis "sine psoriasis". J. Rheumatol. 30: 2638-2640 (2003).
Scatena R, Bottoni P, Vincenzoni F, Messana I, Martorana GE, Nocca G, De Sole P, Maggiano N, Castagnola M, Giardina B. Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem. Res. Toxicol. 16: 1440-1447 (2003). *
Schaffer RL 3rd, Kulkarni S, Harper A, Millis JM, Cronin DC 2nd. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl. 9: 1211-1215 (2003). *
Scheinin T, Butler DM, Salway F, Scallon B, Feldmann M. Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis. Clin. Exp. Immunol. 133: 38-43 (2003). *
Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125: 1042-1052 (2003). *
Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am. J. Gastroenterol. 98: 1167-1174 (2003). *
Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, Gortz B, Schulz A, Bergmeister H, Kollias G, Steiner G, Smolen JS. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum. 48: 2042-2051 (2003). *
Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clin. Liver Dis. 7: 453-473 (2003).
Schiffrin EL, Amiri F, Benkirane K, Iglarz M, Diep QN. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Hypertension 42: 664-668 (2003). *
Schilling F, Marker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO. Z. Rheumatol. 62: 527-538 (2003).
Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55: 3-29 (2003). *
Schirrmacher S, Blumenstein I, Stein J. Pathogenesis and treatment of pruritus in patients with cholestasis. Z. Gastroenterol. 41: 259-262 (2003).
Schlissel MS. Regulating antigen-receptor gene assembly. Nat. Rev. Immunol. 3: 890-899 (2003).
Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3: 269-279 (2003). *
Schmeling H, Seliger E, Horneff G. Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin. Exp. Rheumatol. 21: 779-784 (2003).
Schmid R. Hans Popper, 1903-1988. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 73-75. October 17 - 19 (2003). *
Schmidt CK, Brouwer A, Nau H. Chromatographic analysis of endogenous retinoids in tissues and serum. Anal. Biochem. 315: 36-48 (2003). *
Schmidt CK, Hoegberg P, Fletcher N, Nilsson CB, Trossvik C, Hakansson H, Nau H. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the endogenous metabolism of all-trans-retinoic acid in the rat. Arch. Toxicol. 77: 371-383 (2003). *
Schmidt J, Elflein K, Stienekemeier M, Rodriguez-Palmero M, Schneider C, Toyka KV, Gold R, Hunig T. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. J. Neuroimmunol. 140: 143-152 (2003).
Schmidt R. Dialysis. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 103-104. October 17 - 19 (2003). *
Schmidt-Supprian M, Courtois G, Tian J, Coyle AJ, Israel A, Rajewsky K, Pasparakis M. Mature T cells depend on signaling through the IKK complex. Immunity 19: 377-389 (2003). *
Schmith VD, Campbell DA, Sehgal S, Anderson WH, Burns DK, Middleton LT, Roses AD. Pharmacogenetics and disease genetics of complex diseases. Cell. Mol. Life Sci. 60: 1636-1646 (2003). *
Schmitz ML, Bacher S, Dienz O. NF-kappaB activation pathways induced by T cell costimulation. FASEB J. 17: 2187-2193 (2003). *
Schmucker DL, Owen RL, Outenreath R, Thoreux K. Basis for the age-related decline in intestinal mucosal immunity. Clin. Dev. Immunol. 10: 167-172 (2003). *
Schmuth M, Elias PM, Feingold KR. Beyond glucocorticoids, retinoids and vitamin D - the evolution of nuclear hormone type transcription factor targeting in the skin. J. Dtsch. Dermatol. Ges. 1: 352-362 (2003).
Schneider A, Pogue-Geile K, Barmada MM, Myers-Fong E, Thompson BS, Whitcomb DC. Hereditary, familial, and idiopathic chronic pancreatitis are not associated with polymorphisms in the tumor necrosis factor alpha (TNF-alpha) promoter region or the TNF receptor 1 (TNFR1) gene. Genet. Med. 5: 120-125 (2003).
Schneider J, Schulze G. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. Anticancer Res. 23: 5089-5093 (2003).
Schoemaker MH, Gommans WM, de la Rosa LC, Homan M, Klok P, Trautwein C, van Goor H, Poelstra K, Haisma HJ, Jansen PL, Moshage H. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J. Hepatol. 39: 153-161 (2003). *
Schoen RE, Papachristou GI. Screening intervals for colonic neoplasia. Curr. Opin. Gastroenterol. 19: 51-56 (2003).
Scholmerich J. New developments in aetiological mechanisms of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 15: 585-586 (2003).
Schott E, Bonasio R, Ploegh HL. Elimination in vivo of developing T cells by natural killer cells. J. Exp. Med. 198: 1213-1224 (2003). *
Schotte H, Willeke P, Rust S, Assmann G, Domschke W, Gaubitz M, Schluter B. The transforming growth factor-beta1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus. Lupus 12: 86-92 (2003).
Schreyer AG, Golder S, Seitz J, Herfarth H. New diagnostic avenues in inflammatory bowel diseases. Capsule endoscopy, magnetic resonance imaging and virtual enteroscopy. Dig. Dis. 21: 129-137 (2003).
Schroder O, Stein J. Low dose methotrexate in inflammatory bowel disease: current status and future directions. Am. J. Gastroenterol. 98: 530-537 (2003). *
Schrumpf E, Boberg KM. Hepatic and extrahepatic malignancies and primary sclerosing cholangitis. Gut 52: 165 (2003). *
Schrumpf E, Boberg KM. PSC and IBD - when and how do they relate to each other? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 77. October 15-16 (2003). *
Schubert ML. Gastric secretion. Curr. Opin. Gastroenterol. 19: 519-525 (2003).
Schultz H, Csernok E, Herlyn K, Reichel PH, Moosig F, Cornely OA, Fagerhol MK, Gross WL. ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations. Clin. Exp. Rheumatol. 21 (6 Suppl. 32): S117-S120 (2003). *
Schultz H, Heintz H, van Zandbergen G, Ullrich S, Reinhold-Keller E, Gross WL. ANCA against the bactericidal/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patient. Clin. Exp. Rheumatol. 21: 763-766 (2003).
Schultz H, Schinke S, Weiss J, Cerundolo V, Gross WL, Gadola S. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clin. Exp. Immunol. 133: 252-259 (2003). *
Schultz M, Scholmerich J, Rath HC. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig. Dis. 21: 105-128 (2003).
Schumann J, Prockl J, Kiemer AK, Vollmar AM, Bang R, Tiegs G. Silibinin protects mice from T cell-dependent liver injury. J. Hepatol. 39: 333-340 (2003). *
Schuppan D. Markers of progression. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 37. October 17 - 19 (2003). *
Schuppan D. How should and how does antifibrotic therapy act in biliary liver diseases? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 85. October 15-16 (2003). *
Schuppan D. Progress of knowledge of immunopathogenesis in celiac disease. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 59-60. September 12 - 13 (2003). *
Schurmann M. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med. 24: 213-222 (2003).
Schurmann M. Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am. J. Pharmacogenomics 3: 233-243 (2003).
Schurmann M, Valentonyte R, Hampe J, Muller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur. Respir. J. 22: 748-754 (2003). *
Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426 (2003).
Schutz T, Drude C, Paulisch E, Lange KP, Lochs H. Sugar intake, taste changes and dental health in Crohn's disease. Dig. Dis. 21: 252-257 (2003).
Schuuring J, Wesseling P, Verrips A. Severe tacrolimus leukoencephalopathy after liver transplantation. AJNR Am. J. Neuroradiol. 24: 2085-2088 (2003). *
Schwab M, Eichelbaum M, Fromm MF. Genetic polymorphisms of the human MDR1 drug transporter. Annu. Rev. Pharmacol. Toxicol. 43: 285-307 (2003). *
Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124: 26-33 (2003). *
Schwabe RF, Bataller R, Brenner DA. Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G949-G958 (2003). *
Schwalm JD, Lee CH. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ 168: 847-848 (2003). *
Schwartz M. Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes. Ugeskr. Laeger. 165: 912-916 (2003).
Schwartz RH. T cell anergy. Annu. Rev. Immunol. 21: 305-334 (2003). *
Schwartz RS. Shattuck Lecture - Diversity of the immune repertoire and immunoregulation. N. Engl. J. Med. 348: 1017-1026 (2003). *
Schwarz KB, Rosensweig J, Sharma S, Jones L, Durant M, Potter C, Narkewicz MR. Plasma markers of platelet activation in cystic fibrosis liver and lung disease. J. Pediatr. Gastroenterol. Nutr. 37: 187-191 (2003). *
Schwarze C, Terjung B, Lilienweiss P, Beuers U, Herzog V, Sauerbruch T, Spengler U. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis. Clin. Exp. Immunol. 133: 283-289 (2003). *
Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, Krieg T, Schmidt RE, Wonigeit K. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis. Genes Immun. 4: 168-169 (2003). *
Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: presentation, pathology and management of 13 cases. J. Oral Pathol. Med. 32: 576-585 (2003). *
Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene 22: 7496-7511 (2003). *
Scribano M, Prantera C. Review article: medical treatment of moderate to severe Crohn's disease. Aliment. Pharmacol. Ther. 17 Suppl. 2: 23-30 (2003).
Seagroatt V, Goldacre MJ. Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998. J. Epidemiol. Community Health 57: 883-887 (2003).
Sebastian S, O'Morain CA, Buckley MJ. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment. Pharmacol. Ther. 18: 157-165 (2003). *
Sediva A, Bartunkova J, Bartosova J, Jennette C, Falk RJ, Jethwa HS. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa. Microbes Infect. 5: 27-30 (2003). *
Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111: 951-954 (2003). *
Seegers D, Borm ME, van Belzen MJ, Mulder CJ, Bailing J, Crusius JB, Meijer JW, Wijmenga C, Pena AS, Bouma G. IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur. J. Immunogenet. 30: 421-425 (2003). *
Seelen MA, Trouw LA, van der Hoorn JW, Fallaux-van den Houten FC, Huizinga TW, Daha MR, Roos A. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin. Exp. Immunol. 134: 335-343 (2003). *
Segain JP, Raingeard de la Bletiere D, Sauzeau V, Bourreille A, Hilaret G, Cario-Toumaniantz C, Pacaud P, Galmiche JP, Loirand G. Rho kinase blockade prevents inflammation via nuclear factor kappa B inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 124: 1180-1187 (2003). *
Seibold F. Does conservative therapy of chronic inflammatory bowel diseases still play a role? Swiss Surg. 9: 127-130 (2003).
Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev. Gastroenterol. Disord. 3 Suppl. 1: S30-S38 (2003). *
Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, Janek K, Henklein P, Diescher S, Andrieu M, de la Salle H, Weinschenk T, Schild H, Laderach D, Galy A, Haas G, Kloetzel PM, Reiss Y, Hosmalin A. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4: 375-379 (2003). *
Seki S, Kitada T, Iwai S, Kadoya H, Yamada T, Kawada N, Sakaguchi H, Wakasa K. Immunohistochemical detection of Fas and apoptosis in type-1 autoimmune hepatitis. Hepatogastroenterology 50: 1274-1277 (2003).
Sela B. The identification of the immunodominant gliadin epitope. Harefuah. 142: 554-557, 564 (2003).
Selby WS. Current issues in Crohn's disease. Med. J. Aust. 178: 532-533 (2003). *
Seldin MF, Gallagher G. Looking back and looking forward. Genes Immun. 4: 1-3 (2003). *
Selimoglu MA, Ertekin V. Autoimmune hepatitis triggered by Brucella infection or doxycycline or both. Int. J. Clin. Pract. 57: 639-641 (2003).
Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Kenny TP, Van De Water J, Nantz MH, Kurth MJ, Gershwin ME. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38: 1250-1257 (2003). *
Selmi C, Invernizzi P, Tripputi P, Battezzati PM, Bignotto M, Zuin M, Crosignani A, Podda M. T-cell receptor polymorphism in primary biliary cirrhosis. Ann. Ital. Med. Int. 18: 149-153 (2003).
Selmi C, Zuin M, Biondi ML, Invernizzi P, Battezzati PM, Bernini M, Meda F, Gershwin ME, Podda M. Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity. J. Gastroenterol. Hepatol. 18: 1150-1155 (2003). *
Selvaggi G, Weppler D, Tzakis A. Liver and gastrointestinal transplantation at the University of Miami. Clin. Transpl. 2003: 255-266 (2003).
Selvam R, Vijaya R, Sivakamasundari P. Characterisation of nuclear pore complex oxalate binding protein from human kidney. Mol. Cell. Biochem. 243: 1-8 (2003). *
Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 125: 917-936 (2003). *
Semple JI, Ribas G, Hillyard G, Brown SE, Sanderson CM, Campbell RD. A novel gene encoding a coiled-coil mitochondrial protein located at the telomeric end of the human MHC class III region. Gene 314: 41-54 (2003). *
Sen D, Isenberg DA. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12: 651-658 (2003).
Sen S, Williams R. New liver support devices in acute liver failure: a critical evaluation. Semin. Liver Dis. 23: 283-294 (2003).
Sercarz EE, Maverakis E. Mhc-guided processing: binding of large antigen fragments. Nat. Rev. Immunol. 3: 621-629 (2003). *
Serfaty L, De Leusse A, Rosmorduc O, Desaint B, Flejou JF, Chazouilleres O, Poupon RE, Poupon R. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology 38: 203-209 (2003). *
Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24: 353-362 (2003). *
Serrano MA, Macias RI, Vallejo M, Briz O, Bravo A, Pascual MJ, St-Pierre MV, Stieger B, Meier PJ, Marin JJ. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J. Pharmacol. Exp. Ther. 305: 515-524 (2003). *
Setchell KD, Heubi JE, Bove KE, O'Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH Jr. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology 124: 217-232 (2003). *
Sethy PK, Dutta U, Aggrawal AN, Das R, Gulati M, Sinha SK, Singh K. Pulmonary and hematological alterations in idiopathic ulcerative colitis. Indian J. Gastroenterol. 22: 176-179 (2003).
Settbas Y, Alper M, Akcan Y, Gurbuz Y, Oksuz S. Massive gastrointestinal tuberculosis in a young patient without immunosuppression. World J. Gastroenterol. 9: 2382-2384 (2003). *
Seward DJ, Koh AS, Boyer JL, Ballatori N. Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J. Biol. Chem. 278: 27473-27482 (2003). *
Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonadherence to medication in inflammatory bowel disease. Am. J. Gastroenterol. 98: 1535-1544 (2003). *
Sfikakis PP, Kollias G. Tumor necrosis factor biology in experimental and clinical arthritis. Curr. Opin. Rheumatol. 15: 380-386 (2003).
Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW. Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization. Hepatology 38: 577-588 (2003). *
Shaer AJ, Stewart LR, Cheek DE, Hurray D, Self SE. IgA antiglomerular basement membrane nephritis associated with Crohn's disease: a case report and review of glomerulonephritis in inflammatory bowel disease. Am. J. Kidney Dis. 41: 1097-1109 (2003).
Shafqat N, Marschall HU, Filling C, Nordling E, Wu XQ, Bjork L, Thyberg J, Martensson E, Salim S, Jornvall H, Oppermann U. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism. Biochem. J. 376: 49-60 (2003). *
Shah SM, Rabbani MA, Gul A, Ahmad A. Unusual presentations of Wegener's granulomatosis: pitfalls in early diagnosis. Saudi J. Kidney Dis. Transpl. 14: 177-185 (2003).
Shale MJ, Riley SA. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 18: 191-198 (2003). *
Shanafelt TD, Madueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin. Proc. 78: 1340-1346 (2003). *
Shanahan F. Review article: colitis-associated cancer - time for new strategies. Aliment. Pharmacol. Ther. 18 Suppl. 2: 6-9 (2003). *
Shand A, Forbes A. Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab? Int. J. Colorectal Dis. 18: 1-11 (2003). *
Shankar S, Sterling JC, Rytina E. Pustular pyoderma gangrenosum. Clin. Exp. Dermatol. 28: 600-603 (2003). *
Shapiro H. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins Leukot. Essent. Fatty Acids 68: 219-224 (2003). *
Sharma G, Singh RP, Chan DC, Agarwal R. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res. 23: 2649-2655 (2003).
Sharma MP, Makharia G. In search of a better treatment for ulcerative colitis. Indian J. Gastroenterol. 22: 77-78 (2003).
Sharma R, Awasthi YC, Yang Y, Sharma A, Singhal SS, Awasthi S. Energy dependent transport of xenobiotics and its relevance to multidrug resistance. Curr. Cancer Drug Targets 3: 89-107 (2003).
Sharma SK, Balamurugan A, Pandey RM, Saha PK, Mehra NK. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. Am. J. Respir. Cell. Mol. Biol. 29: 225-231 (2003). *
Shastry BS. Molecular genetics of autism spectrum disorders. J. Hum. Genet. 48: 495-501 (2003). *
Shastry BS. SNPs and haplotypes: genetic markers for disease and drug response (review). Int. J. Mol. Med. 11: 379-382 (2003). *
Shaughnessy J Jr. Primer on medical genomics. Part IX: Scientific and clinical applications of DNA microarrays - multiple myeloma as a disease model. Mayo Clin. Proc. 78: 1098-1109 (2003). *
Shaw C, Banik S, Islam MN, Biswas MC, Biswas G, Biswas S. Rheumatoid arthritis and ocular involvement. J. Indian Med. Assoc. 101: 537-538 (2003).
Shaw SH, Hampe J, White R, Mathew CG, Curran ME, Schreiber S. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum. Genet. 113: 514-521 (2003). *
Shen B. Diagnosis and treatment of patients with pouchitis. Drugs 63: 453-461 (2003).
Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL, Van Wijnen AJ. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4. Mol. Endocrinol. 17: 743-756 (2003). *
Sheridan JM, Bull TJ, Hermon-Taylor J. Use of bioinformatics to predict a function for the GS element in Mycobacterium avium subspecies paratuberculosis. J. Mol. Microbiol. Biotechnol. 5: 57-66 (2003).
Sherman M. Hepatocellular carcinoma: beyond screening. J. Hepatol. 39: 269-271 (2003). *
Sheth S, Shea JC, Bishop MD, Chopra S, Regan MM, Malmberg E, Walker C, Ricci R, Tsui LC, Durie PR, Zielenski J, Freedman SD. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum. Genet. 113: 286-292 (2003). *
Sheu BS, Huang JJ, Yang HB, Huang AH, Wu JJ. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency. Aliment. Pharmacol. Ther. 17: 1283-1290 (2003). *
Shi QY, Kong BH, Ma KD, Zhang XL, Jiang S. Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis. Zhonghua Fu Chan Ke Za Zhi 38: 680-682 (2003).
Shi Y, Agematsu K, Ochs HD, Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 108: 128-137 (2003). *
Shibao K, Hirata K, Robert ME, Nathanson MH. Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis. Gastroenterology 125: 1175-1187 (2003). *
Shigihara T, Shimada A, Yamada S, Maruyama T, Hirose H, Saruta T. Stromal cell-derived factor-1 chemokine gene polymorphism is not associated with onset age of Japanese type 1 diabetes. Ann. N. Y. Acad. Sci. 1005: 328-331 (2003). *
Shih SC, Lee YJ, Liu HF, Dang CW, Chang SC, Lin SC, Kao CR. Polymorphism in transmembrane region of MICA gene and cholelithiasis. World J. Gastroenterol. 9: 1541-1544 (2003). *
Shijubo N, Kojima H, Nagata M, Ohchi T, Suzuki A, Abe S, Sato N. Tumor angiogenesis of non-small cell lung cancer. Microsc. Res. Tech. 60: 186-198 (2003).
Shim TS, Turner OC, Orme IM. Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 83: 367-371 (2003).
Shimada Y, Iiai T, Okamoto H, Suda T, Hatakeyama K, Honma T, Ajioka Y. Toxic megacolon associated with cytomegalovirus infection in ulcerative colitis. J. Gastroenterol. 38: 1107-1108 (2003). *
Shimizu T, Fujii T, Suzuki R, Igarashi J, Ohtsuka Y, Nagata S, Yamashiro Y. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 37: 581-585 (2003). *
Shimoda S, Nakamura M, Ishibashi H, Kawano A, Kamihira T, Sakamoto N, Matsushita S, Tanaka A, Worman HJ, Gershwin ME, Harada M. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 124: 1915-1925 (2003). *
Shin DJ, Campos JA, Gil G, Osborne TF. PGC-1alpha activates CYP7A1 and bile acid biosynthesis. J. Biol. Chem. 278: 50047-50052 (2003). *
Shin HD, Kim LH, Park BL, Jung JH, Kim JY, Chung IY, Kim JS, Lee JH, Chung SH, Kim YH, Park HS, Choi JH, Lee YM, Park SW, Choi BW, Hong SJ, Park CS. Association of Eotaxin gene family with asthma and serum total IgE. Hum. Mol. Genet. 12: 1279-1285 (2003). *
Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, Achiron A. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun. 4: 197-203 (2003). *
Shinoda M, Shimazu M, Mukai M, Tanabe M, Hashiguchi N, Oda M, Kitajima M. Spindle cell carcinoma of the intrahepatic bile duct in a patient with primary sclerosing cholangitis. J. Gastroenterol. 38: 1091-1096 (2003). *
Shiraki T, Sakai N, Kanaya E, Jingami H. Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. J. Biol. Chem. 278: 11344-11350 (2003). *
Shirasaka T, Iizuka M, Yukawa M, Hirai Y, Horie Y, Itou H, Kon-No S, Fukushima T, Watanabe S. Altered expression of epimorphin in ulcerative colitis. J. Gastroenterol. Hepatol. 18: 570-577 (2003). *
Shiratsuch H, Basson MD. Caspase activation may be associated with Mycobacterium avium pathogenicity. Am. J. Surg. 186: 547-551 (2003). *
Shishehbor MH, Bhatt DL, Topol EJ. Using C-reactive protein to assess cardiovascular disease risk. Cleve. Clin. J. Med. 70: 634-640 (2003).
Shito M, Tilles AW, Tompkins RG, Yarmush ML, Toner M. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J. Surg. Res. 111: 53-62 (2003). *
Shizukuishi K, Nagaoka S, Kinno Y, Saito M, Takahashi N, Kawamoto M, Abe A, Jin L, Inoue T. Scoring analysis of salivary gland scintigraphy in patients with Sjogren's syndrome. Ann. Nucl. Med. 17: 627-631 (2003).
Shoda J, Suzuki H, Suzuki H, Sugiyama Y, Hirouchi M, Utsunomiya H, Oda K, Kawamoto T, Matsuzaki Y, Tanaka N. Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol. Res. 27: 323-326 (2003).
Shoda J, Tanaka N, Osuga T. Hepatolithiasis - epidemiology and pathogenesis update. Front. Biosci. 8: e398-e409 (2003).
Shuai K, Liu B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3: 900-911 (2003). *
Siegel JL, Jorgensen R, Angulo P, Lindor KD. Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis. J. Clin. Gastroenterol. 37: 183-185 (2003).
Siegel JL, Luthra H, Donlinger J, Angulo P, Lindor K. Association of primary biliary cirrhosis and rheumatoid arthritis. J. Clin. Rheumatol. 9: 340-343 (2003).
Siest G, Ferrari L, Accaoui MJ, Batt AM, Visvikis S. Pharmacogenomics of drugs affecting the cardiovascular system. Clin. Chem. Lab. Med. 41: 590-599 (2003).
Sifers RN. Alpha1-antitrypsin deficiency. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 93. October 17 - 19 (2003). *
Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn's disease. Can. J. Gastroenterol. 17: 473-478 (2003). *
Signore A, Picarelli A, Annovazzi A, Britton KE, Grossman AB, Bonanno E, Maras B, Barra D, Pozzilli P. 123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases. Nucl. Med. Commun. 24: 305-316 (2003).
Sikorska K, Stalke P, Lakomy EA, Michalska Z, Witczak-Malinowska K, Stolarczyk J. Disturbances of iron metabolism in chronic liver diseases. Med. Sci. Monit. 9 Suppl. 3: 64-67 (2003).
Silen W. Discussion on appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 125: 997 (2003). *
Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL, Sarmanho L, Cabral MM, Queiroz DM. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J. Clin. Microbiol. 41: 5615-5618 (2003). *
Silva FP, Morolli B, Storlazzi CT, Anelli L, Wessels H, Bezrookove V, Kluin-Nelemans HC, Giphart-Gassler M. Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 22: 538-547 (2003). *
Silva RC, Sallorenzo C, Kater CE, Dib SA, Falorni A. Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with type 1 diabetes or autoimmune thyroid diseases. Diabetes Nutr. Metab. 16: 160-168 (2003).
Silver J. The importance of penetration. Inflamm. Bowel Dis. 9: 341 (2003). *
Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR, McLeod RS, Cohen Z, Wade JA, Siminovitch KA. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm. Bowel Dis. 9: 1-9 (2003). *
Simon K, Szymczak A. Unsolved problem of current hepatology: the diagnosis and therapy of autoimmune overlap syndrome. Pol. Arch. Med. Wewn. 109: 201-206 (2003).
Simsek S, Nanayakkara PW, Keek JM, Faber LM, Bruin KF, Pals G. Two Dutch families with hereditary hyperferritinaemia-cataract syndrome and heterozygosity for an HFE-related haemochromatosis gene mutation. Neth. J. Med. 61: 291-295 (2003). *
Sinel'nik TB, Sinel'nik OD, Ribal'chenko VK. Bile acids in the process of canalicular bile formation. Fiziol. Zh. 49: 80-93 (2003).
Singh A, Naidu PS, Patil CS, Kulkarni SK. Effect of FK506 (tacrolimus) in animal models of inflammation. Inflammopharmacology 11: 249-257 (2003). *
Singh UP, Singh S, Taub DD, Lillard JW Jr. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice. J. Immunol. 171: 1401-1406 (2003). *
Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N. Engl. J. Med. 349: 350-357 (2003). *
Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J. Postgrad. Med. 49: 222-228 (2003). *
Sinharay R. Eosinophilic oesophagitis: treatment using Montelukast. Gut 52: 1228-1229 (2003). *
Sitaraman SV, Hoteit M, Gewirtz AT. Semapimod. Cytokine. Curr. Opin. Investig. Drugs 4: 1363-1368 (2003).
Slieker MG, Deckers-Kocken JM, Uiterwaal CS, van der Ent CK, Houwen RH. Risk factors for the development of cystic fibrosis related liver disease. Hepatology 38: 775-776 (2003). *
Slifman NR, Gershon SK, Lee JH, Edwards ET, Braun MM. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum. 48: 319-324 (2003). *
Slitt AL, Cherrington NJ, Maher JM, Klaassen CD. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab. Dispos. 31: 1176-1186 (2003). *
Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 63: 670-677 (2003). *
Smerdel A, Lie BA, Finholt C, Ploski R, Forre O, Undlien DE, Thorsby E. An additional susceptibility gene for juvenile idiopathic arthritis in the HLA class I region on several DR-DQ haplotypes. Tissue Antigens 61: 80-84 (2003). *
Smirnova I, Mann N, Dols A, Derkx HH, Hibberd ML, Levin M, Beutler B. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. U.S.A. 100: 6075-6080 (2003). *
Smit JJ, Van Loveren H, Hoekstra MO, Karimi K, Folkerts G, Nijkamp FP. The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma. J. Immunol. 171: 754-760 (2003). *
Smit JJ, van Loveren H, Hoekstra MO, Nijkamp FP, Bloksma N. Influence of the macrophage bacterial resistance gene, Nramp1 (Slc11a1), on the induction of allergic asthma in the mouse. FASEB J. 17: 958-960 (2003). *
Smith JL. The role of gastric acid in preventing foodborne disease and how bacteria overcome acid conditions. J. Food Prot. 66: 1292-1303 (2003).
Smith TM. Segmented filamentous bacteria in the bovine small intestine. J. Comp. Pathol. 117: 185-190 (2003).
Smolarz B, Szyllo K, Romanowicz-Makowska H, Niewiadomski M, Kozlowska E, Kulig A. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer. Pol. J. Pathol. 54: 233-238 (2003).
Smolinski P, Serafinska S, Gladysz A, Rotter K, Piszko P. Autoimmune liver diseases and overlap syndromes - overview of past and present reports. Przegl. Lek. 60: 810-814 (2003).
Soejima Y, Shimada M, Suehiro T, Hiroshige S, Ninomiya M, Shiotani S, Harada N, Hideki I, Yonemura Y, Maehara Y. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transpl. 9: 581-586 (2003). *
Soetikno RM, Kahng LS, Ono A, Fujii T. Flat and depressed colorectal neoplasms. Curr. Opin. Gastroenterol. 19: 69-75 (2003).
Sohn J, Khaoustov VI, Xie Q, Chung CC, Krishnan B, Yoffe B. The effect of ursodeoxycholic acid on the survivin in thapsigargin-induced apoptosis. Cancer Lett. 191: 83-92 (2003). *
Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76: 735-738 (2003).
Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clin. Exp. Rheumatol. 21: S146-S153 (2003).
Sokol DK, Molleston JP, Filo RS, Van Valer J, Edwards-Brown M. Tacrolimus (FK506)-induced mutism after liver transplant. Pediatr. Neurol. 28: 156-158 (2003).
Sola S, Ma X, Castro RE, Kren BT, Steer CJ, Rodrigues CM. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in TGF-beta 1-induced apoptosis of rat hepatocytes. J. Biol. Chem. 278: 48831-48838 (2003). *
Solano E, Khakhar A, Bloch M, Quan D, McAlister V, Ghent C, Wall W, Marotta P. Liver transplantation for primary sclerosing cholangitis. Transplant. Proc. 35: 2431-2344 (2003). *
Solerio E, Isaia G, Innarella R, Di Stefano M, Farina M, Borghesio E, Framarin L, Rizzetto M, Rosina F. Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig. Liver Dis. 35: 339-346 (2003).
Solga SF. Probiotics can treat hepatic encephalopathy. Med. Hypotheses 61: 307-313 (2003). *
Solga SF, Diehl AM. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J. Hepatol. 38: 681-687 (2003). *
Sollid LM, Lundin KE. Disease mechanisms in coeliac disease. Tidsskr. Nor. Laegeforen. 123: 3230-3233 (2003).
Solmaz M, Sayar K, Kavuk I. Psychological factors in the irritable bowel syndrome. Eur. J. Med. Res. 8: 549-556 (2003).
Solnick JV. Clinical significance of Helicobacter species other than Helicobacter pylori. Clin. Infect. Dis. 36: 349-354 (2003). *
Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. J. Pediatr. 142: 128-132 (2003). *
Sommer AP, McKay DS, Ciftcioglu N, Oron U, Mester AR, Kajander EO. Living nanovesicles - chemical and physical survival strategies of primordial biosystems. J. Proteome Res. 2: 441-443 (2003).
Sommer AP, Oron U, Pretorius AM, McKay DS, Ciftcioglu N, Mester AR, Kajander EO, Whelan HT. A preliminary investigation into light-modulated replication of nanobacteria and heart disease. J. Clin. Laser Med. Surg. 21: 231-235 (2003).
Song C, Li X, Leonard BE, Horrobin DF. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J. Lipid Res. 44: 1984-1991 (2003). *
Song IS, Lee YM, Chung SJ, Shim CK. Multiple alterations of canalicular membrane transport activities in rats with CCl(4)-induced hepatic injury. Drug Metab. Dispos. 31: 482-490 (2003). *
Song S, Crow AR, Freedman J, Lazarus AH. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Blood 101: 3708-3713 (2003). *
Song Z, Zhou Z, Chen T, Hill D, Kang J, Barve S, McClain C. S-Adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice. J. Nutr. Biochem. 14: 591-597 (2003). *
Sonoda J, Evans RM. Biological function and mode of action of nuclear xenobiotic receptors. Pure Appl. Chem. 75: 1733-1742 (2003). *
Sonoda T. The use of laparoscopic techniques in surgery for mucosal ulcerative colitis. Semin. Laparosc. Surg. 10: 169-175 (2003).
Sonwalkar SA, James RM, Ahmad T, Zhang L, Verbeke CS, Barnard DL, Jewell DP, Hull MA. Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut 52: 1518-1521 (2003). *
Sood A, Midha V, Sood N. Reversible posterior leukoencephalopathy due to oral cyclosporine in severe ulcerative colitis. Indian J. Gastroenterol. 22: 233-234 (2003).
Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 52: 1587-1590 (2003). *
Sood HS, Hunt MJ, Tyagi SC. Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L333-L341 (2003). *
Soprano DR, Soprano KJ. Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J. Nutr. 133: 277S-281S (2003). *
Sorensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH, Vilstrup H. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J. Clin. Epidemiol. 56: 88-93 (2003).
Soresi M, Bonfissuto G, Magliarisi C, Riili A, Terranova A, Di Giovanni G, Bascone F, Carroccio A, Tripi S, Montalto G. Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin. Radiol. 58: 372-377 (2003). *
Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment. Pharmacol. Ther. 17 Suppl. 2: 11-17 (2003). *
Sougioultzis S Pothoulakis C. Bacterial infections: small intestine and colon. Curr. Opin. Gastroenterol. 19: 23-30 (2003).
Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist. Updat. 6: 71-84 (2003).
Spatz M, Eibl N, Hink S, Wolf HM, Fischer GF, Mayr WR, Schernthaner G, Eibl MM. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell. Immunol. 221: 5-26 (2003). *
Speckman RA, Wright Daw JA, Helms C, Duan S, Cao L, Taillon-Miller P, Kwok PY, Menter A, Bowcock AM. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum. Genet. 112: 34-41 (2003). *
Spector D, Anthony M, Alexander D, Arab L. Soy consumption and colorectal cancer. Nutr. Cancer 47: 1-12 (2003).
Spector SL, Surette ME. Diet and asthma: has the role of dietary lipids been overlooked in the management of asthma? Ann. Allergy Asthma Immunol. 90: 371-377 (2003).
Spiegel S, Phillipper M, Rossmann H, Riederer B, Gregor M, Seidler U. Independence of apical Cl-/HCO3- exchange and anion conductance in duodenal HCO3- secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G887-G897 (2003). *
Spiliotis J, Tambasis E, Christopoulou A, Rogdakis A, Siambaliotis A, Zografos K, Datsis A. Sandostatin as a "hormonal" temporary protective ileostomy in patients with total or subtotal colectomy. Hepatogastroenterology 50: 1367-1369 (2003).
Spina E, Scordo MG, D'Arrigo C. Metabolic drug interactions with new psychotropic agents. Fundam. Clin. Pharmacol. 17: 517-538 (2003).
Spirli C, Fabris L, Duner E, Fiorotto R, Ballardini G, Roskams T, LaRusso NF, Sonzogni A, Okolicsanyi L, Strazzabosco M. Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes. Gastroenterology 124: 737-753 (2003). *
Spond J, Case N, Chapman RW, Crawley Y, Egan RW, Fine J, Hey JA, Kreutner W, Kung T, Wang P, Minnicozzi M. Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulm. Pharmacol. Ther. 16: 207-214 (2003).
Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 38: 244-251 (2003). *
Sriamornsak P, Nunthanid J, Wanchana S, Luangtana-Anan M. Composite film-coated tablets intended for colon-specific delivery of 5-aminosalicylic acid: using deesterified pectin. Pharm. Dev. Technol. 8: 311-318 (2003).
Srinivasan R, Lewis JD. Malignancies in inflammatory bowel disease. Curr. Opin. Gastroenterol. 19: 366-370 (2003).
Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR. Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis. Genes Immun. 4: 147-152 (2003). *
Stadlbacher S, Dauber EM, Wenda S, Glock B, Hafner M, Kormoczi GF, Mayr WR. The tetranucleotide repeat polymorphism C2_4_4: population data and linkage disequilibria with HLA class I. Immunobiology 207: 137-140 (2003).
Stadnicki A, Bojko B, Myczkowska K, Witalinska-Labuzek J. Selected risk factors of thrombotic complications in patients with ulcerative colitis. Wiad. Lek. 56: 341-347 (2003).
Stadnicki A, Colman RW. Experimental models of inflammatory bowel disease. Arch. Immunol. Ther. Exp. (Warsz.) 51: 149-155 (2003).
Stagg AJ, Hart AL, Knight SC, Kamm MA. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52: 1522-1529 (2003). *
Stahlberg D, Veress B, Tribukait B, Broome U. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis. Colon Rectum 46: 770-778 (2003).
Staikova ND, Kuzmanova SI, Solakov PT. Serologic markers of early rheumatoid arthritis. Folia Med. (Plovdiv.) 45: 35-42 (2003).
Stallmach A, Giese T, Schmidt C, Ludwig B, Mueller-Molaian I, Meuer SC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int. J. Colorectal Dis. 19: 308-315 (2003). *
Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch. Dermatol. 139: 1463-1470 (2003). *
Stanevicha V, Eglite J, Sochnevs A, Gardovska D, Zavadska D, Shantere R. HLA class II associations with rheumatic heart disease among clinically homogeneous patients in children in Latvia. Arthritis Res. Ther. 5: R340-R346 (2003). *
Stange EF, Schreiber S, Folsch UR, von Herbay A, Scholmerich J, Hoffmann J, Zeitz M, Fleig WE, Buhr HJ, Kroesen AJ, Moser G, Matthes H, Adler G, Reinshagen M, Stein J; German Society for Digestive and Metabolic Diseases. Diagnostics and treatment of Crohn's disease - results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases. Z. Gastroenterol. 41: 19-20 (2003).
Stapelbroek JM, Ploos van Amstel JK, van Hattum J, van den Berg LH, Klomp LW, Houwen RH. From gene to disease; Wilson disease: copper storage due to mutations in ATP7B. Ned. Tijdschr. Geneeskd. 147: 603-605 (2003).
Staples JA, Ponsonby AL, Lim LL, McMichael AJ. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ. Health Perspect. 111: 518-523 (2003). *
Stark M, Rothem L, Jansen G, Scheffer GL, Goldman ID, Assaraf YG. Antifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholate. Mol. Pharmacol. 64: 220-227 (2003). *
Starkel P, Bishop K, Horsmans Y, Strain AJ. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. Am. J. Pathol. 162: 587-596 (2003). *
Staros EB. Molecular discoveries alter our view of inflammatory bowel disease. A review from scientific, clinical, and laboratory perspectives. Am. J. Clin. Pathol. 119: 524-539 (2003). *
Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu. Rev. Immunol. 21: 139-176 (2003). *
Starzl TE. The future of transplantation. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 114. October 17 - 19 (2003). *
Staudinger JL, Madan A, Carol KM, Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 31: 523-527 (2003). *
Steckel NK, Kuhn U, Beelen DW, Elmaagacli AH. Indoleamine 2,3-dioxygenase expression in patients with acute graft-versus-host disease after allogeneic stem cell transplantation and in pregnant women: association with the induction of allogeneic immune tolerance? Scand. J. Immunol. 57: 185-191 (2003). *
Steer S, Fisher SA, Fife M, Cuthbert A, Newton J, Wordsworth P, Lewis CM, Mathew CG, Lanchbury JS. Development of rheumatoid arthritis is not associated with two polymorphisms in the Crohn's disease gene CARD15. Rheumatology (Oxford) 42: 304-307 (2003). *
Stehlik C, Hayashi H, Pio F, Godzik A, Reed JC. CARD6 is a modulator of NF-kappa B activation by Nod1- and Cardiak-mediated pathways. J. Biol. Chem. 278: 31941-31949 (2003). *
Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Schule R. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat. Struct. Biol. 10: 820-825 (2003). *
Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21: 785-789 (2003). *
Steinhart A, Ewe K, Griffiths A, Modigliani R, Thomsen O. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 4: CD000301 (2003). *
Steinman L, Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3: 483-492 (2003). *
Steinmuller T, Jonas S, Neuhaus P. Review article: liver transplantation for hepatocellular carcinoma. Aliment. Pharmacol. Ther. 17 Suppl. 2: 138-144 (2003).
Steinwurz F. Clinical experience with the use of infliximab in 44 patients with Crohn's disease. Arq. Gastroenterol. 40: 198-200 (2003).
Stempel D, Sandusky H, Lampi K, Cilluffo M, Horwitz J, Braun J, Goodglick L, Gordon LK. BetaB1-crystallin: identification of a candidate ciliary body uveitis antigen. Invest. Ophthalmol. Vis. Sci. 44: 203-209 (2003). *
Stephens MC, Shepanski MA, Mamula P, Markowitz JE, Brown KA, Baldassano RN. Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am. J. Gastroenterol. 98: 104-111 (2003). *
Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, Zaya MJ. Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Ther. 307: 573-582 (2003). *
Stickel F, Hoehn B, Schuppan D, Seitz HK. Review article: nutritional therapy in alcoholic liver disease. Aliment. Pharmacol. Ther. 18: 357-373 (2003). *
Stickel F, Poschl G, Seitz HK, Waldherr R, Hahn EG, Schuppan D. Acute hepatitis induced by greater celandine (Chelidonium majus). Scand. J. Gastroenterol. 38: 565-568 (2003). *
Stieger B. Biliary cholesterol secretion: more lessons from plants? J. Hepatol. 38: 843-846 (2003). *
Stiehl A. Endoscopic interventions in the biliary tract. Curr. Treat. Options Gastroenterol. 6: 87-92 (2003).
Stiehl A. Endoscopic treatment of patients with primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 84. October 15-16 (2003). *
Stoehlmacher J, Lenz HJ. Cyclooxygenase-2 inhibitors in colorectal cancer. Semin. Oncol. 30: 10-16 (2003).
Stohl W. SLE - systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. Arthritis Res. Ther. 5: 136-138 (2003). *
Stokes DG, Kremer JM. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis. Semin. Arthritis Rheum. 33: 1-18 (2003). *
Stollberger C, Finsterer J, Zlabinger GJ, Weihsengruber F, Redtenbacher S, Bonner G, Herkner K, Deutsch M. Antineutrophil cytoplasmic autoantibody-negative antiproteinase 3 syndrome presenting as vasculitis, endocarditis, polyneuropathy and Dupuytren's contracture. J. Heart Valve Dis. 12: 530-534 (2003).
Stone JH; Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 48: 2299-2309 (2003). *
Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur. J. Gastroenterol. Hepatol. 15: 1275-1280 (2003).
Stoneham S, Lennard L, Coen P, Lilleyman J, Saha V. Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia. Br. J. Haematol. 123: 100-102 (2003). *
Stoopler ET, Carrasco L, Stanton DC, Pringle G, Sollecito TP. Cheilitis glandularis: an unusual histopathologic presentation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 95: 312-317 (2003).
Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm. Bowel Dis. 9: 104-115 (2003). *
Stormont JM, Flaherty M, Condemi J. Hepatic metabisulfite sensitivity in a patient with sclerosing cholangitis. Ann. Allergy Asthma Immunol. 91: 314-317 (2003).
Stover CM, Lynch NJ, Dahl MR, Hanson S, Takahashi M, Frankenberger M, Ziegler-Heitbrock L, Eperon I, Thiel S, Schwaeble WJ. Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene. Genes Immun. 4: 374-384 (2003). *
Strain AJ, Crosby HA, Nijjar S, Kelly DA, Hubscher SG. Human liver-derived stem cells. Semin. Liver Dis. 23: 373-384 (2003).
Strassburg CP. Molecular characterization of autoantigens in liver diseases. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 30. September 12 - 13 (2003). *
Strassburg CP, Manns MP. Autoimmune hepatitis. Best Pract. Res. Clin. Gastroenterol. 17: 291-306 (2003). *
Strassburg CP, Manns MP. Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis. Dtsch. Med. Wochenschr. 128: 96-98 (2003).
Straubinger RK, Greiter A, McDonough SP, Gerold A, Scanziani E, Soldati S, Dailidiene D, Dailide G, Berg DE, Simpson KW. Quantitative evaluation of inflammatory and immune responses in the early stages of chronic Helicobacter pylori infection. Infect. Immun. 71: 2693-2703 (2003). *
Strausberg RL, Schreiber SL. From knowing to controlling: a path from genomics to drugs using small molecule probes. Science 300: 294-295 (2003). *
Strauss E, Gomes de Sa Ribeiro Mde F. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann. Hepatol. 2: 41-45 (2003). *
Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3: 879-889 (2003).
Strick-Marchand H, Weiss MC. Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation. Mech. Dev. 120: 89-98 (2003).
Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K. Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease. Hum. Immunol. 64: 285-289 (2003).
Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K. No association of two Fas gene polymorphisms with Hashimoto's thyroiditis and Graves' disease. Eur. J. Endocrinol. 149: 393-396 (2003). *
Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int. Arch. Allergy Immunol. 132: 310-321 (2003). *
Sturm E. Causes and consequences of cholestasis: nonparenchymal cells and nuclear receptors as regulators of hepatic gene expression in cholestatic liver disease. Doctoral Thesis, University of Groningen (http://www.ub.rug.nl/eldoc/dis/medicine/e.sturm/) (2003). *
Stuve O, Youssef S, Dunn S, Slavin AJ, Steinman L, Zamvil SS. The potential therapeutic role of statins in central nervous system autoimmune disorders. Cell. Mol. Life Sci. 60: 2483-2491 (2003). *
Su C. O brother, where art thou? The case for siblings, environment, and inflammatory bowel disease. Inflamm. Bowel Dis. 9: 211-212 (2003). *
Su C, Lewis JD. Treatment of Crohn's disease: is blocking adhesion the answer? Gastroenterology 125: 1276-1277 (2003). *
Su CG, Lichtenstein GR. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. Gastroenterology 125: 1544-1546 (2003). *
Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur. Neuropsychopharmacol. 13: 267-271 (2003).
Subramaniam N, Campion J, Rafter I, Okret S. Cross-talk between glucocorticoid and retinoic acid signals involving glucocorticoid receptor interaction with the homoeodomain protein Pbx1. Biochem. J. 370: 1087-1095 (2003). *
Sudbo J. Chemoprevention: treatment of persons at high risk of cancer. Tidsskr. Nor. Laegeforen. 123: 1514-1517 (2003).
Sudheer Kumar M, Unnikrishnan MK, Uma Devi P. Effect of 5-aminosalicylic acid on radiation-induced micronuclei in mouse bone marrow. Mutat. Res. 527: 7-14 (2003).
Suerbaum S, Josenhans C, Sterzenbach T, Drescher B, Brandt P, Bell M, Droge M, Fartmann B, Fischer HP, Ge Z, Horster A, Holland R, Klein K, Konig J, Macko L, Mendz GL, Nyakatura G, Schauer DB, Shen Z, Weber J, Frosch M, Fox JG. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc. Natl. Acad. Sci. U.S.A. 100: 7901-7906 (2003). *
Sugamori KS, Wong S, Gaedigk A, Yu V, Abramovici H, Rozmahel R, Grant DM. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol. Pharmacol. 64: 170-179 (2003). *
Sugimoto M, Sadamoto T, Nonaka H. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis. Nihon Arukoru Yakubutsu Igakkai Zasshi 38: 34-45 (2003).
Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel-Ghodsian N, Targan SR, Rotter JI, Yang H. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am. J. Hum. Genet. 72: 509-518 (2003). *
Sugimura M, Kinouchi Y, Takahashi S, Aihara H, Takagi S, Negoro K, Obana N, Kojima Y, Matsumoto K, Kikuchi T, Hiroki M, Oomori S, Shimosegawa T. CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease. Clin. Genet. 63: 160-162 (2003). *
Sugimura T, Shiokawa S, Haraoka S, Fujimoto K, Ohshima K, Nakamuta M, Nishimura J. Local antigen-driven oligoclonal expansion of B cells in the liver portal areas of patients with primary biliary cirrhosis. Liver Int. 23: 323-328 (2003). *
Sugita T. Pharmacological profile of anti-human TNF alpha monoclonal antibody, infliximab (Remicade). Nippon Yakurigaku Zasshi 121: 57-64 (2003).
Sugiura Y, Banno S, Matsumoto Y, Niimi T, Yoshinouchi T, Hayami Y, Naniwa T, Ueda R. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. J. Rheumatol. 30: 1520-1523 (2003).
Suh CH, Freed JH, Cohen PL. T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. J. Immunol. 170: 2229-2235 (2003). *
Sujino M, Masumoto KH, Yamaguchi S, van der Horst GT, Okamura H, Inouye ST. Suprachiasmatic nucleus grafts restore circadian behavioral rhythms of genetically arrhythmic mice. Curr. Biol. 13: 664-668 (2003). *
Suleymanoglu E. Molecular phylogenetics and functional evolution of major RNA recognition domains of recently cloned and characterized autoimmune RNA-binding particle. Genomics Proteomics Bioinformatics 1: 310-320 (2003).
Sullivan GW. Adenosine A2A receptor agonists as anti-inflammatory agents. Curr. Opin. Investig. Drugs 4: 1313-1319 (2003).
Suman L, Civelli EM, Cozzi G, Milella M, Meroni R, Vercelli R, Sala S, Severini A. Long-term results of balloon dilation of benign bile duct strictures. Acta Radiol. 44: 147-150 (2003). *
Sumanasekera WK, Tien ES, Davis JW 2nd, Turpey R, Perdew GH, Vanden Heuvel JP. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 42: 10726-10735 (2003). *
Summerfield JA. Clinical potential of mannose-binding lectin-replacement therapy. Biochem. Soc. Trans. 31: 770-773 (2003). *
Summers AE, Whelan CJ, Parsons ME. Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. Life Sci. 72: 2091-2094 (2003). *
Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 98: 2034-2041 (2003). *
Sumnik Z, Drevinek P, Snajderova M, Kolouskova S, Sedlakova P, Pechova M, Vavrinec J, Cinek O. HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 16: 851-858 (2003).
Sun L, Roesler J, Rosen-Wolff A, Winkler U, Koch R, Thurigen A, Henker J. CARD15 genotype and phenotype analysis in 55 pediatric patients with Crohn disease from Saxony, Germany. J. Pediatr. Gastroenterol. Nutr. 37: 492-497 (2003). *
Sun PD. Structure and function of natural-killer-cell receptors. Immunol. Res. 27: 539-548 (2003). *
Sunagawa H, Takayama H, Yamashiro T, Sasaki H, Sashida Y, Matsuura K, Kayou M. Hepatocellular carcinoma in a patient with primary biliary cirrhosis and seronegativity for markers of hepatitis B virus and hepatitis C virus: report of a case. Surg. Today 33: 219-223 (2003). *
Sundberg JP, King LE Jr. Mouse alopecia areata models: an array of data on mechanisms and genetics. J. Investig. Dermatol. Symp. Proc. 8: 173-175 (2003). *
Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med. Res. Rev. 23: 535-558 (2003). *
Surrenti C, Galli M. Molecular mechanisms of alcohol-induced liver injury. An update. Minerva Gastroenterol. Dietol. 49: 95-105 (2003).
Surudo T, Wojcicki M, Milkiewicz P, Czuprynska M, Lubikowski J, Jarosz K, Andrzejewska J, Zeair S, Sluzar T, Syczewska M, Butkiewicz J, Uminski M. Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation. Transplant. Proc. 35: 2323-2325 (2003). *
Suryaprasad AG, Prindiville T. The biology of TNF blockade. Autoimmun. Rev. 2: 346-357 (2003).
Sutherland L, MacDonald J. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst. Rev. 3: CD000543 (2003). *
Sutton AL, MacDonald PN. Vitamin D: more than a "bone-a-fide" hormone. Mol. Endocrinol. 17: 777-791 (2003). *
Sutton KA, Jungnickel MK, Florman HM. Of fertility, cystic fibrosis and the bicarbonate ion. Nat. Cell Biol. 5: 857-859 (2003). *
Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine A, Iida A, Takahashi A, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34: 395-402 (2003). *
Suzuki C, Sano N, Takikawa H. Effect of dexamethasone on biliary excretion of bile acids and organic anions in rats. Hepatol. Res. 25: 48-54 (2003). *
Svegliati-Baroni G, Ridolfi F, Caradonna Z, Alvaro D, Marzioni M, Saccomanno S, Candelaresi C, Trozzi L, Macarri G, Benedetti A, Folli F. Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J. Hepatol. 39: 528-537 (2003).
Svensson S, Ostberg T, Jacobsson M, Norstrom C, Stefansson K, Hallen D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J. 22: 4625-4633 (2003). *
Swain MG. Pathogenesis of fatigue and pruritus in cholestatic liver disease. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 33. October 15-16 (2003). *
Swale VJ, Perrett CM, Denton CP, Black CM, Rustin MH. Etanercept-induced systemic lupus erythematosus. Clin. Exp. Dermatol. 28: 604-607 (2003). *
Sweeney KJ, Kell MR, Coates C, Murphy T, Reynolds JV. Serum antigen(s) drive the proinflammatory T cell response in acute pancreatitis. Br. J. Surg. 90: 313-319 (2003). *
Sydora BC, Tavernini MM, Wessler A, Jewell LD, Fedorak RN. Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs. Inflamm. Bowel Dis. 9: 87-97 (2003). *
Sykiotis GP, Neumann S, Georgopoulos NA, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Paschke R, Vagenakis AG, Papavassiliou AG. Functional significance of the thyrotropin receptor germline polymorphism D727E. Biochem. Biophys. Res. Commun. 301: 1051-1056 (2003). *
Sylvestre PB, Batts KP, Burgart LJ, Poterucha JJ, Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl. 9: 1086-1093 (2003). *
Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21: 713-758 (2003). *
Szalay F, Hegedus D, Lakatos PL, Tornai I, Bajnok E, Dunkel K, Lakatos P. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis. J. Hepatol. 38: 395-400 (2003). *
Szlosarek PW, Balkwill FR. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 4: 565-573 (2003).
Tabb MM, Sun A, Zhou C, Grun F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM, Blumberg B. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J. Biol. Chem. 278: 43919-43927 (2003). *
Tabone T, Morahan G. Definition of polymorphisms in the gene encoding the interleukin-12 receptor B1 subunit: testing linkage disequilibrium with type I diabetes susceptibility. Genes Immun. 4: 222-227 (2003). *
Tachiiri A, Imamura R, Wang Y, Fukui M, Umemura M, Suda T. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun. 4: 153-159 (2003). *
Taga M, Abe T, Nishimura S, Kimura H, Oki M, Nojima M, Tanaka H, Matsumoto S, Imai K. A case of Sjogren's syndrome associated with chronic hepatitis C and sarcoidosis. Nihon Rinsho Meneki Gakkai Kaishi 26: 336-340 (2003).
Tagle M, Barriga J, Pineiro A. Crohn's disease associated with focal pulmonare lesion. Rev. Gastroenterol. Peru 23: 293-296 (2003).
Tagliacozzi D, Mozzi AF, Casetta B, Bertucci P, Bernardini S, Di Ilio C, Urbani A, Federici G. Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method. Clin. Chem. Lab. Med. 41: 1633-1641 (2003).
Taha AS, Grant V, Kelly RW. Urinalysis for interleukin-8 in the non-invasive diagnosis of acute and chronic inflammatory diseases. Postgrad. Med. J. 79: 159-163 (2003). *
Taimr P. Fibrogenesis, hepatic stellate cells and immune system. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 26. September 12 - 13 (2003). *
Tait BD, Colman PG, Morahan G, Marchinovska L, Dore E, Gellert S, Honeyman MC, Stephen K, Loth A. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61: 146-153 (2003). *
Tait KF, Gough SC. The genetics of autoimmune endocrine disease. Clin. Endocrinol. (Oxf.) 59: 1-11 (2003). *
Tajiri T, Tate G, Mitsuya T, Endo Y, Inoue K, Yoshiba M, Kunimura T, Morohoshi T. Localized giant inflammatory polyposis (filiform polyposis) with diverticula in ulcerative colitis. J. Gastroenterol. 38: 912-914 (2003). *
Takagi S, Kinouchi Y, Chida M, Hiwatashi N, Noguchi M, Takahashi S, Shimosegawa T. Strong telomerase activity of B lymphocyte from mesenteric lymph nodes of patients with inflammatory bowel disease. Dig. Dis. Sci. 48: 2091-2094 (2003). *
Takahashi H, Fuse I, Abe T, Yoshino N, Aizawa Y. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy. Blood Coagul. Fibrinolysis 14: 87-93 (2003).
Takahashi T, Sakaguchi S. Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease. Curr. Mol. Med. 3: 693-706 (2003).
Takahashi T, Sakaguchi S. The role of regulatory T cells in controlling immunologic self-tolerance. Int. Rev. Cytol. 225: 1-32 (2003).
Takara M, Kouki T, DeGroot LJ. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease. Thyroid 13: 1083-1089 (2003).
Takata Y, Huang Y, Komoto J, Yamada T, Konishi K, Ogawa H, Gomi T, Fujioka M, Takusagawa F. Catalytic mechanism of glycine N-methyltransferase. Biochemistry 42: 8394-8402 (2003). *
Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376 (2003). *
Takeshita E, Kumagi T, Matsui H, Abe M, Furukawa S, Ikeda Y, Matsuura B, Michitaka K, Horiike N, Onji M. Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis. J. Gastroenterol. 38: 1060-1065 (2003). *
Takesue Y, Ohge H, Kohyama M, Imamura Y, Murakami Y, Sueda T. Antiinfective host defense mechanism: Toll-like receptors and innate immunity. Nippon Geka Gakkai Zasshi 104: 494-498 (2003).
Takeuchi A, Motohashi H, Okuda M, Inui K. Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. Drug Metab. Pharmacokinet. 18: 409-412 (2003). *
Takeuchi A, Sano N, Takikawa H. Inhibition of ileal bile acid absorption by colestimide. J. Gastroenterol. Hepatol. 18: 548-553 (2003). *
Takizawa K, Takeuchi F, Nabeta H, Hirohata S, Takeuchi A, Matsumura Y, Yamamoto K. Association of transporter associated with antigen processing genes with Behcet's disease in Japanese. Autoimmunity 36: 161-165 (2003).
Talamini MA. Laparoscopy for benign disease: robotics. Semin. Laparosc. Surg. 10: 203-208 (2003).
Talwalkar JA. An evidence-based approach to studies in cirrhosis and portal hypertension: medical management of mild to moderate ascites. Clin. Gastroenterol. Hepatol. 1: 474-479 (2003). *
Talwalkar JA, Kim WR, Rosen CB, Kamath PS, Wiesner RH. Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis. Mayo Clin. Proc. 78: 431-435 (2003). *
Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 362: 53-61 (2003). *
Talwalkar JA, Souto E, Jorgensen RA, Lindor KD. Natural history of pruritus in primary biliary cirrhosis. Clin. Gastroenterol. Hepatol. 1: 297-302 (2003). *
Tamboli CP, Cortot A, Colombel JF. What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease? Eur. J. Gastroenterol. Hepatol. 15: 587-592 (2003). *
Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum. Dis. Clin. North Am. 29: 211-237 (2003).
Tan FK, Tercero GM, Arnett FC, Wang N, Chakraborty R. Examination of the possible role of biologically relevant genes around FBN1 in systemic sclerosis in the Choctaw population. Arthritis Rheum. 48: 3295-3296 (2003). *
Tan JW, Jiang Y, Yao HX, Lu LZ, Zhang SG. Early prevention and treatment of biliary tract complications after orthotopic liver transplantation. Hepatobiliary Pancreat. Dis. Int. 2: 48-53 (2003). *
Tan LK. Obstetric cholestasis: current opinions and management. Ann. Acad. Med. Singapore 32: 294-298 (2003).
Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 48: 982-992 (2003). *
Tanaka M, Kamijo T, Koike K, Ueno I, Nakazawa Y, Kurokawa Y, Sakashita K, Komiyama A, Fujisawa K. Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia. Int. J. Hematol. 78: 168-170 (2003).
Tanaka N, Babazono T, Saito S, Sekine A, Tsunoda T, Haneda M, Tanaka Y, Fujioka T, Kaku K, Kawamori R, Kikkawa R, Iwamoto Y, Nakamura Y, Maeda S. Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52: 2848-2853 (2003). *
Tanaka N, Hora K, Makishima H, Kamijo Y, Kiyosawa K, Gonzalez FJ, Aoyama T. In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha. FEBS Lett. 543: 120-124 (2003). *
Tanaka S, Edberg JC, Chatham W, Fassina G, Kimberly RP. Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins. J. Immunol. 171: 6090-6096 (2003). *
Tanaka Y, Yoshikawa M, Kobayashi Y, Kuroda M, Kaito M, Shiroi A, Yamao J, Fukui H, Ishizaka S, Adachi Y. Expressions of hepatobiliary organic anion transporters and bilirubin-conjugating enzyme in differentiating embryonic stem cells. Biochem. Biophys. Res. Commun. 309: 324-330 (2003). *
Taneja V, Taneja N, Behrens M, Pan S, Trejo T, Griffiths M, Luthra H, David CS. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J. Immunol. 171: 4431-4438 (2003). *
Tang CL. Chemoprevention of colorectal cancer - experimental approach and clinical applications. Ann. Acad. Med. Singapore 32: 169-175 (2003).
Tang HF, Chen XX, Ye HY, Ou BY. Expression of tumor necrosis factor-alpha and nuclear factor-kappaB in childhood ulcerative colitis. Zhonghua Er Ke Za Zhi 41: 743-746 (2003).
Tang L, Sundberg JP, Lui H, Shapiro J. Old wine in new bottles: reviving old therapies for alopecia areata using rodent models. J. Investig. Dermatol. Symp. Proc. 8: 212-216 (2003). *
Tang TH, Li CL, Li X, Jiang FQ, Zhang YK, Ren HQ. The role of donor hepatocytes and/or splenocytes pre-injection in reducing islet xenotransplantation rejection. Hepatobiliary Pancreat. Dis. Int. 2: 344-350 (2003). *
Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 14: 403-411 (2003). *
Taniguchi S, Mochida Y, Uchiumi T, Tahira T, Hayashi K, Takagi K, Shimada M, Maehara Y, Kuwano H, Kono S, Nakano H, Kuwano M, Wada M. Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol. Cancer Ther. 2: 1351-1359 (2003). *
Tanimoto H, Shimoda S, Nakamura M, Ishibashi H, Kawano A, Kamihira T, Matsushita. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J. Autoimmun. 20: 255-263 (2003). *
Tannert A, Pohl A, Pomorski T, Herrmann A. Protein-mediated transbilayer movement of lipids in eukaryotes and prokaryotes: the relevance of ABC transporters. Int. J. Antimicrob. Agents 22: 177-187 (2003). *
Tantisirin O, Puavilai S. Long-term follow-up of erythema nodosum. J. Med. Assoc. Thai. 86: 1095-1100 (2003).
Tao TY, Liu F, Klomp L, Wijmenga C, Gitlin JD. The copper toxicosis gene product murr1 directly interacts with the Wilson disease protein. J. Biol. Chem. 278: 41593-41596 (2003). *
Tarasow E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J, Prokopowicz D. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Hepatogastroenterology 50: 2149-2153 (2003).
Tarkowski A, Collins LV, Jonsson IM, Eriksson K, Sakiniene E, Verdrengh M. Microbial superantigens as virulence factors and ways to counteract their actions. Scand. J. Infect. Dis. 35: 642-646 (2003).
Tauscher A, Kuver R. ABCG5 and ABCG8 are expressed in gallbladder epithelial cells. Biochem. Biophys. Res. Commun. 307: 1021-1028 (2003). *
Taylor PC. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr. Pharm. Des. 9: 1095-1106 (2003).
Taylor PC. Antibody therapy for rheumatoid arthritis. Curr. Opin. Pharmacol. 3: 323-328 (2003).
Tazi-Ahnini R, Cork MJ, Wengraf D, Wilson AG, Gawkrodger DJ, Birch MP, Messenger AG, McDonagh AJ. Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata. Hum. Genet. 112: 400-403 (2003). *
Teboul M, Delaunay F. The orphan nuclear receptor Rev-erb alpha is a major component of the circadian clock. Med. Sci. (Paris) 19: 411-413 (2003).
Teich N, Schulz HU, Witt H, Bohmig M, Keim V. N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer. Pancreatology 3: 67-68 (2003).
Tein I. Carnitine transport: pathophysiology and metabolism of known molecular defects. J. Inherit. Metab. Dis. 26: 147-169 (2003). *
Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, Vogelsang H, Reinisch W. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Am. J. Gastroenterol. 98: 2226-2231 (2003). *
Temple SE, Cheong KY, Almeida CM, Price P, Waterer GW. Polymorphisms in lymphotoxin alpha and CD14 genes influence TNFalpha production induced by Gram-positive and Gram-negative bacteria. Genes Immun. 4: 283-288 (2003). *
Teng S, Jekerle V, Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab. Dispos. 31: 1296-1299 (2003). *
Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin. Liver Dis. 7: 401-413 (2003).
ter Borg PC, van Buuren HR, Visser W. Intrahepatic cholestasis of pregnancy. Ned. Tijdschr. Geneeskd. 147: 1056-1059 (2003).
ter Borg PJC, van Buuren HR, van Berge Henegouwen GR. Extra-hepatic disorders in patients with primary biliary cirrhosis (PBC) Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 36. October 15-16 (2003). *
Terada R, Yamamoto K, Hakoda T, Shimada N, Okano N, Baba N, Ninomiya Y, Gershwin ME, Shiratori Y. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab. Invest. 83: 665-672 (2003). *
Terauchi M, Yanagawa T, Ishikawa N, Ito K, Fukazawa T, Maruyama H, Saruta T. Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population. J. Endocrinol. Invest. 26: 1208-1212 (2003).
Terracciano L. Autoimmune hepatitis: overlap syndromes. Pathologica 95: 252-253 (2003).
Terracciano LM. Immunohistochemical and molecular markers. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 49-50. October 17 - 19 (2003). *
Terres AM, Windle HJ, Ardini E, Kelleher DP. Soluble extracts from Helicobacter pylori induce dome formation in polarized intestinal epithelial monolayers in a laminin-dependent manner. Infect. Immun. 71: 4067-4078 (2003). *
Terry SF. Learning genetics. Health Aff. (Millwood) 22: 166-171 (2003). *
Teruel T, Hernandez R, Benito M, Lorenzo M. Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes. J. Biol. Chem. 278: 263-269 (2003). *
Tervaert JW, Heeringa P. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Neth. J. Med. 61: 404-407 (2003). *
Tessier E, Neirinck L, Zhu Z. High-performance liquid chromatographic mass spectrometric method for the determination of ursodeoxycholic acid and its glycine and taurine conjugates in human plasma. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 798: 295-302 (2003). *
Teymoortash A, Tiemann M, Schrader C, Werner JA. Chronic sclerosing sialadenitis of the submandibular gland is not just a severe chronic sialadenitis. Am. J. Otolaryngol. 24: 278 (2003).
Thakur S, Ranjan P, Ghoshal UC, Muller-Myhsok B, Khan F, Talwar S, Agarwal S. Association of human leucocyte DR and DQ antigens in Crohn's disease in Asian Indians: a family study. Trop. Gastroenterol. 24: 185-188 (2003).
Tham DM, Wang YX, Rutledge JC. Modulation of vascular inflammation by PPARs. Drug News Perspect. 16: 109-116 (2003).
Tham TC, Vandervoort J, Wong RC, Montes H, Roston AD, Slivka A, Ferrari AP, Lichtenstein DR, Van Dam J, Nawfel RD, Soetikno R, Carr-Locke DL. Safety of ERCP during pregnancy. Am. J. Gastroenterol. 98: 308-311 (2003). *
Theise ND. Hepatocytes from extrahepatic stem cells. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 34. October 20 - 21 (2003). *
Thevenot T, Mathurin P, Di Martino V, Nguyen-Khac E, Canva-Delcambre V, Campin G, Cortot A, Colombel JF, Paris JC. Celiac disease and liver involvement. Gastroenterol. Clin. Biol. 27: 28-42 (2003).
Thjodleifsson B, Sigthorsson G, Cariglia N, Reynisdottir I, Gudbjartsson DF, Kristjansson K, Meddings JB, Gudnason V, Wandall JH, Andersen LP, Sherwood R, Kjeld M, Oddsson E, Gudjonsson H, Bjarnason I. Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives? Gastroenterology 124: 1728-1737 (2003). *
Thng CH, Tan AG, Chung YF, Chow PK, Ooi LL. Clinical applications of MR cholangiopancreatography. Ann. Acad. Med. Singapore 32: 536-541 (2003).
Thodis E, Rossos P, Habal F, Oreopoulos D. Negative impact of Crohn's disease on bone mineral mass. J. Musculoskelet. Neuronal. Interact. 3: 246-250 (2003).
Thomas CW Jr, Lowry PW, Franklin CL, Weaver AL, Myhre GM, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ. Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Inflamm. Bowel Dis. 9: 237-245 (2003). *
Thomas G, Cann H. Irruption of genomics in the search for disease related genes. Gut 52 Suppl. 2: ii1-ii5 (2003). *
Thomas J, Bramlett KS, Montrose C, Foxworthy P, Eacho PI, McCann D, Cao G, Kiefer A, McCowan J, Yu KL, Grese T, Chin WW, Burris TP, Michael LF. A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha) versus liver X receptor. J. Biol. Chem. 278: 2403-2410 (2003). *
Thomas T, Thomas TJ. Polyamine metabolism and cancer. J. Cell. Mol. Med. 7: 113-126 (2003). *
Thompson DA, Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog. Retin. Eye Res. 22: 683-703 (2003).
Thompson DA, Gal A. Genetic defects in vitamin A metabolism of the retinal pigment epithelium. Dev. Ophthalmol. 37: 141-154 (2003).
Thompson JS, Iyer KR, DiBaise JK, Young RL, Brown CR, Langnas AN. Short bowel syndrome and Crohn's disease. J. Gastrointest. Surg. 7: 1069-1072 (2003).
Thompson RW, Valentine HL, Valentine WM. Cytotoxic mechanisms of hydrosulfide anion and cyanide anion in primary rat hepatocyte cultures. Toxicology 188: 149-159 (2003). *
Thorgeirsson SS, Grisham JW. Overview of recent experimental studies on liver stem cells. Semin. Liver Dis. 23: 303-312 (2003).
Thuluvath PJ. Should we change the selection criteria for liver transplantation in patients with hepatocellular carcinoma? 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl. 9: 527-532 (2003). *
Thuraisingam A, Leiper K. Medical management of ulcerative colitis. Hosp. Med. 64: 703-707 (2003).
Thuraisingam A, Leiper K. Medical management of Crohn's disease. Hosp. Med. 64: 713-718 (2003).
Thurlow PJ, Marshall AW. Extreme hypereosinophilia in sclerosing cholangitis. Intern. Med. J. 33: 134-136 (2003). *
Tian W, Boggs DA, Uko G, Essiet A, Inyama M, Banjoko B, Adewole T, Ding WZ, Mohseni M, Fritz R, Chen DF, Palmer LJ, Fraser PA. MICA, HLA-B haplotypic variation in five population groups of sub-Saharan African ancestry. Genes Immun. 4: 500-505 (2003). *
Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 78: 40-46 (2003). *
Tierney BC, Martin SW, Franzke LH, Marano N, Reissman DB, Louchart RD, Goff JA, Rosenstein NE, Sever JL, McNeil MM; Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax. Clin. Infect. Dis. 37: 905-911 (2003). *
Tietge UJ, Bahr MJ, Manns MP, Boker KH. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl. Int. 16: 1-8 (2003).
Tietz PS, Marinelli RA, Chen XM, Huang B, Cohn J, Kole J, McNiven MA, Alper S, LaRusso NF. Agonist-induced coordinated trafficking of functionally related transport proteins for water and ions in cholangiocytes. J. Biol. Chem. 278: 20413-20419 (2003). *
Tilg H, Vogelsang H, Ludwiczek O, Lochs H, Kaser A, Colombel JF, Ulmer H, Rutgeerts P, Kruger S, Cortot A, D'Haens G, Harrer M, Gasche C, Wrba F, Kuhn I, Reinisch W. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 52: 1728-1733 (2003). *
Tiliakos AN, Tiliakos NA. Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary? J. Rheumatol. 30: 2727 (2003).
Till JE. Success factors for open access. J. Med. Internet Res. 5: e1 (2003).
Timmer A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig. Dis. 21: 91-104 (2003).
Tirona RG, Leake BF, Wolkoff AW, Kim RB. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther. 304: 223-228 (2003). *
Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, Kim RB. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med. 9: 220-224 (2003). *
Tirosh O, Reifen R. High selenium diet protects against inflammatory bowel disease and restores mitochondrial colonic tissue function. Clin. Nutr. 22: S34 (2003). *
Titi S, Kosik-Warzynska R, Sycz K, Chosia M. Intestinal schistosomiasis - a case report. Pol. J. Pathol. 54: 283-285 (2003).
Tjandra K, Le T, Swain MG. Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis. Gut 52: 1363-1370 (2003). *
Tlaskalova-Hogenova H, Stepankova R, Powrie F, Tuckova L, Sokol D, Funda DP, Rossmann P, Cukrowska B, Hudcovic T, Kozakova H, Rehakova Z, Hrncir T, Drastich P, Smetana K, Frolova L. Mucosal immunity, intestinal microflora and inflammatory bowel disease (IBD). Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 53-54. September 12 - 13 (2003). *
Tobin DJ. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J. Investig. Dermatol. Symp. Proc. 8: 176-181 (2003). *
Togni V, Ota CC, Folador A, Junior OT, Aikawa J, Yamazaki RK, Freitas FA, Longo R, Martins EF, Calder PC, Curi R, Fernandes LC. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with n-3 polyunsaturated fatty acids for one generation. Nutr. Cancer 46: 52-58 (2003).
Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35: 341-348 (2003). *
Tokuno T, Takahashi H, Suzuki C, Yamamoto M, Naishiro Y, Sugaya A, Sakamoto H, Imai K. Analysis of B-cell clonality in the hepatic tissue of patients with Sjogren's syndrome. Scand. J. Rheumatol. 32: 268-272 (2003).
Tomatsu S, Orii KO, Fleming RE, Holden CC, Waheed A, Britton RS, Gutierrez MA, Velez-Castrillon S, Bacon BR, Sly WS. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc. Natl. Acad. Sci. U.S.A. 100: 15788-15793 (2003). *
Tomczak MF, Erdman SE, Poutahidis T, Rogers AB, Holcombe H, Plank B, Fox JG, Horwitz BH. NF-kappa B is required within the innate immune system to inhibit microflora-induced colitis and expression of IL-12 p40. J. Immunol. 171: 1484-1492 (2003). *
Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, Suchy FJ. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr. Res. 53: 288-294 (2003). *
Tomer G, Ceballos C, Concepcion E, Benkov KJ. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am. J. Gastroenterol. 98: 2479-2484 (2003). *
Tomer G, Shneider BL. Disorders of bile formation and biliary transport. Gastroenterol. Clin. North Am. 32: 839-855, vi (2003).
Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73: 736-747 (2003). *
Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev. 24: 694-717 (2003). *
Tomiyama S. Immuno-pathogenesis in Meniere's disease. J. Nippon Med. Sch. 70: 212-218 (2003).
Tonelli F, Paroli GM. Colorectal Crohn's disease: indications to surgical treatment. Ann. Ital. Chir. 74: 665-672 (2003).
Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17: 985-993 (2003). *
Torn C, Gupta M, Nikitina Zake L, Sanjeevi CB, Landin-Olsson M. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum. Immunol. 64: 902-909 (2003).
Torok HP, Glas J, Lohse P, Folwaczny C. Alterations of the CARD15/NOD2 gene and the impact on management and treatment of Crohn's disease patients. Dig. Dis. 21: 339-345 (2003).
Torres EA, De Jesus R, Perez CM, Inesta M, Torres D, Morell C, Just E. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P. R. Health Sci. J. 22: 253-258 (2003).
Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology 206: 17-23 (2003).
Tran TT. Liver transplantation: a clinical update. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Trauner M. When bile ducts say NO: the good, the bad, and the ugly. Gastroenterology 124: 847-851 (2003). *
Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 83: 633-671 (2003). *
Trauner M, Boyer JL. Cholestatic syndromes. Curr. Opin. Gastroenterol. 19: 216-231 (2003).
Trautwein C. Mechanism during liver regeneration. Falk Symposium 138. XII FALK LIVER WEEK 2003 (Part III) In Honour of Hans Popper’s 100th Birthday. State-of-the-art of hepatology: Molecular and Cell Biology. Freiburg (Germany). p. 20. October 20 - 21 (2003). *
Trebble T, Arden NK, Stroud MA, Wootton SA, Burdge GC, Miles EA, Ballinger AB, Thompson RL, Calder PC. Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br. J. Nutr. 90: 405-412 (2003). *
Trebble TM, Wootton SA, Miles EA, Mullee M, Arden NK, Ballinger AB, Stroud MA, Burdge GC, Calder PC. Prostaglandin E2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am. J. Clin. Nutr. 78: 376-382 (2003). *
Tremaine WJ. Gastroduodenal Crohn's disease: medical management. Inflamm. Bowel Dis. 9: 127-128 (2003). *
Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J. Immunol. 170: 5491-5501 (2003). *
Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254: 375-385 (2003). *
Triantafillidis JK, Gikas A, Apostolidiss N, Merikas E, Mallass E, Peros G. The low prevalence of Helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am. J. Gastroenterol. 98: 1213-1214 (2003). *
Triantafillidis JK, Tzourmakliotis D, Peros G, Merikas E, Barbatzas C, Cheracakis P, Gikas A, Konstandellou E. Serum gastrin levels in patients with inflammatory bowel disease. Hepatogastroenterology 50 Suppl. 2: cccxv-cccxvii (2003).
Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146 (2003). *
Trop S, Nagler A, Ilan Y. Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis. Inflamm. Bowel Dis. 9: 75-86 (2003). *
Trotter J, Wallack A, Steinberg T. Low incidence of cytomegalovirus disease in liver transplant recipients receiving sirolimus primary immunosuppression with 3-day corticosteroid taper. Transpl. Infect. Dis. 5: 174-180 (2003). *
Trotter JF. Sirolimus in liver transplantation. Transplant. Proc. 35 (3 Suppl.): 193S-200S (2003).
Trotter JF, Mackenzie S, Wachs M, Bak T, Steinberg T, Polsky P, Kam I, Everson GT. Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation. Transplantation 75: 473-476 (2003).
Trunecka P. Immunological mechanisms of liver allograft rejection. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 44-46. September 12 - 13 (2003). *
Tsang RS, Valdivieso-Garcia A. Pathogenesis of Guillain-Barre syndrome. Expert Rev. Anti. Infect. Ther. 1: 597-608 (2003).
Tsankov N, Angelova I. Rifampin in dermatology. Clin. Dermatol. 21: 50-55 (2003). *
Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell. Biol. 4: 95-104 (2003). *
Tseng TL, Shih YP, Huang YC, Wang CK, Chen PH, Chang JG, Yeh KT, Chen YM, Buetow KH. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res. 63: 647-654 (2003). *
Tsitsami E, Bozzola E, Magni-Manzoni S, Viola S, Pistorio A, Ruperto N, Martini A, Ravelli A. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. Arthritis Rheum. 49: 488-493 (2003). *
Tsou YK, Yeh CT. Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experience. Chang Gung Med. J. 26: 323-329 (2003).
Tsuboi K, Tazuma S, Ochi H, Chayama K. Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity. Hepatol. Res. 25: 38-47 (2003). *
Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, Tokunaga K, Hashimoto H. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J. Rheumatol. 30: 1534-1540 (2003).
Tsuji Y, Akiyama M, Arita K, Senshu T, Shimizu H. Changing pattern of deiminated proteins in developing human epidermis. J. Invest. Dermatol. 120: 817-822 (2003). *
Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Exp. Cell Res. 289: 143-151 (2003). *
Tsujie M, Nakamori S, Okami J, Takahashi Y, Hayashi N, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Int. J. Oncol. 23: 325-331 (2003).
Tsunada S, Iwakiri R, Ootani H, Aw TY, Fujimoto K. Redox imbalance in the colonic mucosa of ulcerative colitis. Scand. J. Gastroenterol. 38: 1002-1003 (2003). *
Tsune I, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Takei Y, Sato N. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology 125: 775-785 (2003). *
Tsunemi Y, Nishibu A, Saeki H, Oyama N, Nakamura K, Kishimoto M, Mitsui H, Tada Y, Torii H, Komine M, Asahina A, Kaneko F, Tamaki K. Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 207: 371-374 (2003).
Tsunemi Y, Saeki H, Kishimoto M, Mitsui H, Tada Y, Torii H, Komine M, Asahina A, Tamaki K, Sekiya T. Cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms in Japanese patients with psoriasis vulgaris. J. Dermatol. Sci. 32: 163-165 (2003).
Tsutsui H, Adachi K, Seki E, Nakanishi K. Cytokine-induced inflammatory liver injuries. Curr. Mol. Med. 3: 545-559 (2003).
Tsutsumi A, Ikegami H, Takahashi R, Murata H, Goto D, Matsumoto I, Fujisawa T, Sumida T. Mannose binding lectin gene polymorphism in patients with type I diabetes. Hum. Immunol. 64: 621-624 (2003).
Tucker ON, Healy V, Jeffers M, Keane FB. Granulomatous appendicitis. Surgeon 1: 286-289 (2003).
Tuncer I, Harman M, Mercan R, Ozturk M, Arslan I, Meral C, Turkdogan MK. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones. Turk. J. Gastroenterol. 14: 91-96 (2003). *
Tung SY, Wu CS. Clinical outcome of endoscopically removed early colorectal cancer. J. Gastroenterol. Hepatol. 18: 1175-1179 (2003). *
Tuo BG, Isenberg JI. Effect of 5-hydroxytryptamine on duodenal mucosal bicarbonate secretion in mice. Gastroenterology 125: 805-814 (2003). *
Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov. Today 8: 692-700 (2003).
Turic D, Robinson L, Duke M, Morris DW, Webb V, Hamshere M, Milham C, Hopkin E, Pound K, Fernando S, Grierson A, Easton M, Williams N, Van Den Bree M, Chowdhury R, Gruen J, Stevenson J, Krawczak M, Owen MJ, O'Donovan MC, Williams J. Linkage disequilibrium mapping provides further evidence of a gene for reading disability on chromosome 6p21.3-22. Mol. Psychiatry 8: 176-185 (2003). *
Turkcapar N, Bayar S, Koyuncu A, Ceyhan K. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice. Hepatogastroenterology 50: 680-683 (2003).
Turnage RH, Sarosi G, Cryer B, Spechler S, Peterson W, Feldman M. Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations. A systematic review. J. Gastrointest. Surg. 7: 606-626 (2003).
Turner MW. The role of mannose-binding lectin in health and disease. Mol. Immunol. 40: 423-429 (2003). *
Turner N, Else PL, Hulbert AJ. Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. Naturwissenschaften 90: 521-523 (2003).
Turpeinen H, Laine AP, Hermann R, Simell O, Veijola R, Knip M, Ilonen J. A linkage analysis of the CTLA4 gene region in Finnish patients with type 1 diabetes. Eur. J. Immunogenet. 30: 289-293 (2003). *
Turrini F, Giribaldi G, Carta F, Mannu F, Arese P. Mechanisms of band 3 oxidation and clustering in the phagocytosis of Plasmodium falciparum-infected erythrocytes. Redox Rep. 8: 300-303 (2003).
Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann. Epidemiol. 13: 419-423 (2003).
Twells RC, Mein CA, Payne F, Veijola R, Gilbey M, Bright M, Timms A, Nakagawa Y, Snook H, Nutland S, Rance HE, Carr P, Dudbridge F, Cordell HJ, Cooper J, Tuomilehto-Wolf E, Tuomilehto J, Phillips M, Metzker M, Hess JF, Todd JA. Linkage and association mapping of the LRP5 locus on chromosome 11q13 in type 1 diabetes. Hum. Genet. 113: 99-105 (2003). *
Twilt M, Swart van den Berg M, van Meurs JC, ten Cate R, van Suijlekom-Smit LW. Persisting uveitis antedating psoriasis in two boys. Eur. J. Pediatr. 162: 607-609 (2003). *
Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z. Itch: scratching more than the surface. QJM 96: 7-26 (2003). *
Tyndall A, Matucci-Cerinic M. Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders. Expert Opin. Biol. Ther. 3: 1041-1049 (2003).
Tzameli I, Chua SS, Cheskis B, Moore DD. Complex effects of rexinoids on ligand dependent activation or inhibition of the xenobiotic receptor, CAR. Nucl. Recept. 1: 2 (2003). *
Uchida N, Ezaki T, Fukuma H, Tsutsui K, Kobara H, Matsuoka M, Masaki T, Watanabe S, Yoshida M, Maeta T, Koi F, Nakatsu T, Kuriyama S. Concomitant colitis associated with primary sclerosing cholangitis. J. Gastroenterol. 38: 482-487 (2003). *
Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, Herr MH, Dahlman I, Payne F, Smyth D, Lowe C, Twells RC, Howlett S, Healy B, Nutland S, Rance HE, Everett V, Smink LJ, Lam AC et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511 (2003). *
Ueda M, Nakamura T, Tohyama T, Kushihata F, Honda Y, Kobayashi N. Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis. J. Hepatobiliary Pancreat. Surg. 10: 245-249 (2003). *
Ugele B, Gebhardt R. Heterogeneity of rat liver parenchyma in taurocholate uptake. Hepatol. Res. 27: 238-247 (2003).
Uhlig HH, Powrie F. Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses. J. Clin. Invest. 112: 648-651 (2003). *
Ulbrich H, Eriksson EE, Lindbom L. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol. Sci. 24: 640-647 (2003). *
Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum. 48: 3542-3543 (2003). *
Ullman T. Hold the bone: good news for young women with IBD. Inflamm. Bowel Dis. 9: 396-397 (2003). *
Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125: 1311-1319 (2003). *
Ullman TA. Patients with low-grade dysplasia should be advised to undergo colectomy. Inflamm. Bowel Dis. 9: 267-269 (2003). *
Ullman TA, Croog V, Maratchi L, Jaffe D, Itzkowitz SH. Ursodeoxycholic acid for chemoprevention in ulcerative colitis and primary sclerosing cholangitis: a retrospective cohort study. Am. J. Gastroenterol. 98: S258 (2003). *
Ulrich D, Hrynyschyn K, Pallua N. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease. Plast. Reconstr. Surg. 112: 1279-1286 (2003).
Ulukaya S, Arikan C, Aydogdu S, Ayanoglu HO, Tokat Y. Immediate tracheal extubation of pediatric liver transplant recipients in the operating room. Pediatr. Transplant. 7: 381-384 (2003).
Ulvestad E. Modelling autoimmune rheumatic disease: a likelihood rationale. Scand. J. Immunol. 58: 106-111 (2003). *
Um JY, Kim HM. Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population. Hereditas 139: 184-188 (2003). *
Umar A, Viner JL, Anderson WF, Hawk ET. Development of COX inhibitors in cancer prevention and therapy. Am. J. Clin. Oncol. 26: S48-S57 (2003).
Underhill DM. Toll-like receptors: networking for success. Eur. J. Immunol. 33: 1767-1775 (2003). *
Uno Y, Sakamoto Y, Yoshida K, Hasegawa T, Hasegawa Y, Koshino T, Inoue I. Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter. J. Hum. Genet. 48: 594-597 (2003). *
Uraushihara K, Kanai T, Ko K, Totsuka T, Makita S, Iiyama R, Nakamura T, Watanabe M. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J. Immunol. 171: 708-716 (2003). *
Urbanek P. Immunological aspects of alcoholic liver disease. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 32-35. September 12 - 13 (2003). *
Uren TK, Johansen FE, Wijburg OL, Koentgen F, Brandtzaeg P, Strugnell RA. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170: 2531-2539 (2003). *
Urganci N, Akyildiz B, Yildirmak Y, Ozbay G. A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection. Turk. J. Gastroenterol. 14: 204-207 (2003). *
Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 189: 41-54 (2003). *
Ushiyama A, Tanaka K, Aiba Y, Shiba T, Takagi A, Mine T, Koga Y. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection. J. Gastroenterol. Hepatol. 18: 986-991 (2003). *
Ustun S, Dagci H, Aksoy U, Guruz Y, Ersoz G. Prevalence of amebiasis in inflammatory bowel disease in Turkey. World J. Gastroenterol. 9: 1834-1835 (2003). *
Vader LW, Stepniak DT, Bunnik EM, Kooy YM, de Haan W, Drijfhout JW, Van Veelen PA, Koning F. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 125: 1105-1113 (2003). *
Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenij L, Koning F. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc. Natl. Acad. Sci. U.S.A. 100: 12390-12395 (2003). *
Vaidya B, Oakes EJ, Imrie H, Dickinson AJ, Perros P, Kendall-Taylor P, Pearce SH. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Clin. Endocrinol. (Oxf.) 58: 732-735 (2003). *
Vainer B, Lamberth K, Brimnes J, Nielsen OH, Claesson MH. Ca2+ response in neutrophils after exposure to bacterial N-formyl-methionyl-leucyl-phenylalanine: delayed response in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 15: 267-273 (2003).
Vainer B, Nielsen OH. Correlation between circulating soluble ICAM-1 and prednisolone-induced amelioration of ulcerative colitis. Scand. J. Gastroenterol. 38: 283-287 (2003). *
Vainer B, Sorensen S, Seidelin J, Nielsen OH, Horn T. Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models. Virchows Arch. 443: 774-781 (2003). *
Vainio H, Miller AB. Primary and secondary prevention in colorectal cancer. Acta Oncol. 42: 809-815 (2003).
Vaiphei K, Gupta N, Sinha SK, Nagi B, Singh K. Association of ulcerative colitis with pulmonary sarcoidosis, subcutaneous lipomatosis and appendiceal adenocarcinoma. Indian J. Gastroenterol. 22: 193-194 (2003).
Valderrama Rojas M, Rodriguez Gorostiza FJ, Alvarez-Sala Walther LA, Torres Segovia FJ, Millan Nunez-Cortes J. Autoimmune hemolytic anemia: a rare complication of ulcerative colitis. An. Med. Interna 20: 78-80 (2003).
Valdes AM, Noble JA, Genin E, Clerget-Darpoux F, Erlich HA, Thomson G. Modeling of HLA class II susceptibility to type I diabetes reveals an effect associated with DPB1. Genet. Epidemiol. 21: 212-223 (2003).
Valentine JF. A map to the diagnosis of Crohn's disease. Inflamm. Bowel Dis. 9: 133-134 (2003). *
Valentino KL, Gutierrez M, Sanchez R, Winship MJ, Shapiro DA. First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. Int. J. Clin. Pharmacol. Ther. 41: 441-449 (2003).
Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjogren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann. Rheum. Dis. 62: 875-879 (2003). *
Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, Arts J, D'Hoore A, Penninckx F, Rutgeerts P. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125: 1025-1031 (2003). *
Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am. J. Gastroenterol. 98: 332-339 (2003). *
Van Belzen MJ, Meijer JW, Sandkuijl LA, Bardoel AF, Mulder CJ, Pearson PL, Houwen RH, Wijmenga C. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 125: 1032-1041 (2003). *
Van Biervliet S, Eggermont E, Marien P, Hoffman I, Veereman G. Combined impact of mucosal damage and of cystic fibrosis on the small intestinal brush border enzyme activities. Acta Clin. Belg. 58: 220-224 (2003).
van Bodegraven AA. Haemostasis in inflammatory bowel diseases: clinical relevance. Scand. J. Gastroenterol. Suppl. 239: 51-62 (2003). *
Van Bodegraven AA, Pena AS. Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 201-212 (2003).
van Brummelen SE, Venneman NG, van Erpecum KJ, VanBerge-Henegouwen GP. Acute idiopathic pancreatitis: does it really exist or is it a myth? Scand. J. Gastroenterol. Suppl. 239: 117-122 (2003). *
van Buuren HR. Ursodeoxycholic acid: high-dose, mono- or combination therapy? Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 83. October 15-16 (2003). *
Van De Merwe JP, Yamada T, Sakamoto Y. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int. J. Urol. 10 Suppl. 1: S35-S38 (2003).
van de Vosse E, Lichtenauer-Kaligis EG, van Dissel JT, Ottenhoff TH. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 54: 817-829 (2003). *
van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur. J. Gastroenterol. Hepatol. 15: 657-663 (2003).
Van Den Bogaert E, Francque S, Pelckmans P, Michielsen P. The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense. Acta Gastroenterol. Belg. 66: 283-287 (2003).
Van den Brande JM, Braat H, van den Brink GR, Versteeg HH, Bauer CA, Hoedemaeker I, van Montfrans C, Hommes DW, Peppelenbosch MP, van Deventer SJ. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124: 1774-1785 (2003). *
van Denderen JC, van der Horst-Bruinsma I, Bezemer PD, Dijkmans BA. Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis. J. Rheumatol. 30: 1558-1560 (2003).
van der Kleij D, Yazdanbakhsh M. Control of inflammatory diseases by pathogens: lipids and the immune system. Eur. J. Immunol. 33: 2953-2963 (2003). *
van der Linde K, Boor PP, Houwing-Duistermaat JJ, Kuipers EJ, Wilson JH, de Rooij FW. Card15 and Crohn's disease: healthy homozygous carriers of the 3020insC frameshift mutation. Am. J. Gastroenterol. 98: 613-617 (2003). *
van der Linde K, Boor PP, Sandkuijl LA, Meijssen MA, Savelkoul HF, Wilson JH, de Rooij FW. A Gly15Arg mutation in the interleukin-10 gene reduces secretion of interleukin-10 in Crohn disease. Scand. J. Gastroenterol. 38: 611-617 (2003). *
van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, Pena AS, van der Horst-Bruinsma IE. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun. 4: 77-78 (2003). *
van der Pol WL, Jansen MD, Kuks JB, de Baets M, Leppers-van de Straat FG, Wokke JH, van de Winkel JG, van den Berg LH. Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients. J. Neuroimmunol. 144: 143-147 (2003).
van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun. 4: 187-196 (2003). *
van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 48: 2132-2145 (2003). *
van der Werf N, Hillebrands JL, Klatter FA, Bos I, Bruggeman CA, Rozing J. Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin. Dev. Immunol. 10: 153-160 (2003). *
van Deventer SJ. New biological therapies in inflammatory bowel disease. Best Pract. Res. Clin. Gastroenterol. 17: 119-130 (2003). *
Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82: 82-90 (2003). *
van Eden W, Koets A, van Kooten P, Prakken B, van der Zee R. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 21: 897-901 (2003). *
Van Gelder RN, Sancar A. Cryptochromes and inner retinal non-visual irradiance detection. Novartis Found. Symp. 253: 31-42 (2003).
van Gossum A, Roland S, Vermeire S, Quertinmont E, Gustot T, Gervy C, Deviere J, Franchimont D. Impact of infliximab on weight regulation and lipid metabolism: immuno-neutralization of TNF-alpha induced leptinemia in Crohn's disease. Clin. Nutr. 22: S51 (2003). *
van Heel DA, Dechairo BM, Dawson G, McGovern DP, Negoro K, Carey AH, Cardon LR, Mackay I, Jewell DP, Lench NJ. The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. Hum. Mol. Genet. 12: 2569-2575 (2003). *
van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3: 697-709 (2003).
Van Laar JM, Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control 10: 57-65 (2003). *
van Lier RA, ten Berge IJ, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. Nat. Rev. Immunol. 3: 931-939 (2003). *
van Loon S, Bart A, den Hertog EJ, Nikkels PG, Houwen RH, De Schryver JE, Oudshoorn JH. Helicobacter heilmannii gastritis caused by cat to child transmission. J. Pediatr. Gastroenterol. Nutr. 36: 407-409 (2003). *
van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. Drug uptake systems in liver and kidney. Curr. Drug Metab. 4: 185-211 (2003).
van Odijk J, Kull I, Borres MP, Brandtzaeg P, Edberg U, Hanson LA, Host A, Kuitunen M, Olsen SF, Skerfving S, Sundell J, Wille S. Breastfeeding and allergic disease: a multidisciplinary review of the literature (1966-2001) on the mode of early feeding in infancy and its impact on later atopic manifestations. Allergy 58: 833-843 (2003). *
van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 62: 113-119 (2003). *
van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 125: 1591-1597 (2003). *
Van Thiel DH, George M, Brems J, Holt D, Zhu Q, Edelstein S, Amiral J, Tarasuk G, Leone N. Antiphospholipid antibodies before and after liver transplantation. Am. J. Gastroenterol. 98: 460-465 (2003). *
van Tilburg JH, Sandkuijl LA, Franke L, Strengman E, Pearson PL, van Haeften TW, Wijmenga C. Genome-wide screen in obese pedigrees with type 2 diabetes mellitus from a defined Dutch population. Eur. J. Clin. Invest. 33: 1070-1074 (2003). *
van Tilburg JH, Sandkuijl LA, Strengman E, van Someren H, Rigters-Aris CA, Pearson PL, van Haeften TW, Wijmenga C. A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel loci on 2q12 and 19q13. J. Clin. Endocrinol. Metab. 88: 2223-2230 (2003). *
van Tuyl SA, Stolk MF, Timmer R. Clinical application of video capsule endoscopy. Scand. J. Gastroenterol. Suppl. 239: 24-28 (2003). *
van Veen T, Crusius JB, van Winsen L, Xia B, Barkhof F, Salvador Pena A, Polman CH, Uitdehaag BM. CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis. J. Neuroimmunol. 140: 188-193 (2003).
Van Vollenhoven RF, Ernestam S, Harju A, Bratt J, Klareskog L. Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious. Arthritis Res. Ther. 5: R347-R351 (2003). *
Vandemergel X, Blocklet D, Decaux G. Possible association between deep infection and hypertrophic osteoarthropathy. Report of three cases and review of the literature. Acta Clin. Belg. 58: 290-295 (2003).
Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G. A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv. Exp. Med. Biol. 544: 181-196 (2003).
Vanden Heuvel JP, Kreder D, Belda B, Hannon DB, Nugent CA, Burns KA, Taylor MJ. Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643. Toxicol. Appl. Pharmacol. 188: 185-198 (2003). *
Vandenbroeck K, Cunningham S, Goris A, Alloza I, Heggarty S, Graham C, Bell A, Rooney M. Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis. Arthritis Rheum. 48: 2773-2778 (2003). *
Vanderhoof JA, Young RJ, Hanner TL, Kettlehut B. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease. J. Pediatr. Gastroenterol. Nutr. 36: 293-294 (2003). *
Vanis N, Gribajcevic M. Enteral and parenteral nutrition in gastroenterology. Med. Arh. 57 (1 Suppl. 2): 93-94 (2003).
Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann. Hepatol. 2: 12-22 (2003). *
Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin. Liver Dis. 23: 259-269 (2003).
Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, Lee WM, Blei AT. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125: 755-764 (2003). *
Vardareli E, Dundar E, Angin K, Saricam T, Inal M. Effects of intrarectal and intraperitoneal N(G)-nitro-L-arginine methyl ester treatment in 2,4,6-trinitrobenzenesulfonic acid induced colitis in rats. Exp. Toxicol. Pathol. 55: 271-276 (2003).
Varderili E, Saricam T, Aslan V, Gulbas Z. Resolution of immune thrombocytopenic purpura after colectomy for ulcerative colitis. Turk. J. Gastroenterol. 14: 270-272 (2003). *
Varona R, Cadenas V, Flores J, Martinez-A C, Marquez G. CCR6 has a non-redundant role in the development of inflammatory bowel disease. Eur. J. Immunol. 33: 2937-2946 (2003). *
Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J. Am. Coll. Surg. 197: 765-769 (2003). *
Vasilescu A, Heath SC, Ivanova R, Hendel H, Do H, Mazoyer A, Khadivpour E, Goutalier FX, Khalili K, Rappaport J, Lathrop GM, Matsuda F, Zagury JF. Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun. 4: 441-449 (2003). *
Vasiliauskas E. Recent advances in the diagnosis and classification of inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 493-500 (2003).
Vassilopoulos D, Niles JL, Villa-Forte A, Arroliga AC, Sullivan EJ, Merkel PA, Hoffman GS. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum. 49: 151-155 (2003). *
Vasu C, Gorla SR, Prabhakar BS, Holterman MJ. Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int. Immunol. 15: 641-654 (2003). *
Vatay A, Bene L, Kovacs A, Prohaszka Z, Szalai C, Romics L, Fekete B, Karadi I, Fust G. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 55: 247-252 (2003). *
Vatn MH. The CARD15 gene mutation in Crohn disease. Scand. J. Gastroenterol. 38: 1105-1106 (2003). *
Vauthey JN, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest? J. Hepatol. 38: 237-239 (2003). *
Vecchi M, Saibeni S, Devani M, Rondonotti E, De Franchis R. Review article: diagnosis, monitoring and treatment of distal colitis. Aliment. Pharmacol. Ther. 17 Suppl. 2: 2-6 (2003). *
Veeramachaneni NK, Lin L, Pippin JA, Winslow ER, Drebin JA. Doxycycline and indomethacin synergistically downregulate beta-catenin signaling and inhibit colon cancer cell growth. J. Surg. Res. 114: 251-252 (2003).
Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin. Drug Saf. 2: 287-304 (2003).
Venkatraman A, Ramakrishna BS, Shaji RV, Kumar NS, Pulimood A, Patra S. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G177-G184 (2003). *
Vennarecci G, Ettorre GM, Boschetto A, Carboni F, Lepiane P, Lonardo MT, Santoro R, Santoro E. Liver transplantation in primary and secondary tumors of the liver. Review of the literature and perspectives. Chir. Ital. 55: 797-810 (2003).
Venneman NG, Van Brummelen SE, Van Berge-Henegouwen GP, Van Erpecum KJ. Microlithiasis: an important cause of 'idiopathic' acute pancreatitis? Ann. Hepatol. 2: 30-35 (2003). *
Venter H, Shilling RA, Velamakanni S, Balakrishnan L, Van Veen HW. An ABC transporter with a secondary-active multidrug translocator domain. Nature 426: 866-870 (2003). *
Venuprasad K, Chattopadhyay S, Saha B. CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response. Hum. Immunol. 64: 38-43 (2003).
Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer AD, Buckels JA, McMaster P, Neuberger J, Mirza DF. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 75: 1983-1988 (2003).